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1 Summary	
1.1 General	
The	 application	 of	 theoretical	 concepts	 in	 chemistry	 has	 wittnessed	 a	 remarkable	
evolution	due	to	the	development	of	efficient	and	powerful	computers	and	software.	
The	support	of	experimental	results	by	theoretical	predictions	is	the	current	field	of	
work	of	numerous	chemists	worldwide,	especially	if	highly	reactive	intermediates,	e.g.	
open‐shell	 systems	 with	 one	 or	 more	 unpaired	 electrons,	 are	 involved.	 A	 central	
question	hereby	is	their	thermodynamic	stability,	particularly	for	biological	systems,	
where	 accurate	 values	 and	 structural	 information	 are	 not	 easily	 accessible.	 The	
enthalpy	change	H	of	a	molecular	transformation	is	an	easily	computable	value	and	a	
universal	descriptor	for	the	outcome	of	a	reaction.	The	stability	of	C‐centered	radicals	
can	conveniently	be	defined	using	the	 isodesmic	hydrogen	atom	transfer	of	Scheme	
1.1.	 In	 literature	 the	 reaction	 enthalpy	 of	 this	 process	 is	 referred	 to	 radical	
stabilization	energy	(RSE)	of	radical	R3C•	compared	to	its	parent	methyl	radical	H3C•.	
Simple	 reaction	 equation	 analysis	 reveals	 that	 the	 bond	 strength	 of	 R3C‐H	 (bond	
dissociation	energy,	BDE)	 is	exactly	 the	sum	of	 the	theoretically	calclulated	RSE	and	
the	CH‐BDE	of	methane.	
R3C H +     H3C
rxnH
= RSE
R3C + H3C H
BDE (R3C-H) = RSE + BDE (H3C-H, exp.) 	
Scheme	1.1	General	definition	of	radical	stability	and	calculation	of	bond	dissociation	energies.	
1.2 Transfer	Hydrogenation	as	a	Redox	Process	in	Nucleotides	
The	fidelity	of	biological	information	storage	is	tightly	linked	to	the	chemical	stability	
of	DNA	 and	RNA	oligonucleotides.	 As	 a	 possible	 threat	 reduction	 of	 the	 pyrimidine	
and	 purine	 bases	 as	 a	 result	 of	 transfer	 hydrogenation	 from	 the	 sugar‐phosphate‐
backbone	 (as	 a	 free	 hydroxyl	 group	 is	 present	 in	 C2’	 position	 of	 RNA)	 have	 been	
1.2	Transfer	Hydrogenation	as	a	Redox	Process	in	Nucleotides		
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studied	herein.	Using	a	combined	theoretical	and	experimental	strategy	the	heats	of	
hydrogenation	of	the	different	bases	have	been	determined.		
HH
H H
H
H
+
HH
H H
+
2-29a 2-12a
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N
R trhHO
R
N
N
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R
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Scheme	1.2	Reaction	scheme	to	calculate	heats	of	hydrogenation	hydH	of	various	substrates.	
The	 best	 agreement	 of	 theory	 and	 experiment	 for	hydH	 has	 been	 obtained	 for	 the	
reaction	involving	transfer	hydrogenation	of	ethane	(2‐29a)	and	ethylene	(2‐12a)	at	
G3B3	level	of	theory	in	addition	to	the	experimental	heat	of	hydrogenation	of	ethylene	
(hydH(2‐12a,	exp.)	=	‐136.3	kJ	mol‐1).	
The	most	easily	hydrogenated	base	
is	 uracil	 (2‐32a),	 followed	 by	
thymine	 (2‐32b)	 and	 cytosine	
(2‐76).	 Comparison	 of	 these	
hydrogenation	 enthalpies	 with	
those	 of	 ketones	 and	 aldehydes	
derived	 from	 sugar	 models	
indicates	 the	 possibility	 of	 near	
thermoneutral	 hydrogen	 transfer	
between	 uracil	 (2‐32a)	 and	 the	
sugar	 phosphate	 backbone	 (see	
Figure	 1.1).	 Regardless	 of	 the	
position,	 the	 hydrogenation	 of	
purine‐derived	 bases	 is	 always	
endothermic.	 Upon	 coupling	 base	
and	sugar	to	complete	nucleosides,	
the	 driving	 force	 for	 the	 intramolecular	 transfer	 hydrogenation	 of	 uridine	 (2‐99)	 is	
decreased	due	 to	omission	of	 stabilizing	hydrogen	bonds	upon	oxidation	 to	yield	2‐
100a.	
hydH
(kJ mol-1)
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Figure	1.1	Heats	of	hydrogenation	hydH	at	298.15	K	of		
selected	nucleobases	and	carbonyl	compounds	(G3B3	are
shown	as	black,	experimental	hydrogenation	enthalpies		
as	red	lines.	
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Figure	1.2	Intramolecular	transfer	hydrogenation	of	uridine	(2‐99)	at	G3(MP2)‐RAD	level	in	kJ	mol‐1.	
Undoubtedly,	 the	 kinetic	 barrier	 for	 direct	 hydrogen	 transfer	 is	 very	 high,	 but	 the	
residues	 present	 in	 enzyme	 active	 sites	 may	 be	 effective	 in	 catalyzing	 a	 stepwise	
mechanism.	All	analytical	methods	used	for	this	purpose,	mostly	mass	spectrometry,	
would	not	be	able	to	predict	the	correct	structure	of	this	reaction.	
1.3 Enhanced	Redox	Properties	in	Open‐shell	Nucleotides	–	A	
Theoretical	Survey	
The	potential	of	biologically	inspired	open‐shell	intermediates	to	act	as	reductants	in	
transfer	hydrogenation	 reactions	 to	alkenes	has	been	 investigated	 theoretically.	The	
radical‐induced	 changes	 in	 dihydrogen	 transfer	 energetics	 are	 likely	 to	 impact	 the	
chemistry	 of	 nucleotide	 and	 peptide‐derived	 radicals.	 This	 may	 be	 particularly	
relevant	for	cases	where	oxidations	of	nucleotide	radicals	have	been	observed	under	
reducing	conditions.	A	prominent	example	is	the	outcome	of	the	substrate	reaction	of	
the	 E441Q	mutant	 of	E.	 coli	 class	 I	 ribonucleotide	 reductase	 (RNR).	 The	 possibility	
that	 the	 base	 present	 in	 e.g.	 radical	3‐11R	 can	 act	 as	 internal	 redox	 partner	 to	 the	
adjacent	C3’‐ribosyl	radical,	 thus	generating	product	radical	3‐14R	 (and	not	3‐13R)	
through	 a	 transfer	 hydrogenation	 process	 has	 been	 examined	 theoretically.	 Mass	
spectrometry	as	the	major	tool	for	the	analysis	of	oligonucleotides	gives	for	this	type	
of	reaction	no	meaningful	conclusion	and	a	dihydro	cytosine	motif	has	presumably	no	
significant	influence	on	the	EPR	parameters.	
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Scheme	1.3	Substrate	reaction	of	class	I	RNR	E441Q	mutant.	
The	results	fully	support	the	strongly	reductive	nature	of	these	species,	if	the	oxidized	
product	 is	 a	 captodatively	 stabilized	 radical.	 As	 revealed	 through	 comparison	 to	
hydrogenation	energies	for	individual	nucleotide	bases	and	also	seen	in	the	reaction	
energies	 for	 intramolecular	 transfer	hydrogenation,	 the	strongly	 reductive	nature	of	
ribosyl	 radicals	 implies	 that	 pyrimidine	 bases	 can	 be	 reduced	 in	 an	 exothermic	
fashion	(see	Figure	1.3).	
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Figure	1.3	Boltzmann‐averaged	transfer	hydrogenation	enthalpy	scale	<trhH>	for	C‐centered	peptide	
radicals	(G3(MP2)‐RAD,	in	kJ	mol‐1)	compared	to	selected	carbonyl	and	sugar	radicals.	
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The	reaction	energies	for	inter‐	and	intramolecular	transfer	hydrogenation	presented	
herein	 permit	 no	 statement	 on	 the	 pathways	 how	 such	 a	 process	 may	 occur.	
Nevertheless,	some	speculations	on	possible	pathways	can	be	made:		
1.)	 Reactions	 involving	 open‐shell	
intermediates	 at	 the	 nucleotide	 base.	 This	
may	be	accompanied	with	either	initial	single	
hydrogen	 atom	 or	 proton‐coupled	 electron	
transfer	to	the	uracil	C6	position,	followed	by	
a	second	H•	 transfer	 to	yield	product	radical	
3‐48Ra.	 2.)	 An	 ionic	 pathway,	 where	 the	
unpaired	 spin	 never	 leaves	 the	 ribose	 unit.	
This	 may	 involve,	 for	 example,	 initial	
protonation	 of	 the	 pyrimidine	 C4	 carbonyl	
oxygen,	followed	by	hydride	transfer	between	
the	 ribose	 C2’	 and	 the	 uracil	 C6	 position.	
After	 deprotonation	 and	 tautomerization	 of	
radical	 cation	 3‐63Rb	 the	 captodatively	
stabilized	product	3‐48Ra	is	formed.	
	
	
1.4 Calculation	of	Chemical	Properties	of	Allenic	Zinc	Compounds	
In	 collaboration	with	 the	 group	 of	 Prof.	 Paul	Knochel,	 the	 formation	 of	 allenic	 zinc	
compounds	has	been	studied	spectroscopically	and	supported	 theoretically	by	NMR	
shift	 calculations	 and	 thermochemical	 analysis.	 The	 zinc	 base	TMPZnCl•LiCl	 (4‐14)	
has	been	used	to	synthesize	neutral	allenic	zinc	intermediates	from	benzylic	propynes	
which	 can	 be	 quenched	 by	 the	 addition	 of	 various	 electrophiles.	 The	 analogous	
zincates	 have	 been	 prepared	 by	 transmetallation	 of	 the	 corresponding	 Li	 organyls	
with	ZnCl2	in	THF.	
O
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O
O
HO
H
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~ H (a) (b) + H
O
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O
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3-62R
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O
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H
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~ H
O
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Scheme	1.4	Possible	pathways	for	stepwise		
hydrogen	transfer	reactions	using	C3’	radical
	3‐52R	as	example.	
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THF-d8, 25 °C
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Scheme	1.5	Syntheses	of	allenic	zinc	compounds	of	proposed	structure	4‐15	and	4‐17.	
Different	basis	sets,	functionals	and	solvation	states	have	been	benchmarked	with	the	
well‐known	Reformatsky	reagent	4‐9.	B3LYP/631SVP	geometries	in	combination	with	
GIAO/mPW1K/IGLO‐III	calculations	in	the	gas	phase	are	sufficient	enough	to	perform	
well	in	calculating	1H	and	13C	NMR	shifts	of	organozinc	reagents	in	THF	solution.	
	
The	
reaction	
outcome	
of	 neutral	 and	 anionic	 zinc	
allenes	 as	 well	 as	 for	 the	
corresponding	 organolithium	
isomers	 were	 successfully	
predicted	 by	 thermochemical	
analysis	 of	 propargyl‐allenyl	
isomerization	 at	 MP2	 level	 of	
theory	(Figure	1.4).	Metalation	
of	propynes	with	n‐BuLi	yielded	
only	 propargylic	
organometalics,	whereas	zincation	or	transmetalation	with	the	aid	of	ZnCl2	afforded	
only	allenic	products.	The	preferred	location	of	metalation	of	various	substrates	has	
been	examined	in	terms	of	their	pKa	values.	Since	the	experimental	determination	of	
Zn
O
O
Br OEt
O
4-9
0
 5
-5
-10
(+0.9)
+1.4
-7.8
(-8.6) -8.2
(-12.4)
Li
THF THF
THF
Zn
THF Cl
THF
Zn
Cl Cl
THF
H
MP2
(kJ/mol)
TMS
H
TMS
X
X
H
	
Figure	1.4	Propargyl	to	allenyl	isomerization	in	THF	solution
(SMD/B3LYP/6‐31G(d))	at	MP2(FC)/6‐31+G(d,p)	level	(gas	
phase	values	in	parenthesis).	
	 1		Summary	
	 11	
acidities	 or	 basicities	 of	 organic	 and	 inorganic	 compounds	 is	 rather	 challenging,	 a	
computational	method	that	predicts	protonation	patterns	in	terms	of	pKa	values	in	a	
fast	and	reliable	way	would	be	of	general	use.	The	B3LYP/6‐311++G(2df,2p)	level	of	
theory	in	combination	with	SMD/B3LYP/6‐31G(d)	free	solvation	energies	and	DMSO	
(4‐24H,	 pKa	 =	 +35.1)	 has	 been	 identified	 as	 a	 good	 compromise	 between	 accuracy	
and	computational	effort	(see	Scheme	1.6).	
R-H       +
G0gas
G0sol
G0(R-H)solv G
0(DMSO-)solv G
0(R-)solv G0(DMSO-H)solv
R         +
R-H       + R         +
S
O
H
H
S
O
H
H
S
O
H
H
H
S
O
H
H
H
4-24H4-24
	
Scheme	1.6	Thermochemical	cycle	for	the	calculation	of	pKa	values	in	solution.	
CN
CO2Et
S
CO2Et
CN
Cl
Cl
TMS TMSSTMSTMS
28.0
32.2
32.4
35.2
37.9
35.7
38.0
35.7
31.3
37.3
15.5 19.4 22.4
34.3
38.3.1
33.7
42.1
42.9
43.2
4-35 4-36 4-37
4-38 4-13a 4-13b 	
Figure	 1.5	 SMD/B3LYP/6‐31G(d)//B3LYP/6‐311++G(2df,2p)	 calculated	 pKa	 values	 using	 DMSO	 as	
reference	for	various	substrates	(corrected	to	THF	solution).	
1.5 The	Chemical	Fate	of	Paroxetine	Metabolites	
The	accumulation	of	pharmaceutically	active	compounds	in	waste	or	drinking	water	
is	of	growing	importance	for	world’s	population.	With	respect	to	environmental	risk	
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assessment	 a	 prominent	 example	 for	 these	 pharmaceuticals	 is	 the	 selective	
serotonine	reuptake	inhibitor	paroxetine	(5‐7).		
Quantum	 chemical	 calculations	 have	 been	 used	 to	
evaluate	the	chemical	properties	and	possible	reaction	
channels	 of	 open‐shell	 piperidine	 5‐12R+,	 which	 is	
considered	 to	 be	 the	 key	 intermediate	 in	 the	
environmental	 (photo)degradation	 of	 paroxetine	 (5‐7).	 This	 includes,	 for	 example,	
bond	 dissociation	 processes,	 hydrogen	 atom	 transfer	 reactions	 and	 radical‐induced	
dehydrations,	which	 should	not	 exceed	 an	experimentally	determined	barrier	 of	ca.	
+100	kJ	mol‐1.		
Considering	 the	
hydrogen	 atom	
transfer,	 the	 [1,4]‐H	
shift	 is	 the	 most	
favorable	pathway	 if	
a	 cluster	 continuum	
model	with	water	as	
solvent	 and	 reagent	
is	 included.	 In	 the	
gas	 phase	 without	
explicit	solvation	the	formation	of	‐hydroxy	radical	5‐18R	is	preferred.	The	unpaired	
spin	at	the	nitrogen	atom	has	a	significant	 impact	on	the	bond	strength	of	the	‐CH	
bond,	 which	 is	 decreased	 dramatically	 and	 opens	 a	 dehydration	 pathway	 never	
considered	before	with	iminium	radical	5‐22R	as	intermediate.		
HN
FOO
O
5-7 	
N
Ar
HO
H
N
Ar
HO
H5-12 5-12R+e
h
H2N
Ar
HO
5-17R
HN
ArG  < 100 kJ mol
-1
5-22RH2O
H2N
ArG  > 100 kJ mol
-1
5-28RH2O
~ [1,4]-H~ [1,7]-H
H2N
Ar
HO
5-18R
Scheme	1.7	Exemplary	reaction	pathways	of	the	hydrolysis	product	4‐12		
of	paroxetine	(5‐7)	upon	photolysis	(Ar	=	p‐F‐C6H5).	
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Table	1.1	Theoretically	calculated	bond	dissociation	energies	 (G3(MP2)‐RAD	 level)	 in	 the	gas	phase	
for	various	piperidines.	
	 N
H
H
5-14 	
NH
5-14R
N
H
H
5-14R+
N
H
5-14 	
N
H
5-12
Ar
HO
	
N
Cl
5-12Cl
Ar
HO
BDE		
(kJ	mol‐1)	
+390.5	 +95.1	 +75.2	 +403.4 +401.7	 +247.2
	
In	addition,	the	stability	of	a	range	of	proposed	dehydrated	product	radicals	has	been	
evaluated	to	support	the	existence	of	proposed	reaction	products.	
	
	
	
	
	
Figure	 1.6	 Comparison	 of	 barriers,	 reaction	 free	 energies	 for	 hydrogen	 atom	 transfer	 reactions	
(black),	 dehydrations	 (red)	 and	 cyclizations	 (blue)	 and	 radical	 stabilization	 energies	 obtained	 at	
G3(MP2)‐RAD	level	of	theory.	
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2 Transfer	Hydrogenation	as	a	Redox	Process	in	
Nucleotides	
Parts	of	this	chapter	have	been	published	in	
Transfer	Hydrogenation	as	a	Redox	Process	in	Nucleotides	
F.	Achrainer,	V.	N.	Emel’yanenko,	W.	Tantawy,	S.	P.	Verevkin,	H.	Zipse,	J.	Phys.	Chem.	B	
2014,	118,	10426	–	10429.	
2.1 Introduction	
Desoxyribonucleic	acid	(DNA)	is	by	far	the	most	valuable	molecule	found	in	nature.	It	
conserves	the	genetic	code	in	form	of	chemical	information,	which	finally	is	translated	
in	a	two‐step	process	into	proteins.[1]	A	complementary	role	is	played	by	ribonucleic	
acid	(RNA),	which	contains	the	information	of	genomic	DNA	after	the	transcription	as	
messenger	RNA	(mRNA).	This	process	is	followed	by	the	translation	of	the	mRNA	by	
the	ribosome	using	its	ribosomal	RNA	(rRNA)	and	with	amino	acid	charged	transfer	
RNA	 (tRNA)	 to	 form	 polypeptides.	 Genomic	 DNA	 is	 a	 polymer	 consisting	 of	 four	
different	 nucleobases	 connected	 to	 2’‐deoxribose‐3’,5’‐phosphate	 backbone,	 the	 two	
purines	 adenine	 (dA,	2‐1)	 and	 guanine	 (dG,	2‐2)	 and	 the	 two	pyrimidines	 thymine	
(dT,	 2‐3)	 and	 cytosine	 (dC,	 2‐4).	 The	 three‐dimensional	 structure	 of	 DNA	 was	
revealed	by	James	Watson	and	Francis	Crick	in	the	early	50ies	of	the	last	century	and	
represents	 a	 double	 helix	 consisting	 of	 two	 complementary	 strands	 connected	 by	
hydrogen	bonds	and	further	stabilized	by	‐	base	stacking.[2]	
Adenosine (dA, 2-1) Thymidine (dT, 2-3) Guanosine (dG, 2-2) Cytidine (dC, 2-4)
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Figure	2.1	Watson‐Crick	base	pairing	of	the	complementary	nucleotides	in	DNA.	
On	the	other	hand,	RNA	is	only	intended	to	be	a	short‐lived	intermediate,	capable	of	
hydrolytic	strand	cleavage	due	to	the	free	C2’	OH	group	(Scheme	2.1).		
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Scheme	2.1	RNA	hydrolysis	in	aqueous	solution.	
In	 ribosomes	 RNA	 participates	 in	 the	 catalytic	 formation	 of	 peptide	 bonds.[3]	More	
than	100	post‐transcriptional	RNA	modifications	have	been	discovered	till	today	with	
the	largest	amount	and	diversity	present	in	tRNA.		
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D (2-5)  (2-6) Um (2-7) m3U (2-8) 	
Figure	2.2	Selected	uridine‐derived	RNA	modifications	marked	in	red	color.	
A	 very	 prominent	 example	 of	 RNA	 modification	 is	 dihydrouridine	 (D,	 2‐5),	 which	
exhibits	 a	 strong	 conformational	 flexibility	 due	 to	 its	 missing	 base	 planarity.[4]	 It	
promotes	C2’‐endo	conformation	formation	of	the	sugar	moiety	thus	mainly	found	at	
positions	 where	 tertiary	 interactions	 and	 loop‐formation	 are	 necessary.[5]	 As	
exemplified	by	dihydrouridine	 (2‐5)	 the	degree	of	 saturation	has	 a	 large	 impact	 on	
base‐pairing	 and	 the	 conformational	 degree	 of	 freedom	 and	 can	 lead	 to	 point	
mutations	at	the	wrong	position.	Mutagens	can	cause	molecular	changes	to	the	DNA	
that	can	affect	their	transcription	or	replication	which	in	severe	case	can	also	lead	to	
cell	 death	 or	 serious	 diseases.	 In	 aqueous	 solution	 spontaneous	 deamination	 of	
cytitidine	(2‐4),	the	so	called	Pucherer	reaction,	results	in	the	formation	of	ammonia	
and	uridine	(U,	2‐9)	which	represents	a	very	potent	transition	mutation.	In	DNA,	this	
unwanted	nucleotide	is	corrected	by	the	enzyme	uracil‐DNA	glycolase	generating	an	
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abasic	 site	 (AP).	 These	 abasic	 sites	 are	 finally	 repaired	 by	 the	 DNA	 base	 excision	
repair	 (BER)	 pathway	 involving	 AP	 endonucleases.[6]	 A	 very	mutagenic	 chemical	 is	
nitrous	acid	HNO2,	which	can	potentially	be	generated	from	a	mixture	of	NaCl,	NaNO2	
and	NaNO3	added	as	a	preservative	to	numerous	meat	products.[7]	Nitrous	acid	reacts	
with	 the	 free	amino‐group	to	 form	unstable	diazonium	ions,	which	hydrolyze	 to	 the	
deaminated	products	(see	Scheme	2.2).	This	hydrolytic	deamination	is	even	faster	for	
dihydrocytosines	as	examined	theoretically	by	Labet	and	coworkers.[8]		
Herein,	 we	 are	 studying	 the	 thermodynamics	 of	 CC‐hydrogenation	 of	 biological‐
relevant	nucleobases	as	potential	threat	for	mutations	in	combination	with	oxidations	
of	the	sugar‐backbone.	This	follows	the	large	differences	in	hydrogenation	enthalpies	
of	molecular	systems	containing	C‐C	and	C‐O	double	bonds.	
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Scheme	 2.2	 Nitrous	 acid‐induced	 hydrolytic	 deamination	 of	 cytidine	 (2‐4)	 and	 adenosine	 (2‐1)	
forming	post‐replicative	transition	mutations.	
2.2 Evaluation	of	Methods	for	the	Determination	of	Heats	of	
Hydrogenation	
Heats	 of	 hydrogenation	 of	 alkenes	 are	 historically	 important	 in	 defining	 essential	
chemical	 concepts	 like	conjugation,	 aromaticity,[9]	 anti‐aromaticity[10]	 and	molecular	
strain.[11]	 However,	 the	 determination	 of	 enthalpy	 values	 for	 potentially	 interesting	
substrates	 sometimes	 cannot	 be	 carried	 out	 due	 to	 their	 instability	 or	 difficult	
syntheses.	 Therefore,	 the	 field	 of	 theoretical	 chemistry	 has	 provided	 a	 number	 of	
valuable	methods	to	predict	accurate	thermochemical	data	with	kcal	mol‐1	accuracy.	
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The	 “Gaussian‐n”	 (Gn)	 theories,	 and	 especially	 G3,[12]	 were	 the	 first	 methods	 to	
produce	enthalpies	of	chemical	accuracy,	but	relied	on	relatively	small	basis	sets	and	
empirical	 corrections.	 Petersson	 introduced	 his	 complete	 basis	 set	 (CBS)	 methods	
implementing	 similar	 concepts,	 but	 included	 pair	 correlation	 extrapolations	 to	 the	
corrections.[13]	 Today,	 the	main	 focus	 of	 theoretical	 chemists	 is	 on	merging	 relative	
computational	 effort	 with	 accuracy.	 The	 Weizmann‐n	 (Wn)	 theories,	 developed	 by	
Martin,	 represent	 probably	 the	 most	 valuable	 method	 for	 benchmarking	
thermochemical	 properties,[14]	 but	 are	 only	 applicable	 for	 very	 small	 or	 highly	
symmetric	 systems.	 Since	 the	 number	 of	 valence	 electrons	 of	 the	 examined	
nucleotides	exceed	 the	usage	of	Weizmann	and	CBS	 theory	 the	performance	of	 four	
different	 approaches,	 including	 DFT,	MP2	 and	 Gaussian	 theory,	 have	 been	 analyzed	
with	a	test	set	of	23	alkenes	and	arenes	and	5	carbonyl	compounds	(see	Theoretical	
Appendix).	Results	for	the	direct	hydrogenation	with	molecular	hydrogen	(2‐11)	are	
summarized	in	Table	2.1	and	Table	2.2.	The	corresponding	experimental	values	can	
either	be	obtained	from	actual	measurements	for	the	hydrogenation	reaction	(hydH)	
or	from	heats	of	formation	of	all	participating	reactants/products	(rxnH).	The	largest	
difference	between	these	two	data	sets	of	5	kJ	mol‐1	can	be	seen	for	cylohexanone	(2‐
16).	Calculations	with	the	G3B3	compound	method	reproduce	the	experimental	hydH	
and	 rxnH	 values	 with	 RMSD	 values	 of	 2.3	kJ	 mol‐1	 and	 2.8	 kJ	 mol‐1,	 respectively	
(Figure	2.3).	Deviations	are	slightly	 larger	 for	 the	G3(MP2)‐RAD	composite	method	
and	 significantly	 larger	 for	 the	 much	 more	 economical	 MP2(FC)/6‐311+G(3df,2p)	
method.	 Deviations	 are	 largest	 for	 the	 hydrogenation	 onf	 benzene	 (2‐14)	 to	
cyclohexane,	when	only	the	G3B3	method	yields	satisfactory	results.	
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Table	2.1	 Calculated	 hydrogenation	 enthalpies	hydH	 of	 some	 selected	 alkenes	 in	 the	 gas	 phase	 (at	
298.15	K	and	1	atm)	and	experimental	values	in	kJ	mol‐1.	
R R'
CR2
H2     +
hydH
R R'
R2C
H
H2-11 	
	
hydH	 rxnH	
MP2(FC)/	
6‐311+G(3df,2p)	
G3(MP2)‐RAD G3B3	 hydH(exp.)	 rxnH(exp.)[15]
H
H
H
H
2-12a 	
‐140.04	 ‐127.31	 ‐133.76
‐136.31	
±	0.21[9]	
‐136.4	
H3C
H
H
H
2-12b 	
‐127.66	 ‐116.54	 ‐122.70
‐124.98	
±	0.21[16]	
‐123.8	
H3C
H
CH3
CH3
2-12c 	
‐114.37	 ‐105.43	 ‐110.79
‐111.63	
±	0.25[17]	
‐111.9	
2-13a 	
‐120.75	 ‐110.31	 ‐116.52
‐118.83	
±	0.42[18]	
‐118.4	
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Table	 2.2	 Calculated	 hydrogenation	 enthalpies	 hydH	 of	 some	 selected	 alkenes	 and	 carbonyl	
compounds	in	the	gas	phase	(at	298.15	K	and	1	atm)	and	experimental	values	in	kJ	mol‐1.	
R R'
X
H2     +
hydH
R R'
X
H
H2-11
X = CR2, O X = CR2, O 	
	 hydH	 rxnH	
	
MP2(FC)/	
6‐311+G(3df,2p)
G3(MP2)‐RAD G3B3	 hydH(exp.)	 rxnH(exp.)[15]
2-13b
H3C
	
‐114.77	 ‐105.53	 ‐110.96
‐111.40	
±	0.37[19]	
‐111.4	
2-14 	
‐186.12	 ‐183.67	 ‐201.04
‐205.27	
±	0.63[9]	
‐206.3	
2-15 	
‐98.59	 ‐93.34	 ‐99.51	
‐98.9	
±	0.63[20]	
‐103.2	
O
2-16 	
‐108.09	 ‐98.82	 ‐104.51
‐109.20	
±	2.9[21]	
‐104.2	
COOH
CH3
2-17
	
‐120.47	 ‐110.62	 ‐116.26
‐118.0	
±	1.3[22]	
‐117.3	
OH3C
H 2-18 	
‐65.23	 ‐62.91	 ‐66.47	
‐69.08	
±	0.42[23]	
‐68.6	
OH3C
CH32-19 	
‐52.40	 ‐50.85	 ‐54.04	
‐55.60	
±	0.42[24]	
‐55.5	
O
2-20 	
‐58.74	 ‐57.31	 ‐60.14	
‐63.51	
±	0.63[23]	
‐60.1	
O
2-21 	
‐47.45	 ‐45.13	 ‐47.92	
‐51.25	
±	0.63[23]	
‐50.4	
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From	 a	 chemical	 point	 of	 view	 it	 is	 important	 to	 note	 that	 hydrogenation	 of	 C‐O	
double	bond	is	significantly	less	exothermic	than	that	of	C‐C	double	bonds.		
	
	
Figure	2.3	Evaluation	of	methods	using	experimentally	available	enthalpies	 in	the	gas	phase	(or	gas	
phase	corrected	of	the	corresponding	liquid	or	solid	substrate).	
R R'
X
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R R'
X
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Aside	 from	 using	 molecular	 hydrogen	 as	 the	 reducing	 agent,	 alternative	 reduction	
reactions	employ	hydrogen	donors	such	as	propan‐2‐ol	(2‐22),	formic	acid	(2‐23),[25]	
Hantzsch’s	ester	2‐24[26],	or	thiazoline	2‐25[27]	(Figure	2.4).		
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Figure	2.4	Selected	organic	hydrogen	donors	and	transition	metal	catalysts.	
Since	transfer	hydrogenations	are	equilibrium	reactions,	 the	formation	of	volatile	or	
stabilized	 byproducts	 like	 acetone,	 carbon	 dioxide	 or	 pyridine	 represents,	 together	
with	different	bond	energies	for	C‐O	and	C‐C	bonds,	the	main	driving	force.[28]		
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Scheme	2.3	Transfer	hydrogenation	of	ethylene	(2‐12a)	using	propan‐2‐ol	(2‐22).	
Fujita	 et	al.	 recently	 reported	 an	 iridium‐based	 catalyst	 system	 (2‐30)	 for	 the	mild	
reversible	dehydrogenative	oxidation	of	alcohols	even	in	water.[29]	
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Scheme	 2.4	 Dehydrogenative	 oxidation	 of	 alcohols	 using	 the	 water‐soluble	 Ir(III)	 catalyst	 2‐30	
developed	by	Fujita	and	coworkers.[29]	
The	energetics	of	 transfer	hydrogenation	 reactions	 can	be	 calculated	with	 the	 same	
theoretical	medthods	used	before.	The	accuracy	in	these	calculations	is	expected	to	be	
higher	 as	 compared	 to	 that	 for	 direct	 hydrogenation	 reactions	 simply	 because	 the	
bonding	 situation	 in	 reactants	 and	 products	 is	 quite	 comparable.	 Using	 ethane	 (2‐
29a)	 as	 hydrogen	 donor	 a	 very	 good	 correlation	 of	 calculated	 vs.	 experimentally	
available	 values	 is	 found	 for	 alkenes	 (Table	 2.3)	 and	 carbonyl	 compounds	 (Table	
2.4).	
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Table	2.3	 Calculated	 transfer	hydrogenation	 enthalpies	trhH	 of	 some	 selected	 alkenes	 (at	298.15	K	
and	1	atm)	and	experimental	values	in	kJ	mol‐1.	
R' R''
CR2
+
trhH
R' R''
R2C
H
H
+
HH
H H
2-12a
H H
HH
H
H
2-29a 	
	 trhH	
MP2(FC)/	
6‐311+G(3df,2p)
G3(MP2)‐RAD G3B3	 trhH(g,	exp.)[15]
H3C
H
H
H
2-12b 	
+12.39	 +10.77	 +11.06 +12.6	
H3C
H
CH3
CH3
2-12c 	
+25.68	 +23.29	 +22.97 +24.5	
2-13a 	
+19.29	 +16.99	 +17.24 +18.0	
2-13b
H3C
	
+25.27	 +21.77	 +22.80 +25.0	
2-15 	
+41.45	 +33.97	 +34.25 +33.2	
O
2-16 	
+31.96	 +28.49	 +29.25 +32.2	
COOH
CH3
2-17
	
‐19.58	 +16.68	 +17.50 +19.1	
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Table	2.4	 Calculated	 transfer	hydrogenation	enthalpies	trhH	 of	 some	 selected	 carbonyl	 compounds	
(at	298.15	K	and	1	atm)	and	experimental	values	in	kJ	mol‐1.	
R R'
O
R R'
O
H
H
+
trhH
+
HH
H H
2-12a
H H
HH
H
H
2-29a 	
	 trhH	
	
MP2(FC)/	
6‐311+G(3df,2p)
G3(MP2)‐RAD G3B3	 trhH(g,	exp.)[15]	
OH3C
H 2-18 	
+75.65	 +65.05	 +67.88 +67.8	
OH3C
CH32-19 	
+87.64	 +76.45	 +79.73 +80.9	
O
2-20 	
+81.31	 +69.99	 +73.62 +76.3	
O
2-21 	
+92.59	 +82.18	 +85.85 +86.0	
	
By	addition	of	the	experimental	heats	of	hydrogenation	for	ethylene	(2‐12a,	hydH	=	
‐136.3	 kJ	 mol‐1)[9]	 to	 the	 heat	 of	 transfer	 hydrogenation	 trhH	 the	 newly	 corrected	
hydH*	 is	 obtained,	 representing	 the	 best	 correlation	 at	 G3B3	 level	 of	 theory	 (see	
Figure	2.5	and	Table	2.5).	The	R2	and	RMSE	values	and	the	slope	of	the	regression	
line	are	similar	for	direct	and	transfer	hydrogenation,	but	the	intercept	as	a	mark	for	
the	 accuracy	 is	 closer	 to	 the	 origin.	 Therefore,	 for	 all	 following	 thermodynamical	
considerations	this	approach	in	combination	with	the	G3B3	values	is	used:	
	
hydH*	(G3B3)	=	trhH	(G3B3)	+	hydH	(2‐12a,	exp.)	 	 (eq.	2.1)	
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Figure	2.5	Correlation	of	direct	vs.	transfer	hydrogenation	at	G3B3	level	of	theory	in	the	gas	phase.	
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Table	 2.5	 Calculated	 corrected	 hydrogenation	 enthalpies	 hydH*	 of	 some	 selected	 alkenes	 and	
carbonyls	(at	298.15	K	and	1	atm)	and	experimental	values	in	kJ	mol‐1.	
	
MP2(FC)/	
6‐311+G(3df,2p
G3(MP2)‐RAD G3B3	 hydH(g,	exp.)	
H3C
H
H
H
2-12b 	
‐123.91	 ‐125.53	 ‐125.24
‐124.98	
±	0.21[16]	
H3C
H
CH3
CH3
2-12c 	
‐110.62	 ‐113.01	 ‐113.33
‐111.63	
±	0.25[9]	
2-13a 	
‐117.01	 ‐119.31	 ‐119.06
‐118.83	
±	0.42[18]	
2-13b
H3C
	
‐111.03	 ‐114.53	 ‐113.50
‐111.40	
±	0.37[19]	
O
2-16 	
‐104.34	 ‐107.81	 ‐107.05
‐109.20	
±	2.9[21]	
COOH
CH3
2-17
	
‐116.72	 ‐119.62	 ‐118.80
‐118.00	
±	1.3[22]	
OH3C
H 2-18 	
‐60.65	 ‐71.25	 ‐68.42	
‐69.08	
±	0.42[23]	
OH3C
CH32-19 	
‐48.66	 ‐59.85	 ‐56.57	
‐55.60	
±	0.42[24]	
O
2-20 	
‐54.99	 ‐66.31	 ‐62.68	
‐63.51	
±	0.63[23]	
O
2-21 	
‐43.71	 ‐54.12	 ‐50.45	
‐51.25	
±	0.63[23]	
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2.3 Synthesis	of	Substrates	for	Calorimetric	Measurements	
2.3.1 Determination	of	Thermochemical	Values	
In	order	to	match	the	theoretically	calculated	values	for	the	heats	of	formation	(fH)	
and	heats	of	hydrogenation	(hydH)	of	nucleobases	and	nucleotides	with	experimental	
values,	 a	 series	 of	 model	 compounds	 has	 been	 synthesized	 and	 their	 respective	
thermochemical	 values	 have	 been	 measured.	 In	 contrast	 to	 measure	 the	 heats	 of	
hydrogenation	hydH	the	indirect	approach	using	fH	does	not	require	the	use	of	any	
hydrogenation	catalyst	and,	more	importantly,	allows	an	accurate	characterization	of	
the	 reaction	 products.	 The	 experimental	 determination	 of	 the	 molar	 enthalpy	 of	
formation	 fH	 in	 the	 gas	 phase	 is	 quite	 sensitive	 to	 experimental	 inaccuracies	 or	
substrate	 impurities.	 Therefore,	 great	 attention	 was	 paid	 to	 the	 synthesis	 and	
purification	of	 the	 investigated	 compounds.	 The	 thermochemical	 target	 value	 is	 the	
standard	 enthalpy	 of	 formation	 in	 the	 gaseous	 state,	 which	 for	 liquid	 substrates	 is	
defined	as:	
	
fH0(g)	=	fH0(l)	+	vapH0	 	 	 	 (eq.	2.2)	
	
or	for	solids	
	
fH0(g)	=	fH0(s)	+	subH0	 	 	 	 (eq.	2.3)	
	
Three	 principle	 methods	 are	 used	 and	 combined	 to	 measure	 standard	 heats	 of	
formation	fH0	in	the	liquid	or	solid	state:	1.)	determination	of	the	heat	of	combustion	
in	a	bomb	calorimeter;	2.)	calorimetric	measurement	of	reaction	enthalpies;	and	3.)	
identification	of	equilibrium	constants,	where	 the	 thermochemical	properties	of	 the	
involved	species	are	well‐known.	Nevertheless,	the	interpretation	of	enthalpies	in	the	
condensed	 phase	 is	 connected	 to	 complications,	 caused	 by	 intermolecular	
interactions	present	in	all	matter.	More	reliable	are	values	for	the	gas	phase	in	which	
ideal	 behavior	 of	 molecules	 is	 expected.	 Enthalpies	 of	 vaporization	 vapH	 or	
sublimation	subH	are	defined	as	the	amount	of	energy	needed	to	convert	condensed	
to	gaseous	phase.	A	well‐established	procedure	to	obtain	vapH	from	the	temperature	
dependence	of	the	vapor	pressure	is	the	transpiration	method.[30]	
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Figure	2.6	Schematical	setup	for	the	determination	of	vapH	via	transpiration	method.[31]	
A	schematic	overview	of	the	apparatus	is	shown	in	Figure	2.6.	The	desired	values	are	
obtained	by	measuring	the	transference	in	a	saturated	inert	gas	stream	applying	the	
Clausius‐Clapeyron	 equation.	Therefore,	 the	preheated	 carrier	 gas	 is	passed	 through	
the	U‐tube	with	different	flow	rates	to	ensure	that	the	gas	is	in	equilibrium	with	the	
coexisting	 liquid	 phase	 at	 each	 temperature	 of	 the	 study.	 The	 saturated	 vapor	
pressure	pisat	at	each	temperature	T	is	calculated	from	the	amount	of	product	found	in	
the	 condensate	 collector	 within	 a	 definite	 period	 of	 time.	 Assuming	 the	 validity	 of	
Dalton’s	law	of	partial	pressures	and	the	ideal	gas	law,	pisat	can	be	calculated	through:	
	
pisat	=	mi	R	T	/	V	Mi	;	 	 V	=	VTG	+	Vi	 	 	 (eq.	2.4)	
	
where	mi	 is	 the	mass	 of	 the	 transported	 compound,	Mi	 is	 its	molar	mass	 and	Vi	 its	
volume	 contribution	 to	 the	 gaseous	 phase.	 The	 volume	 of	 transporting	 gas	 VTG	 is	
determined	from	the	flow	rate	and	time	measurements.	The	following	equation	
	
R	ln	pisat	=	a	+	b/T	+	sgCp	ln	(T/T0)	 	 	 (eq.	2.5)	
	
is	fitted	to	the	experimental	p	and	T	data	using	a	and	b	as	adjustable	parameters.		
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Herein,	sgCp	represents	the	difference	of	molar	heat	capacities	of	the	gaseous	and	the	
solid	phase	and	finally,	the	enthalpy	of	sublimation	at	a	defined	temperature	T	can	be	
derived	according	the	Clausius‐Clapeyron	equation:	
	
subH(T)	=	‐b	+	sgCp	T	 	 	 	 (eq.	2.6)	
2.3.2 Modified	Uracil	and	Thymine	Models	
For	 the	 correct	 numerical	 assignment	 of	 thermodynamic	 properties	 of	 chemical	
compounds	 a	 large	 quantity	 of	 substance	 is	 needed	 in	 high	 purity.	 Attempts	 to	
synthesize	 the	 required	 amounts	 of	 nucleosides	 of	 type	 2‐31a	 or	 2‐31b	 were	 not	
successful	 due	 to	 low‐yielding	 reaction	 steps	 and	 purification	 problems.	 Therefore,	
methyl	 derivatives	 of	 pyrimidine	 bases	 were	 considered	 as	 promising	 synthetic	
targets,	 since	 the	 dihydro	 derivatives	 of	 uracil	 (2‐32a)	 and	 thymine	 (2‐32b)	 are	
commercially	available.		
O
OH
HO N
O
OHOH
O N
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Figure	2.7	Proposed	targets	for	the	synthesis	of	pyrimidine	models.	
The	synthesis	of	nucleosides	involves	the	coupling	of	a	nucleophilic	heterocyclic	base	
and	an	electrophilic	sugar	part.	The	simple	alkylation	of	pyrimdinones	is	not	specific	
in	 terms	 of	 regioselectivity	 and	 multiple	 substitution.	 A	 common	 and	 widely	 used	
method	to	introduce	pyrimidine‐derived	bases,	 like	uracil	or	thymine,	 is	the	Hilbert‐
Johnson	 reaction[32]	 and	 the	 improved	 silyl	 variant	 also	 known	 as	 Vorbrüggen	
procedure.[33]	 The	 advantage	 of	 the	 latter	 is,	 asides	 from	 higher	 yields	 and	milder	
reaction	 conditions,	 the	 application	 of	 easily	 available	 acylated	 sugars,	 which	 are	
more	stable	 than	halo	sugars	and	preserve	 the	 requested	diastereoselectivity	of	 the	
anomeric	center	(see	Scheme	2.5).		
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Scheme	2.5	Examples	for	the	Hilbert‐Johnson	reaction	(top)	and	its	silyl	variant	(bottom).	
The	first	Vorbrüggen	synthesis	of	1‐methyl	uracil	(2‐39a)	was	achieved	by	Micklitz	et	
al.	 using	 a	 mixture	 of	 uracil	 (2‐32a),	 TMSCl,	 hexamethyldisilazane	 (TMS)2NH	 and	
methyl	 iodide.[34]	 However,	 regarding	 the	 expenses	 of	 the	 used	 reagents	 and	 the	
moisture	sensitivity	of	TMS‐protected	pyrimidinones	it	turned	out,	that	this	method	is	
not	beneficial	for	the	large‐scale	synthesis	of	1‐methyl	pyrimidines.		
N
H
NH
O
O
1.) TMSCl, (TMS)2NH, MeI, RT
2.) H2O, NaHCO3
2-32a
N
NH
O
O
2-39aCH3 	
Scheme	2.6	Synthesis	of	1‐methyl	uracil	(2‐39a)	according	to	Micklitz.[34]	
Another	literature‐known	way	to	introduce	a	methyl	group	is	the	reductive	cleavage	
of	 carbamate	 protecting	 groups	 by	 complex	 aluminium	 hydrides.[35]	 Regioselective	
tert‐butoxycarbonyl	 (Boc)	protected	uracil	 (2‐40)	was	prepared	by	DMAP‐catalyzed	
carbamoylation	 with	 Boc2O	 at	 room	 temperature	 in	 42	 %	 yield.[36]	 The	 correct	
regioselectivity	was	proven	by	crystal	structure	determination	(see	Scheme	2.7).	
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Scheme	2.7	Regioselective	carbamoylation	of	uracil	(2‐32a)	and	failed	reductive	cleavage	of	the	Boc	
group.	
Unfortunately,	 all	 attempts	 to	 reduce	 the	 Boc	 group	 to	 a	methyl	moiety	 failed.	 The	
methyl	 group	was	 finally	 introduced	 using	 the	Hilbert‐Johnson	 reaction	 of	 electron‐
rich	 pyrimidines	 (see	Scheme	2.8).[37]	 The	methoxy‐substituted	 pyrimidines	2‐42a	
and	2‐42b	were	available	from	the	natural	bases	uracil	(2‐32a)	and	thymine	(2‐32b)	
via	chlorination[38]	and	subsequent	nucleophilic	aromatic	substitution.	
N
H
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O
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N
N
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
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2-41b (X = CH3, 65 %)
2-42a (X = H, quant.)
2-42b (X = CH3, 73 %)
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Scheme	2.8	Hilbert‐Johnson	reaction	to	give	1‐methyl	pyrimidines.	
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Microwave	 heating	 under	 closed‐vessel	 conditions	 led	 to	 improved	 yields	 for	 the	
substititution	 reaction	 and	 at	 least	 a	 2‐fold	 reduction	 of	 reaction	 time	 compared	 to	
conventional	heating.	Transformation	to	the	methyl	pyrimidinium	salt	was	smoothly	
accomplished	over	night	characterized	by	the	formation	of	yellowish	crystals,	which	
give	the	related	4‐methoxy	pyrimidones	2‐43a	and	2‐43b	 in	good	yields	on	heating.	
The	 last	 step	 involved	 simple	 ether	 cleavage	by	 acidic	 hydrolysis.	 The	 two	nitrogen	
centers	in	pyrimidine	2‐44b	possess	different	Lewis	basicity	and	react	preferably	at	
N1‐position,	 as	 indicated	 by	 the	 high	 methyl	 cation	 affinity	 (MCA)[39]	 of	
+552.4	kJ	mol‐1,	in	contrast	to	+497.3	kJ	mol‐1	for	N3	(Scheme	2.9).	Suitable	crystals	
for	 X‐ray	 analysis	 were	 obtained	 by	 the	 reaction	 of	 methyliodide	 with	 diethoxy	
pyrimidine	2‐44b	at	0	°C,	thus	confirming	the	theoretically	MCA	calculated	values.[40]		
N
N
OEt
OEt
H3C      +
N
N
OEt
OEt
CH3
N
N
OEt
OEt
CH3 MCA =
+497.3
MCA =
+552.4
2-45a 2-44b
2-45b 	
Scheme	 2.9	 Methyl	 cation	 affinities	 obtained	 at	 MP2(FC)/6‐31+G(2d,p)//B98/6‐31G(d)	 level	
(Boltzmann‐averaged,	in	kJ	mol‐1).	
The	 dihydro	 compounds	 of	 1‐methyl	 uracil	 (2‐39a)	 or	 thymine	 (2‐39b)	 were	
synthesized	 in	 quantitative	 yield	 by	 simple	 low‐pressure	 hydrogenation	 over	
heterogenous	transition	metals	in	absolute	ethanol.	
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Scheme	2.10	Synthesis	of	1‐methyl	dihydropyrimidines	2‐46a	and	2‐46b.	
Since	the	largest	effort	and	also	the	largest	errors	are	connected	to	the	determination	
of	 the	 heats	 of	 sublimation	subH,	 minimization	 of	 the	 latter	 is	 highly	 desirable.	 In	
order	to	break	the	strong	three‐dimensional	framework	in	the	solid,	the	N‐methylated	
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derivatives	 of	 thymine	 und	 uracil	 together	 with	 their	 dihydro	 isomers	 have	 been	
synthesized.	 N,N’‐dimethyl	 pyrimidines	 are	 simply	 prepared	 by	 nucleophilic	
substitution	 in	 basic	media	with	 excess	 dimethyl	 sulfate	 (CH3O)2SO2	 as	methylating	
agent.	
N
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O
(CH3O)2SO2, NaOH, 
H2O, 0 °C to RT
N
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O
CH3
2-32a (X = H)
2-32b (X = CH3)
2-47a (X = H, 63 %)
2-47b (X = CH3, 77 %)
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Scheme	2.11	Synthesis	of	N,N‘‐dimethyl	pyrimidines	1‐47a	and	1‐47b.	
Besides	 the	 simple	 reduction	 of	2‐47a	 or	2‐47b	with	H2,	 5,6‐dihydrouracils	 can	be	
synthesized	 following	 a	 procedure	 published	 by	 Lee	 and	 Shim	 involving	 the	 fast	
tandem	Michael	addition/condensation	of	acrylic	acids	and	substituted	ureas.[41]	By	
varying	 the	 substitution	 pattern	 of	 either	 urea	 or	 acrylic	 acid,	 a	 multitude	 of	
differently	functionalized	dihydropyrimidines	is	accessible.	
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Scheme	2.12	Dihydro	pyrimidine	synthesis	according	to	Lee	and	Shim.	
No	 additional	 solvent	 is	 needed	 as	 most	 of	 the	 acrylic	 acids	 are	 liquids,	 but	 high‐
pressure	conditions	are	needed	to	induce	the	reaction.	The	synthesis	and	purification	
was	optimized	using	microwave	heating	under	closed‐tube	conditions.	 Impurities	of	
polymeric	 acrylates	 were	 removed	 by	 silica	 gel	 filtration	 followed	 by	 repeated	
distillation	 and	 precipitation	 steps.	 The	 low	 yields	 are	 mainly	 the	 result	 of	 the	
purification	methods	and	incidental	polymerization.		
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Scheme	 2.13	 Synthesis	 of	 dimethylated	 dihydropyrimidines	 2‐49a	 and	 2‐49b,	 together	 with	 the	
ORTEP	plot	of	2‐49a.	
Indeed,	the	yield	for	2‐49b	was	almost	doubled	by	the	usage	of	synthesis	microwave	
machines	from	25	%	(conventional	heating	in	a	stainless	steel	tube,	190	°C,	2	h)[41]	to	
43	%	(microwave	glass	vial,	150	°C,	1	h).	Similarily,	the	yield	for	the	dihydro	derivative	
of	dimethyl	uracil	2‐49a	was	also	increased	from	27	%	(Pyrex	pressure	tube,	190	°C,	
2	h)	to	52	%	(microwave	glass	vial,	150	°C,	2	h).	
2.3.3 Modified	Cytosine	Models	
Inspired	by	the	work	by	Leonard	and	Hosmane[42]	the	synthesis	of	1‐methyl	cytosine	
(2‐50a)	was	accomplished	in	a	two‐step	procedure	displayed	in	Scheme	2.14.	
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Scheme	2.14	Modified	synthesis	of	1‐methylcytosine	according	to	Leonard	and	Hosmane.[42]	
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The	applied	microwave	heating	reduced	the	reaction	times	for	the	synthesis	of	2‐52a	
from	 published	 15	 to	 2	 hours.[42]	 Replacing	 ammonium	 hydroxide	 NH4+	 OH‐	 with	
ethanolic	 methylamine	 in	 the	 deprotection	 step	 simplified	 the	 purification	 very	
effectively.	No	 time‐consuming	 removal	 of	 ammonia	 and	water	was	needed	 and	 the	
product	isolation	is	simply	accomplished	by	filtration	and	repeated	recrystallization.	
In	 1995,	 the	 Golankiewicz	 group	 published	 a	 novel	 route	 for	 the	 synthesis	 of	 1‐
substituted	cytosines,	including	1,5‐dimethylcytosine	(2‐50b).[43]	Unfortunately,	their	
synthesis	 starts	 from	 1‐methylthymine	 (2‐39b),	 whose	 extensive	 synthesis	 via	
Hilbert‐Johnson‐alkylation	 was	 already	 described	 in	 the	 previous	 chapter	 (Scheme	
2.15).	
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Scheme	2.15	1,5‐Dimethylcytosine	(2‐50b)	synthesis	according	to	Golankiewicz.[43]	
The	 isolation	of	pure	nitrogen‐rich	compounds	in	substance	can	be	quite	dangerous	
and	the	formation	of	HN3	under	the	reaction	conditions	represents	another	potential	
hazard.	 Therefore,	 the	 synthesis	 of	 2‐50b	 was	 attempted	 by	 simple	 nucleophilic	
aromatic	substitution	of	2‐54b	by	methanolic	ammonia	solution	under	high‐pressure	
microwave	conditions	to	save	three	reaction	steps.	
N
N
O
CH3
OEt
2-54b
NH3 (2 M), MeOH
MW, 140 °C, 16 h N
N
NH2
CH3
O
2-50b (1 %) 	
Scheme	2.16	Microwave‐assisted	synthesis	of	1,5‐dimethylcytosine	(2‐50b).	
Mainly	unreacted	starting	material	2‐54b	and	only	traces	of	desired	product	could	be	
isolated.	 The	 synthesis	 of	 gram‐quantities	 of	 highly	 pure	 5,6‐dihydrocytosines	 was	
more	difficult	 than	expected	due	 to	 their	high	acid	sentivity.	 It	 is	 commonly	known,	
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that	in	catalytical	hydrogenations	over	Pd/C,	cytosine	is	often	partly	hydrogenated	to	
5,6‐dihydrocytosine	 (2‐55)	 which	 is	 then	 readily	 hydrolyzed	 to	 the	 dihydrouracil	
derivative.[8,	 44]	 The	 number	 of	 articles	 describing	 the	 chemospecific	 synthesis	 and	
isolation	of	dihydrocytosines	 is	 very	 limited	and	mainly	 consists	of	Brønstedt	base‐
induced	cyclizations	of	urea	derivatives	of	 type	2‐56[45]	 or	 the	aminolysis	of	4‐thio‐
5,6‐dihydrouracils	(2‐57)	in	liquid	ammonia.[46]		
N
R
O
NH2
N
NaNH2, NH3(l)
or
NaOMe, EtOH,  N
N
NH2
O
R
N
NH
R
O
O
P4S10
N
NH
R
O
S
NH3(l)
2-56 2-55 2-57 	
Scheme	2.17	Literature	known	syntheses	for	5,6‐dihydrocytosines.	
In	order	to	avoid	handling	and	exposure	to	hazardous	phosphorous	pentasulfide	and	
its	 byproducts,	 the	 cyclization	 route	 was	 envisaged	 as	 the	 only	 alternative.	 The	
appropriate	 urea	 compounds	 were	 synthesized	 from	 commercially	 available	
secondary	amine	2‐58a	 and	 in	situ	 generated	aqueous	 isocyanic	acid	 in	60	%	yield.	
Slow	evaporation	of	an	ethanolic	solution	of	urea	2‐59b	gave	crystals	suitable	for	X‐
ray	analysis	with	four	crystallographically	independent	urea	molecules	in	the	triclinic	
cell.	 The	 cyclization	 was	 performed	 according	 to	 Cheng	 et	 al.[45b]	 using	 sodium	
methoxide	 in	 refluxing	 absolute	 ethanol.	 Conventional	 heating	 was	 crucial	 for	
successful	synthesis	of	dihydrocytosine	2‐55a.	All	attempts	to	optimize	the	reaction	
by	 means	 of	 temperature	 variation,	 increased	 pressure	 or	 reaction	 time	 using	
microwave	 irradiation	 failed	 and	 only	 inseparable	 mixtures	 of	 byproducts	 were	
formed.		
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CN
N
H
H3C
KOCN, HCl(conc.), H2O,
MW, 60 °C, 30 min
H2N
O
N
CH3
CN
NaOMe, EtOH
refl., 30 min
N
N
NH2
O
CH32-58a 2-59a (60%)
2-55a (87 %) 	
																 	
Scheme	2.18	Modified	synthesis	of	1‐methyl‐5,6‐dihydrocytosine	(2‐55a)	according	to	Cheng	et	al.[45b]	
and	ORTEP	plots	of	urea	2‐59a	and	1‐methyl‐5,6‐dihydrocytosine	(2‐55a)•hemihydrate.	
Nevertheless,	 N‐methylated	 dihydrocytosine	 (2‐55a)	 was	 obtained	 in	 good	 yield	
(87	%)	and	structural	properties	were	proven	by	X‐ray	structure	determination	from	
crystals	 grown	 from	 ethanol	 at	 ‐10	 °C.	 Closer	 inspection	 of	 1H	 NMR	 spectra	 in	
DMSO‐d6	(Figure	2.9)	revealed,	that	with	increased	water	content	the	fast	rotation	of	
the	amino	group	 is	 retarded	(Figure	2.9),	 resulting	 in	 the	appearance	of	 two	broad	
singlets	around	7.5	ppm.		
N
N
H
O
H
N
H
O
CH3
H
N
N
H
N
H
O
CH3
N
N
H
N
H
O
CH3 	
Figure	2.8	 Decreased	 rate	 of	 rotation	 of	 the	 amino	 group	 in	2‐55a	 upon	 coordination	 with	 water	
resulting	in	two	NMR‐distinguishable	amino	protons.	
In	 addition,	 the	 rotation	 barrier	 around	 the	 C‐NH2	 bond	 has	 been	 determined	
spectroscopically	 by	 analyzing	 temperature‐dependent	 1H	 NMR	 spectra	 (Figure	
2.10).	 The	 relative	 population	 of	 the	 intramolecular	 motion	 as	 a	 result	 of	 the	
temperature‐dependent	equilibrium	and	the	conclusive	rate	constant	k	 is	defined	by	
the	Eyring	equation:	
	
k	=	(R	T/NA	h)	exp(‐G‡/R	T)	 	 	 (eq.	2.7)	
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Figure	2.9	 1H	 NMR	 (200	MHz)	 of	 1‐methyl‐5,6‐dihydrocytosine	 (2‐55a)	 in	 DMSO‐d6	with	 different	
water	content.	
The	 coalescence	 temperature	Tc,	 at	which	 the	 rotation	 barrier	 is	 overcome	 and	 the	
two	 signals	 merge	 into	 one	 is	 connected	 to	 the	 rate	 constant	 kc	 by	 the	 following	
relation:	
	
/2	A	‐	B	=	(R	Tc/NA	h)	exp(‐G‡/R	TC)	 	 (eq.	2.8)	
	
where	 A	 and	 B	 are	 the	 chemical	 shifts	 of	 the	 respective	 amino	 protons.	 If	 Tc	 is	
measured	 in	 K	 and	 the	 shifts	 	 in	 Hz,	 the	 free	 energy	 of	 activation	G‡	 is	 given	 in	
kJ	mol‐1	by	
	
G‡	=	19.1	10‐3	Tc	(9.97	+	log	Tc	–	log	A	‐	B)	 	 (eq.	2.9)	
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H H
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Figure	 2.10	 Temperature‐dependent	 1H	 NMR	 (200	 MHz,	 DMSO‐d6)	 of	 dihydrocytosine	 2‐55a	 to	
determine	its	coalescence	temperature	Tc.	
Table	2.6	Activation	free	energy	G‡	for	the	 intramolecular	rotation	of	 the	amino	group	in	2‐55a	 in	
DMSO	together	with	literature	data	for	related	systems.	
N
N
HB
N
HA
O
CH3 	
(NHA)	[ppm]	 (NHB)	[ppm]	 [Hz]a	 kc	[s‐1]	 Tc	[K]	 G‡[kJ	mol‐1]	
7.51	 7.26	 50	 111	 323.15	 +66.54		
	 	 	 	 ±	3	K	 ±	0.64	
	
H O
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The	coalescence	is	reached	at	approximately	50	°C	(Figure	2.10)	leading	to	a	barrier	
of	+66.5	kJ	mol‐1.	Assuming	a	 spectra‐	 and	 temperature	sensor‐specific	deviation	of	
3	°C	during	this	kinetic	study,	an	error	of	±0.6	kJ	mol‐1	should	be	included	to	the	free	
activation	 energy.	 Comparison	 with	 literature‐known	 rotation	 barriers	 (see	 Table	
2.6)	 for	 model	 systems	 like	 DMF	 (2‐60b)	 or	 N,N‐dimethyl	 acetamide	 (2‐60c)	
indicates	that	the	rotation	barrier	for	2‐55a	is	in	between	that	for	trichloro	acetamide	
(2‐61)	and	the	guanidinium	cation	(2‐62).	The	ring	structure	of	dihydro	compound	
2‐55a	can	therefore	be	classified	as	weak	acceptor.	Unfortunatelly,	from	this	study	no	
statement	on	the	influence	of	the	water	content	on	the	internal	rotation	can	be	made.	
The	reported	synthesis	of	dihydrocytosine	can	also	be	extended	to	the	formation	of	5‐
methyl‐5,6‐dihydrocytosine	2‐55b.[40]	The	respective	racemic	urea	2‐59b	was	simply	
synthesized	 by	Michael	 addition	 of	 methylamine	 to	 acrylonitrile	 (2‐63)	 at	 ambient	
temperature,	 followed	 by	 addition	 to	 isocyanic	 acid.	 In	 contrast	 to	 the	 parent	
dihydrocytosine	 2‐55a,	 the	 5‐methyl	 derivative	 2‐55b	 can	 be	 synthesized	 in	 the	
microwave	in	modest	yield	(see	Scheme	2.19).	
CN MeNH2 (33 % in EtOH)
0 °C to RT
N
H
H3C CN
2-63
KOCN, HCl(conc.), 
H2O, RT, over night
H2N
O
N
CH3
CN
2-59b (59%)
2-63a
	
	
NaOMe, EtOH
MW, 80 °C, 30 min
N
N
NH2
O
CH3
2-55b (41 %)
HCl, H2O, RT
N
NH
O
O
CH3
2-46b (quant.) 	 	
Scheme	2.19	Synthesis	of	5‐methyl	dihydrocytosine	2‐55b.	
Increased	stability	of	2‐55b	against	hydrolysis	in	acidic	media	by	attaching	a	methyl	
group	was	not	observed.	Overall	the	synthesized	dihydrocytosine	derivates	represent	
relatively	 instable,	 hydrolysable	 compounds,	which	 should	be	 stored	under	dry	 and	
oxygen‐free	conditions.	
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In	 conclusion,	 three	N‐methylated	 pyrimidine	 pairs	 of	 each	 pyrimidine	 nucleobase,	
respectively,	were	synthesized	in	high	amount	and	purity	and	their	heats	of	formation	
in	 the	 gas	 phase	 fH0(g)	 were	 experimentally	 determined	 via	 bomb	 calorimetry	
together	 with	 the	 commercially	 available	 nucleobases	 uracil	 (2‐32a)	 and	 thymine	
(2‐32b)	 and	 their	 dihydro	 derivatives.	 These	 measurements	 were	 performed	 in	
collaboration	with	the	group	of	Prof.	Dr.	Sergey	Verevkin	at	the	university	of	Rostock.	
The	results	are	displayed	 in	Table	2.7.	For	unknown	reasons,	 the	heat	of	 formation	
fH0(g)	 of	 dihydrocytosine	 2‐55a	 could	 not	 be	 determined	 accurately	 due	 to	
incomplete	 combustion	 to	H2O,	 CO2	 and	NH3.	An	unknown	 residue	 remained	 in	 the	
combustion	 chamber	 that	 was	 not	 detected	 by	 elemental	 analysis.	 Purification	 by	
reversed‐phase	silica	(RP‐18)	using	a	mixture	of	acetone	and	methanol	(15:1)	led	to	
hydrolysis	 of	 2‐55a	 to	 1‐methylated	 dihydrouracil	 (2‐46a)	 in	 a	 ratio	 of	 1:3	
(2‐55a:2‐46a)	determined	by	1H	NMR	spectroscopy.	A	short‐term	amino‐protection	
strategy	 using	 the	 benzyloxycarbamate	 (CBz)	 group	 to	 mask	 the	 reactivity	 against	
hydrolysis	 to	 facilitate	 purification	 failed.	 After	 silica	 gel	 chromatography	 an	
inseparable	mixture	of	CBz‐protected	2‐64a	and	2‐46a	in	the	ratio	1:1	was	obtained.	
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Scheme	2.20	Failed	synthesis	of	CBz‐protected	2‐64a.	
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Table	2.7	Thermochemical	data	obtained	in	this	work	at	298.15	K	and	1	atm.	
N
N
O
O
Y
Y
X
	
cH0	(s)	 fH0	(s)	 supH0	 fH0	(g)	
X	=	H,	Y	=	H	(2‐32a)	 ‐1715.2±1.0 ‐430.5±1.1 +131.9±0.7	
‐298.6±1.3	
‐292.5±2.6[50]
X	=	CH3,	Y	=	H	(2‐32b)	 ‐2359.3±1.0 ‐465.7±1.2 126.3±1.2	
‐339.4±1.7	
‐327.5±1.6[51]
X	=	H,	Y	=	CH3	(2‐47a)	 ‐3088.5±1.8 ‐415.9±2.0 95.6±0.6	
‐320.3±2.1	
‐314.9±1.5[52]
X	=	CH3,	Y	=	CH3	(2‐47b)	 ‐3735.9±1.5 ‐447.9±1.8 95.1±0.6	 ‐352.8±1.9	
X	=	H,	Y	=	CH3,	O→NH2	(2‐50a)	 ‐2749.1±2.9 ‐218.8±3.0 142.8±1.3	 ‐76.0±3.3	
N
N
O
O
Y
Y
X
	
cH0	(s)	 fH0	(s)	 supH0	 fH0	(g)	
X	=	H,	Y	=	H	(2‐65a)	 ‐1936.7±1.4 ‐494.9±1.5 114.8±1.7	
‐380.1±2.3	
‐378.2±2.1[53]
X	=	CH3,	Y	=	H	(2‐65b)	 ‐2585.3±1.4 ‐525.6±1.5 118.6±0.6	 ‐407.0±1.6	
X	=	H,	Y	=	CH3	(2‐49a)	 ‐3314.9±1.2 ‐475.3±1.4 87.4±0.7	 ‐387.9±1.6	
X	=	CH3,	Y	=	CH3	(2‐49b)	 ‐3966.9±2.5 ‐502.6±2.7 83.4±1.0	 ‐419.2±2.9	
X	=	H,	Y	=	CH3,	O→NH2	(2‐55a)	 n/a	 n/a	 n/a	 n/a	
N
N
O
O
H2
N
N
O
O
H
(kJ mol-1)
0.0
fHcr
-415.9
fHg
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fHg
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hydH
-67.6
CH3
CH3
CH3
CH3
2-47a 2-49a 	
Figure	2.11	Schematic	representation	of	energies	required	for	the	determination	of	hydH	of	dimethyl	
uracil	(2‐47a).	
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2.3.4 Modified	Sugar	Models	
The	number	of	heats	of	hydrogenation	hydH	for	carbonyl	compounds	is,	compared	to	
those	for	alkenes	or	alkynes,	comparatively	small	and	even	the	specific	standard	heats	
of	formation	fH0(g)	are	very	limited.	For	instance,	available	thermochemical	data	of	
polyols	is	mainly	restricted	to	simple	systems	like	glycol,	glycerine	or	1,2‐diols	in	their	
standard	 state,	 usually	 liquids	 at	 room	 temperature.	 No	 gas	 phase	 values	 for	 ‐
hydroxy	ketones	are	available.		
The	 most	 simple	 RNA‐related	 substrate	 acting	 as	 H2	 donor	 is	 the	 commercially	
available	 1,4‐anhydroerithritol	 (2‐66)	 and	 its	 oxidized	 ‐hydroxy	 keto	 derivative	
2‐67a.	
O
OHOH
O
OH
+     H2
2-66 2-67a
O
H
2-11
	
Scheme	2.21	1,4‐Anhydroerithritol	(2‐66)	and	its	dehydrogenated	keto	form	2‐67a.	
Attempts	to	synthesize	2‐67a	 in	one	step	via	standard	oxidation	using	chromium	in	
high	oxidation	states	failed	and	only	decomposition	was	observed.		
O
OHOH
2-66
PCC, DCM, RT
PCC, DCM, 0 °C
X
X
O
OH
2-67a
O
	
Scheme	2.22	Attempted	synthesis	of	2‐67a	via	Cr(VI)‐oxidation.	
Using	 a	 two‐step	 synthesis	 including	 selective	 mono‐protection	 of	 the	 hydroxyl	
functionality	 by	 an	 acetyl	 group,	 followed	 by	 Cr(VI)‐oxidation	 yielded	
tetrahydrofuranone	2‐69a	 in	modest	 yield.[54]	Mono‐acetylation	was	 achieved	using	
the	 triethyl	 ortho	 acetate	 and	 catalytic	 amounts	 of	 trifluoro	 acetic	 acid	 in	 refluxing	
THF.	With	 the	 aid	 of	microwave	 heating	 the	 yield	 could	 be	 increased	 to	 89	%	 and	
accelerated	 to	be	 finished	after	15	minutes	 compared	 to	48	h	with	 conventional	oil	
bath	heating.[54]	The	hydroxyl	group	was	oxidized	using	pyridinium	chlorochromate	
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(PCC)	 in	 DCM	 using	 celite	 as	 absorbant	 for	 the	 precipitating	 polymeric	 chromium	
oxides.		
O
OHOH
O
OHO
O
O
O
O
O
H3CC(OEt)3, THF
MW, refl., 15 min
PCC, DCM, 
celite, RT
2-66
2-68a (89 %) 2-69a (69 %) 	
Scheme	 2.23	 Synthesis	 of	 acetoxy‐protected	 tetrahydrofuranone	 2‐69	 according	 to	 Buechi	 and	
coworkers.[54]	
Nevertheless,	 several	 attempts	 to	 achieve	 deprotection	 of	 2‐69a	 under	 basic	
conditions	 resulted	either	 in	decomposition	or	unsuccessful	 isolation	after	work‐up	
due	to	the	good	solubility	of	acyloin	2‐67a	in	water.	
O
O
O
O
2-69a
X
NaOMe,
 MeOH, 0 °C to RT
NH3, H2O,
RT or MW
O
OH O
2-67aX
	
Scheme	2.24	Failed	synthesis	of	‐hydroxy	ketone	2‐67a.	
Replacement	 of	 the	 acetyl	 by	 a	 benzyl	 group	 led	 to	 no	 improvement.	 The	 mono‐
benzylation	was	 accomplished	 using	 1.1	 equivalents	 of	 benzyl	 bromide	 and	NaH	 in	
refluxing	THF	under	microwave	irradiation.	The	Buechi	conditions	(PCC,	DCM,	celite,	
RT)	gave	rise	to	ether	cleavage	and	benzaldehyde	was	isolated	as	main	product.	
O
OHOH
O
OHOPh
O
OPh O
PCC, DCM, 
celite, RT
2-66 2-68b (51 %)
2-69b
BnBr, TBAI, THF,
MW, refl., 4 h
X
	
Scheme	2.25	Benzylation	of	2‐66	and	subsequent	PCC‐oxidation.	
A	one‐step	synthesis	of	2‐67a	inspired	by	the	well‐known	acyloin	condensation	using	
sodium	metal,	 the	 ethyl	 ester	of	diglycolic	 acid	2‐70	 and	TMSCl	 as	 anion	 scavenger	
brought	 no	 success.	 This	 may	 indicate	 that	 stepwise	 one‐electron	 reduction	 of	 the	
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carbonyl	group	in	2‐70	gives	rise	to	ketyl	radical	2‐71	which	can	easily	be	cleaved	in	
‐position	to	give	ethyl	acetate	and	ethyl	glycolate	(2‐72).		
OEtO2C CO2Et
2-70
Na, TMSCl,
PhMe, refl.
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O
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H3O
+ O
OH
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OEtO
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O O
HO+
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Scheme	2.26	Failed	acyloin	condensation	of	ethyl	ester	2‐70.	
Synthesis	 of	 the	 desired	 sugar	 compound	2‐67a	 could	 thus	 not	 be	 achieved	 in	 the	
required	purity	and	amount.	This	can	have	the	effect	that	syntheses	of	the	even	more	
complex	models	 like	2‐73	 or	2‐74a	 is	 not	 likely	 to	be	 completed	 successfully	 since	
they	 are	 not	 commercially	 available	 and	 require	 long	 expensive	 reaction	 steps	
(Scheme	2.27).	
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HO HO
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Scheme	2.27	Proposed	synthesis	of	2‐73	and	2‐74a	based	on	D‐ribose	(2‐75).	
2.4 Experimental	vs.	Theoretical	Heats	of	Hydrogenation	
2.4.1 Thermochemistry	of	Nucleobases	
The	 heats	 of	 hydrogenation	hydH*	 at	 G3B3	 level	 together	 with	 the	 experimentally	
obtained	values	from	Chapter	2.3.3	are	summarized	in	Table	2.8.	
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Table	2.8	Heats	of	hydrogenation	hydH	of	pyridine	nucleobases	and	alkene	models	at	G3B3	level	of	
theory	in	kJ	mol‐1	(at	298.15	K	and	1	atm,	only	the	starting	materials	are	shown).	
HH
H H
H
H
+
HH
H H
+
2-29a 2-12a
N
N
R trhH
N
N
RH
H
	
	 trhH(calc.)a hydH*(calc.)b hydH(exp.)	
H3C
H
H
H
2-12b 	
+11.06	 ‐125.24	
‐125.0±0.2[16]	
‐123.8c	
2-13a 	
+17.24	 ‐119.06	
‐118.8±0.4[18]	
‐118.4c	
N
N
Z
O
Y'
Y
X
	
trhH(calc.)a hydH*(calc.)b hydH(exp.)	
X	=	H,	Y,	Y’	=	H,	Z	=	O	(2‐32a)	 +58.19	 ‐78.11	
‐81.5±2.6c	
‐75.7±3.0[53]	
X	=	H,	Y	=	CH3,	Z	=	O	(2‐39a)	 +58.47	 ‐77.83	 n/a	
X	=	H,	Y,	Y’	=	CH3,	Z	=	O	(2‐47a)	 +63.96	 ‐72.34	 ‐67.6±2.6c	
X	=	CH3,	Y	=	H,	Z	=	O	(2‐32b)	 +66.09	 ‐70.51	 ‐67.6±2.3c	
X	=	CH3,	Y	=	CH3,	Z	=	O	(2‐39b)	 +66.66	 ‐69.64	 n/a	
X	=	CH3,	Y,	Y’	=	CH3,	Z	=	O	(2‐47b) +70.65	 ‐65.65	 ‐66.4±3.5c	
X	=	F,	Y	=	CH3,	Z	=	O	(2‐39c)	 +48.01	 ‐88.29	 n/a	
X	=	H,	Y	=	H,	Z	=	NH2	(2‐76)	 +81.62	 ‐54.68	 n/a	
X	=	H,	Y	=	CH3,	Z	=	NH2	(2‐50a)	 +86.99	 ‐49.31	 n/a	
X	=	CH3,	Y	=	CH3,	Z	=	NH2	(2‐50b)	 +91.28	 ‐45.02	 n/a	
X	=	F,	Y	=	CH3,	Z	=	NH2	(2‐50c)	 +67.74	 ‐68.58	 n/a	
a	Defined	as	trhH	=	fH(C2H4)	+	fH(RCH2‐CH2R)	–	fH(RHC=CHR)	–	fH(C2H6).	b	Addition	of	the	reaction	enthalpies	trhH	to	the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH	 (C2H4,	 2‐12a)	 =	 ‐136.3±0.2	 kJ	 mol‐1	 yields	 the	
hydrogenation	enthalpy	hydH*	of	the	respective	double	bond.	c	Calculated	using	heats	of	formation	fH.[15]		
	
As	 is	 readily	 seen	 in	Table	2.8	 the	most	 easily	 reduced	 naturally	 occuring	 base	 is	
uracil	 (2‐32a)	 with	 an	 experimental	 heat	 of	 hydrogenation	 hydH(exp.)	 of	
‐81.5	kJ	mol‐1	 and	 a	 G3B3	 value	 of	 ‐78.1	 kJ	 mol‐1.	 This	 value	 is	 hardly	 affected	 by	
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alkylation	at	the	N1	position	as	illustrated	by	the	value	for	1‐methyluracil	(2‐39a)	of	
hydH(2‐39a)	=	‐77.8	kJ	mol‐1.	Introduction	of	a	second	methyl	group	at	N3	position	in	
2‐47a	leads	to	hydH(2‐47a)	=	‐72.3	kJ	mol‐1	and	thus	to	a	more	significant	change.	
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Figure	 2.12	 Heats	 of	 hydrogenation	 hydH	 of	 nucleobases	 at	 G3B3	 level	 of	 theory	 at	 298.15	 K.	
Experimental	hydrogenation	enthalpies	(red	lines)	are	shown	together	with	their	standard	deviations	
as	gray	bars.	
This	effect	is	almost	identical	to	the	introduction	of	a	methyl	group	in	C5	position	of	
thymine	 (2‐32b)	 which	 reduces	 the	 hydrogenation	 enthalpy	 by	 7	 kJ	 mol‐1	
(hydH(2‐32b)	=	‐70.5	kJ	mol‐1).	Alkylation	of	the	N1	and	N3	position	in	thymine	again	
reduces	the	enthalpy	by	a	small	margin	to	hydH	=	‐65.7	kJ	mol‐1	 in	2‐47b.	A	similar	
reduction	of	hydrogenation	enthalpies	occurs	on	moving	 to	more	highly	substituted	
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systems	 like	 ethylene	 (2‐12a)/propene	 (2‐12b)	 or	 cyclohexene	 (2‐13a)/1‐
methylcylohexene	(2‐13b)	and	can	thus	be	considered	to	be	a	general	phenomenon	
(see	Chapter	2.2).	Exchange	of	 the	methyl	group	 in	1‐methyl	 thymine	(2‐39b)	by	a	
fluoro	substituent	increases	the	driving	force	for	the	reduction	of	the	C‐C	double	bond	
by	ca.	19	kJ	mol‐1	(hydH(2‐39c)	=	‐88.3	kJ	mol‐1).	The	enhanced	driving	force	is	more	
a	result	of	large	electronegativity	differences	than	steric	hindrance.	Compared	to	the	
parent	 uracil	 derivate	2‐39a	 the	 reaction	 enthalpy	 of	 2‐39c	 is	 around	 10	 kJ	 mol‐1	
more	 exothermic.	 5‐Fluoro‐5,6‐dihydrouracil	 (2‐65c)	 is	 a	 metabolite	 of	 the	 widely	
prescribed	 cytostatic	 drug	 5‐fluorouracil	 (2‐32c)	 most	 commonly	 used	 in	 the	
treatment	 of	 breast	 and	 colorectal	 cancer.[55]	 2‐65c	 is	 produced	 by	 the	 enzyme	
dihydropyrimidine	 dehydrogenase	 (Scheme	 2.28),	 followed	 by	 two	 subsequent	
enzymatic	 degradation	 steps	 to	 low	 toxic	 fluoro‐‐alanine	 (2‐79).[56]	 The	 large	
difference	in	heats	of	hydrogenation	can	be	the	reason	for	the	lack	in	specifity	of	the	
dehydrogenase	enzyme.	
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Scheme	2.28	Metabolic	pathway	of	the	degradation	of	5‐fluorouracil	(2‐32c).	
The	 hydrogenation	 of	 pyrimidine	 bases	 is	 much	 more	 exothermic	 than	 the	 purine	
bases	 adenine	 (2‐81)	 or	 guanine	 (2‐82).	 The	most	 stable	 reaction	 products	 are	 in	
both	cases	those	involving	reduction	of	the	C8‐N7	double	bond	with	positive	heats	of	
hydrogenation	 of	hydH(2‐77a)	 =	 +7.70	 kJ	mol‐1	 and	hydH(2‐78b)	 =	 +5.20	 kJ	mol‐1	
(Figure	2.12).	Regardless	at	which	position	the	reduction	occurs,	all	enthalpic	values	
are	 positive	 and	 hydrogenation	 is	 therefore	 unlikely	 to	 happen	 as	 graphically	
displayed	 in	 Figure	 2.13.	 The	 large	 differences	 between	 pyrimidine‐	 and	 purine‐
based	nucleobases	reflect	the	intrinsically	large	discrepancy	in	hydrogenations	of	C‐C	
and	C‐N	double	bonds.	This	can	readily	be	seen	in	hydrogenation	enthalpies	of	small	
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model	 systems	 like	 propene	 (hydH(2‐12b)	 =	 ‐125.0	 kJ	 mol‐1)	 and	 N‐methylimine	
(hydH(2‐83)	=	‐62.8	kJ	mol‐1).[15,	57]	
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Figure	 2.13	 Regioselective	 hydrogenation	 of	 adenine	 (2‐81)	 and	 guanine	 (2‐82)	 at	 G3B3	 level	 of	
theory	obtained	at	298.15	K	and	1	atm	(in	kJ	mol‐1).	
The	most	difficult	pyrimidine	base	to	reduce	is	cytosine	(2‐76)	with	a	hydrogenation	
value	 of	 hydH(2‐76)	 =	 ‐54.7	 kJ	 mol‐1,	 which	 is	 probably	 a	 result	 of	 the	 different	
substitution	 pattern	 at	 C4	 position	 (amino	 vs.	 carbonyl	 group).	 The	 order	 of	
hydrogenation	 energies	 found	 here	 in	 the	 gas	 phase	 parallels	 that	 of	 the	
experimentally	measured	 one‐electron	 reduction	potentials	 in	 the	 gas	 phase	 and	 in	
polar	organic	solvents.[58]	A	different	energetic	outcome	is	observed,	if	the	tautomeric	
forms	of	uracil	or	cytosine	are	considered	to	be	relevant.	The	isomerization	enthalpies	
isoH	 in	gas	phase	at	G3B3	level	are	displayed	in	Figure	2.14.	For	uracil	(2‐32a)	the	
canonical	 structure	 of	 its	 reduced	 form	 2‐65a	 is	 the	 most	 stable	 among	 the	
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tautomeric	 amides.	 The	 high	 endothermicity	 of	 bis‐enol	 2‐88a	 (isoH(2‐88a)=	
+134.7	kJ	 mol‐1)	 is	 without	 doubt	 the	 consequence	 of	 abolition	 of	 the	 aromatic	
stabilization.	 Recently,	 Ribeiro	 da	 Silva	 and	 coworkers	 used	 this	 approach	 in	
combination	with	 its	hydrogenation	 energy	 to	 verify	 the	question	wether	uracil	 (2‐
32a)	 is	aromatic.[53]	For	cytosine	(2‐76)	the	canonical	dihydro	structure	2‐89	 is	not	
the	 global	 minimum,	 but	 imine	 tautomer	 2‐90	 either	 in	 its	 E	 or	 Z	 form	 with	
isoH(E‐2‐90)	=	‐20.3	kJ	mol‐1	and	isoH(Z‐2‐90)	=	‐16.9	kJ	mol‐1,	respectively.		
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Figure	2.14	Isomerization	enthalpies	isoH	of	the	hydrogenated	pyrimidines	2‐65a	and	2‐89	at	G3B3	
level	of	theory	in	kJ	mol‐1.	
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Besides	 of	 increased	 rates	 of	 hydrolysis	 as	 cause	 for	 the	mutagenetic	 properties	 of	
dihydrocytosines,	these	results	also	indicate	an	impact	of	the	tautomeric	equilibrium	
on	 base‐pairing.	 The	 experimentally	 measured	 heats	 of	 hydrogenation	 are	 closely	
similar	to	the	theoretically	obtained	G3B3	values	and	therefore	provide	a	quantitative	
guideline	 for	 the	 redox	 properties	 of	 nucleobases	 with	 respect	 to	 reductive	
hydrogenation.	
2.4.2 Thermochemistry	of	Sugar	Models	
The	 theoretically	 obtained	 numbers	 for	 the	 sugar	 models	 together	 with	 available	
experimental	 values	 of	 selected	 carbonyl	 compounds	 are	 found	 in	 Table	 2.9	 and	
Table	2.10.	
Table	2.9	Boltzmann‐averaged	heats	of	hydrogenation	<hydH>	of	some	selected	carbonyl	compounds	
at	G3B3	level	of	theory	in	kJ	mol‐1	(at	298.15	K	and	1	atm,	only	the	starting	materials	are	shown).	
HH
H H
H
H
+
HH
H H
+
2-29a 2-12a
O
R
trhH
OH
R
H
	
	 trhH>(calc.)a hydH*>(calc.)b hydH(exp.)	
CH3‐CHO	(2‐18)	 +67.88	 ‐68.42	
‐69.1	±	0.4[23]	
‐68.6c	
(CH3)2CO	(2‐19)	 +79.73	 ‐56.57	
‐55.6	±	0.4[24]	
‐55.5c	
(CH3)2CH‐CHO	
(2‐93)	
+66.65	 ‐69.65	 ‐68.1c	
O
O
2-94 	
+72.36	 ‐63.94	 ‐60.8c	
O2-21 	
+85.85	 ‐50.45	
‐51.3	±	0.6[23]	
‐50.4c	
a	 Defined	 as	trhH	 =	fH(C2H4)	 +	 fH(R2CH‐OH)	 –	fH(R2C=O)	 –	fH(C2H6).	 b	 Addition	 of	 the	 reaction	 enthalpies	 trhH	 to	 the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH	 (C2H4,	 2‐12a)	 =	 ‐136.3±0.2	 kJ	 mol‐1	 yields	 the	
hydrogenation	enthalpy	hydH*	of	the	respective	double	bond.	c	Calculated	using	heats	of	formation	fH.[15]	
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Table	2.10	Boltzmann‐averaged	heats	of	hydrogenation	<hydH>	of	ribose	and	desoxyribose		models	at	
G3B3	level	of	theory	in	kJ	mol‐1	(at	298.15	K	and	1	atm,	only	the	starting	materials	are	shown).	
HH
H H
H
H
+
HH
H H
+
2-29a 2-12a
trhH O
OH
R
O
R
O
H

	 trhH>(calc.)a	 hydH*>(calc.)b	
O
O2-95 	
+74.18	 ‐62.12	
O
OH O
2-67a 	
+65.87	 ‐70.43	
O
O
2-96 	
+50.41	 ‐85.89	
O
OH
HO
O
2-97a 	
+61.71	 ‐74.59	
O
X
HO
O 	
	 	
X	=	OH	(2‐97b)	 +48.21	 ‐88.09	
X	=H	(2‐98b)	 +73.60	 ‐62.70	
O
XOH
O
	
	 	
X	=	OH	(2‐97c)	 +52.84	 ‐83.46	
X	=H	(2‐98c)	 +55.31	 ‐80.99	
a	 Defined	 as	trhH	 =	fH(C2H4)	 +	 fH(R2CH‐OH)	 –	fH(R2C=O)	 –	fH(C2H6).	 b	 Addition	 of	 the	 reaction	 enthalpies	 trhH	 to	 the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH	 (C2H4,	 2‐12a)	 =	 ‐136.3±0.2	 kJ	 mol‐1	 yields	 the	
hydrogenation	enthalpy	hydH*	of	the	respective	double	bond.		
	
Systematic	differences	in	hydrogenation	enthalpies	between	compounds	containing	a	
formyl	or	ketone	functionality	are	not	observed,	since	multiple	secondary	factors	like	
ring	 strain,	 electrostatic	 interactions	 and	 stabilizing	 hydrogen	 bonds	 have	 to	 be	
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considered.	For	example,	the	heat	of	hydrogenation	is	lowered	by	ca.	4	kJ	mol‐1	if	the	
ketone	moiety	is	incorporated	into	the	cyclopentane	ring	of	2‐21	(hydH(2‐21,	exp.)	=	
‐51.3±0.6	kJ	mol‐1,	hydH	 (2‐21,	G3B3)	=	 ‐50.5	kJ	mol‐1)	 compared	to	acyclic	acetone	
(2‐19).	 Installing	 an	 electronegative	 oxygen	 atom,	 present	 in	 all	 furanose	 sugars,	
reduces	 the	 driving	 force	 of	 hydrogenation	 by	 approximately	 12	 kJ	mol‐1	
(hydH(2‐95)	=	‐62.1	kJ	mol‐1),	which	is	even	further	reduced	by	attaching	a	hydroxyl	
group	in		position	resulting	in	2‐67a	(hydH(2‐67a)	=	‐70.4	kJ	mol‐1).	
The	 hydrogenation	 enthalpies	 for	 the	 sugar‐derived	 reaction	 partners	 collected	 in	
Table	2.9	and	Table	2.10	are	shown	graphically	in	Figure	2.15	in	a	comparable	way	
(that	is,	as	the	hydrogenation	enthalpies	of	the	respective	oxidized	forms)	in	order	to	
allow	 side‐by‐side	 comparison.	 That	 means	 all	 sugar	 building	 blocks	 with	 a	 less	
favorable	 (less	negative)	hydrogenation	enthalpy	are	 in	principle	able	 to	 reduce	 the	
respective	nucleobase.	The	 important	 sugar	models	 are	 all	 located	 in	 the	 range	of	 ‐
70.4	to	‐88.1	kJ	mol‐1	and	thus	bracket	the	hydrogenation	enthalpies	of	uracil	(2‐32a),	
its	N‐methylated	derivatives	and	thymine	(2‐32b).	The	most	effective	reducing	agent	
found	 in	 the	 RNA	 sugar	 models	 is	 the	 C2’	 hydroxyl	 group,	 whose	 transfer	
hydrogenation	 with	 uracil	 (2‐32a)	 to	 yield	 dihydrouracil	 2‐65a	 and	 2‐97a	 is	
predicted	 to	 be	 exothermic	 by	 ‐78.1	 ‐	 (‐74.6)	 =	 ‐3.5	 kJ	mol‐1.	 Removal	 of	 the	
C2’	hydroxyl	 group	 as	 is	 the	 case	 in	DNA	 leaves	 only	 over	 the	 C3’	 and	 C5’	 hydroxyl	
groups	 as	 reducing	 agents.	 The	 former	 of	 these	 is	 reactive	 enough	 (hydH(2‐98b)	 =	
‐62.7	kJ	mol‐1)	to	reduce	uracil	and	thymine	in	an	exothermic	fashion.	Overall	it	can	be	
concluded	that	transfer	hydrogenation	from	sugar	components	to	uracil	(2‐32a)	may	
be	thermochemically	favorable.	
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Figure	 2.15	 Heats	 of	 hydrogenation	 hydH	 at	 298.15	 K	 of	 selected	 nucleobases	 and	 carbonyl	
compounds.	 Experimental	 hydrogenation	 enthalpies	 (red	 lines)	 are	 shown	 together	 with	 their	
standard	deviations	as	gray	bars.	
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2.4.3 Complete	Nucleosides	
Comparison	of	the	computed	data	for	the	individual	components	of	Figure	2.15	with	
those	 for	 the	 nucleosides	 in	 Figure	 2.16	 shows	 that	 sugar‐to‐base	 transfer	
hydrogenation	 energetically	 becomes	 more	 positive	 on	 covalent	 coupling	 of	 both	
redox	 partners.	 However,	 even	 for	 the	 least	 favorable	 process,	 the	 formation	 of	 C2’	
oxidized	nucleoside	2‐100a	from	uridine	(2‐99),	the	endothermicity	amounts	to	only	
+10.8	kJ	mol‐1	in	the	gas	phase,	which	is	a	result	of	the	loss	of	the	hydrogen	bond	upon	
oxidation.[59]	Using	either	 the	C3’	 (as	 in	2‐100b)	or	 the	C5’	 (as	 in	2‐100c)	hydroxyl	
groups	as	redox	partners	leads	to	even	less	positive	reaction	energies.	This	difference,	
which	 is	 obtained	 from	Boltzmann‐averaged	enthalpies,	 can	potentially	be	modified	
through	 intermolecular	 interactions	 as	 present	 in	 base‐paired	 systems	 or	 in	 polar	
solvents.	
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Figure	2.16	Heats	of	transfer	hydrogenation	<trhH>	of	uridine	(2‐99)	to	the	three	possible	reaction	
products	as	obtained	at	G3(MP2)‐RAD	level	at	298.15	K	in	the	gas	phase	(left)	and	in	aqueous	solution	
(right).	
Implicit	water	solvation	using	an	IEF‐PCM	model	in	combination	with	UAHF	radii	led	
to	 exothermic	 values	 for	 the	 keto	 models	 with	 the	 largest	 change	 for	 2‐100a	
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(trhH(sol)	=	‐6.6	kJ	mol‐1).	The	oxidation	of	the	C3’	position	present	in	2‐100b	gives	
only	 moderate	 changes	 in	 structural	 parameters	 concerning	 the	 base	 and	 the	 C2’	
hydroxy	 substituent,	 which	 is	 important	 for	 hydrogen‐bonding.	 Application	 of	 the	
more	recent	SMD	solvation	model	by	Truhlar	and	Cramer[60]	leads	to	uniformly	more	
endothermic	 values.	 Irrespective	 of	 the	 used	 theory	 the	 relative	 order	 remains	
unchanged.	 The	 large	 endothermicity	 for	 the	 transfer	 of	 dihydrogen	 upon	 implicit	
solvation	 from	the	C5’	hydroxyl	group	to	 form	2‐100c	 is	a	combination	of	 the	weak	
redox	power	of	the	formyl	residue	and	the	poor	solvation	of	relevant	hydrogen	bonds	
between	the	base	and	the	C2’‐OH	group.	The	strong	impact	of	solvation	after	omission	
of	the	C2’	hydroxyl	group	is	depicted	in	Figure	2.17,	where	the	black	bars	represent	
the	most	favorable	and	the	red	bars	the	least	favorable	conformers	in	the	gas	phase.		
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Figure	 2.17	 Relative	 stabilities	 of	 uridine	 (2‐99)	 and	 its	 redox	 products	 2‐100a	 and	 2‐100b	 at	
G3(MP2)‐RAD	 level	 of	 theory	 in	 the	 gas	 phase	 and	 with	 implicit	 solvation	 (water,	 SMD/B3LYP/	
6‐31G(d)).	
The	 small	 energy	 gap	 of	 herein	 considered	 conformers	 of	2‐100a	 shows	 a	 distinct	
stabilization	in	the	gas	phase.	Most	of	the	conformers	of	C2’	oxidized	2‐100a	possess	
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a	syn	base	orientation,	pointing	 its	C2	carbonyl	residue	directly	 to	 the	C3’	hydrogen	
atom.	For	the	least	stable	conformer	of	2‐100a	 in	the	gas	phase	this	hydrogen	atom	
exhibits	the	highest	Mulliken	charge	of	all	ring	protons.	The	distance	of	the	proton	at	
C3’	 position	 to	 the	 carbonyl	 oxygen	 in	 the	 base	 (r(C3’H‐C2O)	 =	 259	 pm)	 is	 only	
slightly	longer	than	the	related	C3’OH	and	C2’CO	distance	(r(C3’OH‐C2’CO)	=	231	pm).	
The	similar	stabilization	in	the	SMD	model	of	ca.	10	kJ	mol‐1	of	2‐100a	and	2‐100b	is	
the	result	of	weak	interactions	of	the	OH	proton	and	the	neighboring	carbonyl	oxygen	
atom.		
The	 close	proximity	of	nucleobases	 in	RNA	opens	 the	possibility	of	 inter‐nucleotide	
transfer	 hydrogenation.	 Therefore,	 the	 energetics	 for	 an	 intermolecular	 transfer	
hydrogenation	 including	 two	 uridine	 molecules,	 where	 one	 is	 acting	 as	 hydrogen	
donor	 to	 give	2‐101a	 and	 the	 other	 as	 acceptor	 yielding	 5,6‐dihydrouridine	 (2‐5),	
have	 also	 been	 investigated	 theoretically	 using	G3(MP2)‐RAD	and	 SMD	 calculations	
(see	 Scheme	 2.29).	 Compared	 to	 the	 intramolecular	 transfer	 hydrogenation,	 the	
intermolecular	 process	 is	 slightly	 less	 favorable	 by	 2.9	 kJ	 mol‐1	 (<trhH>inter	 =	
+13.7	kJ	mol‐1).	 Secondary	 effects	 are	 again	 almost	 compensated	 by	 implicit	 water	
solvation	yielding	an	endothermic	reaction	enthalpy	of	+10.1	kJ	mol‐1.	
O
OHOH
HO N
NH
O
O
O
OH
HO N
NH
O
O
O
H
H
H
trhH>
O
OHOH
HO N
NH
O
O
H
INTRA
INTER
O
OH
HO N
NH
O
O
O
H
H
+10.8 kJ mol-1 (gas phase)
+7.4 kJ mol-1 (SMD)
+
+13.7 kJ mol-1 (gas phase)
+10.1 kJ mol-1 (SMD)
2-99
2-100a
2-101a 2-5
	
Scheme	2.29	Intra‐	vs.	intermolecular	transfer	hydrogenation	of	uridine	(2‐99)	at	G3(MP2)‐RAD	level	
and	298.15	K.	
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DNA	systems,	in	contrast,	are	much	less	prone	to	this	type	of	redox	process	due	to	the	
removal	of	 the	C2’	hydroxyl	group	und	exchange	of	the	uracil	base	by	thymine.	This	
limits	the	risk	of	transfer	hydrogenation	to	the	terminal	C3’	and	C5’	positions	carrying	
thymine	 (2‐32b)	 as	 redox	 partner.	 The	 results	 of	 a	 hypothetical	 2’‐desoxyuridine	
nucleoside	 2‐102	 are	 depicted	 in	 Figure	 2.18.	 A	 redox	 reaction	 involving	 the	 C5’	
hydroxyl	 group	 leading	 to	 the	 formylated	 redox	 product	 2‐103c	 features	 an	 even	
larger	 endothermic	 enthalpy	 of	 +21.5	 kJ	 mol‐1	 compared	 to	 2‐100c	
(<trhH>(2‐100c)	=	+8.5	kJ	mol‐1)	 in	 the	gas	phase.	On	the	other	hand,	 the	hydrogen	
transfer	 from	 the	 C3’	 OH	 group	 is	 slightly	 exothermic	 (<trhH>(2‐103b)	 =	
‐0.74	kJ	mol‐1).	 As	 expected,	 2‐103b	 profits	 mostly	 from	 the	 displacement	 of	 the	
hydroxyl	group	with	a	simple	hydrogen	atom	upon	solvation	and	is	the	only	example	
where	the	driving	force	for	transfer	hydrogenation	is	increased.	
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Figure	2.18	Comparison	of	Boltzmann‐averaged	heats	of	transfer	hydrogenation	<trhH>	of	ribose	and	
2’‐desoxyribose	derived	nucleosides	at	298.15	K	(G3(MP2)‐RAD	level,	SMD/B3LYP/6‐31G(d)	implicit	
water	solvation).	
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2.5 C5‐modified	Dihydrocytosines	as	Intermediates	in	their	
Demethylation	Process	
Epigenetic	modifications	play	a	crucial	role	in	the	development	and	differentiation	of	
cells.	Unlike	simple	genetics	based	on	the	change	of	the	genotype,	the	changes	in	gene	
expression	 have	 other	 causes	 or	 mechanisms	 such	 as	 non‐coding	 RNAs,	 histone	
modifications[61]	 or	 DNA	 methylation.[62]	 The	 latter	 is	 usually	 observed	 at	 the	 C5	
position	of	cytosine	in	CpG	(cytosine‐phosphatidyl‐guanine)	rich	areas	in	the	genome	
promoter	 region.[63]	The	 so‐called	5th	base	5‐methyl	desoxycytosine	 (m5dC,	2‐4a)	 is	
an	 epigenetic	 mark	 which	 correlates	 with	 gene	 silencing	 due	 to	 prohibition	 of	 the	
transcription	by	m5dC‐affine	proteins.[64]	Recently,	conversion	of	m5dC	in	neurons	or	
embryonic	stem	cells	by	TET	(ten‐eleven	translocation)	enzymes,	which	utilize	‐keto	
glutarate	and	an	 iron(II)‐oxo	species,	was	 found	to	 lead	 to	5‐hydroxymethylcytosine	
(hm5dC,	 2‐4b)[65]	 and	 further	 to	 5‐formylcytosine	 (f5dC,	 2‐4c)[66]	 and	 5‐
carboxycytosine	(ca5dC,	2‐4d).[67]	
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Figure	2.19	Selection	of	modified	DNA	bases,	R	=	2’‐desoxyribose.	
The	biological	effects	of	active	cytosine	demethylation	is	believed	to	revert	the	native	
state	 of	 stem	 cells.[68]	 Two	 mechanisms	 are	 currently	 discussed	 extensively	 in	 the	
literature	(see	Scheme	2.30),	one	involving	special	glycosylases,[69]	followed	by	base	
excision	repair	(BER)	and	second	the	active	decarboxylation	of	ca5dC	(2‐4d).	
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Scheme	2.30	Proposed	mechanisms	for	the	oxidative	demethylation	of	m5dC	(2‐4a).	
Chemical	 model	 studies	 have	 shown,	 that	 decarboxylation	 of	 ca5dC	 (2‐4d)	 is	
accelerated	by	saturation	of	the	C5‐C6	double	bond	either	by	nucleophilic	attack	of	a	
thiol	residue[70]	or	complete	reduction	(see	Scheme	2.31).[68]	
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Scheme	2.31	In‐vitro	decarboxylation	of	silylated	2’‐desoxycytidine	2‐105.	
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The	influence	of	the	side	chain	on	the	reduction	potential	in	terms	of	C5‐C6‐transfer	
hydrogenation	 has	 been	 examined	 at	 the	 G3B3	 level	 of	 theory	 and	 the	 isodesmic	
reaction	as	discussed	in	the	previous	chapters.	The	results	are	summarized	in	Table	
2.11.	The	ease	of	hydrogenation	of	cytosine	derivatives	apparently	depends	on	three	
main	 criteria:	 1.)	 ‐	 and	 ‐accepting	 properties	 of	 the	 group	 at	 C5	 position;	 2.)	
intramolecular	 interactions	 and	 steric	 effects;	 and	3.)	 solvent	 interactions.	 The	 first	
criterion	is	mainly	relevant	for	the	dihydro	compounds,	whereas	the	second	has	to	be	
included	 for	 the	 unsaturated	 parent	 system.	 The	 largest	 hydrogenation	 enthalpy	 in	
the	gas	phase,	apart	 from	the	non‐natural	5‐fluoro	derivative	2‐50c,	 is	observed	 for	
the	1‐methylcytosine	derivate	with	R	=	H	(2‐50a).	The	stereo‐electronic	influences	of	
a	methyl	(2‐50b)	or	a	hydroxymethyl	group	(2‐50d)	is	comparable	low,	giving	almost	
the	same	hydrogenation	enthalpies	(<hydH>(2‐50b)	=	‐45.0	kJ	mol‐1,	<hydH>(2‐50d)	
=	‐42.5	kJ	mol‐1).	The	very	low	driving	force	of	C‐C	double	bond	reduction	in	5‐formyl	
cytosine	2‐50e	 of	 only	 ‐3.8	 kJ	mol‐1	 is	 a	 consequence	 of	 the	 loss	 of	 the	 vinylogous	
amide	resonance	mainly	responsible	for	the	strong	hydrogen	bond	(Scheme	2.32).		
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Scheme	2.32	Vinylogous	amide	resonace	in	cytosines	2‐50e	(R	=	H)	and	2‐50f	(R	=	OH).	
In	 addition,	 the	 electron‐withdrawing	 ability	 as	 	 acceptor	 to	 increase	 the	
electrophilicity	of	the	C‐C	double	bond	is	disabled.	The	final	oxidization	product	2‐50f	
exhibits	the	second	lowest	hydrogenation	enthalpy	(<hydH>(2‐50f)	=	‐11.7	kJ	mol‐1).	
Abstraction	of	 a	proton	 to	 give	 carboxylate	2‐50g	 enhances	 the	driving	 force	by	ca.	
31	kJ	 mol‐1,	 implying	 that	 electronic	 effects	 are	 negligible.	 Implicit	 water	 solvation	
(SMD/B3LYP/6‐31G(d))	 of	 the	 hydroxyl	 group	 in	 2‐50d	 is	 compensated	 by	 the	
enlarged	size	of	the	group.		
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Table	2.11	Boltzmann‐averaged	heats	of	hydrogenation	<hydH*>	of	cytosine	derivatives	at	G3B3	level	
of	theory	in	kJ	mol‐1	(at	298.15	K	and	1	atm).	
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R	 trhH>	 trhH>(sol)a	 hydH*>a	 hydH*>(sol)b	
‐H	(2‐50a)	 +86.99	 +79.50	 ‐49.31	 ‐56.80	
‐CH3	(2‐50b)	 +91.28	 +86.02	 ‐45.02	 ‐50.28	
‐CH2OH	(2‐50d)	 +93.78	 +85.66	 ‐42.45	 ‐50.64	
‐CHO	(2‐50e)	 +132.52	 +117.11	 ‐3.78	 ‐19.19	
‐COOH	(2‐50f)	 +124.57	 +106.83	 ‐11.73	 ‐19.47	
‐COO―	(2‐50g)	 +93.43	 +100.38	 ‐42.87	 ‐35.92	
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Rc	 trhH>	 trhH>(sol)a	 hydH*>a	 hydH*>(sol)b	
‐H	(2‐110a)	 +57.18	 +49.37	 ‐79.12	 ‐86.93	
‐CH3	(2‐110b)	 +64.23	 +57.12	 ‐72.07	 ‐79.18	
‐CH2OH	(2‐110d)	 +58.58	 +58.12	 ‐77.72	 ‐78.18	
‐CHO	(2‐110e)	 +85.74	 +85.73	 ‐50.56	 ‐50.57	
‐COOH	(2‐110f)	 +77.30	 +76.41	 ‐59.00	 ‐59.89	
‐COO―	(2‐110g)	 +89.47	 +67.14	 ‐46.83	 ‐69.16	
a	 Addition	 of	 the	 reaction	 enthalpies	trhH	 to	 the	 experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	hydH(C2H4,	
2‐12a)	 =	 ‐136.3±0.2	 kJ	 mol‐1	 yields	 the	 hydrogenation	 enthalpy	 hydH*	 of	 the	 respective	 double	 bond.	 b	 Addition	 of	 Gsolv	
(SMD/B3LYP/6‐31G(d))	to	the	enthalpies	H298		yields	H(sol).	c	Mixture	of	(E)‐	and	(Z)‐imines.	
	
As	 already	 discussed	 in	 Chapter	 2.4.1,	 the	 imine	 tautomer	 of	 cytosine	 has	 a	
significant	effect	on	the	C‐C	bond	hydrogenation.	The	same	trend	is	observed	for	C5‐
modified	 cytosines	 (see	 Table	 2.11),	 with	 the	 overall	 order	 remaining	 constant.	
Implicit	solvation	has	only	an	impact	on	carboxylate	2‐110f,	which	indicates	that	the	
tautomeric	 imine	 form,	 claimed	 to	 be	 involved	 in	 the	 decarboxylation	 of	 silylated	
ca5dC	(2‐105,	Scheme	2.30),	is	a	populated	structural	motif	in	aqueous	solution.	
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Since	the	driving	force	for	C5‐C6	hydrogenation	shows	a	minimal	value	for	formylated	
cytosine	 2‐50d,	 the	 energetics	 for	 a	 combined	 inter‐	 and	 intramolecular	 redox	
reaction	 of	 hydroxymethyl‐substituted	 2‐50c	 have	 been	 examined	 and	 depicted	 in	
Table	2.12.		
Table	2.12	Boltzmann‐averaged	heats	of	 transfer	hydrogenation	<trhH>	of	hydroxymethyl	 cytosine	
1‐50c	at	G3B3	level	of	theory	in	kJ	mol‐1	(at	298.15	K	and	1	atm).	
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As	expected,	an	intramolecular	hydrogenation	reaction	transferring	H2	from	the	side	
chain	 to	 the	 pyrimidine	 scaffold	 is	 not	 very	 likely	 from	 a	 thermochemical	 point	 of	
view.	Again	tautomerization	increases	the	driving	force	by	approximately	30	kJ	mol‐1.	
On	the	other	hand	an	intermolecular	reaction	has	an	almost	thermoneutral	reaction	
enthalpy	value	of	+1.5	kJ	mol‐1,	which	 is	shifted	 to	exothermic	 ‐17.1	kJ	mol‐1	 for	 the	
imine	 tautomer	 in	 the	 gas	 phase.	 In	 conclusion,	 no	 clear	 evidence	 for	 a	 preferred	
decarboxylation	 mechanism	 of	 m5dC	 (2‐4a)	 has	 been	 found	 on	 the	 basis	 of	 the	
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thermochemical	results.	Especially,	it	remains	currently	open	at	which	oxidation	step	
a	 C‐C	 bond	 cleavage	 occurs	 to	 regain	 2’‐desoxycytosine	 in	 the	 DNA	 strand,	 and	 no	
supporting	 argument	 can	be	derived	 from	 the	 calculations.	Due	 to	 the	 formation	of	
toxic	 byproducts	 (CH2O	 for	 2‐4b	 and	 HCOOH	 for	 2‐4c)	 hints	 for	 deprotonated	
carboxylate	2‐4d	as	plausible	intermediate	can	be	assumed.	
2.6 Conclusion	
The	fidelity	of	biological	information	storage	is	tightly	linked	to	the	chemical	stability	
of	DNA	 and	RNA	oligonucleotides.	 As	 a	 possible	 threat	 reduction	 of	 the	 pyrimidine	
and	 purine	 bases	 as	 a	 result	 of	 transfer	 hydrogenation	 from	 the	 sugar‐phosphate‐
backbone	 (as	 a	 free	 hydroxyl	 group	 is	 present	 in	 C2’	 position	 of	 RNA)	 have	 been	
studied	herein.	Using	a	combined	theoretical	and	experimental	strategy	the	heats	of	
hydrogenation	 of	 the	 different	 bases	 have	 been	 determined.	 The	best	 agreement	 of	
theory	 and	 experiment	 for	 hydH	 has	 been	 obtained	 for	 the	 isodesmic	 reaction	
involving	 transfer	 hydrogenation	 of	 ethane	 (2‐29a)	 and	 ethylene	 (2‐12a)	 at	 G3B3	
level	 of	 theory	 (Scheme	 2.33)	 in	 combination	 with	 the	 experimental	 heat	 of	
hydrogenation	of	ethylene	(hydH(2‐12a,	exp.)	=	‐136.3	kJ	mol‐1).	
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Scheme	2.33	Isodesmic	reaction	to	calculate	various	heats	of	hydrogenation	hydH.	
The	most	 easily	 hydrogenated	 base	 is	 uracil	 (2‐32a),	 followed	 by	 thymine	 (2‐32b)	
and	 cytosine	 (2‐76).	 Comparison	 of	 these	 hydrogenation	 enthalpies	 with	 those	 of	
ketones	 and	 aldehydes	 derived	 from	 sugar	models	 indicates	 the	 possibility	 of	 near	
thermoneutral	 hydrogen	 transfer	 between	 uracil	 (2‐32a)	 and	 the	 sugar	 phosphate	
backbone	(see	Figure	2.20).	Regardless	of	the	position,	the	hydrogenation	of	purine‐
derived	bases	is	always	endothermic.	
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Figure	 2.20	 Heats	 of	 hydrogenation	 hydH	 at	 298.15	 K	 of	 selected	 nucleobases	 and	 carbonyl	
compounds.	 Experimental	 hydrogenation	 enthalpies	 (red	 lines)	 are	 shown	 together	 with	 their	
standard	deviations	as	gray	bars.	
Upon	 coupling	 base	 and	 sugar	 to	 complete	 nucleosides,	 the	 driving	 force	 for	 the	
intramolecular	transfer	hydrogenation	of	uridine	(2‐99)	is	decreased	due	to	changes	
in	 the	 hydrogen	 bonding	 pattern	 upon	 oxidation	 to	 yield	 2‐100a.	 All	 analytical	
methods	 used	 for	 this	 purpose,	 mostly	 mass	 spectrometry,	 would	 not	 be	 able	 to	
predict	 the	 correct	 structure	 of	 the	 reaction	 products.	 The	 rather	 similar	
hydrogenation	enthalpies	found	here	for	some	of	the	sugar	and	base	components	of	
nucleosides	raise	the	question	how	the	information	stored	in	oligonucleotides	can	be	
preserved	 under	 the	 potential	 threat	 of	 internal	 hydrogen	 transfer	 reactions,	
undoubtedly	with	 a	 very	 high	 kinetic	 barrier.	 End‐capping	 and	 post‐transcriptional	
methylation	including	the	formation	of	cyclic	DNA	will	of	course	eliminate	the	risk	of	
transfer	hydrogenation	as	an	unwanted	redox	process.	
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Figure	 2.21	 Intramolecular	 transfer	 hydrogenation	 of	 uridine	 (2‐99)	 at	 G3(MP2)‐RAD	 level	 and	
298.15	K.	
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2.7 Experimental	
2.7.1 General	Considerations	
All	 reactions	 were	 carried	 out	 under	 magnetic	 stirring	 and,	 if	 air	 or	 moisture	
sensitive,	 in	 flame‐dried	 glass	 flasks	 using	 standard	 Schlenk	 techniques	 and	 P4O10‐
predried	N2	 as	 inert	 gas.	 Syringes	were	 used	 to	 transfer	 reagents	 and	 solvents	 and	
were	 purged	with	 N2	 prior	 to	 use.	Microwave	 syntheses	were	 performed	 in	 a	 CEM	
Discover	Synthesis	System.	
Solvents	 (p.a.	 quality)	 were	 dried	 according	 to	 standard	methods[71]	 by	 distillation	
from	 drying	 agents	 and	were	 stored	 under	N2	 over	 4	 Å	molecular	 sieves.	 Reagents	
were	purchased	from	Across,	Aldrich,	Alfa	Aesar	and	Fluka	and	used	without	further	
purification	if	not	otherwise	noted.	
Thin	layer	chromatography	(TLC)	was	performed	using	aluminium	plates	coated	with	
SiO2	(Merck	60,	F254).	The	spots	were	visualized	by	either	UV	light	or	staining	the	TLC	
plates	with	the	reagents	listed	below,	followed	by	heating	with	a	heat	gun:	
 Neat	iodine	
 Ninhydrine	(0.3	g)	in	100	mL	n‐butanol	and	3	mL	glacial	acetic	acid	
 Ce(SO4)2	(5.0	g),	(NH4)6Mo7O24•4	H2O	(25.0	g),	conc.	H2SO4	(50	mL)	in	450	mL	
water	
Flash	column	chromatography	was	performed	according	to	recommendations	by	Still	
using	 SiO2	60	 (0.04‐0.063	mm,	 230‐300	mesh)	 from	Across.[72]	 The	 solvents	 for	 the	
chromatography	were	of	technical	grade	and	distilled	prior	to	use.	
2.7.2 Analytical	Methods	
Nuclear	magnetic	resonance	spectra	were	recorded	on	either	Varian	Mercury	200,	
Varian	 Inova	400	 or	Varian	600	 instruments.	The	chemical	 shifts		were	specified	 in	
ppm	relative	to	the	deuterated	solvent:[73]	
 CDCl3	(1H:	7.26,	13C:	77.0)	
 DMSO‐d6	(1H:	2.50,	13C:	39.5)	
 CD3OD	(1H:	3.31,	13C:	40.0)	
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The	signals	were	assigned	to	the	corresponding	nuclei	by	1H1H‐COSY,	1H13C‐HSQC	or	
1H13C‐HMBC	 experiments.	 For	 the	 characterization	 of	 the	 observed	 signal	
multiplicities,	 the	 following	 abbreviations	 were	 used:	 s	 (singlet),	 d	 (doublet),	 t	
(triplet),	 q	 (quartet),	 dd	 (doublet	 of	 doublets),	 br	 (broad)	 and	 m	 (multiplet).	 The	
coupling	constants	nJ	with	n	=	2,3,4	(distance	between	the	protons)	are	given	in	Hz.	
Melting	points	are	uncorrected	and	were	measured	on	a	Büchi	B‐540	apparatus.	
Infrared	 spectra	 were	 recorded	 from	 4000‐500	 cm−1	 on	 a	 Perkin‐Elmer	 FT‐IR	
Spectrum	BX‐spectrometer	 using	 the	 ATR‐technique.	 For	 the	 band	 characterization,	
the	following	abbreviations	were	used:	vs	(very	strong),	s	(strong),	m	(medium)	and	
w	(weak).	
Mass	 spectra	 were	 recorded	 on	 a	 Finnigan	 MAT	 95q	 or	 MAT90	 instrument	 for	
electron	impact	ionisation	(EI,	70	eV).	Electron	spray	ionisation	(ESI)	measurements	
were	 performed	 on	 a	 Thermo	 Finnigan	 LTQ	 FT	 apparatus.	 High	 resolution	 mass	
spectra	(HRMS)	were	recorded	on	the	same	instruments.	
Elemental	analyses	(CHNS)	were	performed	by	the	microanalytical	laboratory	of	the	
central	 analytics	 divison	 of	 the	 faculty	 for	 chemistry	 and	 pharmacy	 using	 either	 an	
Elementar	vario	EL	or	Elementar	vario	micro	cube	device.	
2.7.3 Calorimetry	
Combustion	 calorimetry	 and	 enthalpy	 measurements	 were	 performed	 by	 the	
group	of	Prof.	Dr.	Sergey	Verevkin	at	the	university	of	Rostock.	The	details	can	be	found	
herein.[74]		
2.7.4 Typical	Procedures	
2.7.4.1 Typical	procedure	for	the	methylation	of	pyrimidines	(TP1)	
To	 a	 suspension	 of	 the	 corresponding	pyrimidine	derivative	 in	 20%	aqueous	NaOH	
was	added	dimethyl	sulfate	dropwise	at	0	°C.	After	one	hour	the	ice	bath	was	removed	
and	stirring	at	room	temperature	was	continued	for	an	additional	hour.	The	colorless	
solution	was	transferred	to	a	separating	funnel	and	extracted	with	CHCl3.	The	organic	
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phase	was	dried	over	MgSO4	and	concentrated	under	 reduced	pressure	 to	yield	 the	
crude	methylated	pyrimidines	as	colorless	solids.	
2.7.4.2 Typical	procedure	for	the	synthesis	of	N,N’‐dimethyl	
dihydropyrimidines	(TP2)	
A	dry	and	nitrogen‐flushed	10‐mL	microwave	vessel	was	charged	with	N,N′‐dimethyl	
urea,	 the	 corresponding	 acrylic	 acid	 and	 a	 magnetic	 stir	 bar.	 It	 was	 sealed	 and	
irradiated	 (200	 W,	 closed	 vessel,	 PowerMAX)	 to	 150	 °C.	 After	 cooling	 to	 room	
temperature	 the	 crude	 mixtures	 were	 purified	 either	 by	 fractional	 distillation	 or	
column	chromatography.	
2.7.4.3 Typical	procedure	for	the	chlorination	of	pyrimidine	bases	(TP3)	
A	pressure	tube	was	charged	with	the	corresponding	pyrimidine	base	and	mixed	with	
phosphoryl	 chloride	 POCl3	 followed	 by	 pyridine	 as	 HCl	 scavenger.	 The	 tube	 was	
quickly	sealed	and	heated	either	in	the	oil	bath	or	in	the	microwave	to	150	°C	until	all	
starting	material	was	consumed	(TLC	control).	The	dark	solution	was	poured	onto	ice	
water/sat.	NaHCO3	solution	and	extracted	with	CH2Cl2.	The	combined	organic	extracts	
were	dried	over	MgSO4	filtered	and	evaporated	to	dryness.	
2.7.4.4 Typical	procedure	for	the	nucleophilic	aromatic	substitution	of	
chloro	pyrimidines	(TP4)	
Sodium	 methoxide	 was	 slowly	 added	 under	 stirring	 to	 its	 parent	 alcohol	 in	 a	
microwave	vial.	 The	 resulting	 suspension	was	 cooled	by	 an	 ice	bath	 and	 the	 chloro	
pyrimidine	was	added	in	small	portions	or	dropwise	via	syringe.	The	vial	was	sealed	
and	heated	under	microwave	irradiation	to	90	°C	(200	W,	closed	vessel,	PowerMAX)	
until	 TLC	 control	 showed	 complete	 consumption	 of	 the	 starting	 material.	 The	
suspension	was	diluted	with	water	and	extracted	with	CH2Cl2.	The	combined	organic	
phase	was	dried	over	MgSO4,	filtered	and	evaporated	under	reduced	pressure.	
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2.7.4.5 Typical	procedure	for	the	methylation/rearrangement	of	
electron	rich	pyrimidines	(TP5)	
In	 a	 round‐bottom	 flask	 alkoxy‐substituted	 pyrimidines	 were	 dissolved	 in	 methyl	
iodide,	sealed	by	a	stopper	and	placed	in	the	refrigerator	overnight.	Excess	of	methyl	
iodide	was	removed	under	reduced	pressure	and	the	remaining	solid	was	melted	and	
cooled	down	again.	The	melting	steps	were	monitored	by	TLC.	If	further	purification	
was	needed	column	chromatography	was	applied.	
2.7.4.6 Typical	procedure	for	the	acidic	demethylation	of	pyrimidones	
(TP6)	
A	10	mL	microwave	vial	was	charged	with	the	pyrimidone	and	dissolved	in	aqueous	
HCl.	The	reaction	mixture	was	heated	in	the	microwave	under	closed‐shell	conditions	
for	30	minutes.	The	crude	product	was	either	collected	by	 filtration	after	cooling	 to	
0	°C	or	by	column	chromatography.	
2.7.5 Target	Compounds	
2.7.5.1 1,3‐Dimethylpyrimidine‐2,4(1H,3H)‐dione	(2‐47a)	
N
N
O
O
CH3
CH3 	
According	 to	 TP1	 the	 title	 compound	 was	 prepared	 by	 reacting	 uracil	 (4.48	 g,	
40.0	mmol)	with	dimethyl	sulfate	(8.5	mL,	11.3	g,	89.6	mmol)	in	20	mL	aqueous	NaOH	
solution.	 After	 extraction	with	 CHCl3	 (3x	 100	mL)	 the	 crude	 uracil	was	 purified	 by	
column	chromatography	on	silica	using	CHCl3/MeOH	(20:1)	as	eluent	to	yield	2‐47a	
as	colorless	solid	(3.54	g,	25.3	mmol,	63.2	%).	Alternatively,	2‐47a	can	be	purified	by	
recrystallization	from	EtOH.	
	
M.p.	122.1	‐	123.0	°C.	Rf	(CHCl3/MeOH,	20:1)	=	0.55.	
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1H	NMR	 (600	MHz,	 CDCl3)	 	 7.10	 (d,	 3J	 7.9	 Hz,	 1H,	 C(6)H),	 5.66	 (d,	 3J	 7.9	 Hz,	 1H,	
C(5)H),	3.34	(s,	3H,	N(3)CH3),	3.27	(s,	3H,	N(1)CH3)	ppm.	
13C	NMR	 (150	MHz,	CDCl3)		 163.2	 (C(4)),	 151.8	 (C(2)),	 142.7	 (C(6)),	 101.1	 (C(5)),	
36.9	(NCH3),	27.6	(NCH3)	ppm.	
IR	 (ATR)		 (cm−1)	=	3079	 (w),	1714	 (m),	1700	 (m),	1653	 (vs),	1483	 (m),	1438	 (s),	
1399	(m),	1372	(s),	1343	(s),	1264	(w),	1234	(m),	1178	(m),	1147	(m),	1002	(w),	985	
(w),	932	(w),	812	(vs),	759	(vs),	726	(m),	684	(m),	625	(w).	
HRMS	(EI,	70	eV,	m/z):	[M]+	calcd	for	C6H8N2O2,	140.0586;	found,	140.0588.	
EA	(%	calcd,	%	found	for	C6H8N2O2):	C	(51.42,	51.49),	H	(5.75,	5.91),	N	(19.99,	20.05).	
NMR	spectra	are	in	agreement	with	already	published	data.[75]	
2.7.5.2 1,3,5‐Trimethylpyrimidine‐2,4(1H,3H)‐dione	(2‐47b)	
N
N
O
O
CH3
CH3 	
According	 to	 TP1	 the	 methylated	 thymine	 derivative	 2‐47b	 was	 prepared	 by	 the	
reaction	 of	 thymine	 (2.52	 g,	 19.98	 mmol)	 with	 dimethyl	 sulfate	 (4.0	 mL,	 3.01	 g,	
23.9	mmol)	in	10	mL	aqueous	NaOH	solution.	After	extraction	with	CHCl3	(3x	100	mL)	
the	 crude	 product	 was	 purified	 by	 column	 chromatography	 on	 silica	 using	
CHCl3/MeOH	 (20:1)	 as	 eluent	 to	 yield	2‐47b	 as	 colorless	 solid	 (2.38	 g,	 15.4	mmol,	
77	%).	
	
M.p.	148.3	‐	150.0	°C.	Rf	(CHCl3/MeOH,	20:1)	=	0.57.	
1H	NMR	(300	MHz,	CDCl3)		6.97	(q,	4J	1.2	Hz,	1H,	C(6)H),	3.34	(s,	3H,	N(3)CH3),	3.33	
(s,	3H,	N(1)CH3),	1.90	(d,	4J	1.2	Hz,	3H,	CHCH3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		164.0	(C(4)),	151.8	(C(2)),	138.9	(C(6)),	109.5	(C(5)),	36.6	
(NCH3),	27.9	(NCH3),	12.9	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3066	(w),	2992	(w),	2954	(w),	2929	(w),	2850	(w),	1700	(m),	1661	
(s),	1633	(vs),	1508	(w),	1450	(s),	1421	(m),	1382	(m),	1366	(m),	1339	(s),	1230	(s),	
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1193	(s),	1069	(m),	1048	(m),	1001	(s),	960	(m),	926	(m),	840	(w),	808	(w),	776	(s),	
763	(vs),	753	(vs),	667	(m).	
HRMS	(EI,	70	eV,	m/z):	[M]+	calcd	for	C7H10N2O2,	154.0742;	found,	154.0741.		
EA	 (%	 calcd,	 %	 found	 for	 C7H10N2O2):	 C	 (54.54,	 54.23),	 H	 (6.54,	 6.53),	 N	 (18.17,	
18.15).	
NMR	spectra	are	in	agreement	with	already	published	data.[75]	
2.7.5.3 1,3‐Dimethyl‐5,6‐dihydropyrimidine‐2,4‐dione	(2‐49a)	
N
N
O
CH3
O
CH3
	
2‐49a	 was	 prepared	 according	 to	TP2	 by	 heating	N,N′‐dimethyl	 urea	 (2.20	 g,	 25.0	
mmol)	 and	 acrylic	 acid	 (1.7	mL,	 1.81	 g,	 25.1	mmol)	 at	 150	 °C	 for	 two	 hours.	 After	
cooling	to	room	temperature	the	yellowish	oil	was	distilled	fractionally	under	reduced	
pressure	(p	=	0.29	mbar,	b.p.	=	114	‐	116	°C)	to	yield	dihydrouracil	2‐49a	as	colorless	
oil	which	solidified	upon	standing	(1.85	g,	13.0	mmol,	52.1	%).	
	
M.p.	40.7	‐	42.2		°C.	Rf	(CHCl3/MeOH,	20:1)	=	0.53.	
1H	NMR	(600	MHz,	CDCl3)		3.26	(dt,	3J	6.9	Hz,	3J	4.4	Hz,	2H,	C(6)H2),	3.03	(d,	3J	6.8	Hz,	
3H,	N(3)CH3),	2.92	(d,	3J	5.9	Hz,	3H,	N(1)CH3),	2.61	(dt,	3J	6.8	Hz,	3J	5.2	Hz,	2H,	C(5)H2)	
ppm.	
13C	NMR	 (150	MHz,	 CDCl3)		 169.1	 (C(4)),	 153.7	 (C(2)),	 42.6	 (C6),	 35.5	 (N(3)CH3),	
31.1	(C5),	27.2	(N(1)CH3)	ppm.	
HRMS	(EI,	70	eV,	m/z):	[M]+	calcd	for	C6H10N2O2,	142.0742;	found,	142.0731.		
EA	 (%	 calcd,	 %	 found	 for	 C6H10N2O2):	 C	 (50.69,	 50.54),	 H	 (7.09,	 6.87),	 N	 (19.71,	
19.79).	
NMR	spectra	were	in	agreement	with	already	published	data.[41]	
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2.7.5.4 rac‐1,3,5‐Trimethyl‐5,6‐dihydropyrimidine‐2,4‐dione	(2‐49b)	
N
N
O
CH3
O
CH3
	
According	 to	 TP2	 the	 racemic	 dihydropyrimidine	 2‐49b	 was	 prepared	 by	 heating	
N,N′‐dimethyl	urea	(2.20	g,	25.0	mmol)	with	methacrylic	acid	(2.15	g,	2.13	mL,	25.0	
mmol)	at	150	°C	for	one	hour.	After	cooling	to	room	temperature	the	highly	viscous	
mixture	 was	 directly	 transferred	 to	 a	 silica	 gel	 filled	 column	 to	 be	 purified	 by	
chromatography.	 The	 product	 was	 obtained	 as	 colorless	 oil	 which	 solidified	 upon	
cooling	(1.66	g,	10.6	mmol,	43	%).	
 
M.p.	39.4	‐	40.9	°C.	Rf	(CHCl3/MeOH,	20:1)	=	0.55.	
1H	NMR	(300	MHz,	CDCl3)		3.24	(dd,	2J	12.3	Hz,	3J	6.1	Hz,	1	H,	C(6)Ha),	3.06	(s,	3H,	
N(3)CH3),	3.05	 (dd,	 2J	 12.3	Hz,	 3J	10.5	Hz,	1H,	C(6)Hb),	2.96	 (s,	3H,	N(1)CH3),	2.72	 ‐	
2.58	(m,	1H,	C(4)H),	1.15	(dd,	3J	7.0	Hz,	4J	0.85	Hz,	3H,	C(4)CH3)	ppm.	
13C	NMR	 (75	MHz,	CDCl3)		172.2	 (C(4)),	153.8(C(2)),	49.5	 (C(6)),	35.4	 (C(5)),	35.4	
(N(3)CH3),	27.6	(N(1)CH3),	13.1	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3353	(w),	2997	(w),	2968	(w),	2935	(w),	2898	(w),	2797	(w),	1706	
(s),	1659	(vs),	1525	(w),	1494	(s),	1450	(s),	1418	(vs),	1402	(s),	1377	(s),	1343	(m),	
1284	(s),	1270	(s),	1209	(s),	1160	(m),	1134	(s),	1092	(s),	1030	(s),	985	(w),	949	(w),	
911	(m),	889	(w),	761	(s),	731	(m).	
HRMS	(EI,	70	eV,	m/z):	[M]+	calcd	for	C7H12N2O2,	156.0899;	found,	156.0875.		
EA	 (%	 calcd,	 %	 found	 for	 C7H12N2O2):	 C	 (53.83,	 53.81),	 H	 (7.74,	 7.63),	 N	 (17.94,	
18.03).	
NMR	spectra	are	in	agreement	with	already	published	data.[41]	
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2.7.5.5 2,4‐Dichloropyrimidine	(2‐41a)	
N
N
Cl
Cl 	
According	to	TP3	uracil	(2‐32a,	1.76	g,	15.70	mmol)	was	reacted	with	POCl3	(2.8	mL,	
1.67	g,	10.9	mmol)	and	pyridine	(1.2	mL,	1.22	g,	15.4	mmol)	for	two	hours	at	150	°C	
(oil	 bath).	 After	 work‐up	 and	 purification	 by	 column	 chromatography	 (SiO2,	
PE/EtOAc,	10:1)	the	title	compound	2‐41a	was	isolated	as	colorless,	sublimable	solid	
(0.97	g,	6.51	mmol,	42	%).	
	
M.	p.	59.4	–	61.1	°C	(no	decomp.).	Rf	(SiO2,	PE/EtOAc,	10:1)	0.26.	
1H	NMR	 (400	MHz,	 CDCl3)	 	 8.53	 (d,	 3J	 5.3	 Hz,	 1H,	 C(6)H),	 7.34	 (d,	 3J	 5.2	 Hz,	 1H,	
C(5)H)	ppm.	
13C	NMR	 (100	MHz,	CDCl3)		162.8	 (C(4)),	161.	2	 (C(2)),	160.2	 (C(6)),	120.5	 (C(5))	
ppm.	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C4H235Cl2N2	147.9595	(M+),	found	147.9601.	
NMR	spectra	are	in	agreement	with	already	published	data.[76]		
2.7.5.6 2,4‐Dichloro‐5‐methylpyrimidine	(2‐41b)	
N
N
Cl
Cl 	
According	to	TP3	the	mixture	of	thymine	(1‐32b,	1.89	g,	15.00	mmol),	POCl3	(2.8	mL,	
1.67	g,	10.9	mmol)	and	pyridine	(1.2	mL,	1.22	g,	15.4	mmol)	was	heated	for	one	hour	
to	150	°C	in	the	microwave	(100	W,	closed	vessel,	PowerMAX	on).	After	work‐up	and	
purification	 by	 column	 chromatography	 (SiO2,	 PE/EtOAc,	 5:1)	 the	 chlorinated	
methylpyrimidine	2‐41b	was	obtained	as	colorless	oil	(1.59	g,	9.76	mmol,	65	%)	
	
Rf	(SiO2,	PE/EtOAc,	5:1)	0.48.	
1H	NMR	(300	MHz,	CDCl3)		8.41	(s,	1H,	C(6)H),	2.35	(s,	3H,	C(5)CH3)	ppm.	
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13C	 NMR	 (300	 MHz,	 CDCl3)	 	 162.61	 (C(2)),	 160.08	 (C(4)),	 158.29	 (C(6)),	 129.11	
(C(5)),	15.89	(C(5)CH3)	ppm.	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C5H435Cl2N2	161.9746	(M+),	found	161.9749.	
NMR	spectra	are	in	agreement	with	already	published	data.[77]	
2.7.5.7 2,4‐Dimethoxypyrimidine	(2‐42a)	
N
N
OMe
OMe 	
An	excess	of	NaOMe	 (2.50	g,	46.3	mmol)	was	heated	with	 chloro	pyrimidine	2‐41a	
(1.50	g,	10.1	mmol)	in	methanol	(20	mL)	under	microwave	conditions	(closed	vessel,	
100	W,	POWERMax	on)	 for	 one	hour	 to	90	 °C.	 Following	 the	work‐up	procedure	 in	
TP4,	 2,4	 dimethoxypyrimidine	 (2‐42a)	 was	 obtained	 after	 purification	 by	 column	
chromatography	(SiO2,	PE/EtOAc,	5:1)	as	colorless	liquid	(1.40	g,	10.0	mmol)	in	99	%	
yield.	
	
Rf	(SiO2,	PE/EtOAc,	5:1)	0.45.	
1H	NMR	 (300	MHz,	 CDCl3)		8.15	 (d,	 3J	 5.7	Hz,	 1	H,	 C(6)H),	 6.34	 (d,	 3J	 5.7	Hz,	 1	H,	
C(5)H),	3.96	(s,	3	H,	OMe),	3.93	(s,	3	H,	OMe)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		171.4	(C(4)),	165.4	(C(2)),	158.2	(C(6)),	102.0	(C(5)),	54.6	
(OMe),	53.6	(OMe)	ppm.	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C6H8N2O2	140.0586	(M+),	found	140.0581.	
NMR	spectra	are	in	agreement	with	already	published	data.[77]	
2.7.5.8 2,4‐Dimethoxy‐5‐methylpyrimidine	(2‐42b)	
N
N
OMe
OMe 	
Following	TP4	2‐42b	was	synthesized	by	the	reaction	of	sodium	methoxide	(1.50	g,	
27.8	mmol)	with	chloropyrimidine	2‐41b	(1.04	g,	6.38	mmol)	in	MeOH	(5	mL)	in	the	
microwave	 (90	 °C,	 closed	vessel,	 100	W,	POWERMax	on)	 for	90	min.	After	work‐up	
2.7	Experimental		
76	
and	purification	by	column	chromatography	(SiO2,	PE/EtOAc,	5:1)	2‐42b	was	isolated	
as	colorless	sublimable	solid	(0.72	g,	4.67	mmol,	73	%).	
	
M.	p.	57.0	–	58.2	°C	(no	decomp.).	Rf	(SiO2,	PE/EtOAc,	5:1)	0.31.	
1H	NMR	(300	MHz,	CDCl3)		7.85	(q,	4J	0.8	Hz,	1	H,	C(6)H),	3.96	(s,	3	H,	OMe),	3.93	(s,	
3	H	OMe),	2.02	(q,	4J	0.8	Hz,	3	H,	C(5)CH3)	ppm.	
13C	NMR	 (75	MHz,	 CDCl3)	 	169.5	 (C(4)),	 164.0	 (C(2)),	 156.8	 (C(6)),	 111.0	 (C(5)),	
54.5	(OMe),	53.7	(OMe),	11.8	(C(5)CH3)	ppm.	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C7H10N2O2	154.0742	(M+),	found	154.0729.	
2.7.5.9 2,4‐Diethoxy‐5‐methylpyrimidinium	iodide	(2‐45b)	
N
N
OEt
OEt
CH3
I
	
According	 to	 TP5	 pyrimidine	 2‐44b	 (0.63	 g,	 3.46	 mmol)	 was	 dissolved	 in	 methyl	
iodide	 (0.28	 mL,	 0.63	 g,	 4.46	 mmol)	 and	 stored	 over	 night	 at	 around	 0	 °C	 in	 the	
refrigerator.	 Excess	 MeI	 was	 removed	 from	 the	 crystalline	 precipitate	 under	 high	
vacuum.[40]	
2.7.5.10 4‐Ethoxy‐1,5‐dimethylpyrimidine‐2(1H)‐one	(2‐111a)	
N
N
OEt
O
CH3 	
The	pyrimidinium	salt	2‐45b	was	melted	with	the	aid	of	a	heat	gun	and	subsequently	
cooled	 to	 room	 temperature	 again.	 The	 precipitated	 solid	 was	 purified	 by	 column	
chromatography	 (SiO2,	 EtOAc/MeOH,	 10:1)	 to	 yield	 pyrimidone	2‐111	 as	 colorless	
solid	(0.35	g,	2.07	mmol,	60	%).[40]	
	
M.	p.	109.5	–	110.5	°C	(no	decomp.).	Rf	(SiO2,	EtOAc/MeOH,	10:1)	0.28.	
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1H	NMR	(300	MHz,	CDCl3)		7.17	(s,	1H,	C(6)H),	4.43	(q,	3J	7.1	Hz,	2H,	OCH2CH3),	3.44	
(s,	3H,	C(5)CH3),	1.92	(s,	3H,	N(1)CH3),	1.35	(t,	3J	7.1	Hz,	3H,	OCH2CH3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		170.6	(C(4)),	157.4	(C(2)),	144.7	(C(6)),	104.6	(C(5)),	63.3	
(OCH2CH3),	37.7	(N(1)CH3),	14.4	(OCH2CH3),	12.1	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3041(w),	2992	(w),	1656	(vs),	1632	(vs),	1566	(m),	1535	(s),	1462	
(s),	1422	(vs),	1390	(s),	1365	(s),	1343	(vs),	1324	(vs),	1252	(s),	1179	(m),	1159	(vs),	
1109	(s),	1060	(s),	1032	(vs),	934	(s),	917	(s),	902	(m),	815	(m),	780	(vs),	745	(s),	
693	(m).	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C8H12N2O2	168.0893	(M+),	found	168.0890.	
2.7.5.11 4‐Ethoxy‐1‐ethyl‐5‐methylpyrimidine‐2(1H)‐one	(2‐111b)	
N
N
OEt
O
	
2‐111b	 was	 isolated	 as	 side	 product	 after	 melting	 the	 pyrimidinium	 salt	 2‐45b	
(0.83	g,	2.56	mmol)	for	two	times	(99.0	mg,	0.54	mmol,	21	%).[40]	
	
M.	p.	75.1	–	77.5	°C	(no	decomp.).	Rf	(SiO2,	EtOAc/MeOH,	10:1)	0.46.	
1H	NMR	(300	MHz,	CDCl3)		7.16	(s,	1H,	C(6)H),	4.42	(q,	3J	7.1	Hz,	2H,	OCH2CH3),	3.84	
(q,	3J	7.2	Hz,	2H,	NCH2CH3),	1.91	(s,	3H,	C(5)CH3),	1.34	(t,	3J	7.1	Hz,	2H,	OCH2CH3),	1.30	
(t,	3J	7.1	Hz,	2H,	OCH2CH3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		170.3	(C(4)),	156.7	(C(2)),	143.5	(C(6)),	104.7	(C(5)),	63.2	
(OCH2CH3),	45.2	(NCH2CH3),	14.6	(OCH2CH3),	14.4	(NCH2CH3),	12.2	(C(5)CH3)	ppm.	
IR	 (ATR)		 (cm−1)	 3048	 (w),	 2975	 (m),	 2951	 (w),	 1665	 (vs),	 1636	 (vs),	 1571	 (w),	
1527	(s),	1483	(m),	1461	(s),	1443	(s),	1426	(vs),	1393	(m),	1376	(vs),	1361	(s),	1328	
(vs),	1279	(m),	1234	(vs),	1172	(m),	1154	(vs),	1106	(s),	1098	(m),	1074	(m),	1031	
(s),	1012	(m),	972	(m),	938	8m),	902	(m),	885	(w),	806	(m),	784	(vs),	761	(m),	744	
(s),	690	(w),	620	(w),	582	(m),	566	(w).	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C9H14N2O2	182.1050	(M+),	found	182.1052.	
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2.7.5.12 4‐Methoxy‐1‐methylpyrimidine‐2(1H)‐one	(2‐43a)	
N
N
OMe
O
CH3 	
According	 to	 TP5	 2‐43a	 was	 isolated	 from	 a	 mixture	 of	 2,4‐dimethoxypyrimidine	
(2‐42a,	1.26	g,	8.99	mmol)	and	methyl	iodide	(0.60	mL,	1.36	g,	9.58	mmol)	by	column	
chromatography	using	silica	as	stationary	phase	 (EtOAc/MeOH,	15:1).	The	colorless	
solid	(2‐43a)	was	obtained	in	a	yield	of	63	%	(0.79	g,	5.64	mmol),	together	with	37	%	
starting	material	(2‐42a,	0.47	g,	3.35	mmol).	
	
M.	p.	146.5	–	147.3	°C	(no	decomp.).	Rf	(SiO2,	EtOAc/MeOH,	15:1)	0.30.	
1H	NMR	(400	MHz,	CDCl3)		7.40	(d,	3J	7.1	Hz,	1H,	C(6)‐H),	5.84	(d,	3J	7.1	Hz,	1H,	C(5)‐
H),	3.92	(s,	3H,	OMe),	3.46	(s,	3H,	NMe).	
13C	NMR	(75	MHz,	CDCl3)		171.8	(C(4)),	157.0	(C(2)),	147.4	(C(6)),	95.3	(C(5)),	54.3	
(OCH3),	37.9	(NCH3)	ppm.	
IR	(ATR)		(cm−1)	3009	(w),	2990	(w),	2950	(w),	1656	(s),	1632	(vs),	1574	(m),	1535	
(s),	1488	(vs),	1471	(m),	1453	(s),	1430	(w),	1409	(s),	1351	(s),	1301	(vs),	1229	(s),	
1200	(s),	1176	(m),	1123	(s),	1045	(m),	1023	(s),	989	(m),	898	(w),	785	(vs),	779	(vs),	
720	(m),	618	(m),	564	(s).	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C6H8O2N2	140.0586	(M+),	found	140.0581.	
2.7.5.13 4‐Methoxy‐1,5‐dimethylpyrimidine‐2(1H)‐one	(2‐43b)	
N
N
OMe
O
CH3 	
2‐43b	 was	 isolated	 in	 41	 %	 yield	 (0.27	 g,	 1.75	 mmol,	 TP5)	 after	 purification	 by	
column	 chromatography	 (SiO2,	 EtOAc/MeOH,	 10:1)	 of	 a	 mixture	 of	 2‐42b	 (0.65	 g,	
4.22	mmol)	 and	 MeI	 (0.9	 mL),	 together	 with	 0.33	 g	 of	 unreacted	 starting	 material	
(2‐42b,	2.14	mmol,	51	%).	
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M.	p.	141.1	–	142.1	°C	(no	decomp.).	Rf	(SiO2,	EtOAc/MeOH,	10:1)	0.32.	
1H	NMR	(300	MHz,	CDCl3)		7.18	(q,	4J	1.1	Hz,	1	H,	C(6)H),	3.96	(s,	3	H,	OCH3),	3.44	(s,	
3	H,	NCH3),	1.92	(d,	4J	1.1	Hz,	3	H,	C(5)CH3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		170.8	(C(4)),	157.1	(C(2)),	144.6	(C(6)),	104.3	(C(5)CH3),	
54.5	(OMe),	37.6	(NCH3),	11.9	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3027	(w),	2959	(w),	1659	(vs),	1629	(vs),	1563	(w),	1538	(s),	1472	
(s),	1434	(s),	1390	(m),	1377	(m),	1359	(s),	1329	(s),	1257	(s),	1191	(m),	1171	(s),	
1135	(s),	1007	(m),	993	(vs),	932	(m),	887	(w),	779	(vs),	743	(s),	693	(w),	628	(s).	
HR‐MS	(EI,	70	eV)	m/z	calc.	for	C7H10N2O2	154.0742	(M+),	found	154.0724.	
	
2.7.5.14 1‐Methyluracil	(2‐39a)	
N
NH
O
CH3
O
	
Following	 the	 general	 procedure	TP6,	 pyrimidone	 2‐43a	 (0.33	 g,	 2.35	 mmol)	 was	
heated	with	HCl	(3.8	%	in	H2O)	for	30	min	to	110	°C	in	the	microwave	(100	W,	closed	
vesell,	PowerMAX	on).	The	flask	was	placed	in	the	fridge	over	night;	the	precipitated	
solid	 was	 filtered	 off	 and	 washed	 with	 pentane.	 After	 drying	 under	 high	 vacuum,	
uracil	derivate	2‐39a	was	obtained	as	colorless	needles	(0.17	g,	1.35	mmol,	57	%).	
	
M.	p.	232.7	–	234.2	°C	(no	decomp.).	Rf	(SiO2,	EtOAc/MeOH,	10:1)	0.38.	
1H	NMR	(400	MHz,	DMSO‐d6)		11.20	(s	br,	1	H,	NH),	7.60	(d,	3J	7.8	Hz,	1	H,	C(6)H),	
5.51	(dd,	3J	7.8	Hz,	4J	2.3	Hz,	1	H,	C(5)H),	3.22	(s,	3	H,	NCH3)	ppm.	
13C	NMR	(100	MHz,	DMSO‐d6)		163.9	(C(4)),	151.2	(C(2)),	146.4	(C(6)),	100.5	(C(5)),	
35.2	(NCH3)	ppm.	
IR	(ATR)		(cm−1)	3000	(w),	2977	(w),	2874	(w),	2827	(w),	1759	(w),	1652	(s),	1619	
(s),	1525	(m),	1482	(m),	1459	(m),	1420	(s),	1376	(s),	1329	(s),	1222(m),	1198	(m),	
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1159	(m),	1143	(m),	1046	(m),	990	(m),	855	(s),	802	(vs),	754	(vs),	722	(s),	627	(w),	
558	(s).	
HRMS	(EI,	70	eV,	m/z):	calcd	for	C5H6N2O2,	126.0429	(M+);	found,	126.0420.	
EA	(%	calcd,	%	found	for	C5H6N2O2):	C	(47.62,	47.50),	H	(4.80,	4.90),	N	(22.21,	22.07).	
NMR	spectra	are	in	agreement	with	already	published	data.[78]	
2.7.5.15 1‐Methylthymine	(2‐39b)	
N
NH
O
CH3
O
	
According	to	TP6	4‐methoxypyrimidone	2‐43b	(0.18	g,	1.17	mmol)	was	dissolved	in	
2	mL	aqueous	HCl	 (3.8	%)	and	heated	 in	 the	microwave	 cavity	 for	30	min	 (110	 °C,	
closed	vessel,	100	W,	PowerMAX	on).	Thymine	2‐39b	(0.14	g,	0.99	mmol,	85	%)	was	
obtained	after	purification	by	column	chromatography	(SiO2,	EtOAc/MeOH,	10:1).	
	
M.	p.	289.7	–	291.3	°C	(decomp.).	Rf	(SiO2,	EtOAc/MeOH,	10:1)	0.51.	
1H	NMR	(400	MHz,	DMSO‐d6)		11.19	(s	broad,	1H,	NH),	7.49	(d,	4J	1.2	Hz,	1H,	C(6)H),	
3.19	(s,	3H,	NMe),	1.74	(d,	4J	1.2	Hz,	3H,	C(5)CH3)	ppm.	
13C	NMR	(100	MHz,	DMSO‐d6)		164.4	(C(4)),	151.2	(C(2)),	142.3	(C(6)),	108.1	(C(5)),	
34.9	(NCH3),	11.8	(C(5)CH3)	ppm.	
IR	 (ATR)	 	 (cm−1)	 3148	 (w),	 3062	 (m),	 3001	 (m),	 2957	 (m),	 2927	 (m),	 2828	 (m),	
1762	(w),	1713	(s),	1696	(s),	1650	(vs),	1639	(vs),	1515	(m),	1484	(s),	1464	(s),	1422	
(vs),	1378	(s),	1368	(s),	1328	(vs),	1208	(s),	1150	(s),	1066	(vs),	1050	(s),	1010	(m),	
949	(s),	889	(s),	787	(s),	756	(vs),	693	(vs),	654	(m).	
HRMS	(EI,	70	eV,	m/z):	calcd	for	C6H8N2O2,	140.0586	(M+);	found,	140.0572.		
EA	(%	calcd,	%	found	for	C6H8N2O2):	C	(51.42,	51.33),	H	(5.75,	5.86),	N	(19.99,	19.89).	
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2.7.5.16 1‐tert‐Butoxycarbonyluracil	(2‐40)	
N
NH
O
O
OO 	
A	suspension	of	uracil	(2‐32a,	1.12	g,	10.0	mmol),	excess	Boc2O	(2.23	g,	78.9	mmol)	
and	catalytical	amounts	of	DMAP	(0.06	g,	0.049	mmol)	 in	acetonitrile	(20	mL)	were	
stirred	for	two	hours	at	room	temperature	until	everything	was	dissolved.	All	volatile	
compounds	 were	 removed	 and	 the	 solid	 residue	 was	 purified	 by	 recrystallisation	
from	EtOAc	or	column	chromatography	on	silica	using	a	mixture	of	petrol	ether/ethyl	
acetate	(1:1)	as	eluent.	Boc‐protected	uracil	2‐40	was	isolated	by	recrystallisation	as	
colorless	solid	(0.89	g,	4.19	mmol)	in	41.9	%	yield.	
	
M.	p.	>	300	°C.	Rf	(SiO2,	PE/EtOAc,	1:1)	0.42.	
1H	NMR	(300	MHz,	CDCl3)		8.88	(s,	1H,	NH),	7.87	(d,	3J	8.4	Hz,	1H,	C(6)H),	5.79	(d,	3J	
8.4	Hz,	1H,	C(5)H),	1.60	(s,	9H,	C(CH3)3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		162.6	(C(4)),	148.2	(NHCO2),	147.1	(C(2)),	139.7	(C(6)),	
103.7	(C(5)),	87.3	(C(CH3)3),	27.8	(C(CH3)3)	ppm.	
IR		(cm−1)	3126	(w),	3105	(w),	3042	(w),	2982	(w),	2935	(w),	2842	(w),	1791	(w),	
1753	 (s),	 1733	 (s),	 1703	 (vs),	 1634	 (m),	 1477	 (w),	 1459	 (w),	 1450	 (w),	 1403	 (m),	
1362	(s),	1265	(vs),	1234	(s),	1147	(vs),	1126	(vs),	1099	(vs),	1034	(w),	992	(w),	856	
(s),	862	(m),	835	(vs),	777	(s),	765	(s),	754	(s),	733	(m),	659	(vs).	
HRMS	(EI,	70	eV,	m/z):	calcd	for	C9H13N2O4,	213.0875	(M+H)+;	found,	213.0848.		
NMR	spectra	are	in	agreement	with	already	published	data.[36]	
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2.7.5.17 1‐Methyl‐5,6‐dihydrouracil	(2‐46a)	
N
NH
O
O
CH3 	
A	 50	 mL	 Schlenk	 flask	 equipped	 with	 stirring	 bar	 and	 additional	 stop‐cock	 was	
charged	with	1‐methyluracil	 (2‐39a,	 0.19	 g,	 1.51	mmol),	 palladium	on	 carbon	 (5%,	
0.02	g,	0.94	mol)	and	ethanol	(10	mL).	After	flushing	the	flask	for	30	seconds	with	
hydrogen	 gas,	 the	 substrate	 was	 hydrogenated	 under	 atmospheric	 pressure	 until	
complete	 reduction	 was	 confirmed	 by	 1H	 NMR	 spectroscopy	 or	 TLC	 (SiO2,	
CHCl3/EtOH,	9:1).	The	hydrogen	was	 replaced	by	nitrogen	and	 the	dark	 suspension	
was	filtered	over	a	plug	of	celite.	After	removal	of	the	solvent	the	dihydro	compound	
2‐46a	was	obtained	as	colorless	solid	(0.19	g,	1.48	mmol)	in	almost	quantitative	yield.	
	
An	alternative	way	to	synthesize	2‐46a	is	the	following:	
Dihydrocytosine	2‐55a	(0.10	g,	0.79	mmol)	was	dissolved	in	aqueous	HCl	(1.9	%,	1.0	
mL)	and	stirred	at	 room	temperature	 for	 five	minutes.	All	volatile	 compounds	were	
removed	under	 reduced	pressure	and	 the	 remaining	 colorless	 solid	was	purified	by	
column	 chromatography	 (SiO2,	 CHCl3/EtOH,	 9:1)	 to	 obtain	 the	 hydrolysis	 product	
2‐46a	(0.06	g,	0.47	mmol)	in	60	%	yield.	
	
M.	p.	169.6	–	170.8	°C	(no	decomp.).	Rf	(SiO2,	CHCl3/EtOH,	9:1)	0.49.	
1H	NMR	(400	MHz,	DMSO‐d6)		10.04	(s	broad,	1H,	NH),	3.33	(t,	3J	6.9	Hz,	2H,	C(6)H2),	
2.85	(s,	3H,	NCH3),	2.54	(t,	3J	6.9	Hz,	2H,	C(5)H2)	ppm.	
13C	NMR	(100	MHz,	DMSO‐d6)		170.5	(C(4)),	153.1	(C(2)),	43.1	(C(6)),	34.0	(NCH3),	
30.6	(C(5))	ppm.	
IR	(ATR)		(cm−1)	3386	(w),	3818	(m),	3069	(m),	2975	(w),	2946	(w),	2924	(w),	1692	
(vs),	1505	(vs),	1458	(s),	1408	(vs),	1371	(s),	1335	(s),	1292	(s),	1267	(s),	1241	(vs),	
1202	(vs),	1123	(m),	1070	(s),	1046	(m),	986	(m),	957	(m),	844	(s),	831	(vs),	767	(s),	
736	(vs),	712	(s).	
HRMS	(EI,	70	eV,	m/z):	calcd	for	C5H8N2O2,	128.0586	(M+);	found,	128.0579.	
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EA	(%	calcd,	%	found	for	C5H8N2O2):	C	(46.87,	45.03),	H	(6.29,	6.13),	N	(21.86,	20.98).	
2.7.5.18 rac‐1‐Methyl‐5,6‐dihydrothymine	(2‐46b)	
N
NH
O
O
CH3 	
A	 50	 mL	 Schlenk	 flask	 equipped	 with	 stirring	 bar	 and	 additional	 stop‐cock	 was	
charged	with	 thymine	 derivative	2‐39b	 (0.14	 g,	 1.00	mmol),	 Rhodium	on	 activated	
Al2O3	 (5%,	 0.03	 g,	 1.46	mol)	 and	 ethanol	 (10	mL).	 After	 flushing	 the	 flask	 for	 30	
seconds	 with	 hydrogen	 gas,	 the	 stopper	 was	 closed	 and	 the	 substrate	 was	
hydrogenated	 under	 atmospheric	 pressure	 until	 complete	 reduction	was	 confirmed	
by	 1H	 NMR	 spectroscopy	 or	 TLC	 (SiO2,	 MeOH).	 The	 hydrogen	 was	 replaced	 by	
nitrogen	and	the	dark	suspension	was	filtered	over	a	plug	of	celite	and	washed	with	
EtOH.	 After	 removal	 of	 the	 solvent	 the	 dihydro	 compound	 2‐46b	 was	 obtained	 as	
colorless	solid	(0.13	g,	0.91	mmol)	in	a	yield	of	91	%.	
	
M.	p.	150.4	–	151.8	°C	(no	decomp.).	Rf	(SiO2,	CHCl3/EtOH,	9:1)	0.59.	
1H	NMR	 (400	MHz,	DMSO‐d6)		10.03	(s	br,	1	H,	NH),	3.35	(dd,	2J	12.2	Hz,	3J	6.3	Hz,	
1	H,	C(6)Ha),	 3.17	–	3.06	 (m,	1	H,	C(6)Hb),	 2.86	 (s,	 3	H,	NCH3),	 2.72	–	2.60	 (m,	1	H,	
C(5)H),	1.06	(d,	3J	7.0	Hz,	3	H,	C(5)CH3)	ppm.	
13C	NMR	(100	MHz,	DMSO‐d6)		173.2	(C(4)),	153.2	(C(2)),	49.7	(C(6)),	34.5	(NCH3),	
34.0	(C(5)),	12.4	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3199	(w),	3076	(w),	2980	(w),	2942	(w),	2883	(w),	1686	(vs),	1494	
(s),	1449	(m),	1408	(m),	1392	(s),	1338	(m),	1240	(vs),	1151	(w),	1105	(w),	1069	(w),	
1043	(w),	954	(w),	913	(w),	837	(s),	752	(vs),	728	(s),	678	(m).	
HR‐MS	(ESI,	m/z):	calcd	for	C6H9N2O2,	141.0670	(M‐H)‐;	found,	141.0670.	
EA	 (%	 calcd,	 %	 found	 for	 C6H10N2O2):	 C	 (50.69,	 50.74),	 H	 (7.09,	 7.08),	 N	 (19.71,	
19.70).	
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2.7.5.19 1‐(2‐Cyanoethyl)‐1‐methylurea	(2‐59a)	
H2N N
CN
O
CH3 	
3‐(Methylamino)propionitrile	(4.26	g,	50.6	mmol),	dissolved	in	10	mL	water	and	5	mL	
conc.	HCl	was	dropped	slowly	to	a	solution	of	potassium	cyanate	(5.70	g,	70.3	mmol)	
in	15	ml	water.	The	reaction	was	completed	by	heating	the	reaction	flask	to	60	°C	for	
30	min	(100	W,	open	vessel,	PowerMAX	on)	in	the	microwave.	After	cooling	to	room	
temperature	 the	 solvent	was	 removed	under	 reduced	pressure	and	 the	 residue	was	
purified	 by	 column	 chromatography	 on	 SiO2	 (crude	 mixture	 charged	 on	 SiO2,	
EtOAc/MeOH,	10:1).	Urea	2‐59a	was	obtained	as	colorless	solid	(3.86	g,	30.4	mmol,	
60.0	%).	
	
M.p.	116.7	‐	117.7	°C	(no	decomp.).	Rf	(EtOAc/MeOH,	10:1)	0.25.	
1H	 NMR	 (400	 MHz,	 DMSO‐d6)	 	 5.94	 (s	 broad,	 2	 H,	 NH2),	 3.43	 (t,	 3J	 6.7	 Hz,	 2	 H,	
NCH2CH2CN),	2.83	(s,	3	H,	NCH3),	2.64	(t,	3J	6.7	Hz,	2	H,	NCH2CH2CN)	ppm.	
13C	 NMR	 (100	 MHz,	 DMSO‐d6)	 	 158.3	 (CO),	 119.3	 (CN),	 44.0	 (NCH2CH2CN),	 34.5	
(NCH3),	16.0	(NCH2CH2CN)	ppm.	
IR	(ATR)		(cm−1)	3396	(m),	3286	(w),	3182	(m),	2941	(w),	2775	(w),	2247	(w),	1656	
(s),	1600	 (vs),	1505	 (vs),	1443	 (m),	1411	 (vs),	1361	 (m),	1330	(m),	1288	 (s),	1222	
(m),	1159	(m),	1105	(s),	1066	(s),	1013	(vs),	990	(m),	820	(w),	775	(s),	728	(m).	
HRMS	(ESI,	m/z):	calcd	for	C5H10N3O,	128.0824	(M+H)+;	found,	128.0819.		
2.7.5.20 1‐Methyl‐5,6‐dihydrocytosine	(2‐55a)	
N
N
NH2
O
CH3 	
In	a	10	mL	round‐bottom	flask	equipped	with	reflux	condenser	and	magnetic	stir	bar	
a	 mixture	 of	 urea	2‐59a	 (1.05	 g,	 8.26	mmol)	 and	 sodium	methoxide	 (0.17	 g,	 3.15	
mmol)	in	absolute	ethanol	(10	mL)	was	refluxed	for	30	minutes.	The	formed	colorless	
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precipitate	 was	 filtered	 off	 upon	 cooling	 and	 washed	 with	 a	 small	 amount	 of	 cold	
ethanol.	Recrystallization	from	ethanol	yielded	2‐55a	as	colorless,	acid	sensitive	solid	
(0.91	g,	7.16	mmol,	86.7	%).	
	
M.p.	224.1	‐	225.0	°C	(decomp.).	
1H	NMR	 (400	MHz,	DMSO−d6)		7.49	ppm	(s	broad,	1	H,	NHaH),	7.26	(s	broad,	1	H,	
NHbH),	 3.19	 (t,	 3J	 7.0	 Hz,	 2	 H,	 C(6)H2),	 2.79	 (s,	 3	 H,	 NCH3),	 2.41	 (t,	 3J	 7.0	 Hz,	 2	 H,	
C(5)H2).	
13C	NMR	 (100	MHz,	 DMSO−d6)	 	 168.3	 ppm	 (C(4)),	 159.5	 (C(2)),	 44.0	 (C(6)),	 35.0	
(NCH3),	25.8	(C(5)).	
IR	(ATR)		(cm−1)	3311	(m),	3016	(w),	2918	(w),	1654	(w),	1616	(s),	1538	(s),	1482	
(m),	1464	(m),	1426	(vs),	1394	(s),	1315	(vs),	1273	(vs),	1256	(vs),	1180	(m),	1130	
(s),	1071	(w),	1000	(w)	952	(w),	881	(m),	839	(w),	789	(vs),	753	(s),	710	(vs),	608	(s),	
572	(vs).	
HRMS	(ESI,	m/z):	calcd	for	C5H10N3O	,	128.0824	(M+H)+;	found,	128.0819.		
EA	(%	calcd,	%	found	for	C5H9N3O):	C	(47.99,	47.95),	H	(5.64,	5.50),	N	(33.58,	33.48).	
2.7.5.21 rac‐2‐Methyl‐3‐(methylamino)‐propionitrile	(2‐63a)	
N
H
CNH3C
	
Methacrylonitrile	 (12.6	 mL,	 10.1	 g,	 147	 mmol)	 was	 added	 via	 syringe	 under	 ice	
cooling	 to	 ethanolic	 MeNH2	 solution	 (33%,	 6.74	 mL,	 54.1	 mmol)	 and	 stirred	 over	
night	at	room	temperature.	The	solvent	was	removed	under	reduced	pressure	and	the	
crude	propionitrile	2‐63a	was	obtained	as	yellowish	oil	 (1.83	g,	18.6	mmol,	34	%),	
which	was	used	without	further	purification.[40]	
	
1H	NMR	(200	MHz,	CDCl3)		2.89	–	2.61	ppm	(m,	3	H,	CH2CHCN),	2.45	(s,	3	H,	NCH3),	
1.30	(d,	3J	5.9	Hz,	3	H,	(CH)CNCH3).	
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2.7.5.22 rac‐1‐(2‐Cyanopropyl)‐1‐methylurea	(2‐59b)	
H2N N
O
CH3
CN
	
Propionitrile	2‐63a	 (0.40	 g,	 4.11	mmol)	 in	water	 (1.25	mL)	was	 carefully	 acidified	
with	conc.	HCl	(0.41	mL,	4.91	mmol)	and	then	added	dropwise	to	a	stirred	solution	of	
potassium	cyanate	(0.47	g,	5.75	mmol)	in	a	25	mL	round	bottom	flask.	After	stirring	
over	night	at	room	temperature	all	volatile	components	were	removed	at	the	rotary	
evaporator	and	 the	remaining	solid	was	purified	by	column	chromatography	(crude	
mixture	charged	on	SiO2,	EtOAc/MeOH,	10:1).	Title	compound	2‐59b	was	isolated	as	
colorless	solid	in	59	%	yield	(0.34	g,	2.41	mmol).[40]	
	
M.p.	127.4	‐	128.4	°C	(no	decomp.).	Rf	(EtOAc/MeOH,	10:1)	0.30.	
1H	NMR	(400	MHz,	CD3OD)		3.47	(qd,	2J	14.1	Hz,	3J	7.6	Hz,	2	H,	NCH2),	3.11	(m,	1	H,	
CH2CHCN),	3.02	(s,	3	H,	NCH3),	1.27	(d,	3J	7.1	Hz,	3	H,	(CH)CNCH3)	ppm.	
13C	NMR	(100	MHz,	CD3OD)		161.8	(C=O),	123.1	(CN),	52.7	(CH2),	36.3	(NCH3),	26.2	
(CH),	15.4	(CH3)	ppm.	
IR	 (ATR)		 (cm−1)	 3400	 (w),	 3191	 (m),	 2943	 (w),	 2241	 (w),	 1656	 (vs),	 1601	 (vs),	
1504	(vs),	1453	(m),	1437	(m),	1414	(vs),	1381	(m),	1353	(m),	1333	(m),	1293	(s),	
1176	(w),	1105	(s),	1075	(s),	1035	(s),	935	(w),	914	(w),	814	(w),	776	(s).	
HRMS	(ESI,	m/z):	calcd	for	C6H12N3O,	142.0975	(M+H)+;	found,	142.0977.	
2.7.5.23 4‐Amino‐1,5‐dimethyldihydropyrimidin‐2(1H)‐one	(2‐55b)	
N
N
NH2
O
CH3 	
A	10	mL	microwave	vial	was	 charged	with	urea	2‐59b	 (0.32g,	 2.27	mmol),	 sodium	
methoxide	(0.50	g,	0.93	mmol)	and	EtOH	(3	mL).	The	suspension	was	heated	 in	the	
microwave	cavity	for	30	min	under	closed	vessel	conditions	(80	°C,	100	W,	PowerMAX	
on).	The	suspension	was	filtered	after	cooling	to	room	temperature	and	washed	with	
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cold	ethanol.	After	recrystallization	from	EtOH,	2‐55b	was	obtained	as	colorless,	acid‐
sensitive	solid	(0.27	g,	1.91	mmol,	84	%).[40]	
	
M.p.	183.7	‐	185.0	°C	(decomp.).	
1H	NMR	(400	MHz,	CD3OD)		3.48	(d,	2J	12.5	Hz,	1	H,	C(6)Hb),	3.29	(m,	1	H,	C(5)H),	
3.05	(d,	2J	12.5	Hz,	1	H,	C(6)Ha),	2.96	(s,	3	H,	NCH3),	1.24	(d,	3J	6.5	Hz,	3	H,	CH3)	ppm.	
13C	NMR	 (100	MHz,	 CD3OD)		 174.7	 (C(2)),	 161.4	 (C(4)),	 52.0	 (C(6)),	 36.0	 (NCH3),	
32.2	(C(5)),	16.1	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	2930	(w),	1685	(vs),	1626	(s),	1576	(m),	1493	(s),	1442	(vs),	1393	
(vs),	1330	(m),	1292	(s)	1137	(m),	862	(m),	753	(s),	731	(s),	703	(s),	677	(s),	677	(s),	
632	(s),	617	(s),	589	(vs),	565	(vs).	
HRMS	(ESI,	m/z):	calcd	for	C6H11N3O,	141.0897	(M+);	found,	141.0896.	
2.7.5.24 N,N‐Dimethyl‐N’‐(1‐methyl‐2‐oxo‐1,2‐dihydropyrimidin‐4‐
yl)formimidamide	(2‐52a)	
N
N
N
O
CH3
N
	
Cytosine	 (2‐51a,	 0.75	 g,	 6.75	 mmol)	 was	 suspended	 in	 N,N‐dimethylformamide	
dimethyl	 acetal	 (6	 mL)	 in	 a	 dry	 and	 clean	 10	 mL	microwave	 vial	 and	 sealed	 by	 a	
septum.	 Subsequently	 trifluoroacetic	 acid	 (0.1	 mL,	 0.15	 g,	 1.32	 mmol)	 was	 added	
carefully	via	syringe	and	heated	in	the	microwave	cavity	for	two	hours	(200	W,	closed	
vessel,	PowerMAX	on)	to	120	°C.	After	cooling	to	room	temperature	the	dark	colored	
suspension	 was	 filtered	 off,	 washed	 with	 toluene	 and	 dried	 under	 high	 vacuum.	
Analytically	 pure	 samples	 were	 obtained	 after	 recrystallization	 from	 toluene	 as	
yellowish	solid	(0.81	g,	4.50	mmol,	67%).	
	
M.p.	193.1	‐	196.5 °C	(decomp.).	
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1H	NMR	(300	MHz,	CDCl3)		8.80	(s,	1H,	NCHN(CH3)2),	7.33	(d,	3J	6.9	Hz,	1H,	C(6)H),	
5.99	(d,	3J	6.9	Hz,	1H,	C(5)H),	3.45	(s,	3H,	NCH3),	3.12	(s,	3H,	NCHN(CH3)2),	3.10	(s,	3H,	
NCHN(CH3)2)	ppm.	
13C	NMR	 (75	MHz,	 CDCl3)	 	 172.1	 (C(4)),	 158.3	 (NCHN(CH3)2),	 157.5	 (C(2)),	 146.5	
(C(6)),	102.4	(C(5)),	41.3	(NCH3),	38.0	(NCHN(CH3)2),	35.0	(NCHN(CH3)2)	ppm.	
IR	(ATR)		(cm−1)	3008	(w),	2951	(w),	2918	(w),	2805	(w),	1654	(m),	1589	(vs),	1576	
(s),	1510	(s),	1458	(m),	1440	(m),	1415	(s),	1393	(s),	1347	(s),	1325	(vs),	1269	(s),	
1248	 (s),	 1200	 (m),	 1172	 (m),	 1152	 (m),	 1132	 (w),	 1098	 (vs),	 1058	 (,),	 1040	 (m),	
1007	(m),	980	(s),	950	(m),	884	(m),	820	(w),	814	(m),	799	(vs),	785	(s),	729	(m),	718	
(m).	
HRMS	(ESI,	m/z):	calcd	for	C8H13N4O,	181.1089	(M+H)+;	found,	181.1083.		
NMR	spectra	are	in	agreement	with	already	published	data.[42]	
2.7.5.25 1‐Methylcytosine	(2‐50a)	
N
N
NH2
O
CH3 	
A	 10	mL	microwave	 vial	 equipped	with	 septum	 and	 stirring	 bar	was	 charged	with	
formimidamide	2‐52a	 (0.50	g,	2.77	mmol)	and	ethanolic	MeNH2	solution	 (33	wt.%,	
5.0	mL).	The	resulting	suspension	was	heated	for	30	minutes	to	60	°C	under	closed‐
shell	conditions	(100	W,	PowerMAX	on).	The	precipitated	colorless	solid	was	filtered	
off	and	washed	with	toluene.	After	recrystallization	from	EtOH	and	drying	under	high	
vacuum,	1‐methylcytosine	(2‐50a,	0.30	g,	2.40	mmol,	86	%)	was	obtained	as	colorless	
solid.	
 
M.p.	295.5	‐	296.2	°C	(decomp.).	
1H	NMR	 (400	 MHz,	 DMSO‐d6)	 	 7.53	 (d,	 3J	 7.1	 Hz,	 1H,	 C(6)H),	 6.96	 (s	 broad,	 1H,	
NHaH),	 6.89	 (s	 broad,	 1H,	NHbH),	 5.59	 (d,	 3J	 7.1	Hz,	 1H,	 C(5)H),	 3.17	 (s,	 3H,	NCH3)	
ppm.		
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13C	NMR	(100	MHz,	DMSO‐d6)		166.1	(C(4)),	156.4	(C(2)),	146.6	(C(6)),	92.9	(C(5)),	
36.7	(NCH3)	ppm.	
IR	(ATR)		(cm−1)	3337	(m),	3129	(m),	2919	(w),	2786	(w),	1968	(w),	1899	(w),	1749	
(w),	1619	(vs),	1525	(s),	1485	(s),	1436	(m),	1419	(s),	1370	(s),	1325	(s),	1260	(s),	
1209	(s),	1156	(s),	1127	(s),	1050	(m),	987	(m),	949	(m),	807	(m),	799	(s),	781	(vs),	
770	(s),	665	(vs).		
HRMS	(ESI,	m/z):	calcd	for	C5H8N3O,	126.0667	(M+H)+;	found,	126.0662.		
EA	(%	calcd,	%	found	for	C5H7N3O):	C	(47.99,	47.95),	H	(5.64,	5.50),	N	(33.58,	33.48).	
NMR	spectra	are	in	agreement	with	already	published	data.[42]	
2.7.5.26 4‐Amino‐1,5‐dimethylpyrimidin‐2(1H)‐one	(2‐50b)	
N
N
NH2
O
CH3 	
In	a	pressure	 tube	equipped	with	 stirring	bar	and	screw	cap	4‐ethoxypyrimidinone	
2‐54b	(0.48	g,	2.85	mmol)	was	mixed	with	excess	methanolic	ammonia	(2	M,	15	mL,	
30.0	mmol),	 closed	 and	 heated	 in	 the	 microwave	 for	 16	 h	 and	 140	 °C	 (300 W, 
PowerMAX on).	All	volatile	components	were	removed	under	reduced	pressure	und	
the	residue	was	purified	by	column	chromatography	(SiO2,	DCM/MeOH,	10:1)	to	give	
2‐50b	as	colorless	solid	(38	mg,	0.27	mmol,	1	%).[40]	
	
M.p.	280	‐	290	°C	(under	slow	decomp.).	Rf	(DCM/MeOH,	10:1)	0.20.	
1H	NMR	(300	MHz,	CD3OD)		7.42	(q,	4J	1.0	Hz,	1	H,	C(6)H),	3.35	(s,	3	H,	NCH3),	1.93	
(d,	4J	1.1	Hz,	3	H,	C(5)CH3)	ppm.	
13C	NMR	(100	MHz,	CD3OD)		167.5	(C(4)),	159.6	(C(2)),	145.7	(C(6)),	103.9	(C(5)),	
37.5	(NCH3),	13.0	(C(5)CH3)	ppm.	
IR	(ATR)		(cm−1)	3381	(m),	3095	(m),	2928	(w),	1810	(w),	1668	(s),	1612	(vs),	1517	
(s),	1480	(s),	1426	(s),	1394	(s),	1363	(vs),	1326	(s),	1278	(m),	1223	(m),	1161	(s),	
1104	(s),	1065	(m),	1044	(m),	909	(m),	879	(w),	781	(vs),	756	(m),	704	(m).	
HRMS	(ESI,	m/z):	calcd	for	C6H10N3O,	140.0818	(M+H)+;	found,	140.0821.		
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2.7.5.27 rac‐cis‐4‐Hydroxytetrahydrofuran‐3‐yl	acetate	(2‐68a)	
O
OHOO
	
A	dry	N2‐flushed	100	mL	round	bottom	Schlenk	flask,	equipped	with	stirring	bar	and	
reflux	condenser,	was	charged	with	1,4‐anhydroerithritol	 (2‐66,	5.20	g,	50.0	mmol),	
triethyl	orthoacetate	(13.8	mL,	12.21	g,	75.3	mmol)	and	25	mL	dry	THF.	Via	syringe,	
TFA	(0.1	mL,	0.15	g,	1.32	mmol)	was	slowly	added	to	 the	colorless	solution	and	the	
mixture	 was	 refluxed	 for	 15	 min	 in	 the	 microwave	 (80	 °C,	 200	 W,	 open	 vessel,	
PowerMAX	on).	After	cooling	to	room	temperature	the	solution	was	concentrated	to	a	
colorless	oil,	which	was	redissolved	in	20	mL	of	a	mixture	of	5	%	aqueous	oxalic	acid	
and	acetone	(1:10)	and	stirred	for	30	minutes	at	ambient	temperature.	Solid	Na2SO4	
and	NaHCO3	was	added	to	remove	traces	of	water	and	acid.	The	resulting	slurry	was	
filtered	over	a	pad	of	 silica	and	washed	with	acetone.	The	 filtrate	was	concentrated	
and	finally	purified	by	column	chromatography	(SiO2,	EtOAc)	to	give	acetate	2‐68a	as	
colorless	liquid	(6.22	g,	42.6	mmol,	89	%)	
	
Rf	(EtOAc)	0.56.	
1H	NMR	 (300	MHz,	 CDCl3)	 	 5.11	 (td,	 3J	 4.2	Hz,	 3J	 5.62	Hz,	 1	H,	 C(3)H),	 4.43	 (q,	 3J	
5.5	Hz,	1	H,	C(4)H),	4.05	(dd,	2J	10.2	Hz,	3J	5.8	Hz,	1H,	C(2)Ha),	3.96	(dd,	2J	9.5	Hz,	3J	
5.8	Hz,	1	H,	C(5)Ha),	3.81	(dd,	2J	10.2	Hz,	3J	4.2	Hz,	1	H	C(2)Hb),	3.70	(dd,	2J	9.4	Hz,	3J	
5.3	Hz,	1	H,	C(5)Hb),	2.33	(s	br,	1	H,	OH),	2.13	(s,	3	H,	CH3)	ppm.	
13C	NMR	(75	MHz,	CDCl3)		170.7	(CO),	73.7	(C(3)HOAc),	72.3	(C(5)H2),	70.8	(C(4)H),	
70.5	(C(2)H2),	20.8	(COCH3)	ppm.	
NMR	spectra	are	in	agreement	with	already	published	data.[54]	
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2.7.5.28 rac‐(R)‐Tetrahydro‐4‐oxofuran‐3‐yl	acetate	(2‐69a)	
O
OO O
	
To	a	solution	of	acetate	2‐68a	 (7.17	g,	49.1	mmol)	and	DCM	(150	mL)	 in	a	250	mL	
round	bottom	flask	was	added	celite	(5.5	g),	followed	by	PCC	(20.84	g,	96.7	mmol)	at	
room	 temperature	 The	 dark	 colored	 suspension	 was	 stirred	 two	 days	 at	 room	
temperature	and	then	filtered	over	a	plug	of	silica	and	washed	with	EtOAc.	The	filtrate	
was	concentrated	under	reduced	pressure	and	the	dark	residual	oil	was	purified	by	
column	chromatography	(SiO2)	using	EtOAc	as	eluent.	Ketone	2‐69a	was	obtained	as	
yellowish	liquid	in	69	%	yield	(4.92	g,	34.1	mmol).	
	
Rf	(EtOAc)	0.81.	
1H	NMR	(300	MHz,	CDCl3)		5.18	(t,	3J	8.0	Hz,	1	H,	C(4)H),	4.53	(dd,	2J	9.8	Hz,	3J	8.1	Hz,	
1	H,	C(5)Ha),	4.11	(d,	2J	17.5	Hz,	1	H,	C(2)Ha),	4.07	(d,	2J	17.5	Hz,	1	H,	C(2)Hb),	3.87	(t,	
3J	9.2	Hz,	1	H,	C(5)Hb),	2.13	(s,	3	H,	CH3)	ppm.	
13C	 NMR	 (75	 MHz,	 CDCl3)	 	 209.0	 (C(3)O),	 169.8	 (CH3CO),	 71.5	 (C(4)H),	 69.7	
(C(2)H2),	69.2	(C(5)H2),	20.4	(CH3)	ppm.	
NMR	spectra	are	in	agreement	with	already	published	data.[54]	
2.7.5.29 rac‐cis‐4‐(Benzyloxy)tetrahydrofuran‐3‐ol	(2‐68b)	
O
OHO 	
In	 a	 100	 mL	 Schlenk	 flask	 equipped	 with	 stirring	 bar	 and	 reflux	 condenser	 1,4‐
anhydroerithritol	(2‐66,	0.52	g,	5.00	mmol)	was	dissolved	in	dry	THF	(50	mL).	Under	
ice	cooling	NaH	(60	%	in	oil,	0.15	g,	6.25	mmol)	was	added	in	small	portions,	followed	
by	 tetrabutylammonium	 iodide	 (0.20	 g,	 0.054	mmol)	 and	 benzyl	 bromide	 (0.6	 mL,	
0.86	 g,	 5.03	 mmol).	 The	 reaction	 mixture	 was	 refluxed	 for	 4	 h	 under	 microwave	
irradiation	 (100	W,	 open	 vessel	 PowerMAX	 on).	 Saturated	 aqueous	 NH4Cl‐solution	
was	 added	 to	 quench	 the	 reaction	 and	 the	 mixture	 was	 extracted	 with	 CH2Cl2	
(3x	20	mL).	 The	 organic	 phase	 was	 dried	 over	 MgSO4,	 filtered	 and	 evaporated	 to	
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dryness.	The	residue	was	purified	by	column	chromatography	(SiO2,	PE/EtOAc,	1:1)	
and	benzyl	ether	2‐68b	was	obtained	as	yellowish	oil	(0.50	g,	2.57	mmol,	51	%).	
	
Rf	(PE/EtOAc,	1:1)	0.43.	
1H	NMR	(400	MHz,	CDCl3)		7.53	–	7.29	(m,	5	H,	Ph),	4.62	(s,	2	H,	PhCH2),	4.26	(qd,	3J	
5.4	 Hz,	 3J	 4.0	 Hz,	 1	 H,	 C(4)H),	 4.07	 (q,	 3J	 5.5	 Hz,	 1	 H,	 C(3)H),	 3.90	 (ddd,	 2J	 9.7	 Hz,	
3J	5.5	Hz	4J	2.4	Hz,	2	H,	C(5)H2),	3.83	–	3.71	(m,	2	H,	C(2)H2),	2.77	(d,	 3J	5.6	Hz,	1	H,	
OH).	
13C	NMR	(100	MHz,	CDCl3)		137.1	(Ph,	Cq),	128.6	(Ph,	Co),	128.2	(Ph,	Cp),	127.9	(Ph,	
Cm),	78.3	(C(3)H),	73.4	(C(5)H2),	72.6	(PhCH2),	70.3	(C(4)H),	70.0	(C(2)H2)	ppm.	
IR	(ATR)		(cm−1)	3427	(w),	3064	(w),	3031	(w),	2942	(w),	2870	(w),	1733	(w),	1606	
(w),	1586	(w),	1497	(w),	1454	(m),	1403	(w),	1371	(w),	1331	(w),	1247	(w),	1209	
(m),	1125	(s),	1066	(vs),	1027	(s),	1005	(s),	904	(s),	736	(vs),	697	(vs).	
HRMS	(EI,	70	eV,	m/z):	calcd	for	C11H14O3,	194.2271	(M+);	found,	194.0945.	
2.8 Theoretical	Appendix	
Geometry	optimizations	of	all	systems	have	been	performed	at	 the	B3LYP/6‐31G(d)	
level	of	theory.	Thermochemical	corrections	to	298.15	K	have	been	calculated	at	the	
same	level	of	theory	using	the	rigid	rotor/harmonic	oscillator	model.	A	scaling	factor	
of	 0.9806	 has	 been	 used	 for	 this	 latter	 part.	 Single	 point	 energies	 have	 then	 been	
calculated	 at	 the	 MP2(FC)/6‐311+G(3df,2p)	 level.	 Combination	 of	 the	 MP2	 total	
energies	 with	 thermochemical	 corrections	 obtained	 at	 B3LYP	 level	 yield	 the	
enthalpies	termed	as	"MP2"	in	the	text.		
	
H(HL)	=	Etot(HL)	+	H(B3LYP,	scal.)	–	Etot(B3LYP)	 	 (eq.	2.10)	
	
In	the	conformationally	flexible	sugar	systems	enthalpies	and	free	energies	have	been	
calculated	 as	 Boltzmann‐averaged	 values	 (w		1%)	 over	 all	 available	 conformers	
obtained	 by	 a	 preliminary	 conformational	 search	 using	 the	 MM3*	 force	 field[79]	
implemented	in	MacroModel	9.7.[80]	
The	Boltzmann‐averaged	enthalpies	of	n	conformers	are	obtained	by	eq.	2.11:	
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exp ∆
	
∑ ∆
	
	
H298 	 ∑ wiHini 1 			 	 	 (eq.	2.11)	
	
Improved	relative	energies	are	obtained	using	the	G3(MP2)‐RAD	scheme	proposed	by	
Radom	et	al.[81]	These	are	based	on	the	same	geometries	and	thermal	corrections	as	
the	MP2	level:	
	
Etot(G3(MP2)‐RAD)	=	Etot(CCSD(T)/6‐31G(d)//B3LYP/6‐31G(d)	+	
+	DE(G3MP2large)	+	DE(HLC)	 	 	 (eq.	2.12)	
	
DE(G3MP2large)	=	MP2(FC)/G3MP2large	–	MP2(FC)/6‐31G(d)	 (eq.	2.13)	
	
DE(HLC)	=	‐A	n()	 	 	 	 (eq.	2.14)	
	
with	A	=	9.413x10‐3	au	and	n()	representing	the		valence	electrons,	respectively.	
G3B3	theory	as	 the	most	expensive	method	 is	used	 in	addition	 for	the	prediction	of	
accurate	 thermochemical	 data.	 This	 composite	method	 is	 a	 variant	 of	 G3	 theory	 in	
which	 structures	 and	 zero	 point	 vibrational	 energies	 are	 again	 obtained	 at	 the	
B3LYP/6‐31G(d)	level	of	theory,	but	scaled	by	a	factor	of	0.9600:	
	
Etot(G3B3)	=	Etot(QCISD(T)/6‐31G(d)//B3LYP/6‐31G)	+	
+	DE(+)	+	DE(2df,p)	+	DE(G3large)	+	DE(HLC)	 	 (eq.	2.15)	
	
DE(+)	=	MP4(FC)/6‐31+G(d)	–	MP4(FC)/6‐31G(d)	 (eq.	2.16)	
	
DE(2df,p)	=	MP4(FC)/6‐31G(2df,p)	–	MP4(FC)/6‐31G(d)	 (eq.	2.17)	
	
DE(G3large)	=	MP2(Full)/G3large	–	MP2(FC)/6‐31G(2df,p)	–	
–	MP2(FC)/6‐31+G(d)	+	MP2(FC)/6‐31G(d)	 (eq.	2.18)	
	
DE(HLC)	=	–A	n()	 	 	 	 (eq.	2.19)	
	
with	A	=	6.760x10‐3	au	and	the	number	of		valence	electrons	(n()),	respectively.	
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Additional	consideration	of	solvation	was	included	by	calculating	free	energies	using	
the	polarizable	continuum	solvation	model	 in	 its	 IEF‐PCM,[82]	or	SMD[60]	variant	and	
adding	 them	 to	 the	 gas	 phase	 enthalpies.	 In	 case	 for	 the	 IEF‐PCM	 calculations	 the	
United	 Atom	 Hartree	 Fock	 (UAHF)	 radii	 in	 combination	 with	 HF/6‐31G(d)	 theory	
have	been	used.[83]		
Methyl	 cation	 affinities	 are	 defined	 as	 the	 negative	 of	 the	 reaction	 enthalpy	 for	
attaching	 the	 methyl	 cation	 CH3+	 to	 a	 Lewis	 base.	 These	 values	 are	 obtained	 from	
MP2(FC)/6‐31+G(d,p)//B98/6‐31G(d)	 single‐point	 calculations	 on	 B98/6‐31G(d)	
optimized	geometries.[39b]	
CCSD(T)	 calculations	 have	 been	 performed	 with	 MOLPRO,[84]	 the	 geometry	
optimizations,	 frequencies	 and	 PCM	 calculations	 with	 Gaussian03	 Rev.	D.01.[85]	 The	
SMD	model	is	implemented	in	Gaussian09	Rev.	C.01.[86]	
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Table	 2.13	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 evaluation	 of	 the	
thermodynamics	of	hydrogenations	in	Hartree	(Enthalpies	are	scaled	by	a	factor	of	0.9806,	bold	style	
scaling	factor	0.960).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	 Etot(G3B3)	
H2	
(2‐11)	
‐1.1754824	
‐1.162230	
‐1.162439	
‐1.1627376	 ‐1.1797548	 ‐1.1772139	
C2H4	
(2‐12a)	
‐78.5874583	
‐78.533222	
‐78.534261	
‐78.3932565	 ‐78.4841764	 ‐78.5584753	
C2H6	
(2‐29a)	
‐79.8304175	
‐79.752210	
‐79.753731	
‐79.6200539	 ‐79.7231382	 ‐79.7970825	
	
(2‐12b)	
‐117.9075622	
‐117.823957	
‐117.825562	
‐117.8188568	 ‐117.7498898	 ‐117.8617142	
	
(2‐12b_H)	
‐119.1442484	
‐119.036632	
‐119.038730	
‐118.8387761	 ‐118.9847913	 ‐119.0961374	
	
(2‐12d)	
‐157.2272881	
‐157.114574	
‐157.116735	
‐156.8420116	 ‐157.0170527	 ‐157.1664745	
	
(2‐12d_H)	
‐158.4588061	
‐158.322279	
‐158.324922	
‐158.0609392	 ‐158.2492313	 ‐158.3980083	
	
(2‐12e)	
‐157.2247688	
‐157.111721	
‐157.113891	
‐156.8374652	 ‐157.0132640	 ‐157.1625634	
	
(2‐12e_H)	
‐158.4580417	
‐158.320984	
‐158.323644	
‐158.0577369	 ‐158.2466245	 ‐158.3954185	
	
(2‐12c)	
‐196.5435871	
‐196.401462	
‐196.404186	
‐196.0622753	 ‐196.2797744	 ‐196.4667624	
	
(2‐12c_H)	
‐197.7711161	
‐197.605112	
‐197.608325	
‐197.2791990	 ‐197.5103125	 ‐197.6965220	
	
(2‐12f)	
‐235.8566952	
‐235.685358	
‐235.688638	
‐235.2823275	 ‐235.5982599	 ‐235.8068708	
	
(2‐12f_H)	
‐237.0824808	
‐236.887348	
‐236.891117	
‐236.4996100	 ‐236.8293853	 ‐237.0370979	
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Table	 2.14	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 evaluation	 of	 the	
thermodynamics	of	hydrogenations	in	Hartree	(Enthalpies	are	scaled	by	a	factor	of	0.9806,	bold	style	
scaling	factor	0.960).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	 Etot(G3B3)	
	
(2‐13a)	
‐234.6482949	
‐234.497636	
‐234.500560	
‐234.0907903	 ‐234.3346521	 ‐234.5599626	
	
(2‐13a_H)	
‐235.8804308	
‐235.705840	
‐235.709253	
‐235.3102004	 ‐235.5671030	 ‐235.7919572	
	
(2‐13b)	
‐273.9679943	
‐273.788360	
‐273.791835	
‐273.3164436	 ‐273.6020693	 ‐273.8651663	
	
(2‐13b_H)	
‐275.1956310	
‐274.992155	
‐274.996117	
‐274.5334849	 ‐274.8326090	 ‐275.0949548	
	
(2‐111a)	
‐195.3271387	
‐195.206463	
‐195.208803	
‐194.8640872	 ‐195.1120818	 ‐195.2866149	
	
(2‐111c)	
‐194.1010581	
‐194.004811	
‐194.006652	
‐193.6543158	 ‐193.8393857	 ‐194.0276521	
	
(2‐111a_H)	
‐196.5570824	
‐196.421194	
‐196.415027	
‐196.0714928	 ‐196.3328989	 ‐196.5159818	
	
(2‐111b)	
‐234.6481260	
‐234.498408	
‐234.501299	
‐234.0902607	 ‐234.3894031	 ‐234.5990778	
	
(2‐111b_H)	
‐235.8725613	
‐235.698748	
‐235.702131	
‐235.3032829	 ‐235.6163327	 ‐235.8252866	
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Table	 2.15	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 evaluation	 of	 the	
thermodynamics	of	hydrogenations	in	Hartree	(Enthalpies	are	scaled	by	a	factor	of	0.9806,	bold	style	
scaling	factor	0.960).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	 Etot(G3B3)	
O
	
(2‐112)	
‐308.6661323	
‐308.533542	
‐308.536069	
‐308.0237581	 ‐308.2794877	 ‐308.5495467	
O
	
(2‐20)	
‐309.8912545	
‐309.734975	
‐309.737983	
‐309.2381019	 ‐309.5073166	 ‐309.7767310	
OH
	
(2‐20_H)	
‐311.0903700	
‐310.910427	
‐310.913908	
‐310.4336237	 ‐310.7193125	 ‐310.9869990	
O
	
(2‐113)	
‐269.3493447	
‐269.246710	
‐269.248654	
‐268.8008516	 ‐269.0135973	 ‐269.2465050	
O
	
(2‐21)	
‐270.7528268	
‐270.446741	
‐270.449158	
‐270.1926349	 ‐270.4194450	 ‐270.6514230	
OH
	
(2‐21H)	
‐271.7666701	
‐271.616566	
‐271.619466	
‐271.2042119	 ‐471.4471532	 ‐271.6773793	
	
(2‐14)	
‐232.2486519	
‐232.144431	
‐232.146423	
‐231.7204866	 ‐231.9272682	 ‐232.1539252	
	
(2‐113)	
‐233.4189363	
‐233.292286	
‐233.294720	
‐232.8748896	 ‐233.1044328	 ‐233.3302537	
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Table	 2.16	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 evaluation	 of	 the	
thermodynamics	of	hydrogenations	in	Hartree	(Enthalpies	are	scaled	by	a	factor	of	0.9806,	bold	style	
scaling	factor	0.960).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	 Etot(G3B3)	
	
(2‐15)	
‐347.7628540	
‐347.617217	
‐347.619981	
‐346.9846288	 ‐347.2846510	 ‐347.6260014	
	
(2‐15_H)	
‐348.9881530	
‐348.818330	
‐348.821587	
‐348.4301190	 ‐348.5108895	 ‐348.8517656	
	
(2‐114)	
‐462.0881956	
‐461.922716	
‐461.925828	
‐461.0759667	 ‐461.4478683	 ‐461.9049122	
	
(2‐114_H)	
‐463.3149440	
‐463.125949	
‐463.129536	
‐462.2860819	 ‐462.6752734	 ‐463.1317287	
O
	
(2‐115)	
‐230.0205817	
‐229.947034	
‐229.948421	
‐229.5720577	 ‐229.7850438	 ‐229.9663352	
O
	
(2‐116)	
‐231.2217833	
‐231.124790	
‐231.126648	
‐230.7544168	 ‐230.9884512	 ‐231.1689219	
O
	
(1‐115_H)	
‐232.4492889	
‐232.328040	
‐232.330394	
‐231.9685290	 ‐232.2167178	 ‐232.3966020	
COOH
	
(2‐17a)	
‐267.1607213	
‐267.088420	
‐267.089746	
‐266.6965087	 ‐266.8689034	 ‐267.0682344	
COOH
	
(2‐17a_H)	
‐268.3966254	
‐268.300724	
‐268.302524	
‐267.9199367	 ‐268.1054945	 ‐268.3041419	
COOH
	
(2‐17)	
‐306.4800904	
‐306.378691	
‐306.380572	
‐305.9218865	 ‐306.1363530	 ‐306.3732717	
COOH
	
(2‐17_H)	
‐307.7102187	
‐307.585051	
‐307.587411	
‐307.1410246	 ‐307.3687575	 ‐307.6050132	
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Table	 2.17	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 evaluation	 of	 the	
thermodynamics	of	hydrogenations	in	Hartree	(Enthalpies	are	scaled	by	a	factor	of	0.9806,	bold	style	
scaling	factor	0.960).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	 Etot(G3B3)	
CONH2 	
(2‐117a)	
‐247.2915608	
‐247.207201	
‐247.208758	
‐246.8293544	 ‐247.0088563	 ‐247.2053282	
CONH2 	
(2‐117a_H)	
‐248.5268483	
‐248.418748	
‐248.420784	
‐248.0517816	 ‐248.2444024	 ‐248.4402537	
CONH2
	
(2‐117)	
‐286.6097901	
‐286.496121	
‐286.498241	
‐286.0539105	 ‐286.2754358	 ‐286.5095110	
CONH2
	
(2‐117_H)	
‐287.8410266	
‐287.703689	
‐287.706283	
‐287.2737922	 ‐287.5083306	 ‐287.7418860	
H2CO	
(2‐118)	
‐114.5004726	
‐114.470349	
‐114.470898	
‐114.3062517	 ‐114.3794877	 ‐114.4595066	
CH3OH	
(2‐118_H)	
‐115.7144073	
‐115.659682	
‐115.660724	
‐115.5135682	 ‐115.6022827	 ‐115.6811433	
CH3CHO	
(2‐18)	
‐153.8301215	
‐153.770515	
‐153.771634	
‐153.5380635	 ‐153.6538781	 ‐153.7717845	
CH3CH2OH	
(2‐18_H)	
‐155.0342871	
‐154.950239	
‐154.951848	
‐154.7365194	 ‐154.8685341	 ‐154.9850011	
(CH3)2CO	
(2‐19)	
‐193.1556945	
‐193.066834	
‐193.068510	
‐192.7680241	 ‐192.9263032	 ‐193.0819798	
(CH3)2HCOH	
(2‐19_H)	
‐194.3534513	
‐194.240614	
‐194.242772	
‐193.9614458	 ‐194.1361519	 ‐194.4166760	
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Table	2.18	Experimental	reaction	enthalpies	hydH	at	298.15	K	and	1	atm.	Only	the	starting	material	is	
shown,	if	not	otherwise	noted	leads	the	reaction	to	fully	saturated	products.	
R R'
X
+     H2
hydH
R R'
X
H
H
	
	 hydH(g,	exp.)	 rxnH(g,	exp.)	 	 hydH(g,	exp.)	 rxnH(g,	exp.)	
C2H4	
(2‐12a)	
‐136.31	
±	0.21	
‐84.0[13]–(+52.4[13])=	
=	‐136.4	 	
(2‐12c)	
‐111.63	
±	0.25	
‐153.6[13]–(‐41.7[13])=	
=	‐111.9	
	
(2‐12b)	
‐124.98	
±	0.21	
‐103.8[13]–(+20.0[13])=	
=	‐123.8	 	
(2‐12f)	
‐110.40	
±	0.42	
‐178.1[13]–(‐68.1[13])=	
=	‐110.0	
	
(2‐12d)	
‐117.78	
±	0.42	
‐134.2[13]–(‐16.91[3])=	
=	‐117.3	 	
(2‐13a)	
‐118.83	
±	0.42	
‐123.4[13]–(‐5.0[13])=	
=	‐118.4	
	
(2‐12e)	
‐118.53	
±	0.42	
‐125.7[13]–(‐7.1[13])=	
=	‐118.6	 	
(2‐13b)	
‐111.40	
±	0.37	
‐154.7[13]–(‐43.3[18])=	
=	‐111.4	
	
(2‐111a)	
‐112.13	
±	0.84	
‐76.4[13]–	
(+34.0[13])=	
=	‐110.4	
O
	
(2‐116)	
‐107.11	
±	2.5	
‐184.1[13]–	
(‐75.0[17])=	
=	‐109.1	
	
(2‐111c)	
‐215.10	
±	0.42	
‐76.4[13]–	
(+134.3[13])=	
=‐210.7	
COOH
	
(2‐17a)	
‐127.00	
±	0.8	
‐455.7[13]–	
(‐330.7[25])=	
=	‐125.0	
	
(2‐111b)	
‐100.80	
±	0.63	
‐106.2[13]–	
(‐3.8[13])=	
=	‐102.4	
COOH
	
(2‐17)	
‐118.00	
±	1.3	
‐532.1[26]–	
(‐414.8[25])=	
=	‐117.3	
O
	
(2‐16)	
‐109.20	
±	2.9	
‐226.1[13]–	
(‐121.9[5])=	
=	‐104.2	
CONH2 	
(2‐117a)	
n/a	
‐259.0[13]–	
(‐130.2[13])=	
=	‐128.8	
O
	
(2‐113)	
‐97.10	
±	2.7	
‐192.1[13]–	
(‐100.3[5])=	
=	‐91.8	
CONH2
	
(2‐117)	
n/a	
‐282.6[14]–	
(‐157.7[15])=	
=	‐124.9	
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Table	2.19	Experimental	reaction	enthalpies	hydH	at	298.15	K	and	1	atm.	Only	the	starting	material	is	
shown,	if	not	otherwise	noted	leads	the	reaction	to	fully	saturated	products.	
R R'
X
+     H2
hydH
R R'
X
H
H
	
	 hydH(g,	exp.)	 rxnH(g,	exp.)	 	 hydH(g,	exp.)	 rxnH(g,	exp.)	
	
(2‐14)	
‐205.27	
±	0.63	
‐123.4[13]–	
(+82.9[13])=	
=	‐206.3	
H2CO	
(2‐118)	
n/a	
‐201.0[13]–	
(‐108.6[13])=	
=	‐92.4	
	
(2‐113)	
‐229.62	
±	0.42	
‐123.4[13]–	(+104.6[23])=	
=	‐228.0	
CH3CHO	
(2‐18)	
‐69.08	
±	0.42	
‐234.8[13]–	
(‐166.2[13])=	
=	‐68.6	
	
(2‐15)	
‐98.90	
±	0.63	
‐163.51[28]–	
(‐60.33[28])=	
=‐103.18	
(CH3)2CO	
(2‐19)	
‐55.60	
±	0.42	
‐272.6[13]–	
(‐217.1[13])=	
=	‐55.5	
	
(2‐114)	
‐107.90	
±	4.2	
155.9[21]–	
(+263.8[21])=	
=	‐107.9	
O
	
(2‐20)	
‐63.51	
±	0.63	
‐286.2[13]–	
(‐226.1[13])=	
=	‐60.1	
O
	
(2‐115)	
‐151.13	
±	0.50	
‐184.1[13]–	
(‐34.8[13])	=	
=	‐149.3	
O
	
(2‐21)	
‐51.25	
±0.63	
‐242.5[13]–	
(‐192.1[13])=	
=	‐50.4	
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Table	2.20	 Total	 energies	 and	 enthalpies	 at	 different	 levels	 of	 theory	 for	 the	 calculation	 of	methyl	
cation	affinities	in	Hartree	(298.15	K,	1	atm).	
N
N
OEt
OEt 	
(2‐44b)	
Etot(B98)	
H298(B98)	
Etot(MP2)	
N
N
OEt
OEt
CH3 	
(2‐45b)	
Etot(B98)	
H298(B98)	
Etot(MP2)	
1	
‐611.1161887	
‐610.873842	
‐609.7211139	 1	
‐650.8067520	
‐650.520970	
‐649.2934405	
3	
‐611.1178437	
‐610.875378	
‐609.7229677	 3	
‐650.8060519	
‐650.520195	
‐649.2929392	
5	
‐611.1145925	
‐610.872055	
‐609.7200057	 5	
‐650.8051392	
‐650.519158	
‐649.2922938	
7	
‐611.1168212	
‐610.874107	
‐609.7222598	 9	
‐650.8051247	
‐650.519171	
‐649.2923529	
9	
‐611.1168454	
‐610.874105	
‐609.7222944	 29	
‐650.8058740	
‐650.519946	
‐649.292805	
10	
‐611.1172867	
‐610.874756	
‐609.7224794	 	 	 	
13	
‐611.1154176	
‐610.872972	
‐609.7206011	 	 	 	
21	
‐611.1147290	
‐610.872161	
‐609.7202038	 	 	 	
25	
‐611.1147292	
‐610.872163	
‐609.7201984	 	 	 	
29	
‐611.1155970	
‐610.873053	
‐609.7207422	 	 	 	
31	
‐611.1174031	
‐610.874775	
‐609.7227726	 	 	 	
43	
‐611.1147276	
‐610.872174	
‐609.7201900	 CH3 	
‐39.4629218	
‐39.427474	
‐39.3523741	
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Table	2.21	Total	energies	and	enthalpies	of	2‐46b	at	different	 levels	of	theory	for	the	calculation	of	
methyl	cation	affinities	in	Hartree	(298.15	K,	1	atm).	
N
N
OEt
OEt
CH3
	
(2‐46b)	
Etot(B98)	
H298(B98)	
Etot(MP2)	
1	
‐650.7859814	
‐650.500113	
‐649.2722425	
2	
‐650.7854689	
‐650.500427	
‐649.2718718	
3	
‐650.7856311	
‐650.499767	
‐649.2722384	
5	
‐650.7851171	
‐650.499292	
‐649.2718906	
9	
‐650.7806036	
‐650.495061	
‐649.2688269	
10	
‐650.7851724	
‐650.499366	
‐649.2718622	
16	
‐650.7843227	
‐650.498329	
‐649.2712649	
21	
‐650.7842847‐	
‐650.498194	
‐649.271112	
23	
‐650.7835741	
‐650.598033	
‐649.270848	
25	
‐650.7854689	
‐650.499485	
‐649.2718645	
27	
‐650.7805203	
‐650.495062	
‐649.2690546	
31	
‐650.7810252	
‐650.495705	
‐649.2694903	
33	
‐650.7853882	
‐650.499452	
‐649.2718343	
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Table	2.22	Total	energies	and	enthalpies	of	pyrimdines	in	Hartree	(enthalpies	(in	bold)	are	scaled	by	a	
factor	of	0.960).	
N
N
O
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
N
N
O
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X,	Y	=H	
(2‐32a)	
‐414.8159434	
‐414.724772	
‐414.6572476	
X,	Y	=H	
(2‐65a)	
‐416.0289298	
‐415.914487	
‐415.8734750	
X	=	CH3,	Y	=H	
(2‐39a)	
‐454.1274497	
‐454.007679	
‐453.9580397	
X	=	CH3,	Y	=H	
(2‐46a)	
‐455.3400379	
‐455.197082	
‐455.1740712	
X,	Y	=CH3	
(2‐47a)	
‐493.4392316	
‐493.290815	
‐493.2538114	
X,	Y	=CH3	
(2‐49b)	
‐494.6502952	
‐494.478691	
‐494.4677559	
N
H
N
OH
O
	
(2‐86a)	
‐415.9980937	
‐415.884173	
‐415.8468161	
N
H
N
O
OH
	
(2‐87a)	
‐415.9954471	
‐415.881679	
‐415.8442822	
N
N
OH
OH 	
(2‐88a)	
‐415.9640223	
‐415.850845	
‐415.8208951	 	 	 	
N
N
O
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
N
N
O
O
X
Y
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X,	Y	=H	
(2‐32b)	
‐454.1363070	
‐454.016574	
‐453.9697571	
X,	Y	=H	
(2‐65b)	
1	
‐455.3449323	
‐455.201904	
‐455.1832440	
	
	
	 2	
‐455.3431628	
‐455.200035	
‐455.1824297	
X	=	CH3,	Y	=H	
(2‐39b)	
‐493.4477629	
‐493.299382	
‐493.2643087	
X	=	CH3,	Y	=H	
(2‐46b)	
‐494.6560380	
‐494.484519	
‐494.4771760	
X,	Y	=CH3	
(2‐47b)	
‐532.7590321	
‐532.582022	
‐532.5594004	
X,	Y	=CH3	
(2‐49b)	
‐533.9660220	
‐533.765876	
‐533.5706006	
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Table	2.23	Total	energies	and	enthalpies	of	5‐fluorouracils	in	Hartree	(enthalpies	(in	bold)	are	scaled	
by	a	factor	of	0.960).	
N
N
O
O
X
YF
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
N
N
O
O
X
YF
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X	=	CH3,	Y	=H	
(2‐39c)	
‐533.3476842	
‐533.234925	
‐553.1453376	
X	=	CH3,	Y	=H		
(2‐39c_H)	
1	
‐554.5618042	
‐554.425684	
‐554.3653367	
	 	 	 2	
‐554.5413167	
‐554.425136	
‐554.3657365	
Table	2.24	Total	energies	and	enthalpies	of	cytosines	in	Hartree	(enthalpies	(in	bold)	are	scaled	by	a	
factor	of	0.960).	
N
N
NH2
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
N
N
NH2
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X,	Y	=	H	
(2‐51a)	
‐394.9280116	
‐394.825402	
‐394.7861943	
X,	Y	=	H	
(2‐89)	
‐396.1318383	
‐396.005912	
‐395.9935408	
Y	=	H,	X	=	CH3	
(2‐50a)	
‐434.2405254	
‐434.109345	
‐434.1019629	
Y	=	H,	X	=	CH3	
(2‐55a)	
‐435.4426401	
‐435.288341	
‐435.3070659	
Y	=	F,	X	=	CH3	
(2‐50c)	
‐533.4646979	
‐533.340568	
‐533.2718708	
Y	=	F,	X	=	CH3		
(2‐50c_H)	
1	
‐534.6720074	
‐534.524314	
‐534,4848121	
	 	 	 2	
‐534.6662343	
‐534.518614	
‐534.4806182	
N
H
NH
NH
O
	
(2‐90)	
	 	
N
H
N
NH
OH
	
(2‐92)	
	 	
(Z)	
‐396.1382092	
‐396.011889	
‐396.0003783 (Z)	
‐396.1129394	
‐395.987035	
‐395.9791404	
(E)	
‐396.1396599	
‐396.013164	
‐396.0018491 (E)	
‐396.1061293	
‐395.980325	
‐395.9730619	
N
H
NH
NH2
O
	
(2‐91)	
‐396.1202114	
‐395.994175	
‐395.9865041 	 	 	
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Table	2.25	Total	energies	and	enthalpies	of	purines	 in	Hartree	(enthalpies	(in	bold)	are	scaled	by	a	
factor	of	0.960).	
N
NN
N
NH2
X 	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
N
N
H
N
N
NH2
X 	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X	=	H	
(2‐81)	
‐467.3181723	
‐467.20185	
‐467.1472225	
X	=	H	
(2‐84a)	
‐468.4966380	
‐468.357056	
‐468.3318829	
X	=	CH3	
(2‐78)	
‐506.6323182	
‐506.487227	
‐506.4435314	
X	=	CH3	
(2‐78a)	
‐507.8101382	
‐507.642105	
‐507.6276997	
N
NHN
N
H
NH2
	
(2‐84b)	
‐468.4878746	
‐468.348256	
‐468.3264731
N
H
NN
N
H
NH2
H
	
(2‐84c)	
‐468.4799493	
‐468.341103	
‐468.3180097	
N
H
NN
N
H
NH2
H 	
(2‐84e)	
‐468.4587445	
‐468.320171	
‐468.2978730
N
NN
N
H
NH2H
H 	
(2‐84d)	
‐468.4729584	
‐468.334040	
‐468.3088378
N
NHN
N
O
X
NH2
	
E(B3LYP)	
H(B3LYP)	
E(G3B3)	
N
NH
H
N
N
O
X
NH2
	
E(B3LYP)	
H(B3LYP)	
E(G3B3)	
X	=	H	
(2‐82)	
‐542.5500873	
‐542.428237	
‐542.3566067	
X	=	H	
(2‐85a)	
‐543.7270992	
‐543.582282	
‐543.5398687
X	=	CH3	
(2‐77)	
‐581.8638077	
‐581.713213	
‐581.6526319	
X	=	CH3	
(2‐77a)	
‐583.0404668	
‐582.867234	
‐582.8355398
N
NHN
N
H
O
NH2
H
H 	
(2‐85b)	
‐543.7224349	
‐543.577733	
‐543.5379056 	 	 	
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Table	2.26	Total	energies	and	enthalpies	of	selected	sugar	models	in	Hartree	(enthalpies	(in	bold)	are	
scaled	by	a	factor	of	0.960).	
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	 	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
OH
	
(2‐93_H)	
1	
‐233.6618379	
‐233.522060	
‐233.5858929	
O
	
(2‐93)	
1	
‐232.4580811	
‐232.341867	
‐232.3718377	
2	
‐233.6625681	
‐233.522728	
‐233.587655	 2	
‐232.4593316	
‐232.343227	
‐232.3726607	
O
OH 	
(2‐94_H)	
1	
‐344.5448134	
‐344.438299	
	
O
O 	
(2‐94)	
1	
‐343.3463411	
‐343.263072	
‐343.2136285	
2	
‐344.5454703	
‐344.438896	
	 2	
‐343.3480306	
‐343.264785	
‐343.2147455	
3	
‐344.5424526	
‐344.436072	
	 	 	 	
O
XY
Z
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
O
XY
Z
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X	=	OH;	Y,	Z	=	H	
(2‐95_H)	
1	
‐307.6577335	
‐307.533899	
‐307.5564863	
X	=	O;	Y,	Z	=	H	
(2‐95)	
‐306.4597096	
‐306.359471	
‐306.3464079	
2	
‐307.6575200	
‐307.533735	
‐307.5563964	 	 	 	
3	
‐307.6593194	
‐307.535268	
‐307.5575085	 	 	 	
4	
‐307.6558074	
‐307.532020	
‐307.5540924	 	 	 	
X,	Y	=	H;Z	=	CH2OH	
(2‐96_H)	
1	
‐346.9766601	
‐346.823487	
‐346.8603195	
X,	Y	=	H;Z	=	CHO	
(2‐96)	
1	
‐345.7669591	
‐345.637832	
‐345.6411485	
2	
‐346.9778207	
‐346.824637	
‐346.8609139	 2	
‐345.7662732	
‐345.637020	
‐345.6402498	
10	
‐346.9732134	
‐346.820299	
‐346.8574578	 4	
‐345.7638860	
‐345.634574	
‐345.6383975	
	 	 	 6	
‐345.7642283	
‐345.635036	
‐345.6392464	
X,	Y	=	OH;	Z	=	H	
(2‐67a_H)	
‐382.8706514	
‐382.741106	
‐382.7510111	
X	=	O;	Y	=	OH;	Z	=	H	
(2‐67)	
‐381.6667793	
‐381.561212	
‐381.5370053	
	 	
2.8	Theoretical	Appendix		
108	
Table	2.27	Total	energies	and	enthalpies	of	selected	sugar	models	in	Hartree	(enthalpies	(in	bold)	are	
scaled	by	a	factor	of	0.960).	
O
XY
Z
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
O
XY
Z
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X,	Y	=	OH;	Z	=	CH2OH	
(2‐97_H)	
1	
‐497.3972201	
‐497.233613	
‐497.249057	
X	=	O;	Y	=	OH;	
Z	=	CH2OH	
(2‐97a)	
1	
‐496.1930950	
‐496.053292	
‐496.0336568	
2	
‐497.3966623	
‐497.233200	
‐497.2486509	 2	
‐496.1914556	
‐496.051718	
‐496.031876	
3	
‐497.396408	
‐497.232676	
‐497.2474595	 3	
‐496.1867202	
‐496.046887	
‐496.0291221	
X	=	OH;	Y	=	O;	
Z	=	CH2OH	
(2‐97b)	
1	
‐496.1883279	
‐496.048049	
‐496.0291077	
X,	Y	=	OH;	Z	=	CHO	
(2‐97c)	
1	
‐496.1889342	
‐496.049109	
‐496.030260	
2	
‐496.1867424	
‐496.046697	
‐496.028740	 2	
‐496.1852568	
‐496.045196	
‐496.0263953	
3	
‐496.1879531	
‐496.047759	
‐496.0283554	 3	
‐496.1849254	
‐496.045335	
‐496.0267649	
4	
‐496.1864131	
‐496.046279	
‐496.0279963	 4	
‐496.1840697	
‐496.044422	
‐496.0260538	
5	
‐496.1885387	
‐496.048272	
‐496.0277656	 	 	 	
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Table	2.28	Total	energies	and	enthalpies	of	selected	sugar	models	in	Hartree	(enthalpies	(in	bold)	are	
scaled	by	a	factor	of	0.960).	
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
O
X
Y
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
X	=	OH;	Y	=	CH2OH	
(2‐98_H)	
1	
‐422.1838555	
‐422.025546	
‐422.052147	
X	=	O;	Y	=	CH2OH	
(2‐98b)	
1	
‐420.9859207	
‐420.850984	
‐420.8410426	
2	
‐422.1831374	
‐422.024915	
‐422.007705	 2	
‐420.9846209	
‐420.849734	
‐420.8411106	
3	
‐422.1830676	
‐422.024661	
‐422.0497733	 3	
‐420.9838296	
‐420.848370	
‐420.8409192	
4	
‐422.1825881	
‐422.024374	
‐422.0507128	 4	
‐420.9848834	
‐420.850029	
‐420.8412873	
	 	 	 5	
‐420.9827371	
‐420.848125	
‐420.8409637	
X	=	OH;	Y	=	CHO	
(2‐98c)	
1	
‐420.9763079	
‐420.841856	
‐420.8338108	 	 	 	
2	
‐420.6743994	
‐420.840167	
‐420.8336657	 	 	 	
3	
‐420.9734584	
‐420.839131	
‐420.8325499	 	 	 	
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Table	 2.29	 Total	 energies	 and	 enthalpies	 of	 2‐99	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/RHF/6‐
31G(d),	SMD/RHF	=	SMD/RHF/6‐31G(d),	SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	
are	scaled	by	a	factor	of	0.9806.	
O
OHOH
UHO
	
									(2‐99)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
3	
‐911.0212169	
‐910.781544	
‐910.0447029	 ‐0.0373859 ‐0.1892244	 ‐0.1436952	
4	
‐911.0204214	
‐910.780870	
‐910.0424546	 ‐0.0371309 ‐0.1860212	 ‐0.1406832	
5	
‐911.0228334	
‐910.783386	
‐910.0434866	 ‐0.0318721 ‐0.1741648	 ‐0.1300220	
7	
‐911.0237487	
‐910.784341	
‐910.0454086	 ‐0.0338641 ‐0.1630256	 ‐0.1231536	
8	
‐911.0211417	
‐910.781848	
‐910.0412588	 ‐0.0344537 ‐0.1782923	 ‐0.1316156	
12	
‐911.0150796	
‐910.775838	
‐910.0389124	 ‐0.0431070 ‐0.2010330	 ‐0.1574957	
14	
‐911.0193592	
‐910.779999	
‐910.0425980	 ‐0.0370991 ‐0.1776230	 ‐0.1378944	
15	
‐911.0206915	
‐910.781176	
‐910.0434705	 ‐0.0382624 ‐0.1910251	 ‐0.1448904	
20	
‐911.0208040	
‐910.781488	
‐910.0411089	 ‐0.0367644 ‐0.1776230	 ‐0.1331455	
26	
‐911.0217813	
‐910.782356	
‐910.0423789	 ‐0.0362226 ‐0.0182627	 ‐0.1334802	
30	
‐911.0177153	
‐910.778192	
‐910.0396637	 ‐0.0398879 ‐0.1987701	 ‐0.1499580	
32	
‐911.0140701	
‐910.774939	
‐910.0380209	 ‐0.0418639 ‐0.2042999	 ‐0.1589619	
38	
‐911.0196752	
‐910.780438	
‐910.0408434	 ‐0.0365413 ‐0.1746907	 ‐0.1308188	
46	
‐911.0089992	
‐910.769985	
‐910.0326888	 ‐0.0472344 ‐0.2263713	 ‐0.0179918	
52	
‐911.0149713	
‐910.775724	
‐910.0389055	 ‐0.0414655 ‐0.2020369	 ‐0.1566830	
	 	
	 2		Transfer	Hydrogenation	as	a	Redox	Process	in	Nucleotides	
	 111	
Table	2.30	Total	 energies	and	enthalpies	of	2‐100a	 in	Hartree	 (IEF‐PCM	=	 IEF‐PCM/UAHF/RHF/6‐
31G(d),	SMD/RHF	=	SMD/RHF/6‐31G(d),	SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	
are	scaled	by	a	factor	of	0.9806.	
O
OH
DHO
O 	
							(2‐100a)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
3	
‐911.0263257	
‐910.787378	
‐910.0404475	 ‐0.0407803	 ‐0.0450671	 ‐0.0330513	
4	
‐911.0273771	
‐910.788420	
‐910.0418003	 ‐0.0425811	 ‐0.0453539	 ‐0.0333541	
12	
‐911.0235957	
‐910.784703	
‐910.0388268	 ‐0.0427404	 ‐0.0467085	 ‐0.0343899	
14	
‐911.0251896	
‐910.786278	
‐910.0405951	 ‐0.0425811	 ‐0.0464854	 ‐0.0343262	
20	
‐911.0210149	
‐910.782422	
‐910.0377503	 ‐0.0450990	 ‐0.0493061	 ‐0.0367963	
22	
‐911.0193315	
‐910.780773	
‐910.0358254	 ‐0.0456089	 ‐0.0494973	 ‐0.0368122	
26	
‐911.0238742	
‐910.784929	
‐910.0377293	 ‐0.0394417	 ‐0.0475212	 ‐0.0344378	
28	
‐911.0239698	
‐910.785123	
‐910.0390913	 ‐0.0408122	 ‐0.0456408	 ‐0.0334816	
29	
‐911.0198328	
‐910.780921	
‐910.0360959	 ‐0.0454495	 ‐0.0492423	 ‐0.0369078	
32	
‐911.0215563	
‐910.782713	
‐910.0367788	 ‐0.0441747	 ‐0.0486049	 ‐0.0362545	
35	
‐911.0214100	
‐910.782748	
‐910.0373742	 ‐0.0457523	 ‐0.0502144	 ‐0.0374497	
36	
‐911.0197080	
‐910.781074	
‐910.0354080	 ‐0.0463738	 ‐0.0504535	 ‐0.0374975	
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Table	2.31	Total	 energies	and	enthalpies	of	2‐100b	 in	Hartree	 (IEF‐PCM	=	 IEF‐PCM/UAHF/RHF/6‐
31G(d),	SMD/RHF	=	SMD/RHF/6‐31G(d),	SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	
are	scaled	by	a	factor	of	0.9806.	
O
OH
DHO
O 	
					(2‐100b)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
5	
‐911.0304761	
‐910.791385	
‐910.0440071	 ‐0.0390433	 ‐0.0436010	 ‐0.0317605	
1	
‐911.0298031	
‐910.790674	
‐910.0429591	 ‐0.0390911	 ‐0.0434575	 ‐0.0314896	
31	
‐911.0225138	
‐910.783658	
‐910.0365456	 ‐0.0455611	 ‐0.0492742	 ‐0.0359198	
43	
‐911.0242865	
‐910.785195	
‐910.0374874	 ‐0.0439675	 ‐0.0473778	 ‐0.0346290	
11	
‐911.0252970	
‐910.785893	
‐910.0396597	 ‐0.0430910	 ‐0.0449874	 ‐0.0335931	
41	
‐911.0247679	
‐910.785427	
‐910.0396816	 ‐0.0432026	 ‐0.0466607	 ‐0.0350593	
12	
‐911.0223091	
‐910.783331	
‐910.0340028	 ‐0.0452105	 ‐0.0475212	 ‐0.0348362	
29	
‐911.0223898	
‐910.783494	
‐910.0363806	 ‐0.0446687	 ‐0.0491786	 ‐0.0358083	
23	
‐911.0179882	
‐910.779506	
‐910.0315295	 ‐0.0483499	 ‐0.0473459	 ‐0.0355214	
22	
‐911.0212167	
‐910.782287	
‐910.0337362	 ‐0.0454177	 ‐0.0481587	 ‐0.0351549	
16	
‐911.0232252	
‐910.783904	
‐910.0370678	 ‐0.0437125	 ‐0.0454495	 ‐0.0338162	
24	
‐911.0226481	
‐910.783776	
‐910.0358720	 ‐0.0437444	 ‐0.0483180	 ‐0.0352346	
15	
‐911.0235880	
‐910.784849	
‐910.0386462	 ‐0.0426289	 ‐0.0472981	 ‐0.0351071	
45	
‐911.0218448	
‐910.782803	
‐910.0353906	 ‐0.0446687	 ‐0.0481587	 ‐0.0353461	
18	
‐911.0231484	
‐910.784448	
‐910.0384192	 ‐0.0429317	 ‐0.0471706	 ‐0.0350433	
26	
‐911.0227501	
‐910.783841	
‐910.0360538	 ‐0.0434257	 ‐0.0482384	 ‐0.0352346	
14	
‐911.0228695	
‐910.784094	
‐910.0373376	 ‐0.0431388	 ‐0.0489395	 ‐0.0363341	
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Table	2.32	 Total	 energies	 and	enthalpies	of	2‐100c	 in	Hartree	 (IEF‐PCM	=	 IEF‐PCM/UAHF/RHF/6‐
31G(d),	SMD/RHF	=	SMD/RHF/6‐31G(d),	SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	
are	scaled	by	a	factor	of	0.9806.	
O
OHOH
DO
	
						(2‐100c)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
3	
‐911.0272732	
‐910.788350	
‐910.0413697	 ‐0.0343581	 ‐0.0393620	 ‐0.0273940	
4	
‐911.0266050	
‐910.787656	
‐910.0402824	 ‐0.0351867	 ‐0.0405094	 ‐0.0282386	
1	
‐911.0242927	
‐910.785713	
‐910.0379924	 ‐0.0364616	 ‐0.0401747	 ‐0.0280474	
2	
‐911.0239887	
‐910.785282	
‐910.0369889	 ‐0.0366688	 ‐0.0411468	 ‐0.0285733	
5	
‐911.0218560	
‐910.783048	
‐910.0381677	 ‐0.0355533	 ‐0.0408600	 ‐0.0292745	
9	
‐911.0182163	
‐910.779527	
‐910.0360793	 ‐0.0441587	 ‐0.0476647	 ‐0.0356011	
22	
‐911.0172687	
‐910.778431	
‐910.0339739	 ‐0.0450511	 ‐0.0484933	 ‐0.0355692	
29	
‐911.0185799	
‐910.779921	
‐910.0358754	 ‐0.0430910	 ‐0.0465332	 ‐0.0347087	
10	
‐911.0169287	
‐910.778293	
‐910.0343487	 ‐0.0442384	 ‐0.0476168	 ‐0.0353939	
12	
‐911.0175012	
‐910.778900	
‐910.0345217	 ‐0.0434257	 ‐0.0464216	 ‐0.0344856	
23	
‐911.0171919	
‐910.778382	
‐910.0345503	 ‐0.0438559	 ‐0.0482702	 ‐0.0356330	
24	
‐911.0152672	
‐910.776495	
‐910.0321516	 ‐0.0450033	 ‐0.0515212	 ‐0.0380712	
17	
‐911.0142450	
‐910.775577	
‐910.0305657	 ‐0.0455133	 ‐0.0525092	 ‐0.0388042	
18	
‐911.0166327	
‐910.777872	
‐910.0337989	 ‐0.0431070	 ‐0.0490352	 ‐0.0359676	
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Table	2.33	Total	energies	and	enthalpies	of	2’‐desoxyuridine	derivatives	in	Hartree	(IEF‐PCM	=	IEF‐
PCM/UAHF/RHF/6‐31G(d),	 SMD/RHF	=	 SMD/RHF/6‐31G(d),	 SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	
Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.9806.	
O
OH
UHO
	
						(2‐102)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
16	
‐835.8095887	
‐835.575484	
‐834.8921372	 ‐0.0357286	 ‐0.041114948	 ‐0.0306290	
4	
‐835.8094814	
‐835.575384	
‐834.8921402	 ‐0.0356967	 ‐0.041130884	 ‐0.0307087	
17	
‐835.8064828	
‐835.572462	
‐834.8885524	 ‐0.0372744	 ‐0.043887817	 ‐0.0328123	
11	
‐835.8057103	
‐835.571914	
‐834.8891138	 ‐0.0368760	 ‐0.041290244	 ‐0.0317446	
19	
‐835.7999511	
‐835.566409	
‐834.8839495	 ‐0.0416568	 ‐0.046660685	 ‐0.0360314	
25	
‐835.8045845	
‐835.570772	
‐834.8873804	 ‐0.0372903	 ‐0.042134854	 ‐0.0322386	
20	
‐835.8019848	
‐835.568330	
‐834.8846159	 ‐0.0397285	 ‐0.044652746	 ‐0.0344696	
8	
‐835.8035680	
‐835.569370	
‐834.8873750	 ‐0.0382305	 ‐0.044079049	 ‐0.0330035	
21	
‐835.8014477	
‐835.567699	
‐834.8841822	 ‐0.0400472	 ‐0.045194571	 ‐0.0349477	
O
DHO
O 	
					(2‐102a)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
4	
‐835.8203423	
‐835.586613	
‐834.8924698	 ‐0.0392982	 ‐0.0426607	 ‐0.0305653	
5	
‐835.8179974	
‐835.584470	
‐834.8907488	 ‐0.0350274	 ‐0.0423102	 ‐0.0308521	
10	
‐835.8179955	
‐835.584187	
‐834.8903383	 ‐0.0385811	 ‐0.0420870	 ‐0.0305175	
6	
‐835.8173347	
‐835.583937	
‐834.8913796	 ‐0.0369556	 ‐0.0422783	 ‐0.0308840	
3	
‐835.8164597	
‐835.582940	
‐834.8880846	 ‐0.0352027	 ‐0.0388998	 ‐0.0278243	
15	
‐835.8155124	
‐835.581893	
‐834.8891498	 ‐0.0410990	 ‐0.0441906	 ‐0.0323183	
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Table	2.34	Total	 energies	and	enthalpies	of	2‐102b	 in	Hartree	 (IEF‐PCM	=	 IEF‐PCM/UAHF/RHF/6‐
31G(d),	SMD/RHF	=	SMD/RHF/6‐31G(d),	SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	
are	scaled	by	a	factor	of	0.9806.	
O
OH
DO
(2‐102b)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(IEF‐PCM)	
Gsolv	
(SMD/RHF)	
Gsolv	
(SMD/B3LYP)	
3	
‐835.8074053	
‐835.574272	
‐834.8833873	 ‐0.0378321	 ‐0.0445731	 ‐0.032127029	
11	
‐835.8073201	
‐835.574091	
‐834.8827890	 ‐0.0369716	 ‐0.0444456	 ‐0.031903925	
10	
‐835.8074380	
‐835.574075	
‐834.8834016	 ‐0.0380234	 ‐0.0399835	 ‐0.028812336	
7	
‐835.8064560	
‐835.573308	
‐834.8831734	 ‐0.0408281	 ‐0.0421508	 ‐0.030772467	
12	
‐835.8059451	
‐835.572852	
‐834.8808612	 ‐0.0349636	 ‐0.0396488	 ‐0.027935854	
9	
‐835.8059253	
‐835.572737	
‐834.8818252	 ‐0.0361110	 ‐0.0400154	 ‐0.028844208	
8	
‐835.8058083	
‐835.572678	
‐834.8824767	 ‐0.0372266	 ‐0.0419277	 ‐0.030135026	
2	
‐835.8054852	
‐835.572416	
‐834.8823594	 ‐0.0418480	 ‐0.0429476	 ‐0.031330228	
5	
‐835.8053664	
‐835.571870	
‐834.8831479	 ‐0.0342465	 ‐0.0394576	 ‐0.028541423	
Table	2.35	Total	energies	and	enthalpies	of	2‐101a	in	Hartree	(SMD/B3LYP	=	SMD/B3LYP/6‐31G(d)).	
Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.9806.	
O
OH
UHO
O 	
						(2‐101a)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/B3LYP)	
1	
‐909.8061657	
‐909.591280	
‐908.8155227	 ‐0.0323183	
2	
‐909.8123978	
‐909.597240	
‐908.8223991	 ‐0.0319836	
3	
‐909.8081638	
‐909.593056	
‐908.8173047	 ‐0.0331788	
5	
‐909.8096299	
‐909.594523	
‐908.8208075	 ‐0.0328123	
19	
‐909.8081346	
‐909.593092	
‐908.8190508	 ‐0.0322386	
20	
‐909.8065770	
‐909.591410	
‐908.8178018	 ‐0.0344378	
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Table	2.36	 Total	 energies	 and	 enthalpies	 of	2‐5	 in	Hartree	 (SMD/B3LYP	 =	 SMD/B3LYP/6‐31G(d)).	
Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.9806.	
O
OHOH
DHO
	
									(2‐5)	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/B3LYP)	
1	
‐912.2346594	
‐911.971495	
‐911.2609410	 ‐0.0309000	
2	
‐912.2352624	
‐911.972025	
‐911.2616209	 ‐0.0314099	
4	
‐912.2358271	
‐911.972564	
‐911.2613678	 ‐0.0303900	
5	
‐912.2348283	
‐911.971566	
‐911.2600266	 ‐0.0328282	
6	
‐912.2337086	
‐911.970528	
‐911.2593800	 ‐0.0315533	
7	
‐912.2337596	
‐911.970552	
‐911.2587305	 ‐0.0327007	
17	
‐912.2327437	
‐911.969646	
‐911.2580174	 ‐0.0328760	
21	
‐912.2326890	
‐911.969415	
‐911.2589268	 ‐0.0350274	
22	
‐912.2327064	
‐911.969505	
‐911.2575578	 ‐0.0331469	
24	
‐912.2340577	
‐911.970624	
‐911.2614736	 ‐0.0358401	
25	
‐912.2348474	
911,971416	
‐911.2627737	 ‐0.0358401	
26	
‐912.2332681	
‐911.970125	
‐911.2589568	 ‐0.0330354	
30	
‐912.2336469	
‐911.970339	
‐911.2604294	 ‐0.0348521	
31	
‐912.2326054	
‐911.969529	
‐911.2578578	 ‐0.0337525	
34	
‐912.2337008	
‐911.970465	
‐911.2605727	 ‐0.0359039	
45	
‐912.2341964	
‐911.970938	
‐911.2615065	 ‐0.0358242	
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Table	 2.37	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
C2H6	
(2‐29a)	
‐79.8304175	
‐79.753731	
‐79.7203960	 +0.0029004	
C2H4	
(2‐12a)	
‐78.5874583	
‐78.534261	
‐78.5052780	 +0.0022789	
N
N
NH2
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	H	(2‐50a)	
‐434.2405254	
‐434.109345	
‐434.2331433	 ‐0.0257367	
R	=	CH3	(2‐50b)	
‐473.5584583	
‐473.398611	
‐473.3854549	 ‐0.0251470	
R	=	CH2OH	(2‐50d)	
1	
‐548.7651036	
‐548.599088	
‐548.5753134	 ‐0.0303581	
2	
‐548.7677647	
‐548.601634	
‐548.5769431	 ‐0.0295773	
3	
‐548.7608470	
‐548.594935	
‐548.5722890	 ‐0.0312984	
4	
‐548.7593125	
‐548.593748	
‐548.5709093	 ‐0.0322545	
R	=	CHO	(2‐50e)	
1	
‐547.5770463	
‐547.434425	
‐547.3731338	 ‐0.0243981	
2	
‐547.5667770	
‐547.424454	
‐547.3636529	 ‐0.0272506	
R	=	COOH	(2‐50f)	
1_cis	
‐622.8237269	
‐622.675041	
‐622.6018475	 ‐0.0263582	
2_cis	
‐622.8198331	
‐622.671191	
‐622.5977883	 ‐0.0274100	
1_trans	
‐622.8085409	
‐622.660175	
‐622.5884452	 ‐0.0341509	
2_trans	
‐622.8076541	
‐622.658666	
‐622.5868574	 ‐0.0308043	
R	=	COO‐	(2‐50g)	
‐622.2773582	
‐622.142163	
‐622.0695262	 ‐0.1050025	
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Table	 2.38	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
N
NH2
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	H	(2‐50a_H)	
‐435.4426401	
‐435.288341	
‐435.4613650	 ‐0.0279677	
R	=	CH3	(2‐50b_H)	
1	
‐474.7566525	
‐474.573777	
‐474.5891094	 ‐0.0263104	
2	
‐474.7560883	
‐474.573253	
‐474.5879469	 ‐0.0273303	
R	=	CH2OH	(2‐50d_H)	
1	
‐549.9633330	
‐549.774349	
‐549.7793027	 ‐0.0304537	
2	
‐549.9611157	
‐549.772345	
‐549.7783167	 ‐0.0324617	
3	
‐549.9646092	
‐549.775688	
‐549.7792427	 ‐0.0323979	
4	
‐549.9581624	
‐549.769483	
‐549.7746694	 ‐0.0346768	
5	
‐549.9612629	
‐549.772146	
‐549.7766523	 ‐0.0323342	
6	
‐549.9633517	
‐549.774208	
‐549.7785414	 ‐0.0314577	
7	
‐549.9612243	
‐549.772188	
‐549.7765387	 ‐0.0318402	
9	
‐549.9590339	
‐549.770231	
‐549.7757985	 ‐0.0339278	
10	
‐549.9615959	
‐549.772784	
‐549.7779405	 ‐0.0321111	
11	
‐549.9544567	
‐549.766001	
‐549.7716961	 ‐0.0372584	
R	=	CHO	(2‐50e_H)	
1	
‐548.7510620	
‐548.586124	
‐548.5563421	 ‐0.0308362	
2	
‐548.7553955	
‐548.590231	
‐548.5606182	 ‐0.0276331	
3	
‐548.7531804	
‐548.588270	
‐548.5594703	 ‐0.0307087	
4	
‐548.7565413	
‐548.591506	
‐548.5602137	 ‐0.0285574	
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Table	 2.39	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
N
NH2
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	COOH	(2‐50f_H)	
1_cis	
‐624.0062617	
‐623.834764	
‐623.7919499	 ‐0.0330354	
2_cis	
‐624.0053481	
‐623.833541	
‐623.7914946	 ‐0.0316011	
3_cis	
‐624.0052870	
‐623.833673	
‐623.7922157	 ‐0.0329079	
4_cis	
‐624.0026586	
‐623.831009	
‐623.7887904	 ‐0.0328442	
1_trans	
‐623.9957156	
‐623.824275	
‐623.7825411	 ‐0.0361429	
2_trans	
‐624.0052232	
‐623.833458	
‐623.7929951	 ‐0.0309000	
3_trans	
‐624.0000148	
‐623.828296	
‐623.7871639	 ‐0.0349636	
4_trans	
‐623.9958690	
‐623.824099	
‐623.7822311	 ‐0.0347405	
R	=	COO‐	(2‐50g_H)	
1	
‐623.4759175	
‐623.317740	
‐623.2720404	 ‐0.1017356	
2	
‐623.4723049	
‐623.313705	
‐623.2670067	 ‐0.1006041	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	H	(2‐110a)	
1_z	
‐434.2342507	
‐434.102731	
‐434.0760307	 ‐0.0183902	
1_e	
‐434.2371023	
‐434.105420	
‐434.0786424	 ‐0.0168125	
R	=CH3	(2‐110b)	
1_z	
‐473.5546156	
‐473.394427	
‐473.3819639	 ‐0.0163026	
1_e	
‐473.5562119	
‐473.395874	
‐473.3838536	 ‐0.0159998	
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Table	 2.40	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960..	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	CH2OH	(2‐110d)	
1_z	
‐548.7631447	
‐548.596750	
‐548.5740513	 ‐0.0230594	
3_z	
‐548.7536463	
‐548.587654	
‐548.5661059	 ‐0.0287645	
5_z	
‐548.7581435	
‐548.592271	
‐548.5699223	 ‐0.0221829	
1_e	
‐548.7573473	
‐548.591157	
‐548.5695303	 ‐0.0257207	
3_e	
‐548.7601500	
‐548.593795	
‐548.5712023	 ‐0.0244937	
4_e	
‐548.7573997	
‐548.591190	
‐548.5702179	 ‐0.0254339	
5_e	
‐548.7576094	
‐548.591633	
‐548.5701593	 ‐0.0239200	
R	=	CHO	(2‐110e)	
1_z	
‐547.5519348	
‐547.409436	
‐547.3509995	 ‐0.0297685	
2_z	
‐547.5614317	
‐547.418610	
‐547.3595335	 ‐0.0213543	
1_e	
‐547.566174	
‐547.422983	
‐547.3641067	 ‐0.0218642	
2_e	
‐547.5624143	
‐547.419536	
‐547.3601792	 ‐0.0206531	
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Table	 2.41	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	COOH	(2‐110f)	
1_cis_z	
‐622.7989419	
‐622.650227	
‐622.5795887	 ‐0.0308362	
3_cis_z	
‐622.8017297	
‐622.652806	
‐622.5817134	 ‐0.0282068	
1_trans_z	
‐622.7861378	
‐622.637654	
‐622.5693547	 ‐0.0366529	
3_trans_z	
‐622.8159662	
‐622.667168	
‐622.5955925	 ‐0.0259757	
1_trans_e	
‐622.7978767	
‐622.648931	
‐622.5793543	 ‐0.0310912	
3_trans_e	
‐622.8003044	
‐622.651184	
‐622.5810062	 ‐0.0267407	
1_cis_e	
‐622.8133855	
‐622.664080	
‐622.5929472	 ‐0.0231232	
3_cis_e	
‐622.8121212	
‐622.662792	
‐622.5912299	 ‐0.0226292	
R	=	COO‐	(2‐110g)	
1_z	
‐622.2335030	
‐622.098321	
‐622.0282506	 ‐0.1209066	
1_e	
‐622.2630732	
‐622.126877	
‐622.0560384	 ‐0.1033133	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	H	(2‐110a_H)	
1_z	
‐435.4492329	
‐435.294442	
‐435.2940215	 ‐0.0193304	
1_e	
‐435.4505804	
‐435.295615	
‐435.2953803	 ‐0.0190595	
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Table	 2.42	 Total	 energies	 and	 enthalpies	 of	 cytosine	 derivatives	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	
H298(B3LYP)	
Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	CH3	(2‐110b_H)	
1_z	
‐474.7632422	
‐474.579845	
‐474.5965349	 ‐0.0174659	
2_z	
‐474.7645077	
‐474.581175	
‐474.5968633	 ‐0.0174659	
1_e	
‐474.7644661	
‐474.580939	
‐474.5976662	 ‐0.0173065	
2_e	
‐474.7651597	
‐474.581630	
‐474.5977392	 ‐0.0183264	
R	=	CHO	(2‐110e_H)	
1_z	
‐548.7622965	
‐548.596836	
‐548.5682272	 ‐0.0208921	
2_z	
‐548.7622494	
‐548.596775	
‐548.5691788	 ‐0.0206531	
1_e	
‐548.7594360	
‐548.593968	
‐548.5656983	 ‐0.0229957	
2_e	
‐548.7596258	
‐548.594083	
‐548.5664423	 ‐0.0216889	
3_e	
‐548.7615166	
‐548.596013	
‐548.5686101	 ‐0.0220555	
4_e	
‐548.7600351	
‐548.594527	
‐548.5650274	 ‐0.0225654	
R	=	COO‐	(2‐110g_H)	
1_z	
‐623.4490713	
‐623.290738	
‐623.2501482	 ‐0.1166517	
2_z	
‐623.4565970	
‐623.298097	
‐623.2593895	 ‐0.1112335	
1_e	
‐623.4725575	
‐623.290738	
‐623.2708916	 ‐0.1015444	
2_e	
‐623.4673347	
‐623.298097	
‐623.2652818	 ‐0.1008910	
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Table	 2.43	 Total	 energies	 and	 enthalpies	 of	 5‐hydroxymethylcytosine	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	 H298(B3LYP)	 Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	CH2OH	(2‐110d_H)	
1_z	
‐549.9618560	 ‐549.772965	 ‐549.7802626	 ‐0.0288761	
2_z	 ‐549.9677169	 ‐549.778465	 ‐549.7857887	 ‐0.0245893	
3_z	 ‐549.9756513	 ‐549.786123	 ‐549.7900967	 ‐0.0229638	
4_z	 ‐549.9690127	 ‐549.779891	 ‐549.7840751	 ‐0.0239678	
5_z	 ‐549.9743994	 ‐549.784849	 ‐549.7897560	 ‐0.0221033	
6_z	 ‐549.9718822	 ‐549.782434	 ‐549.7870924	 ‐0.0233144	
9_z	 ‐549.9652735	 ‐549.776068	 ‐549.7825313	 ‐0.0254180	
10_z	 ‐549.9672040	 ‐549.777891	 ‐549.7847642	 ‐0.0244618	
11_z	 ‐549.9639815	 ‐549.774885	 ‐549.7822338	 ‐0.0256092	
1_e	 ‐549.9671276	 ‐549.777880	 ‐549.7847945	 ‐0.0252267	
2_e	 ‐549.9689878	 ‐549.779618	 ‐549.7869038	 ‐0.0243502	
3_e	 ‐549.9687916	 ‐549.779342	 ‐549.7845836	 ‐0.0258642	
4_e	 ‐549.9677159	 ‐549.778436	 ‐549.7848790	 ‐0.0256411	
5_e	 ‐549.9698354	 ‐549.780339	 ‐549.7861214	 ‐0.0251152	
6_e	 ‐549.9706906	 ‐549.781107	 ‐549.7870163	 ‐0.0239359	
7_e	 ‐549.9665252	 ‐549.777331	 ‐549.7837855	 ‐0.0269159	
9_e	 ‐549.9661910	 ‐549.776832	 ‐549.7831341	 ‐0.0252745	
10_e	 ‐549.9681360	 ‐549.778728	 ‐549.7854841	 ‐0.0244777	
11_e	 ‐549.9637211	 ‐549.774597	 ‐549.7817262	 ‐0.0270594	
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Table	 2.44	 Total	 energies	 and	 enthalpies	 of	 5‐carboxylcytosine	 in	 Hartree	 (SMD/B3LYP	 =	
SMD/B3LYP/6‐31G(d)).	Enthalpies	(in	bold)	are	scaled	by	a	factor	of	0.960.	
N
NH
NH
O
CH3
R
	
Etot(B3LYP)	 H298(B3LYP)	 Etot(G3B3)	
Gsolv	
(SMD/B3LYP)	
R	=	COOH	(2‐110f_H)	
1_cis_z	
‐624.0102209	 ‐623.838337	 ‐623.7979038	 ‐0.0279996	
2_cis_z	 ‐624.0100184	 ‐623.838150	 ‐623.7989956	 ‐0.0268044	
1_trans_z	 ‐624.0188390	 ‐623.847137	 ‐623.8042210	 ‐0.0258323	
2_trans_z	 ‐624.0023838	 ‐623.830493	 ‐623.7918446	 ‐0.0304378	
3_trans_z	 ‐624.0154545	 ‐623.843355	 ‐623.8017670	 ‐0.0246212	
1_trans_e	 ‐624.0025596	 ‐623.830705	 ‐623.7905745	 ‐0.0311709	
2_trans_e	 ‐624.0072582	 ‐623.835083	 ‐623.7964036	 ‐0.0270594	
3_trans_e	 ‐624.0070404	 ‐623.835020	 ‐623.7958151	 ‐0.0274896	
4_trans_e	 ‐624.0032904	 ‐623.831208	 ‐623.7912226	 ‐0.0284617	
1_cis_e	 ‐624.0125869	 ‐623.840480	 ‐623.7993073	 ‐0.0258642	
2_cis_e	 ‐624.0090833	 ‐623.836963	 ‐623.7966272	 ‐0.0260554	
3_cis_e	 ‐624.0110725	 ‐623.839071	 ‐623.7992894	 ‐0.0263423	
4_cis_e	 ‐624.0121306	 ‐623.839984	 ‐623.7983733	 ‐0.0256729	
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2.9 Crystallographic	Appendix	
2.9.1 1,3‐Dimethyl‐5,6‐dihydrouracil	(2‐49a)	
	
2‐49a	
Formula	 C6H10N2O2	 T	(K)	 173(2)	
Mr	(g	mol‐1)	 142.156	 Diffractometer	 Oxford	Xcalibur	
(MoK)	
Crystal	sytem	 Monoclinic	 Angle	 	
Space	group	 P21/c	 Refls.	measured	 4972	
a	(Å)	 8.5501(6)	 Refls.	in	refinement	 1425	
b	(Å)	 12.0430(6)	 Observed	refls.	 992	
c	(Å)	 7.3700(6)	 Rint	 0.0250	
	(°)	 90	 Mean	(I)/I	 0.0341	
	(°)	 111.828(8)	 R(Fobs)	 0.0364	
	(°)	 90	 Rw(F2)	 0.0923	
V	(Å3)	 704.47(8)	 S	 0.954	
Z	 4	 Hydrogen	refinement Constr.	
	(g	cm‐1)	 1.34035(15)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.38	x	0.34	x	0.21 Max	e‐	density	(e	Å‐3)	 0.129	
	(mm‐1)	 0.102	 Min	e‐	density	(e	Å‐3)	 ‐0.149	
Hydrogen	atoms	of	methyl	group	disordered,	split	model	applied.	
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2.9.2 2,4‐Diethoxy‐5‐methylpyrimidinium	iodide	(2‐45b)	
	
2‐45b	
Formula	 C10H17IN2O2	 T	(K)	 100(2)	
Mr	(g	mol‐1)	 324.159	 Diffractometer	 Bruker	D8Venture
(MoK)	
Crystal	sytem	 Monoclinic	 Angle	 2.90<27.58	
Space	group	 C2/c	 Refls.	measured	 17213	
a	(Å)	 8.9980(7)	 Refls.	in	refinement	 1495	
b	(Å)	 11.3959(9)	 Observed	refls.	 1270	
c	(Å)	 12.7487(11)	 Rint	 0.0578	
	(°)	 90	 Mean	(I)/I	 0.0312	
	(°)	 97.786(3)	 R(Fobs)	 0.0354	
	(°)	 90	 Rw(F2)	 0.0864	
V	(Å3)	 1295.20(18)	 S	 1.214	
Z	 4	 Hydrogen	refinement Constr.	
	(g	cm‐1)	 1.6624(2)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.166	x	0.087	x	0.075 Max	e‐	density	(e	Å‐3)	 0.538	
	(mm‐1)	 2.458	 Min	e‐	density	(e	Å‐3)	 ‐0.523	
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2.9.3 1‐tert‐Butoxycarbonyluracil	(2‐40)	
	
2‐40	
Formula	 C9H12N2O4	 T	(K)	 173(2)	
Mr	(g	mol‐1)	 212.203	 Diffractometer	 Oxford	Xcalibur	
(MoK)	
Crystal	sytem	 Monoclinic	 Angle	 4.19<<26.34	
Space	group	 P21	 Refls.	measured	 3484	
a	(Å)	 9.1475(11)	 Refls.	in	refinement	 1112	
b	(Å)	 6.2855(5)	 Observed	refls.	 866	
c	(Å)	 9.7621(13)	 Rint	 0.0323	
	(°)	 90	 Mean	(I)/I	 0.0493	
	(°)	 116.975(16)	 R(Fobs)	 0.00334	
	(°)	 90	 Rw(F2)	 0.0678	
V	(Å3)	 500.22(12)	 S	 0.931	
Z	 2	 Hydrogen	refinement C	bound	constr.	
N	bound	refall.	
	(g	cm‐1)	 1.4089(3)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.32	x	0.12	x	0.09 Max	e‐	density	(e	Å‐3)	 0.139	
	(mm‐1)	 0.112	 Min	e‐	density	(e	Å‐3)	 ‐0.165	
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2.9.4 1‐(2‐Cyanoethyl)‐1‐methylurea	(2‐59a)	
	
2‐59a	
Formula	 C5H9N3O	 T	(K)	 100(2)	
Mr	(g	mol‐1)	 127.145	 Diffractometer	 Bruker	D8Venture
(MoK)	
Crystal	sytem	 Triclinic	 Angle	 3.16<<25.09	
Space	group	 P1bar	 Refls.	measured	 8883	
a	(Å)	 5.7659	(5)	 Refls.	in	refinement	 4541	
b	(Å)	 13.0836(11)	 Observed	refls.	 3101	
c	(Å)	 18.1683(17)	 Rint	 0.0398	
	(°)	 77.013(3)	 Mean	(I)/I	 0.0706	
	(°)	 82.897(3)	 R(Fobs)	 0.0463	
	(°)	 85.689(3)	 Rw(F2)	 0.1136	
V	(Å3)	 1323.7(2)	 S	 1.016	
Z	 8	 Hydrogen	refinement C	bound	constr.	
N	bound	refall.	
	(g	cm‐1)	 1.27601(19)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.132	x	0.048	x	0.041 Max	e‐	density	(e	Å‐3)	 0.226	
	(mm‐1)	 0.093	 Min	e‐	density	(e	Å‐3)	 ‐0.210	
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2.9.5 1‐Methyl‐5,6‐dihydrocytosine	•	½	H2O	(2‐55a)	
	
2‐55a	•	½	H2O	
Formula	 C5H10N3O1.5	 T	(K)	 100(2)	
Mr	(g	mol‐1)	 136.152	 Diffractometer	 Bruker	D8Venture
(MoK)	
Crystal	sytem	 Orthorombic	 Angle	 3.28<<27.53	
Space	group	 Pbcn	 Refls.	measured	 12062	
a	(Å)	 12.4314(4)	 Refls.	in	refinement	 1496	
b	(Å)	 8.6973(2)	 Observed	refls.	 1357	
c	(Å)	 12.0417(4)	 Rint	 0.0303	
	(°)	 90	 Mean	(I)/I	 0.0188	
	(°)	 90	 R(Fobs)	 0.0336	
	(°)	 90	 Rw(F2)	 0.0917	
V	(Å3)	 1301.94(7)	 S	 1.051	
Z	 8	 Hydrogen	refinement Refall.	
	(g	cm‐1)	 1.38925(7)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.157	x	0.127	x	0.120 Max	e‐	density	(e	Å‐3)	 0.389	
	(mm‐1)	 0.105	 Min	e‐	density	(e	Å‐3)	 ‐0.168	
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2.9.6 rac‐1‐(2‐Cyanopropyl)‐1‐methylurea	(2‐59b)	
	
2‐59b	
Formula	 C6H11N3O	 T	(K)	 100(2)	
Mr	(g	mol‐1)	 141.171	 Diffractometer	 Bruker	D8Venture
(MoK)	
Crystal	sytem	 Monoclinic	 range	 	
Space	group	 C2/c	 Refls.	measured	 10282	
a	(Å)	 25.977(5)	 Refls.	in	refinement	 1415	
b	(Å)	 5.9042(8)	 Observed	refls.	 1143	
c	(Å)	 10.2324(156)	 Rint	 0.0461	
	(°)	 90	 Mean	(I)/I	 0.0263	
	(°)	 97.469(4)	 R(Fobs)	 0.0716	
	(°)	 90	 Rw(F2)	 0.2141	
V	(Å3)	 1556.1(4)	 S	 1.156	
Z	 8	 Hydrogen	refinement Mixed	
	(g	cm‐1)	 1.2052(3)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.253	x	0.093	x	0.018 Max	e‐	density	(e	Å‐3)	 0.705	
	(mm‐1)	 0.086	 Min	e‐	density	(e	Å‐3)	 ‐0.306	
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2.9.7 N,N‐Dimethyl‐N’‐(1‐methyl‐2‐oxo‐1,2‐dihydropyrimidin‐4‐
yl)formimidamide	(2‐52a)	
	
2‐52a	
Formula	 C8H12N4O	 T	(K)	 100(2)	
Mr	(g	mol‐1)	 180.207	 Diffractometer	 Bruker	D8Venture
(MoK)	
Crystal	sytem	 Monoclinic	 range	 	
Space	group	 P21/n	 Refls.	measured	 11720	
a	(Å)	 10.4269(5)	 Refls.	in	refinement	 	
b	(Å)	 5.9290(3)	 Observed	refls.	 1691	
c	(Å)	 13.7501(6)	 Rint	 0.0288	
	(°)	 90	 Mean	(I)/I	 0.0193	
	(°)	 90.7826(16)	 R(Fobs)	 0.0371	
	(°)	 90	 Rw(F2)	 0.1025	
V	(Å3)	 849.97	 S	 1.063	
Z	 4	 Hydrogen	refinement Constr.	
	(g	cm‐1)	 1.40826(12)	 Shift/errormax	 0.001	
Crystal	size	(mm)	 0.259	x	0.137	x	0.046 Max	e‐	density	(e	Å‐3)	 0.355	
	(mm‐1)	 0.099	 Min	e‐	density	(e	Å‐3)	 ‐0.181	
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3 Enhanced	Redox	Properties	in	Open‐shell	Nucleotides	–	
A	Theoretical	Survey	
Parts	of	this	chapter	have	been	published	in		
Transfer	Hydrogenation	in	Open‐shell	Nucleotides	–	A	Theoretical	Survey	
F.	Achrainer,	H.	Zipse,	Molecules	2014,	19,	21489	–	21505.	
3.1 Introduction	
As	 already	 described	 in	 Chapter	 2	 transfer	 hydrogenation	 between	 alcohols	 and	
alkenes	 represents	 a	 synthetically	 and	 technically	 relevant	 process	 to	 hydrogenate	
unsaturated	 compounds.[87]	 Over	 the	 past	 years	 numerous	 variants	 ranging	 from	
transition	metal	catalysis[88]	over	metal‐free	routes	or	organocatalytic	approaches[89]	
have	been	developed	to	be	compatible	with	sensitive	starting	materials	or	to	induce	
high	 enantioselectivities.	 The	 driving	 force	 for	 this	 type	 of	 process	 derives	 from	
systematically	 higher	 heats	 of	 hydrogenation	 hydH	 for	 alkenes	 as	 compared	 to	
aldehydes	and	ketones.	For	example	taking	the	reaction	of	ethanol	(3‐1)	with	propene	
(3‐2)	 of	 Scheme	 3.1	 to	 yield	 acetaldehyde	 (3‐3)	 and	 propane	 (3‐4)	 the	 reaction	
enthalpy	 trhH	 amounts	 to	 ‐55.2	 kJ	 mol‐1	 when	 experimentally	 measured	 heats	 of	
formation	are	used.[15]	
OH
H3C H
H
HH3C
H H
+
3-1 3-2
trhH O
H3C HH3C
H H
+
3-3 3-4
H
H
H
	
Scheme	3.1	Transfer	hydrogenation	of	ethanol	(3‐1)	to	propene	(3‐2).	
A	multitude	of	actual	pathways	exist	for	utilizing	this	driving	force,	the	most	relevant	
of	which	will	most	likely	involve	open‐shell	intermediates	under	biological	conditions.	
The	combined	theoretical	and	experimental	study	(see	Chapter	2.4)	to	determine	the	
heats	 of	 hydrogenation	 of	 pyrimidine	 und	 purine	 bases	 indicates	 that	 the	
hydrogenation	 enthalpies	 of	 oxidized	 sugar	 models	 are,	 in	 part,	 closely	 similar	 to	
those	of	the	pyrimidine	bases.[74]		
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How	 will	 these	 energetics	 change	 on	 introducing	 a	 radical	 center	 in	 direct	
neighbourhood	of	the	reacting		system	in	the	hydrogen‐donor	or	‐acceptor?	This	can	
in	 principle	 be	 discussed	with	 reference	 to	 the	 reaction	 in	Scheme	3.2	with	 either	
ethanol	 (3‐1)	 or	 ethanol‐2‐yl	 radical	 (3‐1R).	 While	 the	 reaction	 of	 closed‐shell	
reactants	 is	 exothermic	 (trhH	 =	 ‐55.2	 kJ	 mol‐1)	 the	 latter	 is	 significantly	 more	
exothermic	with	a	value	of	‐84.6	kJ	mol‐1.	This	increase	in	driving	force	of	29.4	kJ	mol‐1	
implies	that	ethanol‐2‐yl	radical	(3‐1R)	is	a	better	dihydrogen	donor	than	its	closed‐
shell	parent	ethanol.	In	contrast,	installation	of	a	radical	center	in	the	alkene	partner	
leads	to	a	close	to	thermoneutral	reaction	enthalpy	of	‐4.4	kJ	mol‐1.	
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Scheme	3.2	Experimentally	determined	transfer	hydrogenation	enthalpy	trhH	for	selected	open‐shell	
systems	at	298.15	K	in	the	gas	phase.	
On	 closer	 inspection	 of	 the	 reactant	 and	 product	 radicals	 involved,	 it	 also	 becomes	
evident	 that	 the	 driving	 force	 is	 identical	 to	 the	 differences	 in	 radical	 stabilization	
energies	(RSE)	of	the	reactant	and	product	radicals.	
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*
C C
C
C
C
C
H
H
H
H
H
pz

*
C O
O
O
C
C
O
H
H
H
E
C
pz
O H
nO
3-2R
3-3R
	
Figure	3.1	Qualitatitive	 frontier	orbital	 interaction	scheme	 for	 the	 formation	of	 the	allyl	 (3‐2R)	and	
the	formyl	methyl	radical	(3‐3R).	
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Open‐shell	 species	 like	 ribosyl	 radical	 3‐5R	 possess	 enhanced	 stability	 because	 of	
their	 special	 substitution	 pattern	 of	 an	 electron‐withdrawing	 and	 an	 electron‐
donating	 group	 in	 direct	 connection	 to	 the	 radical	 center	 (Figure	 3.1).	 This	
synergistic	 effect	 is	 commonly	 referred	 in	 the	 literature	 as	 “captodative”	 or	 “push‐
pull”	 effect[90]	 with	 the	 open‐shell	 glycyl	 model	 (3‐6R)[91]	 and	 the	
semidehydroascorbate	 acid	 radical	 (3‐7R)[92]	 as	 the	most	 prominent	 examples	 (see	
Scheme	3.3).		
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Scheme	3.3	Resonance	contributions	 in	 the	C‐centered	 semiquinone	 radicals	3‐5R	 and	3‐7R	 and	 in	
glycyl	peptide	radical	3‐6R.	
Another	 useful	 approach	 to	 define	 the	 captodative	 effect	 is	 the	 comparison	 of	 the	
radical	 stabilization	 energy	 (RSE)	 of	 the	 individual	 components.	 The	 sum	 of	 the	
calculated	RSE	of	 the	hydroxyethyl	 radical	 (3‐1Rb)	and	 the	acetonyl	 radical	3‐8R	 is	
‐70.7	kJ	mol‐1,	whereas	the	RSE	of	3‐9R	in	the	trans	form	is	‐92.4	kJ	mol‐1	(see	Table	
3.1).	 The	 energetic	 difference	 of	 21.7	 kJ	 mol‐1	 indicates	 a	 substantial	 captodative	
stabilization.	
HO
O
CH3
+
3-9R 3-10R
HO O
+
3-1Rb 3-8R
rxnH
	
Scheme	 3.4	 EGroup	 exchange	 reaction	 to	 define	 the	 stabilizing	 captodative	 effect.	 The	 reaction	
enthalpy	amounts	to	‐40.7	kJ	mol‐1	at	G3(MP2)‐RAD	level.	
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Table	3.1	Radical	stabilization	energies	calculated	at	G3(MP2)‐RAD	level	at	298.15	K,	in	kJ	mol‐1.	
R H + CH3
RSE
R + CH4
3-10R 3-10 	
R‐H	 RSE(calc.)	 RSE	(exp.)[93]	
HO
3-1Rb 	
‐38.3	 ‐42.7	
O
3-8R 	
‐32.4	 ‐38.1	
O
OH 3-9R 	
‐92.4	 n/a	
3.2 Ribonucleotide	Reductase	
The	radical‐induced	changes	in	dihydrogen	transfer	energetics	are	likely	to	impact	the	
chemistry	 of	 nucleotide	 radicals.	 This	may	 be	 particularly	 relevant	 for	 cases	where	
oxidations	 of	 nucleotide	 radicals	 have	 been	 observed	 under	 reducing	 conditions.	 A	
prominent	example	is	the	outcome	of	the	substrate	reaction	of	the	E441Q	mutant	of	E.	
coli	 class	 I	 ribonucleotide	 reductase	 (RNR).[94]	 This	 family	 of	 ubiquitous	 radical	
enzymes	catalyzes	the	conversion	of	nucleotides	to	desoxynucleotides	to	provide	the	
monomeric	 building	 blocks	 for	 cell	 growth	 and	 DNA	 synthesis.[95]	 The	 enzyme	 is	
classified	 in	 three	 different	 classes	 by	 the	 cofactor	 responsible	 for	 the	 radical	
generation:	 ‐oxo‐di‐iron‐tyrosyl	 cofactor	 (class	 I,	 aerobic),	 coenzyme	 B12	 (class	 II,	
facultative	aerobic)	and	S‐adenosyl	methionine	which	forms	a	glycyl	radical	(class	III,	
anaerobic).	
O
OHOH
PPO Nbase RNR O
OH
PPO Nbase
	
Scheme	3.5	RNR‐catalyzed	reduction	of	ribonucleotides	to	2’‐desoxynucleotides.	
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Class	I	RNR,	found	in	mammals	and	E.	coli,	is	one	of	the	best	examined	enzyme	and	is	
composed	 of	 two	 heterodimeric	 subunits,	 the	 large	 R1	 (2)[96]	 and	 the	 small	 R2	
(2).[97]	The	catalytic	machinery	and	the	binding	site	for	the	nucleotide	reduction	are	
located	in	the	R1	section.	The	required	radical	for	the	reaction	is	formed	and	stored	in	
the	R2	unit	by	a	di‐iron‐oxo	tyrosyl	(Y122•)	radical	cofactor.	Two	remarkable	facts	have	
been	 the	 subject	 of	 scientific	 controversy	 in	 the	 last	 decades:	 1.)	 The	 long	 half‐life	
time	 of	 around	 four	 days	 of	 the	 radical,	 which	 results	 in	 a	 low	 affinity	 of	 the	 two	
subunits	to	form	the	active	RNR;	and	2.)	the	transport	of	the	radical	from	the	tyrosyl	
Y122•	of	R2	to	 the	cysteine	moiety	C439	 in	 the	active	site	of	R1.	A	 long‐range	proton‐
coupled	 electron	 transfer	 (PCET)	 has	 been	 proposed	 to	 initiate	 catalysis	 upon	
estimation	of	a	distance	of	at	least	25	Å	on	the	basis	of	an	MD	docking	model.[98]	
As	already	mentioned,	during	the	reaction	progress	the	radical	is	transferred	from	the	
Y122	residue	on	2	to	cysteine	C439	 in	the	active	site	of	2.	Essential	residues	for	the	
catalytic	 activity	 are	 two	 additional	 cysteines	 (C225	 and	 C462),[99]	 a	 glutamate	 (E441),	
acting	 as	 general	 acid‐base	 catalyst[100]	 and	 an	 asparagine	 (N437)	 which	 helps	 to	
stabilize	 the	 conformation	of	C225	 and	C462.[101]	These	 two	cysteine	 residues	provide	
the	 reducing	 equivalents	 to	 convert	 ribonucleotides	 into	 the	 desired	 2’‐desoxy	
derivatives	(see	Figure	3.2).	The	regeneration	of	the	free	thiol	groups	is	achieved	by	
subsequent	thioredoxin/NADPH	reduction.[102]	
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Figure	3.2	Proposed	mechanisms	for	the	RNR‐catalyzed	reduction	of	nucleoside	diphosphates.	
By	 replacing	 glutamate	 E441	 with	 a	 glutamine	 and	 incubating	 with	 cytidine	
diphosphate	 the	 catalytical	 activity	 is	 suppressed	 completely	 and	no	2’‐reduction	 is	
detected.	 Instead,	 in	 a	 characteristic	 time‐dependent	 manner	 signals	 of	 two	 open‐
shell	 intermediates	are	observed.	Using	a	combination	of	high‐field	EPR	and	ENDOR	
measurements	 and	 computational	 predictions	 of	 EPR	 parameters,	 one	 of	 these	
intermediates	has	been	identified	as	semidione	radical	anion	3‐13R.	
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Scheme	3.6	Substrate	reaction	of	class	I	RNR	E441Q	mutant.	
How	 oxidized	 intermediate	 3‐13R	 can	 be	 formed	 under	 the	 reductive	 conditions	
present	 in	 the	 experiment	 has	 still	 not	 been	 rationalized	 in	 a	 satisfactory	way,	 but	
most	 likely	 a	 stepwise	H	 atom	 transfer	 occurs.[103]	 The	 possibility	 that	 the	 cytosine	
base	present	 in	radical	3‐11R	 can	act	as	 internal	 redox	partner	 to	 the	adjacent	C3’‐
ribosyl	 radical,	 thus	 generating	 product	 radical	 3‐14R	 (and	 not	 3‐13R)	 through	 a	
transfer	hydrogenation	process	is	feasible	from	a	thermochemical	point	of	view.	Mass	
spectrometry	as	the	major	tool	for	the	analysis	of	oligonucleotides	gives	for	this	type	
of	reaction	no	meaningful	conclusion	and	a	dihydro	cytosine	motif	has	presumably	no	
significant	influence	on	the	EPR	parameters.	
3.3 Validation	of	Theoretical	Methods	
3.3.1 Closed‐shell	Systems	
The	validation	for	the	reaction	energies	of	the	transfer	hydrogenation	of	closed‐shell	
reactants	has	already	been	carried	out	in	Chapter	2.2	and	the	G3B3	method[104]	has	
been	 identified	 as	 the	 method	 of	 choice	 in	 combination	 with	 the	 experimentally	
determined	 hydrogenation	 enthalpy	 of	 ethylene	 (3‐15,	 hydH	 =	
‐136.3±0.2	kJ	mol‐1).[105]	Nevertheless,	 applying	 this	method	 to	open‐shell	molecules	
of	 the	 size	 of	 sugar	 models	 and	 complete	 nucleosides	 is	 difficult	 due	 to	 hardware	
limitations.	 Therefore,	 the	 also	 examined	 ROMP2(FC)/6‐311+G(3df,2p)	 single	 point	
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approach[106]	 in	 combination	 with	 UB3LYP/6‐31G(d)	 optimized	 structures	 and	
thermochemical	 corrections	 to	 298.15	 K	 using	 the	 rigid	 rotor/harmonic	 oscillator	
model	 were	 evaluated	 to	 estimate	 the	 driving	 force	 of	 the	 radical‐induced	
hydrogenation	 of	 ethylene	 (3‐15).	 Improved	 energies	 were	 obtained	 using	 the	
G3(MP2)‐RAD	composite	method	introduced	by	Radom	et	al.[81]		
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Figure	3.3	Heats	of	hydrogenation	hydH	at	298.15	K	(G3(MP2)‐RAD,	 in	kJ	mol‐1)	 in	the	gas	phase	of	
selected	 pyrimidine	 bases	 and	 carbonyl	 compounds.	 Experimental	 hydrogenation	 enthalpies	 are	
shown	as	red	lines	together	with	their	standard	deviation	as	grey	bars.	
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Table	3.2	Calculated	and	experimentally	determined	heats	of	hydrogenation	hydH	at	298.15	K	in	the	
gas	phase,	in	kJ	mol‐1.	
HH
H H
H
H
+
HH
H H
+
3-24 3-15
N
N
R
O
R
trhH N
N
R
OH
R
H
H
H
	
Reactants	
MP2(FC)/	
6‐311+G(3df,2p)
G3(MP2)‐RAD	 Exp.[15]		
trhHa	 hydHb	 trhHa	 hydHb trhHa	 hydHb	
Ethylene	(3‐15)	 0.0	 ‐136.3	 0.0	 ‐136.3 0.0	 ‐136.3±0.2[105]
Propene	(3‐2)	 +12.4	 ‐123.9	 +10.8	 ‐125.5 +12.6	 ‐125.0±0.2[16]	
O
OH
HO
O
3-20 	
+44.5	 ‐91.8	 +44.9	 ‐91.4	 n/a	 n/a	
O
OHOH
O
3-21 	
+50.3	 ‐86.0	 +50.2	 ‐86.1	 n/a	 n/a	
Uracil	(3‐16)	 +56.1	 ‐80.2	 +57.0	 ‐79.3	 +53.6	±	2.1[74]	 ‐81.5±2.1	
O
OH
HO
O
3-22 	
+58.3	 ‐78.0	 +58.8	 ‐77.5	 n/a	 n/a	
1,3‐Dimethyl	
uracil	(3‐18)	
+62.4	 ‐73.9	 +62.7	 ‐73.6	 +68.5±	2.1[74]	 ‐67.6±2.6	
Thymine	(3‐17)	 +64.2	 ‐72.1	 +63.8	 ‐72.5	 +68.8	±	4.2[74]	 ‐67.6±2.3	
Acetaldehyde	(3‐3)	 +65.8	 ‐70.5	 +65.1	 ‐71.2	 +67.8	 ‐69.1±0.4[23]	
Acetone	(3‐8)	 +77.8	 ‐58.5	 +76.5	 ‐59.8	 +80.9	 ‐55.6±0.4[24]	
Cytosine	(3‐19)	 +82.4	 ‐53.9	 +80.2	 ‐56.1	 n/a	 n/a	
Adenine	(3‐25)	 +152.6	 +13.6	 +139.0 +2.7	 n/a	 n/a	
Guanine	(3‐26)	 +155.2	 +18.9	 +141.2 +4.9	 n/a	 n/a	
a	 Defined	 as	 trhH	 =	 fH(C2H4)	 +	 fH(R2CH‐OH)	 –	 fH(R2C=O)	 –	 fH(C2H6)	 and	 trhH	 =	 fH(C2H4)	 +	 fH(RCH2‐CH2R)	 –	
fH(RHC=CHR)	 –	 fH(C2H6),	 respectively.	 b	 Addition	 of	 the	 reaction	 enthalpies	 trhH	 to	 the	 experimentally	 determined	
hydrogenation	 enthalpy	 of	 ethylene	hydH	 (C2H4,	3‐15)	 =	 ‐136.3±0.2	 kJ	mol‐1	 yields	 the	 hydrogenation	 enthalpy	hydH	 of	 the	
respective	double	bond.	
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The	hydrogenation	enthalpies	are	summarized	in	Table	3.2	and	shown	in	Figure	3.3	
such	 that	 a	 side‐by‐side	 comparison	 of	 all	 possible	 hydrogen	 transfer	 reactions	 is	
possible	 in	 a	 graphical	 way.	 In	 accordance	 with	 Chapter	 2.4	 and	 from	 this	
representation	 it	 is	apparent	 that	uracil	 (3‐16)	as	 the	most	easily	 reduced	base	can	
react	exothermally	with	sugar	models	like	1’‐anhydroribose	3‐23	in	a	formal	transfer	
hydrogen	reaction	to	form	ketone	3‐22.	
The	 calculated	 reaction	 enthalpies	 obtained	 at	 G3(MP2)‐RAD	 and	MP2	 level	 are	 in	
good	agreement	with	experimental	values	and	are	found	to	fit	the	chemical	accuracy	
of	one	kcal	mol‐1.	Introduction	of	two	methyl	groups	present	in	dimethyl	uracil	3‐18	
leads	 to	hydH	 =	 ‐73.6	 kJ	mol‐1	 vs.	 ‐79.3	 kJ	mol‐1	 for	 uracil	 (3‐16)	 at	 G3(MP2)‐RAD	
level,	 which	 is	 almost	 the	 same	 result	 as	 obtained	 for	 thymine	 (3‐17,	 hydH	 =	
‐72.5	kJ	mol‐1).	 The	 reduced	 hydrogenation	 enthalpy	 of	 around	 +7	 kJ	mol‐1	 (hydH	
(3‐16/3‐17))	is	also	observed	in	related	systems	like	ethylene/propene	(hydH	(exp.,	
3‐15/3‐2)	 =	 +11.3	 kJ	mol‐1),	 cyclohexene[18]/1‐methylcyclohexene[19]	 (hydH(exp.,	
3‐27/3‐28)	 =	 +7.4	 kJ	mol‐1)	 and	 cyclopentene[18]/1‐methylcylopentene[19]	
(hydH(exp.,	3‐29/3‐30)	=+11.3	kJ	mol‐1)	and	can	therefore	be	considered	as	general	
phenomenon.	The	most	difficult	pyrimidine	base	to	reduce	is	cytosine	(3‐19,	hydH	=	
‐56.1	kJ	mol‐1)	due	to	the	different	substitution	pattern.	Hydrogenation	of	the	purine	
bases	adenine	(3‐25)	and	guanine	(3‐26)	is	significantly	more	difficult,	a	result	of	the	
intrinsically	large	differences	in	reductions	of	C‐C	and	C‐N	double	bonds.[15,	57]	
N
NN
N
H
NH2
3-25
+2.7
+14.5
+36.5
N
NHN
N
H
3-26
+4.9
+20.6
O
NH2 N
NN
N
H
3-31
-6.5
+15.7
+72.8 (cis)
+112.9 (trans)
-21.5
	
Figure	3.4	Hydrogenation	enthalpies	hydH	 of	adenine	 (3‐25),	 guanine	 (3‐26)	and	 their	parent	 lead	
structure	purine	(3‐31)	at	G3(MP2)‐RAD	level	of	theory	(gas	phase,	298.15	K,	in	kJ	mol‐1).	
For	instance	the	hydrogenation	enthalpies	for	the	canonical	structures	of	adenine	and	
guanine	are	all	endothermic	with	energetically	best	values	of	hydH(3‐25)	=	+2.7	and	
hydH(3‐26)	=	+4.9	kJ	mol‐1,	respectively.	The	reduction	of	the	oxidized	sugar	models	
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3‐20,	3‐21	and	3‐22	(see	Table	3.2)	to	give	1’‐anhydroribose	(3‐23)	are	all	located	in	
a	range	from	‐77.5	to	‐91.4	kJ	mol‐1	in	the	gas	phase	at	G3(MP2)‐RAD	level.	As	a	result,	
transfer	hydrogenation	to	yield	5,6‐dihydro	uracil	and	2’‐keto	sugar	3‐22	is	predicted	
to	 be	 slightly	 exothermic	 by	 ‐79.3	 –	 (‐77.5)	 =	 ‐1.8	 kJ	 mol‐1.	 The	 other	 two	 sugar	
derivatives	 3‐20	 and	 3‐21	 are,	 in	 contrast,	 not	 effective	 as	 dihydrogen	 donors	 to	
reduce	uracil	in	an	exothermic	fashion.		
3.3.2 Open‐shell	Systems	
Substantial	 changes	 in	 reaction	 enthalpies	 are	 observed	 for	 open‐shell	 systems	 as	
redox	partners.	Applying	 the	same	strategy	of	 transfer	hydrogenation	with	ethylene	
(3‐15)/ethane	(3‐24)	to	radicals	with	reactive	‐	and	‐hydrogen	atoms	gives	overall	
more	 positive	 heats	 of	 hydrogenation	 due	 to	 the	 loss	 of	 radical	 stabilization.	 The	
redox	 data	 for	 a	 variety	 of	 small	 C‐centered	 radicals	 obtained	 at	 various	 levels	 is	
collected	in	Table	3.3	and	validated	with	experimentally	available	values.	
ROMP2	 and	 G3(MP2)‐RAD	 give	 almost	 the	 same	 results,	 but	 underestimate	 the	
experimental	enthalpy	constantly	except	for	the	cyclopentyl	radical	(3‐32R)	which	is	
the	result	of	 the	distinct	ring	strain.	 Inspection	of	 the	obtained	correlation	reveals	a	
large	discrepancy	 for	 the	open‐shell	 pair	 acetone	 (3‐8R)	 and	 iso‐propanol	 (3‐33R),	
which	 is	most	 likely	 caused	 by	 the	 experimentally	 determined	 heat	 of	 formation	 of	
propan‐2‐ol‐1‐yl	 radical	 3‐33R	 (fH(exp.)	 =	 ‐96.2±4.2	 kJ	 mol‐1)	 supported	 by	
additional	calculations	(see	Appendix	Table	3.35).[107]	Recent	high‐level	calculations	
at	CBS‐QB3	level[108]	gave	a	revised	value	of	fH	=	‐64.0	kJ	mol‐1	for	3‐33R[109]	which	
gave	an	overall	better	correlation.	The	G3(MP2)‐RAD	correlation	is	mainly	the	result	
of	the	reaction	enthalpies	involving	C‐based	reactants	(see	Figure	3.5).	By	abstracting	
a	 hydrogen	 atom	 from	 the	 parent	 closed‐shell	molecule	 the	 heats	 of	 hydrogenation	
hydH	are	shifted	significantly	to	less	exothermic	values,	which	is	nothing	else	than	a	
reflection	 of	 the	 radical	 stabilization	 energies	 of	 the	 respective	 open‐shell	
intermediate.		
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Table	 3.3	 Validation	 of	 theoretical	 methods	 with	 experimentally	 available	 data	 for	 the	 open‐shell	
induced	transfer	hydrogenation	trhH	at	298.15	K	in	the	gas	phase,	in	kJmol‐1.	
H H
HH
H
H
R'
R
X
+
trhH
H
H H
HH
R'
R
X
+
H
H
H
3-24 3-15X = O, CR2 X = O, CR2 	
Initial	
radical	
UB3LYP/6‐31G(d)
ROMP2(FC)/	
6‐311+G(3df,2p)
G3(MP2)‐RAD	 Exp.	
trhH	 hydHa	 trhH	 hydHa	 trhH	 hydHa	 trhH	
3-2R 	
+82.8	 ‐53.5	 +71.5	 ‐64.8	 +72.7	 ‐63.7	 +65.4±5.9	
3-34R 	
+88.4	 ‐47.9	 +72.9	 ‐63.4	 +72.8	 ‐63.5	 +64.6±2.2	
OH
3-35R 	
+79.5	 ‐56.8	 +62.5	 ‐73.8	 +64.9	 ‐71.4	 +55.4±17.3	
3-27R 	
+96.3	 ‐40.0	 +85.8	 ‐50.5	 +81.6	 ‐54.7	 +74.9±4.9	
3-29R 	
+88.3	 ‐48.0	 +79.9	 ‐56.5	 +75.9	 ‐60.4	 +82.7±7.6	
O
3-3R 	
+137.3	 +1.0	 +90.1	 ‐46.2	 +91.4	 ‐44.9	 +94.9±17.1	
O
3-8R 	
+149.0	 +12.7	 +98.3	 ‐38.0	 +99.3	 ‐37.0	
+74.1±8.1	
+106.3±3.9b	
O
3-36R 	
+161.6	 +25.3	 +105.7 ‐30.6	 +106.6 ‐29.7	 +106.6±13.5c	
O
3-37R 	
+154.6	 +18.3	 +104.8 ‐31.5	 +104.6 ‐31.7	 +91.9±9.3	
a	 Addition	 of	 the	 reaction	 enthalpies	trhH	 to	 the	 experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	hydH(C2H4,	
2‐15)	 =	 ‐136.3±0.2	 kJ/mol	 yields	 the	 hydrogenation	 enthalpy	 hydH	 of	 the	 respective	 double	 bond.	 b	 With	 a	 fH0(2‐33R)	 =	
‐64.02	kJ	mol‐1	at	CBS‐QB3	level	of	theory.[109]	c	Applying	radical	fH	calculated	by	Benson	group	additivity	values.	
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Figure	3.5	Correlation	of	experimentally	available	trhH(exp.)	vs.	trhH(calc.)	at	G3(MP2)‐RAD	level	of	
theory	in	the	gas	phase	at	298.15K.	
According	 to	 these	 results	 all	 oxygen‐containing	 open‐shell	 intermediates	 are	 in	
principle	able	to	hydrogenate	the	double	bonds	of	the	pyrimidine	bases.	For	example,	
reaction	 of	 the	 ethanol	 derived	 radical	3‐1R	 with	 uracil	 (3‐16)	 gives	 an	 increased	
driving	 force	of	 ‐79.3	–	 (‐44.9)	=	 ‐34.4	kJ	mol‐1	 at	G3(MP2)‐RAD	 level,	 compared	 to	
‐8.1	kJ	 mol‐1	 for	 the	 closed‐shell	 reaction	 (see	 Figure	3.6).[74]	 The	 enhanced	 redox	
power	of	ketones	compared	to	aldehydes	persists	constantly	despite	the	origin	of	the	
reactants	indicated	by	almost	the	same	difference	in	hydrogenation	energies.	Overall	
it	 can	 be	 concluded	 that	 the	 obtained	 G3(MP2)‐RAD	 values	 reflect	 the	 real	 facts	 of	
radical‐induced	transfer	hydrogenation.	
OH
O
O
O
O
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Figure	3.6	Comparison	of	open‐	and	closed‐shell‐induced	transfer	hydrogenation	of	uracil	(3‐16).		
3.4 Open‐shell	Sugar	Models	
The	 heats	 of	 hydrogenation	 of	 ribose‐derived	 radicals	 are	 also	 shifted	 compared	 to	
their	 closed‐shell	 counterparts	 and	 cover	 now	 a	 range	 from	 ‐14.4	 to	 ‐94.5	 kJ	mol‐1	
depending	on	the	position	of	the	unpaired	electron.	The	energies	for	pentose‐derived	
aldehydes,	ketones	and	alkenes	are	collected	in	Table	3.4	and	Table	3.5.	The	smallest	
hydrogenation	 enthalpies	 are	 found	 for	 donor/acceptor	 substituted	 radicals	
combining	a	hydroxyl	group	donor	with	a	carbonyl	acceptor‐substituent	as	is	the	case	
in	 3‐43R.	 Introduction	 of	 a	 hydroxymethyl	 substituent	 present	 in	 3‐43R	 (hydH	 =	
‐14.4	kJ	mol‐1),	 but	not	 in	 radical	3‐39Ra	 (hydH	 =	 ‐11.6	kJ	mol‐1)	has	only	 a	minor	
influence	on	 the	hydrogenation	enthalpies.	This	conclusion	 is	also	supported	by	 the	
almost	 negligible	 difference	 in	 energies	 of	 radical	 3‐42Ra	 and	 3‐43R,	 where	 the	
substituent	and	the	radical	center	are	interchanged.		
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Table	3.4	Boltzmann‐averaged	hydrogenation	enthalpies	<hydH>	at	298.15	K	in	the	gas	phase	for	diol‐
derived	radicals.	Only	the	initial	radicals	are	shown.	
H H
HH
H
H
+
trhH
H H
HH
+
3-24 3-15
O
O
R O R
HOHO OH
H
	
	
ROMP2(FC)/	
6‐311+G(3df,2p)	
G3(MP2)‐RAD	
<trhH>a	 <hydH>b	 <trhH>a	 <hydH>b	
O
HO O
3-39Ra
	
+129.0	 ‐7.28	 +124.7	 ‐11.6	
O
HO OH
3-39Rb
	
+76.5	 ‐59.8	 +73.8	 ‐62.5	
O
OH OH
3-40Ra
	
+13.8	 ‐122.5	 +18.1	 ‐118.2	
O
OHO
3-40Rb
	
+104.6	 ‐31.7	 +101.4	 ‐34.9	
O
HO OH
3-40Rc
	
+65.9	 ‐70.4	 +65.2	 ‐71.1	
a	 Defined	 as	trhH	 =	fH(C2H4)	 +	fH(•R2CH‐OH)	 –	fH(•R2C=O)	 –fH(C2H6).	 b	 Addition	 of	 the	 reaction	 enthalpies	trhH	 to	 the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH(C2H4,	 3‐15)	 =	 ‐136.3±0.2	 kJ	 mol‐1[105]	 yields	 the	
hydrogenation	enthalpy	hydH	of	the	respective	double	bond.	
	
Systematically	larger	enthalpies	are	calculated	for	ribose	radicals	carrying	a	carbonyl	
acceptor	 and	 the	 ring	 oxygen	 as	 alkoxy	 donor.	 A	 typical	 example	 is	 3‐44Ra	 with	
hydH	=	‐33.1	kJ	mol‐1	at	G3(MP2)‐RAD	level	(see	Table	3.5).	This	group	also	includes	
radicals	 3‐41Ra	 and	 3‐41Rb,	 in	 which	 the	 oxidized	 C5’	 position	 acts	 as	 acceptor	
substituent	 to	 the	radical	 center.	The	 influence	of	 the	C2’	hydroxyl	group	present	 in	
3‐41Rb,	but	not	in	3‐46Rb,	appears	to	be	negligible	according	to	the	almost	identical	
hydrogenation	energies	(hydH	(3‐46Rb)	=	‐26.7	vs.	hydH	(3‐41Rb)	=	‐27.5	kJ	mol‐1).	
The	 small	 hydrogenation	 enthalpies	 obtained	 herein	 for	 all	 push/pull‐substituted	
radicals	 reflect	 the	 efficient	 interaction	 of	 the	 alkoxy/hydroxyl‐donor	 and	 carbonyl‐
acceptor	 substituents.[90a,	 93]	 As	 shown	 in	 Scheme	 3.7	 for	 the	 example	 of	 radical	
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3‐39Ra,	 these	 can	 be	 rationalized	 with	 the	 admixture	 of	 charge‐transfer	
configurations	such	as	D	and	E	to	the	canonical	Lewis	structures	A	and	B.	
O
O O
H
O
O O
H
O
O O
H
O
O O
H
O
O O
H
E
A
B C D3-39Ra
	
Scheme	3.7	Resonance	stabilization	of	donor/acceptor	substituted	radical	3‐39Ra.	
The	 relevance	 of	 the	 charge‐transfer	 configurations	D	 and	 E	 also	 implies	 that	 the	
carbonyl	oxygen	atom	may	be	a	better	hydrogen‐bond	acceptor	at	the	radical	stage	as	
compared	to	its	closed‐shell	parent.	Similarly,	the	hydroxyl	group	in	3‐39Ra	may	be	a	
better	 hydrogen‐bond	 donor	 as	 compared	 to	 closed‐shell	 analogs	 (and	 also	
significantly	more	acidic).[100,	 110]	And	 indeed,	optimized	 structures	of	 the	dimers	of	
3‐39Ra	 compared	 to	3‐39a	 at	 (U)B3LYP	 level	 show	 significantly	 shorter	 hydrogen	
bond	distances	for	the	open‐shell	species	(Figure	3.7).	
						 	
Figure	3.7	Dimers	of	 radical	3‐39Ra	 (left)	and	 its	closed‐shell	parent	3‐39a	 (right)	at	 (U)B3LYP/6‐
31G(d)	level	of	theory.	Distances	are	given	in	pm.	
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Table	3.5	Boltzmann‐averaged	 hydrogenation	 enthalpies	 <hydH>	 at	 298.15	 K	 in	 the	 gas	 phase	 for	
ribose	and	1’‐desoxyribose‐derived	radicals.	Only	the	initial	radicals	are	shown.	
H H
HH
H
H
+
trhH
H H
HH
+
3-24 3-15
O
O
R O R
HOHO OH
H
R R
	
	
ROMP2(FC)/	
6‐311+G(3df,2p)	
G3(MP2)‐RAD	
<trhH>a	 <hydH>b	 <trhH>a	 <hydH>b	
O
OHO
3-41RaHO
	
+104.0	 ‐32.3	 +100.1	 ‐36.2	
O
HO
O OH
3-42Ra
	
+125.4	 ‐11.0	 +121.3	 ‐15.0	
O
OHOH
O
3-41Rb
	
+115.5	 ‐20.8	 +108.8	 ‐27.5	
O
HO
HO O
3-43R
	
+128.2	 ‐8.09	 +121.9	 ‐14.4	
O
OH
HO
O
3-44Ra
	
+105.3	 ‐31.0	 +103.2	 ‐33.1	
O
OH
HO 3-41Rc
O 	
+39.5	 ‐96.8	 +41.8	 ‐94.5	
O
HO
O
3-45R
	
+93.3	 ‐43.0	 +94.1	 ‐42.3	
O
O 3-46Ra
HO
	
+118.8	 ‐17.5	 +114.8	 ‐21.5	
O
OH
O
3-46Rb 	
+115.7	 ‐20.7	 +109.6	 ‐26.7	
a	 Defined	 as	trhH	 =	fH(C2H4)	 +	fH(•R2CH‐OH)	 –	fH(•R2C=O)	 –fH(C2H6).	 b	 Addition	 of	 the	 reaction	 enthalpies	trhH	 to	 the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH(C2H4,	 3‐15)	 =	 ‐136.3±0.2	 kJ	 mol‐1[105]	 yields	 the	
hydrogenation	enthalpy	hydH	of	the	respective	double	bond.	
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The	 captodative	 effect	 of	 an	alkoxy	group	 is	 not	 that	distinct	 than	 for	 an	alcohol	 as	
electron‐donating	group	(hydH(3‐42Ra/3‐41Ra)	=	‐21.2	kJ	mol‐1).		
Again,	hydrogenation	enthalpies	for	sugar	models	containing	an	allyl	radical	such	as	
3‐39Rb	 and	3‐40Rc,	 are	 systematically	 larger	 compared	 to	 those	 of	 the	 respective	
tautomeric	forms.	This	may	be	exemplified	with	radical	3‐39Rb	whose	hydrogenation	
energy	of	hydH(3‐39Rb)	=	 ‐62.5	kJ	mol‐1	 is	50.9	kJ	mol‐1	 larger	 than	 that	of	‐keto	
radical	3‐39Ra.	The	obtained	hydrogenation	product	is	identical	for	both	species	and	
the	energy	difference	of	50.9	kJ	mol‐1	thus	corresponds	to	the	difference	in	stability	of	
the	enol	and	keto	 form.	Radical	3‐40Ra	or	3‐41Rc	with	 isolated	unpaired	electrons	
react	as	typical	alkene	(hydH(exp.,	propene)	=	‐125.0±0.2	kJ	mol‐1	vs.	hydH(3‐40Ra)	=	
‐118.2	 kJ	 mol‐1)	 or	 ketone	 (hydH(3‐22)	 =	 ‐77.5	 kJ	 mol‐1	 vs.	 hydH(3‐41Rc)	 =	
‐94.5	kJ	mol‐1),	respectively.	
Reaction	energies	 for	 the	dihydrogen	 transfer	between	 the	open‐shell	 sugar	models	
and	the	nucleotide	bases	can	be	calculated	from	the	hydrogenation	energies	in	Table	
3.3	and	Table	3.5	in	a	straightforward	manner.	For	the	reduction	of	uracil	(3‐16)	with	
C3’	ribosyl	radical	3‐47R	as	an	example	(see	Scheme	3.8),	the	reaction	enthalpy	trhH	
is	 identical	to	the	difference	in	hydrogenation	enthalpy	of	uracil	and	oxidized	ribose	
radical	3‐43R,	which	is	trhH	=	‐64.9	kJ	mol‐1.	
3-43R
ON
H
NH
O
3-16
+
ON
H
NH
O
3-48
+
3-47R
trhH 
= -64.9 kJ mol-1
O
OH
HO
HO
H
H
H
O
HO
HO O
hydH (3-16) = -79.3 kJ mol-1
hydH (3-43R) = -14.4 kJ mol-1
+     H2
+     H2
	
Scheme	 3.8	 Transfer	 hydrogenation	 between	 ribose	 model	 3‐47R	 and	 uracil	 (3‐16)	 using	
hydrogenation	energies	calculated	at	G3(MP2)‐RAD	level.	
In	 pictoral	 terms,	 this	 difference	 equates	 to	 the	 horizontal	 distance	 on	 the	
hydrogenation	enthalpy	scale	shown	in	Figure	3.8.	Closer	inspection	of	this	scale	also	
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shows	 that	 under	 these	 circumstances	 all	 resonance‐stabilized	 radicals	 can	 act	 as	
hydrogen	 donor	 for	 the	 three	 pyrimidine	 bases	 (as	 well	 as	 their	 N‐methylated	
derivatives)	if	the	product	represents	an	acetonyl	or	formyl	radical.	
<hydH> 
(kJ mol-1)
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Figure	3.8	Graphical	representation	of	hydrogenation	enthalpies	<hydH>	at	298.15	K	(G3(MP2)‐RAD,	
in	 kJ	 mol‐1)	 of	 selected	 open‐shell	 systems	 in	 comparison	 to	 pyrimidine	 bases	 uracil	 (3‐16)	 and	
thymine	(3‐17).	
3.5 Open‐shell	Nucleotides	
In	 order	 to	 assess	 the	 thermodynamics	 of	 such	 a	 process	 in	 complete	 nucleosides,	
intramolecular	transfer	hydrogenation	reactions	have	been	studied	for	different	types	
of	 uridinyl	 radicals,	 where	 the	 unpaired	 spin	 is	 located	 on	 either	 C2’,	 C3’	 or	 C4’	
position.	 The	 energies	 for	 intramolecular	 dihydrogen	 transfer	 between	 sugar	 and	
base	fragments	are	depicted	in	Figure	3.9.	
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Figure	3.9	Boltzmann‐averaged	transfer	hydrogenation	enthalpy	scale	<trhH>	for	C‐centered	uridinyl	
and	 cytidinyl	 radicals	 (G3(MP2)‐RAD,	 in	 kJ	mol‐1),	 black	bars	 gas	 phase,	 blue	bars	 addition	 of	Gsolv	
(IEF‐PCM/UAHF/UHF/6‐31G(d)	in	water).	Only	the	product	radicals	are	shown.	
The	 reaction	 products	 are	 shown	 with	 the	 C‐C	 or	 C‐O	 double	 bond	 in	 the	 ribose	
fragment	indicating	the	origin	of	the	H2	equivalent.	The	ROMP2	values	can	be	found	in	
the	Theoretical	Appendix.	 Energies	 have	 been	 calculated	 in	 the	 gas	 phase	 (black	
bars)	as	well	as	 in	aqueous	phase	 (blue	bars)	 in	order	 to	 identify	 the	 influence	of	a	
polar	(hydrogen‐bonding)	medium	on	the	reaction	outcome.	Comparison	of	the	data	
of	 individual	 components	 with	 those	 of	 the	 nucleosides	 in	 Figure	 3.9	 shows	 that	
sugar‐to‐base	 transfer	 hydrogenation	 becomes	 slightly	 less	 effective	 on	 covalent	
coupling	 both	 redox	 partners.	 The	 only	 exception	 is	 uridin‐1‐yl	 radical	3‐50R	 with	
trhH(3‐50R)	 =	 ‐50.4	 kJ	 mol‐1,	 compared	 to	 the	 hydrogenation	 energies	 of	 the	
separated	fragments	(see	Figure	3.10).	
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Figure	3.10	 Comparison	 of	 the	 redox	 data	 for	 individual	 components	 (black	 bars)	 and	 nucleosides	
(red	bars)	in	the	gas	phase	at	G3(MP2)‐RAD	level	of	theory.	
This	 difference	 can	 be	 traced	 back	 to	 the	 presence	 of	 a	 second	 electron‐donating	
substituent	 in	 radical	 3‐50R,	 which	 is	 not	 present	 in	 ribose	 model	 3‐44Ra.	 More	
generally,	the	most	exothermic	intramolecular	transfer	hydrogenation	process	is	that	
of	 C3’	 uridinyl	 radical	 3‐52R	 yielding	 the	 C2’	 oxidized	 open‐shell	 product	 3‐48Ra	
with	a	reaction	energy	of	trhH(3‐48Ra)	=	‐61.6	kJ	mol‐1	at	G3(MP2)‐RAD	level	in	the	
gas	 phase.	 Transfer	 hydrogenation	 starting	 from	 the	 C2’	 radical	 to	 yield	3‐49Ra	 is	
somewhat	less	exothermic	at	trhH(3‐49Ra)	=	‐53.8	kJ	mol‐1,	closely	followed	by	the	
reaction	 of	 the	 C1’	 radical	 to	 give	 product	 radical	 3‐50R	 with	 trhH	 (3‐50R)	 =	
‐50.4	kJ	mol‐1.	 Hydrogenation	 energies	 under	 the	 circumstances	 of	 generating	 C‐C	
(instead	 of	 C‐O)	 double	 bonds	 in	 the	 ribose	 fragment	 are,	 in	 comparison,	
compararively	 less	 exothermic.	 Switching	 from	 uridine	 to	 cytosine	 leads	 to	
significantly	 smaller	 reaction	 energies,	 in	 line	 with	 the	 smaller	 hydrogenation	
energies	of	 cytosine	 (3‐19)	as	 compared	 to	uracil	 (3‐16)	 summarized	 in	Table	3.2.	
The	above	results	have	again	been	obtained	from	Boltzmann‐averaged	enthalpies	for	
fully	 flexible	 nucleoside	 radicals	 and	 can	 potentially	 be	 modified	 through	
intermolecular	interactions	present	in	base‐paired	systems	or	polar	solvents.	In	order	
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to	 obtain	 an	 estimate	 for	 the	 magnitude	 of	 these	 kind	 of	 effects,	 solvation	 free	
energies	 Gsolv	 in	 water	 were	 calculated	 using	 the	 continuum	 solvation	 model[82]	
(IEF‐PCM/UAHF/UHF//UB3LYP/6‐31G(d))[111]	 and	 combined	 with	 the	 gas	 phase	
results.	 The	 resulting	 hydrogenation	 energies	 (see	 Figure	 3.11)	 in	 polar	 solution	
show	that	the	C2’‐oxidized	uridinyl	radical	3‐48R	and	the	respective	cytodinyl	radical	
3‐14R	 benefit	 most	 from	 the	 solvation	 resulting	 in	 a	 more	 exothermic	 reaction	
outcome.	The	usage	of	different	PCM	models,	 radii	or	 theory	 leads	 to	rather	similar	
thermodynamics	 (see	 Theoretical	 Appendix)	 The	 higher	 exothermicity	 is	 the	
consequence	of	the	better	solvation	of	the	product	radical	due	to	the	omission	of	the	
hydrogen	bond	upon	oxidation	of	the	C2’	hydroxyl	group.	
3-52R 	
  Hgas = 0.0     Hgas = +3.3 
  Hsol = +4.3 kJ mol
-1    Hsol = 0.0 kJ mol
-1 
3-48Ra 	
  Hgas = 0.0     Hgas = +5.1 
  Hsol = 0.0 kJ mol
-1    Hsol = +6.9 kJ mol
-1 
Figure	3.11	Graphical	representation	of	the	two	most	stable	conformers	of	uridinyl	radical	3‐52R	and	
3‐48Ra	obtained	at	G3(MP2)‐RAD	level	in	gas	phase	and	with	implicit	solvation	of	water.	
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3.6 Open‐shell	Peptides	
An	 obvious,	 but	 never	 considered,	 alternative	 dihydrogen	 donor	 could	 be	 the	 RNR	
mutant	 with	 its	 redox	 active	 amino	 acid	 residues	 serine	 (Ser,	3‐53)	 and	 threonine	
(Thr,	 3‐54)	 itself.	 The	 oxidized	 form	 of	 serine,	 ‐formyl	 glycine	 (3‐55)	 is	 a	 post‐
translational	 modification	 found	 in	 the	 active	 center	 of	 sulfatases	 and	
sulfotransferases.	3‐55	 is	 generated	by	 the	 formyl	 generating	enzyme	 (FGE)	 from	a	
cysteine	 (Cys,	3‐56)	 under	 aerobic	 conditions	 (see	 Scheme	3.9).[112]	 Residue	3‐55	
forms	 a	 metastable	 hydrate	 3‐55‐H2O,	 which	 attacks	 the	 sulfate	 ester	 in	 a	
nucleophilic	manner	 to	 give	 the	hydrolyzed	product	 followed	by	 fragmentation	 and	
the	release	of	hydrogensulfate	HSO4‐	and	regenerated	3‐55.		
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Scheme	3.9	FGE‐catalyzed	post‐translational	modification	of	cysteine	to	‐formyl	glycine	(3‐55)	and	
the	following	hydrolysis	of	sulfate	esters.	
Inspection	 of	 the	 linear	 sequence	 of	 the		 subunit	 of	 class	 I	 RNR[96]	 shows	 that	 a	
serine	 moiety	 (S436)	 is	 in	 close	 proximity	 to	 the	 spin‐carrying	 cysteine	 C439.	
Thermodynamic	 data	 for	 hydrogen	 atom	 transfer	 from	 all	 possible	 open‐shell	 RNR	
cofactors	to	generate	the	redox	precursor	3‐53R	or	3‐54R	are	summarized	in	Table	
3.6.	 All	 reactions	 involving	 peptide‐derived	 radicals,	 like	 glycyl	 (3‐6R),	 cysteinyl	
(3‐56R)	 and	 the	 O‐centered	 tyrosyl	 radical	 3‐57R,	 are	 unfavored	 from	 a	
thermochemical	point	of	view.	The	C‐centered	radical	3‐53R	of	serine	is	destabilized	
compared	to	the	glycyl	radical	3‐6R	by	a	value	of	RSE	=	+16.7	kJ	mol‐1.	The	decrease	
of	 stability	 in	 C‐substituted	 peptide	 radicals	 has	 already	 been	 investigated	 by	
Hioe.[113]		
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Table	3.6	 Bond	 dissociation	 and	 radical	 stabilization	 energies	 of	 enzymatically	 relevant	 radicals	 at	
G3(MP2)‐RAD	level	in	the	gas	phase	(at	298.15	K,	in	kJ	mol‐1).		
H
N
O
N
H
O
OHR
H
N
O
N
H
O
OHR
3-53 (Ser, R=H)
3-54 (Thr, R=CH3)
3-53R (R=H)
3-54R (R=CH3)
rxnH
H
N
O
N
H
O
X
H
N
O
N
H
O
X
H 	
R•	 RSE	 BDEa	
rxnH> solH>
Ser	(2‐53) Thr	(2‐54) Ser	(2‐53)	 Thr	(2‐54)
3‐53	(R=H)	 ‐58.1	 +381.2    
3‐54	(R=Me)	 ‐50.4	 +388.9    
X•	 	 	    
Cys‐S•	(3‐56R)	 ‐13.4	 +368.2 +13.0	 +20.7	
+15.3b	
+11.7c	
+23.0b	
+18.6c	
Gly•	(3‐6R)	 ‐74.8	 +364.5 +16.7	 +24.4	
+9.15b	
+15.0c	
+16.8b	
+21.8c	
Tyr‐O•	(3‐57R)	 ‐151.0[113]	 +346.1 +35.1	 +42.8	 	 	
3-58R
N
NN
N
NH2
O
OHOH
‐6.8[114]	 +432.5 ‐51.3	 ‐43.6	 	 	
a	BDE(R‐H)=	RSE	(R•)	+	BDE(Ref‐H)	with	BDE(H3C‐H)	=	+439.3,	BDE(HO‐H)	=	+497.1	and	BDE(HS‐H)	=	+381.6	kJ	mol‐1.[115]		
bAddition	of	Gsolv	 in	water	at	 IEF‐PCM/UAHF/UHF/6‐31G(d)//UB3LYP/6‐31G(d)	 level.	 c	Addition	of	Gsolv	 in	heptane	at	 IEF‐
PCM/UAHF/UHF/6‐31G(d)//UB3LYP/6‐31G(d)	level.	
	
Due	 to	 repulsive	 interactions	between	 the	C	 substituent	 and	 the	peptide	backbone	
the	 radical	 stabilization	 is	 strongly	 conformation‐dependent,	 which	 is	 shown	 in	
Figure	3.12.	Hydrogen‐bonding	of	the	hydroxyl	group	has	no	supporting	effect	to	the	
push‐pull	stabilization.	The	methyl	group	in	the	C	radical	of	threonine	(2‐54R)	leads	
to	a	reduction	of	+7.7	kJ	mol‐1	of	the	reduction	of	the	RSE	compared	to	serine.		
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Figure	3.12	Relative	conformational	energies	in	the	gas	phase	at	298.15	K	for	serine	peptide	3‐53	and	
its	open‐shell	form	3‐53R	obtained	at	G3(MP2)‐RAD	level	(black	bars	C7,	red	bars	C5	conformation).	
In	the	case	of	serine,	the	radical	formation	in	the	gas	phase	is	endothermic	for	either	
the	 cysteinyl	 (rxnH(3‐56R)	 =	 +13.0	 kJ	 mol‐1)	 or	 the	 glycyl	 radical	 (rxnH(3‐6R)	 =	
+16.7	kJ	mol‐1).	Mimicking	the	environment	in	the	active	site	of	RNR	and	the	role	of	
hydrogen	 bonds	 by	 inclusion	 of	 implicit	 solvation	 lowers	 the	 enthalpy	 slightly,	 but	
negative	 values	 are	 not	 reached.	 Hydrogen	 transfer	 by	 glycine	 benefits	 from	
hydrophilic	 solvation	 in	 water	 (solH(3‐6R)	 =	 +9.2	 kJ	 mol‐1),	 whereas	 the	 reaction	
involving	 the	cysteinyl	radical	profits	 from	the	hydrophobicity	of	heptanes	 to	model	
the	 unpolar	 environment	 in	 the	 enzyme	 (solH(2‐65R)	 =	 +11.7	 kJ	mol‐1).	Coote	 and	
coworkers	 recently	 reported	 that	 the	 stability	 of	 carboxy‐aminoxyl	 and	 peroxyl	
radicals	is	strongly	affected	by	anionic	point	charges	and	an	associated	SOMO‐HOMO	
conversion	even	on	a	 long‐range	scale.[116]	The	glutamate	residue	(E441),	responsible	
for	 embedding	 the	 nucleotide	 in	 the	 active	 site,	 is	 located	 in	 near	 proximity	 to	 the	
serine	 residue	 and	 could	 have	 a	 positive	 effect	 on	 the	 hydrogen	 transfer	 on	 closer	
inspection.	Unfortunately,	 this	 residue	has	been	 replaced	 in	 the	E441Q	mutant	by	a	
glutamine.	
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Figure	3.13	Graphical	representation	of	the	energetically	most	favorable	conformations	of	closed‐shell	
peptides	 serine	 (3‐53)	 and	 threonine	 (3‐54,	 left)	and	 their	 radicals	 (right)	at	G3(MP2)‐RAD	 level	of	
theory.	
As	 expected,	 only	 for	 the	 non‐stabilized	 primary	 5’‐adenosyl	 radical	 3‐58R	 the	
hydrogen	 exchange	 is	 strongly	 exothermic.	Therefore,	 it	 is	 unlikely	 that	 the	peptide	
backbone	 of	 RNR	 can	 act	 as	 dihydrogen	 donor.	 The	 reaction	 enthalpies	 for	 the	
subsequent	 transfer	 hydrogenation	 are	 nevertheless	 depicted	 in	 Table	 3.7	 and	
graphically	displayed	in	Figure	3.14.	
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Table	3.7	Boltzmann‐averaged	 hydrogenation	 enthalpies	 <hydH>	 at	 298.15	 K	 in	 the	 gas	 phase	 for	
serine‐	and	threonine‐derived	radicals.	Only	the	initial	radicals	are	shown.	
H H
HH
H
H
+
trhH
H H
HH
+
3-24 3-15
H
N
O
N
H
O
OHR
H
H
N
O
N
H
O
OR
R	
ROMP2(FC)/	
6‐311+G(3df,2p)	
G3(MP2)‐RAD	
<trhH>a	 <hydH>b	 <trhH>a	 <hydH>b	
H	(3‐59R)	 +89.60	 ‐46.7	 +84.8	 ‐51.7	
CH3	(3‐60R)	 +92.8	 ‐43.5	 +90.1	 ‐46.2	
H
N
O
N
H
O
O
3-61Ra 	
+78.7	 ‐57.6	 +79.2	 ‐57.1	
H
N
O
N
H
O
OH
3-61Rb 	
+88.0	 ‐48.3	 +92.5	 ‐43.8	
a	 Defined	 as	trhH	 =	fH(C2H4)	 +	fH(•R2CH‐OH)	 –	fH(•R2C=O)	 –fH(C2H6).	 b	 Addition	 of	 the	 reaction	 enthalpies	trhH	 to	 the	
experimentally	 determined	 hydrogenation	 enthalpy	 of	 ethylene	 hydH(C2H4,	 3‐15)	 =	 ‐136.3±0.2	 kJ	 mol‐1[105]	 yields	 the	
hydrogenation	enthalpy	hydH	of	the	respective	double	bond.	
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Figure	 3.14	 Boltzmann‐averaged	 transfer	 hydrogenation	 enthalpy	 scale	 <trhH>	 for	 C‐centered	
peptide	radicals	(G3(MP2)‐RAD,	in	kJ	mol‐1)	compared	to	selected	carbonyl	radicals.	
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Again,	all	peptide‐derived	radicals	are	 in	principle	capable	to	reduce	the	pyrimidine	
bases	 in	 an	 exothermic	 manner,	 except	 for	 radical	 3‐61Ra	 in	 combination	 with	
cytosine	(trhH(3‐19)	=	‐56.1	–	(‐57.1)	=	+1.0	kJ	mol‐1).	The	radical	stabilization	as	a	
result	 of	 the	 push‐pull	 effect	 of	 the	 electron‐donating	 amino	 and	 the	 electron‐
accepting	 carbonyl	 group	 is	 not	 as	 as	 significant	 in	 glycyl	 radical	 3‐6R	 due	 to	 the	
steric	repulsion	of	the	C	substituent.	The	driving	force	at	G3(MP2)‐RAD	level	in	the	
gas	 phase	 for	 the	 formation	 of	 5,6‐dihydrouracil	 is	 for	 serine	 C	 radical	 3‐53R	
trhH(3‐53R)	 =	 ‐27.6	 kJ	 mol‐1	 and	 for	 threonine	 radical	 3‐54R	 trhH(3‐54R)	 =	
‐33.1	kJ	mol‐1,	 respectively.	 Upon	 oxidation,	 the	 resulting	 hydrogen	 bond	 accepting	
formyl	group	in	3‐59R	cannot	compensate	the	repulsive	interactions	on	the	RSE	(see	
Figure	3.15).	Therefore,	3‐59R	 and	3‐60R	 are	acting	 in	a	comparable	way	 just	 like	
simple	 delocalized		 radicals.	Oxidation	 of	 the	 threonine‐derived	 radical	 to	 form	3‐
61Ra	 with	 the	 unpaired	 spin	 in	 the	 side	 chain	 is	 unlikely	 due	 to	 simple	
thermochemical	considerations.	
			 	
Figure	3.15	 Graphical	 representation	of	 the	 energetically	most	 favorable	 conformations	of	 oxidized	
peptide	radicals	3‐59R	(left)	and	3‐60R	(right)	at	G3(MP2)‐RAD	level	of	theory.	
3.7 Conclusion	
The	potential	of	biologically	inspired	open‐shell	intermediates	to	act	as	reductants	in	
transfer	hydrogenation	 reactions	 to	alkenes	has	been	 investigated	 theoretically.	The	
results	 fully	 support	 the	 strongly	 reductive	 nature	 of	 these	 species,	 if	 the	 oxidized	
product	 is	 a	 captodatively	 stabilized	 radical.	 As	 revealed	 through	 comparison	 to	
hydrogenation	energies	for	individual	nucleotide	bases	and	also	seen	in	the	reaction	
energies	 for	 intramolecular	 transfer	 hydrogenation	 in,	 for	 example,	 the	 C3’	 uridinyl	
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radical	 3‐52R,	 the	 strongly	 reductive	 nature	 of	 ribosyl	 radicals	 implies	 that	
pyrimidine	bases	can	be	reduced	in	an	exothermic	fashion.		
The	reaction	energies	for	inter‐	and	intramolecular	transfer	hydrogenation	presented	
herein	 permit	 no	 statement	 on	 the	 pathways	 how	 such	 a	 process	 may	 occur.	
Nevertheless,	 some	 speculations	 on	 possible	 pathways	 can	 be	 made.	 While	 a	
concerted	 dihydrogen	 shift	 can	 most	 likely	 be	 ruled	 out	 in	 view	 of	 the	 relative	
orientation	 of	 the	 donor	 and	 acceptor	 fragments	 in	 3‐52R,	 two	 different	 reaction	
types	for	stepwise	H2	transfer	are	feasible	(see	Scheme	3.10):	1.)	Reactions	involving	
open‐shell	intermediates	at	the	nucleotide	base.	This	may	either	involve	initial	single	
hydrogen	atom	or	proton‐coupled	electron	transfer	to	the	uracil	C6	position,	followed	
by	a	second	H•	transfer	to	yield	product	radical	3‐48R.	Giese	et	al.	recently	reported	
that	 hydrogen	 atom	 transfer	 reactions	 in	 C4’	 desoxythymidine	 radicals	 can	 occur	
quite	 rapidly	 to	 give	 C5	 dihydro	 thymyl	 radical,	 detected	 as	 the	 main	 open‐shell	
species	by	EPR	spectroscopy.[117]	2.)	An	ionic	pathway,	where	the	unpaired	spin	never	
leaves	 the	 ribose	 unit.	 This	 may	 involve,	 for	 example,	 initial	 protonation	 of	 the	
pyrimidine	C4	carbonyl	oxygen,	followed	by	hydride	transfer	between	the	ribose	C2’	
and	the	uracil	C6	position.	After	deprotonation	and	tautomerization	of	radical	cation	
3‐63Rb	the	captodatively	stabilized	product	3‐48Ra	 is	formed.	What	both	pathways	
have	 in	common	is	 the	direct	 inclusion	of	 the	uracil	C6	position	as	shown	in	Figure	
3.11	due	to	the	spatial	proximity	of	this	center	to	the	reacting	C2’	ribose	center.	
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Scheme	3.10	Possible	pathways	for	stepwise	hydrogen	transfer	reactions	using	C3’	radical	3‐52R	as	
example.	
Also,	recent	theoretical	studies	by	Gutowski	and	coworkers	on	the	strand	cleavage	of	
2’‐desoxycytosine‐3’‐phosphate	 revealed	 that	 the	 barriers	 for	 the	 hydrogen	 atom	
transfer	 from	 the	 C2’	 position	 of	 the	 sugar	 unit	 are	 lowered	 significantly	 upon	
addition	 of	 “H•”	 (either	 concerted	 or	 stepwise)	 to	 the	 N3	 position	 of	 the	 cytosine	
base.[118]	
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3.8 Theoretical	Appendix	
Geometry	 optimizations	 of	 all	 systems	 have	 been	 performed	 at	 the	 (U)B3LYP/	
6‐31G(d)	 level	 of	 theory.	 Thermochemical	 corrections	 to	 298.15	 K	 have	 been	
calculated	at	the	same	level	of	theory	using	the	rigid	rotor/harmonic	oscillator	model.	
A	scaling	factor	of	0.9806	has	been	used	for	this	latter	part.	Single	point	energies	have	
then	been	calculated	at	the	(RO)MP2(FC)/6‐311+G(3df,2p)	level.	Combination	of	the	
MP2	total	energies	with	thermochemical	corrections	obtained	at	B3LYP	level	yield	the	
enthalpies	termed	as	"ROMP2"	in	the	text.		
	
H(MP2)	=	Etot(MP2)	+	H(B3LYP,	0.9806)	–	Etot(B3LYP)	 	 (eq.	3.1)	
	
In	 the	 conformationally	 flexible	 systems	 enthalpies	 and	 free	 energies	 have	 been	
calculated	 as	 Boltzmann‐averaged	 values	 (w	 	 1%)	 over	 all	 available	 conformers	
obtained	 by	 a	 preliminary	 conformational	 search	 using	 the	 MM3*	 force	 field[79]	
implemented	in	MacroModel	9.7.[80]	
The	Boltzmann‐averaged	enthalpies	of	n	conformers	are	obtained	by	eq.	3.2:	
	
	
exp ∆
	
∑ ∆
	
	
H298 	 ∑ wiHini 1 			 	 	 (eq.	3.2)	
	
Improved	relative	energies	are	obtained	using	the	G3(MP2)‐RAD	scheme	proposed	by	
Radom	et	al.[81]	These	are	based	on	the	same	geometries	and	thermal	corrections	as	
the	MP2	level:	
	
Etot(G3(MP2)‐RAD)	=	Etot((U)CCSD(T)/6‐31G(d)//UB3LYP/6‐31G(d)	+	
+	DE(G3MP2large)	+	DE(HLC)	 	 	 (eq.	3.3)	
	
DE(G3MP2large)	=	(RO)MP2(FC)/G3MP2large	–	(RO)MP2(FC)/6‐31G(d)	 (eq.	3.4)	
	
DE(HLC)	=	‐A	n()	–	B	(n()	–	n())		 	 (eq.	3.5)	
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with	A	=	9.413x10‐3	 au,	B	=	3.969x10‐3	au	and	n()	 and	n()	 represent	 the	valence	
electrons,	respectively.	
Additional	 consideration	 of	 solvation	 was	 included	 by	 calculating	 solvation	 free	
energies	 using	 the	 polarizable	 continuum	 solvation	 model	 in	 its	 IEF‐PCM,[82]	 C‐
PCM[119]	or	SMD[60]	variant	and	adding	them	to	the	gas	phase	enthalpies.	 In	case	for	
the	 IEF‐	 and	 C‐PCM	 calculations	 the	 United	 Atom	 Hartree	 Fock	 (UAHF)	 radii	 in	
combination	with	UHF/6‐31G(d)	theory	have	been	used.[83]	 (U)CCSD(T)	calculations	
have	been	performed	with	MOLPRO,[84]	 the	geometry	optimizations,	 frequencies	and	
PCM	 calculations	 with	 Gaussian03	 Rev.	D.01.[85]	 The	 SMD	model	 is	 implemented	 in	
Gaussian09	Rev.	C.01.[86]	
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Table	3.8	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	in	
the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
C2H6	
(3‐24)	
C2H4	
(3‐15)	
OH 	
(3‐1R)	
O 	
(3‐3R)	
OH 	
(3‐33R)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
UB3LYP	
‐79.834175	
‐79.752210	
‐78.5874583	
‐78.533222	
‐154.3613832	
‐154.291870	
‐153.1715366	
‐153.125159	
‐193.6803856	
‐193.581855	
ROMP2	
‐79.6200629 
‐79.5380979 
‐78.3932565	
‐78.3390202	
‐154.066633	
‐153.9971198	
‐152.8787261	
‐152.8323485	
‐193.2916261	
‐193.1930955	
G3(MP2)‐RAD	
‐79.7268957 
‐79.6449307 
‐78.4841764	
‐78.4299401	
‐154.1927918	
‐154.1232786	
‐152.989464	
‐152.9430864	
‐193.4603518	
‐193.3618212	
	
O 	
(3‐8R) 
	
(3‐4R)	
	
(3‐2R)	
	
(3‐34R_H)	
	
(3‐34R)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
UB3LYP	
‐192.4950213	
‐192.419618	
‐118.4711107	
‐118.377919	
‐117.2603540	
‐117.190479	
‐157.7856471	
‐157.663659	
‐156.5772554	
‐156.478343	
ROMP2	
‐192.1068777	
‐192.0314744	
‐118.1690627	
‐118.0758710	
‐116.9739045	
‐116.9040295	
‐157.3910101	
‐157.2690220	
‐156.1966271	
‐156.0977147	
G3(MP2)‐RAD	
‐192.2600568	
‐192.1846535	
‐118.3090897	
‐118.2158980	
‐117.0984521	
‐117.0285771	
‐157.5736006	
‐157.4516125	
‐156.3632755	
‐156.2643631	
	
	
(3‐27R_H)	
	
(3‐27R)	
	
(3‐29R_H)	
	
(3‐29R)	
OH
	
(3‐36R_H)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
UB3LYP	
‐235.2139163	
‐235.053530	
‐234.0081729	
‐233.871204	
‐195.8948865	
‐195.764645	
‐194.6860804	
‐194.579304	
‐271.1017498	
‐270.966094	
ROMP2	
‐234.6443077	
‐234.4839214	
‐233.4544966	
‐233.3175277	
‐195.4190525	
‐195.2888110	
‐194.2269215	
‐194.1201451	
‐270.5398569	
‐270.4042011	
G3(MP2)‐RAD	
‐234.8956477	
‐234.7352614	
‐233.6883126	
‐233.5513437	
‐195.6277641	
‐195.4975226	
‐194.4182277	
‐194.3114513	
‐270‐7772463	
‐270.6415905	
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Table	3.9	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	in	
the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
O
	
(3‐36R)	
OH
	
(3‐35R)	
OH
	
(3‐35R_H)	
OH
	
(3‐37R_H)	
O
	
(3‐37R)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
UB3LYP	
‐269.9214771	
‐269.808652	
‐192.4759940	
‐192.400134	
‐193.6887929	
‐193.588901	
‐193.6887181	
‐193.588740	
‐193.6793493	
‐193.580597	
‐193.6795750	
‐193.580636	
‐192.4957378	
‐192.419812	
‐192.4968916	
‐192.420785	
ROMP2	
‐269.3582119	
‐269.2453868	
‐192.0973633	
‐192.0215033	
‐193.2966386 
‐193.1967467 
‐193.2968177 
‐193.1968396 
‐193.2877564 
‐193.1890041 
‐193.2880859 
‐193.1891469 
‐192.1049337	
‐192.0290079	
‐192.1062969	
‐192.0301903	
G3(MP2)‐RAD	
‐269.5800170	
‐269.4671919	
‐192.2511757	
‐192.1753157	
‐193.4654625 
‐193.3655706 
‐193.4655549 
‐193.3655768 
‐193.4569905 
‐193.3582382 
‐193.4572485 
‐193.3583095 
‐192.2582774	
‐192.1823516	
‐192.2594781	
‐192.1833715	
	 NH
NH
O
O
	
(3‐16) 
N
H
NH
O
O
	
(3‐16_H) 
N
N
O
O
CH3
CH3
	
(3‐18) 
N
N
O
O
CH3
CH3
	
(3‐18_H)	
N
H
NH
O
O
	
(3‐17)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐414.8159434	
‐414.723082	
‐416.0289298	
‐415.912314	
‐493.4392316	
‐493.288006	
‐494.6502952	
‐494.475402	
‐454.1363070	
‐454.014332	
MP2	
‐414.0942780	
‐414.0014156	
‐415.2957353	
‐415.1791195	
‐492.5231659	
‐492.3719403	
‐493.7221289	
‐493.5472357	
‐453.3203336	
‐453.1983586	
G3(MP2)‐RAD	
‐414.3433253	
‐414.2504637	
‐415.5603634	
‐415.4437476	
‐492.8575198	
‐492.7062942	
‐494.0722892	
‐493.8973960	
‐453.6113003	
‐453.4893302	
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Table	3.10	 Energies	 and	 enthalpies	 for	 nucleobases	 at	 various	 levels	 of	 theory	 in	 the	 gas	 phase	 in	
Hartree	(298.15	K,	1	atm).	
	 NH
NH
O
O
	
(3‐17_H)	
N
H
N
NH2
O
	
(3‐19)	
N
H
N
NH2
O
	
(3‐19_H)	
N
NN
N
H 	
(3‐31)	
N
N
H
N
N
H 	
(3‐31_H)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐455.3449323	
‐455.199176	
‐394.9280116	
‐394.823487	
‐396.1318383	
‐396.003514	
‐411.9463521	
‐411.846036	
‐412.1301989	
‐412.006589	
MP2	
‐454.5187530	
‐454.3729967	
‐394.2120332	
‐394.1075086	
‐395.4035169	
‐395.2751926	
‐411.1656980	
‐411.0653819	
‐412.3345434	
‐412.2109335	
G3(MP2)‐RAD	
‐454.8257664	
‐454.6800101	
‐394.1075086	
‐394.3643732	
‐395.6771488	
‐395.5488245	
‐411.4345202	
‐411.3342041	
‐412.6233834	
‐412.4997735	
	
N
NHN
N
H 	
(3‐31a_H)	
N
NHN
N
H 	
(3‐31b_H) 
N
H
NN
N
H
	
(3‐31c_H) 
N
NN
N
H
H
H 	
(3‐31d_H)	
N
NN
N
H
H
H 	
(3‐31e_H)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐413.1324971	
‐413.008528	
‐413.1109252	
‐412.987804	
‐413.1136403	
‐412.990115	
‐413.0741241	
‐412.951611	
‐4120932267	
‐412.970365	
MP2	
‐412.3432303	
‐412.2192612	
‐412.3176429	
‐412.1945217	
‐412.3252181	
‐412.2016928	
‐412.2813681	
‐412.1588550	
‐412.2962836	
‐412.1734219	
G3(MP2)‐RAD	
‐412.6294486	
‐412.5054795	
‐412.6078629	
‐412.4847417	
‐412.6125301	
‐412.4890048	
‐412.5767815	
‐412.4542684	
‐412.5923974	
‐412.4695357	
	 N
NN
N
H
NH2
	
(3‐25)	
N
N
H
N
N
H
NH2
	
(3‐25_H)	
N
NHN
N
H
NH2
	
(3‐25a_H)	
N
H
NN
N
H
NH2
	
(3‐25b_H)	
N
NHN
N
H
NH2
O
	
(3‐26)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐467.3181723	
‐467.199675	
‐468.4966380	
‐468.354402	
‐468.4878746	
‐468.345603	
‐468.4799493	
‐468.338478	
‐542.5500873	
‐542.425985	
MP2	
‐466.4494932	
‐466.3309998	
‐467.6141961	
‐467.4719598	
‐467.6134757	
‐467.4712041	
‐467.6037901	
‐467.4623188	
‐541.5875930	
‐541.4634907	
G3(MP2)‐RAD	
‐466.75333230	
‐466.6348350	
‐467.9391229	
‐467.7968866	
‐467.9346456	
‐467.7923740	
‐467.9254881	
‐467.7840168	
‐541.9189154	
‐541.7948131	
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Table	3.11	 Energies	 and	 enthalpies	 for	 nucleobases	 at	 various	 levels	 of	 theory	 in	 the	 gas	 phase	 in	
Hartree	(298.15	K,	1	atm).	
	 N
NH
H
N
N
H
NH2
O
	
(3‐26_H)	
N
H
NHN
N
H
NH2
O
	
(3‐26a_H)	
Etot	
H298	
Etot	
H298	
B3LYP	
‐543.7270992
‐543.579564 
‐543.7145259
‐543.566937 
MP2	
‐542.7510040
‐542.6034689 
‐542.7486877
‐542.6010988 
G3(MP2)‐RAD	
‐543.1036030
‐542.9560079 
‐543.0976341
‐542.9500452 
	
Table	3.12	Energies	and	enthalpies	for	ribose	models	at	various	 levels	of	theory	 in	the	gas	phase	 in	
Hartree	(298.15	K,	1	atm).	
	
O
OHOH
HO
	
									(3‐22_H)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
2	 ‐497.397220	 ‐497.230477	 ‐496.5596005	 ‐496.3928574	 ‐496.8895632	 ‐496.7228201	
11	 ‐497.396662	 ‐497.230071	 ‐496.5592698	 ‐496.3926785	 ‐496.8891756	 ‐496.7225843	
16	 ‐497.39640	 ‐497.229533	 ‐496.5582756	 ‐496.3914006	 ‐496.8881060	 ‐496.7212310	
	
O
OH
HO
O 	
										(3‐22)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
3	 ‐496.1930950	 ‐496.050648	 ‐495.3584727	 ‐495.2160257	 ‐495.672666	 ‐495.5302185	
27	 ‐496.1914556	 ‐496.049076	 ‐495.3567252	 ‐495.2143456	 ‐495.670863	 ‐495.5284832	
5	 ‐496.1867202	 ‐496.044244	 ‐495.3538885	 ‐495.2114123	 ‐495.668127	 ‐495.5256512	
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Table	3.13	Energies	and	enthalpies	for	ribose	models	at	various	 levels	of	theory	 in	the	gas	phase	 in	
Hartree	(298.15	K,	1	atm).	
	
O
OH
HO
O 	
								(3‐20)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
5	 ‐496.1883279	 ‐496.045392	 ‐495.3537861	 ‐495.2108502	 ‐495.6679202	 ‐495.5249843	
2	 ‐496.1867424	 ‐496.044049	 ‐495.353377	 ‐495.2106836	 ‐495.6676771	 ‐495.5249837	
8	 ‐496.1879531	 ‐496.045105	 ‐495.3530798	 ‐495.2102317	 ‐495.667255	 ‐495.5244069	
6	 ‐496.1864131	 ‐496.043627	 ‐495.3527991	 ‐495.210013	 ‐495.6668444	 ‐495.5240583	
4	 ‐496.1885387	 ‐496.045615	 ‐495.352261	 ‐495.2093373	 ‐495.6666437	 ‐495.5237200	
	
O
OHOH
O
	
								(3‐21)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐496.1889342	 ‐496.046459	 ‐495.3553908	 ‐495.2129156	 ‐495.6693859	 ‐495.5269107	
7	 ‐496.1852568	 ‐496.042536	 ‐495.3520419	 ‐495.2093211	 ‐495.6655164	 ‐495.5227956	
9	 ‐496.1849254	 ‐496.042696	 ‐495.3518052	 ‐495.2095758	 ‐495.6659202	 ‐495.5236908	
13	 ‐496.1840697	 ‐496.041779	 ‐495.3510202	 ‐495.2087295	 ‐495.6652322	 ‐495.5229415	
	
Table	3.14	Energies	and	enthalpies	 for	2’‐desoxyribose	model	3‐45_H	 at	various	 levels	of	 theory	 in	
the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
O
OH
HO
	(3‐45_H)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
9	 ‐422.1838555	 ‐422.022484	 ‐421.4342941	 ‐421.2729226	 ‐421.7357118	 ‐421.5743403	
6	 ‐422.1831374	 ‐422.021856	 ‐421.4328604	 ‐421.271579	 ‐421.7343532	 ‐421.5730718	
3	 ‐422.1830676	 ‐422.021595	 ‐421.4318483	 ‐421.2703757	 ‐421.7333124	 ‐421.5718398	
15	 ‐422.1825881	 ‐422.021314	 ‐421.4325334	 ‐421.2712593	 ‐421.7342896	 ‐421.5730155	
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Table	3.15	Energies	and	enthalpies	for	2’‐desoxyribose	models	at	various	levels	of	theory	in	the	gas	
phase	in	Hartree	(298.15	K,	1	atm).	
	
O
HO
O 	(3‐45)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
4	 ‐420.9859207	 ‐420.848397	 ‐420.2375691	 ‐420.1000454	 ‐420.5228435	 ‐420.3853198	
6	 ‐420.9846209	 ‐420.847150	 ‐420.2377431	 ‐420.1002722	 ‐420.5228589	 ‐420.385388	
5	 ‐420.9838296	 ‐420.846388	 ‐420.2377331	 ‐420.1002915	 ‐420.5226863	 ‐420.3852447	
7	 ‐420.9848834	 ‐420.847446	 ‐420.237967	 ‐420.1005296	 ‐420.5230925	 ‐420.3856551	
2	 ‐420.9827371	 ‐420.845551	 ‐420.2377247	 ‐420.1005386	 ‐420.5227934	 ‐420.3856073	
	
O
OH
O
	(3‐46)	
B3LYP	 MP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐420.9763079	 ‐420.839282	 ‐420.2305171	 ‐420.0934915	 ‐420.5159564	 ‐420.3789305	
3	 ‐720.6743994	 ‐420.837599	 ‐420.2305048	 ‐420.0937044	 ‐420.5158041	 ‐420.3790037	
6	 ‐720.9734584	 ‐420.836562	 ‐420.2295738	 ‐420.0926774	 ‐420.5146234	 ‐420.377727	
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Table	3.16	Energies	and	enthalpies	for	open‐shell	sugar	models	at	various	levels	of	theory	in	the	gas	
phase	in	Hartree	(298.15	K,	1	atm).	
	
O
OHOH 	
(3‐40R_H)	
O
OHO 	
(3‐40Rb)	
O
HO OH
(3‐40Rc)	
O
OH OH
(3‐40Ra)	
O
OHHO
(3‐39R_H)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
UB3LYP	
‐382.2095753	
‐382.091592	
‐381.0266100	
‐380.931548	
‐381.0020204	
‐380.908302	
‐380.9821186	
‐380.888269	
‐382.2110494	
‐382.092602	
ROMP2	
‐381.5534556	
‐381.4354723	
‐380.3713030	
‐380.2762410	
‐380.3552209	
‐380.2615025	
‐380.3354956	
‐380.2416460	
‐381.5518970	
‐381.4334496	
G3(MP2)
‐RAD	
‐381.8064076	
‐381.6884243	
‐380.6071139	
‐380.5120519	
‐380.591977	
‐380.4982586	
‐380.5741869	
‐380.4803373	
‐381.8047854	
‐381.6863380	
	
O
HO O
(3‐39Ra)	
O
HO OH
(3‐39Rb)	
	 	 	
Etot	
H298	
Etot	
H298	
	 	 	
UB3LYP	
‐381.0374618	
‐380.942058	
‐381.0026090	
‐380.908927	
	 	
	
ROMP2	
‐380.3789169	
‐380.2835131	
‐380.3571748	
‐380.2634928	
	 	 	
G3(MP2)
‐RAD	
‐380.6142424	
‐380.5188386	
‐380.5931358	
‐380.4994538	
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Table	3.17	Energies	and	enthalpies	for	open‐shell	ribose	models	at	various	levels	of	theory	in	the	gas	
phase	in	Hartree	(298.15	K,	1	atm).	
	
O
OH
HO
HO 	(3‐47R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐496.7389357	 ‐496.585185	 ‐495.8984312	 ‐495.7446805	 ‐496.2230396	 ‐496.0692889	
22	 ‐496.7389600	 ‐496.585192	 ‐495.8977324	 ‐495.7439644	 ‐496.2221522	 ‐496.0683842	
10	 ‐496.7380026	 ‐496.584462	 ‐495.8968379	 ‐495.7432973	 ‐496.2214063	 ‐496.0678657	
4	 ‐496.7378733	 ‐496.584388	 ‐495.8966704	 ‐495.7431851	 ‐496.2211722	 ‐496.0676869	
9	 ‐496.7378587	 ‐496.584401	 ‐495.8960390	 ‐495.7425813	 ‐496.2205709	 ‐496.0671132	
26	 ‐496.7364926	 ‐496.582910	 ‐495.8954764	 ‐495.7418938	 ‐496.2200524	 ‐496.0664698	
7	 ‐496.7359818	 ‐496.582573	 ‐495.8948468	 ‐495.7414380	 ‐496.2195662	 ‐496.0661574	
28	 ‐496.7353216	 ‐496.581984	 ‐495.8946429	 ‐495.7413053	 ‐496.2191180	 ‐496.0657804	
	
O
HO
HO O 	(3‐43R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐495.5645486	 ‐495.433943	 ‐494.7248278	 ‐494.5942222	 ‐495.0311105	 ‐494.9005049	
3	 ‐495.5643379	 ‐495.433710	 ‐494.7235412	 ‐494.5929133	 ‐495.0300378	 ‐494.8994099	
2	 ‐495.5603865	 ‐495.430066	 ‐494.7221730	 ‐494.5918525	 ‐495.0287338	 ‐494.8984133	
8	 ‐495.5625623	 ‐495.432013	 ‐494.7216880	 ‐494.5911387	 ‐495.0284445	 ‐494.8978952	
6	 ‐495.5587599	 ‐495.428425	 ‐494.7191816	 ‐494.5888467	 ‐495.0257035	 ‐494.8953686	
7	 ‐495.5595650	 ‐495.429135	 ‐494.7190198	 ‐494.5885898	 ‐495.0255795	 ‐494.8951495	
10	 ‐495.5585514	 ‐495.428313	 ‐494.7183161	 ‐494.5880777	 ‐495.0250338	 ‐494.8947954	
11	 ‐495.5592788	 ‐495.428702	 ‐494.7186330	 ‐494.5880562	 ‐495.0252295	 ‐494.8946527	
	
O
OH
HO
OH 	(3‐42R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
2	 ‐496.7402859	 ‐496.586700	 ‐495.8989489	 ‐495.7453630	 ‐496.2231852	 ‐496.0695993	
1	 ‐496.7382715	 ‐496.584579	 ‐495.8981496	 ‐495.7444571	 ‐496.2222990	 ‐496.0686065	
37	 ‐496.7396709	 ‐496.586103	 ‐495.8976813	 ‐495.7441134	 ‐496.2220197	 ‐496.0684518	
3	 ‐496.7375551	 ‐496.584125	 ‐495.8964631	 ‐495.7430330	 ‐496.2209669	 ‐496.0675368	
30	 ‐496.7372751	 ‐496.583656	 ‐495.8962149	 ‐495.7425958	 ‐496.2204282	 ‐496.0668091	
4	 ‐496.7346958	 ‐496.581372	 ‐495.8953572	 ‐495.7420334	 ‐496.2198706	 ‐496.0665468	
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Table	3.18	Energies	and	enthalpies	for	open‐shell	ribose	models	at	various	levels	of	theory	in	the	gas	
phase	in	Hartree	(298.15	K,	1	atm).	
	
O
HO
O OH 	(3‐42Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
5	 ‐495.5609850	 ‐495.430639	 ‐494.7230698	 ‐494.5927238	 ‐494.9005816	 ‐495.0309276	
7	 ‐495.5643016	 ‐495.433721	 ‐494.7245314	 ‐494.5939508	 ‐494.9003491	 ‐495.0309297	
8	 ‐495.5656280	 ‐495.434880	 ‐494.7240830	 ‐494.5933350	 ‐494.9000286	 ‐495.0307766	
9	 ‐495.5639624	 ‐495.433378	 ‐494.7235357	 ‐494.5929513	 ‐494.8993588	 ‐495.0299432	
4	 ‐495.5622536	 ‐495.431704	 ‐494.7231050	 ‐494.5925554	 ‐494.8988698	 ‐495.0294194	
	
O
OHOH
HO
	(3‐44R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
26	 ‐496.7429036	 ‐496.589652	 ‐495.9034825	 ‐495.7502309	 ‐496.2276791	 ‐496.0744275	
6	 ‐496.7419682	 ‐496.588778	 ‐495.9024489	 ‐495.7492587	 ‐496.2268552	 ‐496.0736650	
7	 ‐496.7417069	 ‐496.588329	 ‐495.9018220	 ‐495.7484441	 ‐496.2261835	 ‐496.0728056	
9	 ‐496.7400111	 ‐496.586627	 ‐495.9009916	 ‐495.7476075	 ‐496.2254693	 ‐496.0720852	
48	 ‐496.7391764	 ‐496.586082	 ‐495.8998893	 ‐495.7467949	 ‐496.2245148	 ‐496.0714204	
10	 ‐496.7391360	 ‐496.585818	 ‐495.8990543	 ‐495.7457363	 ‐496.2234430	 ‐496.0701250	
	
O
OH
HO
O 	(3‐44Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐495.5593527	 ‐495.429210	 ‐494.7214832	 ‐494.5913405	 ‐495.0289152	 ‐494.8987725	
3	 ‐495.5585438	 ‐495.428430	 ‐494.7203944	 ‐494.5902806	 ‐495.0277781	 ‐494.8976643	
2	 ‐495.5563707	 ‐495.426357	 ‐494.7194472	 ‐494.5894335	 ‐495.0268017	 ‐494.8967880	
8	 ‐495.5565169	 ‐495.426425	 ‐494.7182927	 ‐494.5882008	 ‐495.0257388	 ‐494.8956469	
5	 ‐495.5550092	 ‐495.425151	 ‐494.7181693	 ‐494.5883111	 ‐495.0253449	 ‐494.8954867	
7	 ‐495.5556553	 ‐495.425510	 ‐494.7177302	 ‐494.5875849	 ‐495.0252485	 ‐494.8951032	
10	 ‐495.5553354	 ‐495.425353	 ‐494.7177918	 ‐494.5878094	 ‐495.0250310	 ‐494.8950486	
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Table	3.19	Energies	and	enthalpies	for	open‐shell	ribose	models	at	various	levels	of	theory	in	the	gas	
phase	in	Hartree	(298.15	K,	1	atm).	
	
O
OHOH
HO
	(3‐41R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
11	 ‐496.7484927	 ‐496.594142	 ‐495.9057420	 ‐495.7513913	 ‐496.2303854	 ‐496.0760347	
3	 ‐496.7495057	 ‐496.594905	 ‐495.9063667	 ‐495.7517660	 ‐496.2306135	 ‐496.0760128	
41	 ‐496.7461084	 ‐496.592150	 ‐495.9039720	 ‐495.7500136	 ‐496.2286865	 ‐496.0747281	
34	 ‐496.7440079	 ‐496.590081	 ‐495.9031911	 ‐495.7492642	 ‐496.2273662	 ‐496.0734393	
1	 ‐496.7457353	 ‐496.591780	 ‐495.9026737	 ‐495.7487184	 ‐496.2269933	 ‐496.0730380	
40	 ‐496.7457153	 ‐496.591134	 ‐495.9024036	 ‐495.7478223	 ‐496.2265507	 ‐496.0719694	
	
O
OH
HO
O 	(3‐41Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
4	 ‐495.5640058	 ‐495.433366	 ‐494.7228944	 ‐494.5922546	 ‐495.0299643	 ‐494.8993245	
1	 ‐495.5635219	 ‐495.432894	 ‐494.7225180	 ‐494.5918901	 ‐495.0294867	 ‐494.8988588	
2	 ‐495.5607439	 ‐495.430163	 ‐494.7208498	 ‐494.5902689	 ‐495.0282087	 ‐494.8976278	
7	 ‐495.5606439	 ‐495.430036	 ‐494.7207735	 ‐494.5901656	 ‐495.0281588	 ‐494.8975509	
6	 ‐495.5579128	 ‐495.427469	 ‐494.7187897	 ‐494.5883459	 ‐495.0261139	 ‐494.8956701	
	
O
OHOH
O
	(3‐41Rb)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐495.5667105	 ‐495.436100	 ‐494.7268751	 ‐494.5962646	 ‐495.0328193	 ‐494.9022088	
7	 ‐495.5608047	 ‐495.430291	 ‐494.7217550	 ‐494.5912413	 ‐495.0286335	 ‐494.8981198	
	
O
OH
HO
O 	(3‐41Rc)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
8	 ‐495.5363043	 ‐495.406726	 ‐494.6972479	 ‐494.5676696	 ‐495.0067052	 ‐494.8771269	
1	 ‐495.5344524	 ‐495.405050	 ‐494.6968455	 ‐494.5674431	 ‐495.0061551	 ‐494.8767527	
11	 ‐495.5344614	 ‐495.404805	 ‐494.6962923	 ‐494.5666359	 ‐495.0054501	 ‐494.8757937	
13	 ‐495.5354128	 ‐495.406026	 ‐494.6949241	 ‐494.5655373	 ‐495.0044191	 ‐494.8750323	
3	 ‐495.5316145	 ‐495.402565	 ‐494.6940222	 ‐494.5649727	 ‐495.0033158	 ‐494.8742663	
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Table	3.20	Energies	and	enthalpies	for	open‐shell	2’‐desoxyribose	models	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
O
OH
HO
	(3‐45R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
9	 ‐421.5200951	 ‐421.373157	 ‐420.7696730	 ‐420.6227349	 ‐421.0654868	 ‐420.9185487	
3	 ‐421.5184042	 ‐421.371589	 ‐420.7690937	 ‐420.6222785	 ‐421.0649586	 ‐420.9181434	
10	 ‐421.5184392	 ‐421.371678	 ‐420.7688639	 ‐420.6221027	 ‐421.0646903	 ‐420.9179291	
11	 ‐421.5183745	 ‐421.371513	 ‐420.7683399	 ‐420.6214784	 ‐421.0643432	 ‐420.9174817	
7	 ‐421.5164382	 ‐421.369783	 ‐420.7676499	 ‐420.6209947	 ‐421.0635209	 ‐420.9168657	
8	 ‐421.5174683	 ‐421.370555	 ‐420.7668700	 ‐420.6199567	 ‐421.0627337	 ‐420.9158204	
13	 ‐421.5114896	 ‐421.365100	 ‐420.7637524	 ‐420.6173628	 ‐421.0597762	 ‐420.9133866	
	
O
HO
O 	(3‐45R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
8	 ‐420.3327589	 ‐420.209065	 ‐419.5829335	 ‐419.4592396	 ‐419.8630729	 ‐419.7393790	
9	 ‐420.3343007	 ‐420.210456	 ‐419.5823908	 ‐419.4585461	 ‐419.8628199	 ‐419.7389752	
2	 ‐420.3322767	 ‐420.208577	 ‐419.5816695	 ‐419.4579698	 ‐419.8619609	 ‐419.7382612	
5	 ‐420.3295910	 ‐420.206103	 ‐419.5815823	 ‐419.4580943	 ‐419.8616669	 ‐419.7381789	
4	 ‐420.3306986	 ‐420.207077	 ‐419.5812724	 ‐419.4576508	 ‐419.8614524	 ‐419.7378308	
	
O
OH
HO
	(3‐46R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
3	 ‐421.5346756	 ‐421.385781	 ‐420.7808311	 ‐420.6319365	 ‐421.0767406	 ‐420.9278460	
1	 ‐421.5322712	 ‐421.383791	 ‐420.7785680	 ‐420.6300878	 ‐421.0745078	 ‐420.9260276	
12	 ‐421.5303108	 ‐421.381938	 ‐420.7775152	 ‐420.6291424	 ‐421.0737101	 ‐420.9253373	
13	 ‐421.5298020	 ‐421.381327	 ‐420.7770852	 ‐420.6286102	 ‐421.0732112	 ‐420.9247362	
6	 ‐421.5300162	 ‐421.381665	 ‐420.7751596	 ‐420.6268084	 ‐421.0713262	 ‐420.9229750	
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Table	3.21	Energies	and	enthalpies	for	open‐shell	2’‐desoxyribose	models	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
O
HO
O 	(3‐46Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
1	 ‐420.3567811	 ‐420.231507	 ‐419.6032351	 ‐419.4779610	 ‐419.8816649	 ‐419.7563908	
2	 ‐420.3530989	 ‐420.227885	 ‐419.6011761	 ‐419.4759622	 ‐419.8798062	 ‐419.7545923	
5	 ‐420.3502802	 ‐420.225249	 ‐419.5991268	 ‐419.4740956	 ‐419.8776532	 ‐419.7526220	
	
O
OH
O
	(3‐46Rb)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
Etot	 H298	 Etot	 H298	 Etot	 H298	
4	 ‐420.3532614	 ‐420.228076	 ‐419.6018749	 ‐419.4766895	 ‐419.8794258	 ‐419.7542404	
5	 ‐420.3512756	 ‐420.226069	 ‐419.6013255	 ‐419.4761189	 ‐419.8792097	 ‐419.7540031	
	
Table	3.22	Energies	and	enthalpies	for	3‐52R	at	various	levels	of	theory	in	the	gas	phase	and	in	water	
solution	in	Hartree	(IEF‐PCM	=	IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	6‐31G(d)).	
	
O
OH
HO U
HO 	(3‐52R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
7	 ‐910.3664589	 ‐910.140049	 ‐908.8218201  ‐909.3774355	 ‐0.0317446	
22	 ‐910.3653081	 ‐910.139071	 ‐908.8202557  ‐909.3760215	 ‐0.0346130	
29	 ‐910.3645489	 ‐910.138495	 ‐908.8197226  ‐909.3756425	 ‐0.0334816	
1	 ‐910.3647645	 ‐910.138453	 ‐908.8215667  ‐909.3772423	 ‐0.0326848	
16	 ‐910.3646612	 ‐910.138337	 ‐908.8191918  ‐909.3750343	 ‐0.0338003	
6	 ‐910.3640039	 ‐910.137808	 ‐908.8195240  ‐909.3753207	 ‐0.0316489	
11	 ‐910.3637063	 ‐910.137285	 ‐908.8192463  ‐909.3749907	 ‐0.0349158	
2	 ‐910.3624828	 ‐910.136200	 ‐908.8191042  ‐909.3747354	 ‐0.0351549	
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Table	3.23	Energies	and	enthalpies	for	open‐shell	uridine	derivatives	at	various	levels	of	theory	in	the	
gas	 phase	 and	 in	 water	 solution	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	
6‐31G(d)).	
	
O
HO D
HO O 	(3‐48Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
18	 ‐910.4000892	 ‐910.173117	 ‐908.8484744	 ‐909.4013094	 ‐0.0396488	
6	 ‐910.3980589	 ‐910.170862	 ‐908.8461554	 ‐909.3986315	 ‐0.0354736	
34	 ‐910.397375	 ‐910.170378	 ‐908.8460842	 ‐909.399403	 ‐0.0389636	
40	 ‐910.3967976	 ‐910.169766	 ‐908.8447738	 ‐909.3976715	 ‐0.0372106	
31	 ‐910.3964794	 ‐910.169468	 ‐908.8448253	 ‐909.3983395	 ‐0.0378321	
25	 ‐910.3961569	 ‐910.169164	 ‐908.8441937	 ‐909.397007	 ‐0.0373700	
22	 ‐910.3957370	 ‐910.168869	 ‐908.8451302	 ‐909.3979019	 ‐0.0385971	
	
O
OH
HO U
OH 	(3‐49R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
25	 ‐910.3674962	 ‐910.141315	 ‐908.8238780	 ‐909.3796653	 ‐0.0365254	
6	 ‐910.3663915	 ‐910.140426	 ‐908.8234801	 ‐909.3794525	 ‐0.0351708	
17	 ‐910.3661894	 ‐910.140144	 ‐908.8237596	 ‐909.3793673	 ‐0.0372425	
14	 ‐910.3660818	 ‐910.140032	 ‐908.8218777	 ‐909.3778423	 ‐0.0377524	
10	 ‐910.3661606	 ‐910.139888	 ‐908.8220833	 ‐909.3779337	 ‐0.0336728	
5	 ‐910.3655244	 ‐910.139435	 ‐908.8218906	 ‐909.3778962	 ‐0.0317446	
20	 ‐910.3644661	 ‐910.139360	 ‐908.8216169	 ‐909.3775941	 ‐0.0365413	
18	 ‐910.3644661	 ‐910.138423	 ‐908.8216348	 ‐909.3775161	 ‐0.0364776	
4	 ‐910.3641611	 ‐910.138064	 ‐908.8197640	 ‐909.3758322	 ‐0.0361907	
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Table	3.24	Energies	and	enthalpies	for	open‐shell	uridine	derivatives	at	various	levels	of	theory	in	the	
gas	 phase	 and	 in	 water	 solution	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	
6‐31G(d)).	
	
O
HO D
O OH 	(3‐49Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
4	 ‐910.4012167	 ‐910.174298	 ‐908.8480150	 ‐909.4009499	 ‐0.0335294	
8	 ‐910.4009077	 ‐910.173946	 ‐908.8474979	 ‐909.4003928	 ‐0.0336888	
7	 ‐910.4006944	 ‐910.173603	 ‐908.8445872	 ‐909.3978214	 ‐0.0345334	
3	 ‐910.4003671	 ‐910.173463	 ‐908.8443338	 ‐909.3975667	 ‐0.0347405	
14	 ‐910.1721520	 ‐910.172152	 ‐908.8469492	 ‐909.3998964	 ‐0.0345493	
19	 ‐910.3982215	 ‐910.171548	 ‐908.8457340	 ‐909.3989084	 ‐0.0362704	
17	 ‐910.3982919	 ‐910.171204	 ‐908.8460953	 ‐909.3990516	 ‐0.0359198	
34	 ‐910.3980878	 ‐910.171018	 ‐908.8454791	 ‐909.3992915	 ‐0.0369716	
	
O
OH
HO
OH
U
	(3‐51R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
25	 ‐910.3684648	 ‐910.141883	 ‐908.8236613	 ‐909.3799215	 ‐0.0331788	
8	 ‐910.3661481	 ‐910.139772	 ‐908.8207562	 ‐909.3769973	 ‐0.0319358	
36	 ‐910.3657102	 ‐910.138977	 ‐908.8220360	 ‐909.3780845	 ‐0.0373222	
48	 ‐910.3655868	 ‐910.138791	 ‐908.8218973	 ‐909.3780882	 ‐0.0362067	
15	 ‐910.3644762	 ‐910.137891	 ‐908.8222872	 ‐909.3788239	 ‐0.0378321	
	
O
OH
O
OH
D
	(3‐51Ra)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
23	 ‐910.3965350	 ‐910.169704	 ‐908.8443837	 ‐909.3981146	 ‐0.0319039	
25	 ‐910.3947267	 ‐910.167927	 ‐908.8421603	 ‐909.3959421	 ‐0.0334178	
8	 ‐910.3940192	 ‐910.167364	 ‐908.8415184	 ‐909.3946787	 ‐0.0349796	
7	 ‐910.3930112	 ‐910.166435	 ‐908.8406424	 ‐909.3937429	 ‐0.0348999	
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Table	3.25	 Energies	 and	 enthalpies	 for	3‐51Rb	 at	 various	 levels	 of	 theory	 in	 the	 gas	 phase	 and	 in	
water	solution	in	Hartree	(IEF‐PCM	=	IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	6‐31G(d)).	
	
O
HO
OH
D
O 	(3‐51Rb)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
17	 ‐910.3939700	 ‐910.167430	 ‐908.8404581	 ‐909.3942829	 ‐0.0381349	
11	 ‐910.3939989	 ‐910.167312	 ‐908.8417578	 ‐909.3963689	 ‐0.0379756	
14	 ‐910.3933674	 ‐910.166754	 ‐908.8398747	 ‐909.3937218	 ‐0.0389636	
26	 ‐910.3930580	 ‐910.166500	 ‐908.8395743	 ‐909.3933345	 ‐0.0391708	
24	 ‐910.3924285	 ‐910.165864	 ‐908.8388548	 ‐909.3926964	 ‐0.0390592	
16	 ‐910.3920458	 ‐910.165378	 ‐908.8392185	 ‐909.3938731	 ‐0.0385652	
47	 ‐910.3916412	 ‐910.165033	 ‐908.8386118	 ‐909.3932097	 ‐0.0386130	
31	 ‐910.3907606	 ‐910.164173	 ‐908.8384723	 ‐909.3925804	 ‐0.0414496	
4	 ‐910.3907381	 ‐910.164108	 ‐908.8360205	 ‐909.3909259	 ‐0.0376728	
9	 ‐910.3905193	 ‐910.163887	 ‐908.8393586	 ‐909.3942491	 ‐0.0408600	
3	 ‐910.3903952	 ‐910.163778	 ‐908.8356604	 ‐909.3906115	 ‐0.0379118	
29	 ‐910.3900716	 ‐910.163519	 ‐908.8379142	 ‐909.3920216	 ‐0.0412424	
61	 ‐910.3899909	 ‐910.163352	 ‐908.8355369	 ‐909.3902496	 ‐0.0374975	
57	 ‐910.3895568	 ‐910.162941	 ‐908.8382875	 ‐909.3931822	 ‐0.0413699	
5	 ‐910.3895803	 ‐910.162906	 ‐908.8379664	 ‐909.3932337	 ‐0.0382783	
7	 ‐910.3894949	 ‐910.162903	 ‐908.8348492	 ‐909.3895906	 ‐0.0381030	
18	 ‐910.3888004	 ‐910.162372	 ‐908.8375249	 ‐909.3916349	 ‐0.0416568	
10	 ‐910.3888184	 ‐910.162210	 ‐908.8370766	 ‐909.3919609	 ‐0.0408918	
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Table	3.26	Energies	and	enthalpies	for	open‐shell	uridine	derivatives	at	various	levels	of	theory	in	the	
gas	 phase	 and	 in	 water	 solution	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	
6‐31G(d)).	
	
O
OHOH
HO
U
	(3‐50R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
22	 ‐910.3709609	 ‐910.144709	 ‐908.8244957	 ‐909.3812269	 ‐0.0312984	
9	 ‐910.3707755	 ‐910.144399	 ‐908.8237197	 ‐909.3805048	 ‐0.0296569	
73	 ‐910.3705720	 ‐910.144115	 ‐908.8231906	 ‐909.3801665	 ‐0.0291948	
10	 ‐910.3700834	 ‐910.143879	 ‐908.8237039	 ‐909.3805722	 ‐0.0328920	
14	 ‐910.3693185	 ‐910.143173	 ‐908.8241676	 ‐909.3808797	 ‐0.0318880	
3	 ‐910.3695661	 ‐910.143131	 ‐908.8259405	 ‐909.3821488	 ‐0.0345971	
5	 ‐910.3691660	 ‐910.142914	 ‐908.8231324	 ‐909.3798925	 ‐0.0304219	
15	 ‐910.3689906	 ‐910.142449	 ‐908.8246616	 ‐909.3808999	 ‐0.0352346	
23	 ‐910.3682453	 ‐910.142178	 ‐908.8222318	 ‐909.3790728	 ‐0.0345812	
17	 ‐910.3677804	 ‐910.141771	 ‐908.8223483	 ‐909.3791571	 ‐0.0343740	
26	 ‐910.3679035	 ‐910.141711	 ‐908.8214930	 ‐909.3780489	 ‐0.0340872	
	
O
OH
HO
D
O 	(3‐50R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
3	 ‐910.3998174	 ‐910.172796	 ‐908.8481619	 ‐909.4014105	 ‐0.0342306	
4	 ‐910.3986426	 ‐910.171605	 ‐908.8463553	 ‐909.3997694	 ‐0.0329398	
12	 ‐910.3966897	 ‐910.169768	 ‐908.8459416	 ‐909.3978891	 ‐0.0356011	
6	 ‐910.3959926	 ‐910.168975	 ‐908.8442775	 ‐909.3964746	 ‐0.0348362	
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Table	3.27	Energies	and	enthalpies	for	open‐shell	uridine	derivatives	at	various	levels	of	theory	in	the	
gas	 phase	 and	 in	 water	 solution	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	
6‐31G(d)).	
	
O
HO
D
OHHO 	(3‐48Rb)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
13	 ‐910.3767445	 ‐910.150730	 ‐908.8307220	 ‐909.3831237	 ‐0.0311071	
15	 ‐910.3763869	 ‐910.150556	 ‐908.8313908	 ‐909.3835725	 ‐0.0331788	
50	 ‐910.3760145	 ‐910.150190	 ‐908.8306331	 ‐909.3832335	 ‐0.0316171	
9	 ‐910.3757337	 ‐910.149737	 ‐908.8293879	 ‐909.3816343	 ‐0.0338322	
77	 ‐910.3756005	 ‐910.149604	 ‐908.8293250	 ‐909.3815428	 ‐0.0315533	
10	 ‐910.3753370	 ‐910.149541	 ‐908.8300332	 ‐909.3820802	 ‐0.0338322	
29	 ‐910.3749247	 ‐910.149144	 ‐908.8292525	 ‐909.3817863	 ‐0.0340234	
52	 ‐910.3746681	 ‐910.148951	 ‐908.8296750	 ‐909.3826392	 ‐0.0337206	
64	 ‐910.3733917	 ‐910.147801	 ‐908.8291477	 ‐909.3810726	 ‐0.0356170	
32	 ‐910.3734192	 ‐910.147785	 ‐908.8280928	 ‐909.3809674	 ‐0.0346927	
	
O
HO
D
HO OH 	(3‐49Rb)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
4	 ‐910.3748849	 ‐910.148801	 ‐908.8304122	 ‐909.3832439	 ‐0.0333063	
2	 ‐910.3747171	 ‐910.148707	 ‐908.8297656	 ‐909.3832922	 ‐0.0331469	
3	 ‐910.3730306	 ‐910.147143	 ‐908.8291285	 ‐909.3824266	 ‐0.0355533	
1	 ‐910.3728604	 ‐910.147141	 ‐908.8291756	 ‐909.3817016	 ‐0.0360473	
9	 ‐910.3730747	 ‐910.147067	 ‐908.8298582	 ‐909.3832426	 ‐0.0335613	
14	 ‐910.3728936	 ‐910.147045	 ‐908.8295389	 ‐909.3834026	 ‐0.0335135	
13	 ‐910.3725547	 ‐910.146817	 ‐908.8286920	 ‐909.3822069	 ‐0.0334497	
26	 ‐910.3728370	 ‐910.146695	 ‐908.8284112	 ‐909.3817346	 ‐0.0367007	
11	 ‐910.3726297	 ‐910.146691	 ‐908.8284132	 ‐909.3823165	 ‐0.0348202	
5	 ‐910.3724864	 ‐910.146595	 ‐908.8286255	 ‐909.3816298	 ‐0.0339437	
32	 ‐910.3729310	 ‐910.146524	 ‐908.8266122	 ‐909.3798103	 ‐0.0366210	
8	 ‐910.3721682	 ‐910.146428	 ‐908.8277617	 ‐909.3810829	 ‐0.0357604	
34	 ‐910.3723201	 ‐910.146184	 ‐908.8280655	 ‐909.3813644	 ‐0.0370991	
20	 ‐910.3722397	 ‐910.146048	 ‐908.8264528	 ‐909.3777566	 ‐0.0373062	
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Table	3.28	Energies	and	enthalpies	 for	open‐shell	nucleosides	at	various	 levels	of	 theory	 in	 the	gas	
phase	 and	 in	 water	 solution	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d)//B3LYP/	
6‐31G(d)).	
	
O
OH
HO
HO
D
	(3‐48Rc)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
16	 ‐910.3738691	 ‐910.147993	 ‐908.8298603	 ‐909.3831515	 ‐0.0326370	
7	 ‐910.3732249	 ‐910.147421	 ‐908.8287356	 ‐909.3820922	 ‐0.0331788	
12	 ‐910.3722436	 ‐910.146427	 ‐908.8285703	 ‐909.3827738	 ‐0.0348840	
11	 ‐910.3717313	 ‐910.145989	 ‐908.8280772	 ‐909.3821750	 ‐0.0351071	
	
O
OH
HO C
HO 	(3‐14R_H)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
7	 ‐890.4849277	 ‐890.246767	 ‐888.9455584	 ‐889.5085576	 ‐0.03920262	
16	 ‐890.4832920	 ‐890.245216	 ‐888.9432443	 ‐889.5063917	 ‐0.04036595	
29	 ‐890.4831391	 ‐890.245185	 ‐888.9434718	 ‐889.5066110	 ‐0.03984007	
6	 ‐890.4821766	 ‐890.244315	 ‐888.9430036	 ‐889.5060853	 ‐0.03901139	
22	 ‐890.4821561	 ‐890.244292	 ‐888.9425999	 ‐889.5056856	 ‐0.04124244	
1	 ‐890.4821270	 ‐890.244060	 ‐888.9442329	 ‐889.5073369	 ‐0.03953728	
11	 ‐890.4819000	 ‐890.243714	 ‐888.9427660	 ‐889.5059140	 ‐0.04100340	
	
O
HO dhC
HO O 	(3‐14R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H289	 Etot	 Etot	 Gsolv	
18	 ‐890.5064534	 ‐890.267775	 ‐888.9590225	 ‐889.5207963	 ‐0.04995944	
34	 ‐890.5032064	 ‐890.264483	 ‐888.9565121	 ‐889.5188906	 ‐0.04868456	
6	 ‐890.5031211	 ‐890.264261	 ‐888.9555468	 ‐889.5169264	 ‐0.04554516	
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Table	3.29	 RSE‐relevant	 energies	 and	 enthalpies	 for	 open‐	 and	 closed‐shell	 compounds	 at	 various	
levels	of	theory	in	the	gas	phase	(298.15	K,	1	atm,	in	Hartree).	
	
CH3 	
(3‐10R)	
CH4 	
(3‐10)	
OH 	
(3‐1Rb)	
HO
O 	
(3‐9R)	
	
(3‐2)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
(U)B3LYP	
‐39.8382922	
‐39.804975	
‐40.5183890	
‐40.470240	
‐154.3753608	
‐154.304996	
‐307.0460367	
‐306.934651	
‐117.9075622	
‐117.823957	
(RO)MP2	
‐39.7316815	
‐39.6983643	
‐40.4055437	
‐40.3573947	
‐154.0785764	
‐154.0082116	
‐306.4710091	
‐306.3596234	
‐117.6166619	
‐117.5330709	
G3(MP2)‐RAD	
‐39.7851922	
‐39.7518750	
‐40.4651605	
‐40.4170115	
‐154.2043033	
‐154.1339385	
‐306.6936033	
‐306.5822176	
‐117.7498900	
‐117.6662848	
	
	
(3‐4)	 	
(3‐34)	
	
(3‐34_H)	
	
(3‐27)	
	
(3‐27_H)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
119.1442483	
‐119.036640	
‐157.2272881	
‐157.114574	
‐158.4588061	
‐158.322279	
‐234.6482883	
‐234.497595	
‐235.8804309 
‐235.705840 
MP2	
‐118.8387689	
‐118.7311606	
‐156.8420116	
‐156.7292975	
‐158.0609392	
‐157.9244121	
‐234.0908015	
‐233.9401082	
‐235.3102004 
‐235.1356095 
G3(MP2)‐RAD	
‐118.9847884	
‐118.8771801	
‐157.0170527	
‐156.9043386	
‐158.2492314	
‐158.1127043	
‐234.3346577	
‐234.1839644	
‐235.5671031 
‐235.3925122	
	
	
(3‐29)	
	
(3‐29_H)	
O 	
(3‐3)	
HO 	
(3‐1)	
O 	
(3‐8)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐195.3271387	
‐195.206463	
‐196.5570819	
‐196.412193	
‐153.8301215	
‐153.770515	
‐155.0342871	
‐154.950239	
‐193.1556942	
‐193.066834	
MP2	
‐194.8640871	
‐194.7434114	
‐196.0804928	
‐195.9356039	
‐153.5380653	
‐153.4784588	
‐154.7365194	
‐154.6524713	
‐192.7680234	
‐192.6791632	
G3(MP2)‐RAD	
‐195.0650164	
‐194.9443407	
‐196.2948337	
‐196.1499448	
‐153.6538781	
‐153.5942716	
‐154.8685341	
‐154.7844860	
‐192.9263022	
‐192.8374420	
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Table	 3.30	 RSE‐relevant	 energies	 and	 enthalpies	 for	 closed‐shell	 compounds	 at	 various	 levels	 of	
theory	in	the	gas	phase	(298.15	K,	1	atm,	in	Hartree).	
	
HO 	
(3‐33)	
HO
O 	
(3‐9)	
Etot	
H298	
Etot	
H298	
B3LYP	
‐194.3534513	
‐194.240614	
‐307.6756355	
‐307.551738	
MP2	
‐193.9614458	
‐193.848685	
‐307.1063382	
‐306.9824407
G3(MP2)‐RAD	
‐194.1361518	
‐194.0233145
‐307.3360457	
‐307.2121482
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Table	3.31	Gas	phase	radical	stabilization	energies	at	various	levels	in	kJ	mol‐1.	
R H + CH3
RSE
R + CH4 	
R•	
RSE	
RSE(exp.)[115]	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	
(3‐2R)	
‐83.44	 ‐78.74	 ‐71.97	
‐70.3	
‐70.7[93]	
(3‐4R)	
‐17.18	 ‐9.82	 ‐10.12	
‐17.5	
‐17.1[93]	
(3‐34R)	
‐76.23	 ‐72.06	 ‐66.06	 ‐66.5	
(3‐34R_H)	
‐17.45  ‐9.56  ‐10.62 
‐21.0	
‐20.1[93]	
(3‐27R)	
‐102.06  ‐95.70  ‐85.37  ‐96.6	
(3‐27R_H)	
‐34.01  ‐19.28  ‐20.70 
‐39.7	
‐23.0[93]	
(3‐29R)	
‐100.05  ‐93.90  ‐84.66  ‐94.6	
(3‐29R_H)	
‐46.52  ‐32.13  ‐33.38 
‐37.6	
‐39.3[93]	
O
(3‐3R)	
‐52.27  ‐33.92  ‐36.63  ‐44.6	
HO
(3‐1R)	
‐18.11  ‐9.66  ‐10.32 
‐17.5	
‐15.5[93]	
O
(3‐8R)	
‐47.39  29.78  ‐32.42  ‐38.1	
HO
(3‐33R)	
‐17.08  ‐9.03  ‐9.57  ‐44.9	
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Table	3.32	Benson	increment	system	(BGVA)	for	the	assignement	of	heats	of	formation	(in	kJ	mol‐1).	
fH0(exp.)	in	bold	style	are	estimated	by	the	correlation	in	Figure	3.16.	
	 Benson	notation	 BGVA[115]	 fH0(BGVA) fH0(exp.)[115]
HO
(3‐1R)	
C	–	(C)(H2)	
C	–	(C)(O)(H2)	
O	–	(C)(H)	
+160.7	
‐39.6[120]	
‐158.6[120]	
‐37.5	 ‐31.0	±	7.0	
O
(3‐3R)	
C	‐	(CO)(H2)	
CO	–	(C)(H)	
+155.4[120]	
‐145.0[120]	
+10.4	 +10.5	±	9.20[121]	
HO
(3‐33R)	
C	‐	(C)(H2)	
C‐(C)(C)(O)(H)	
C	–	(C)(H3)	
O	–	(C)(H)	
+160.7	
‐51.5[120]	
‐41.8[122]	
‐158.6[120]	
‐91.2	 ‐96.2	±	4.2	
O
(3‐8R)	
C	‐(CO)(H2)	
CO	–	(C)(C)	
C	–	(CO)(H3)	
+155.4[120]	
‐146.9[120]	
‐41.8[122]	
‐33.3	 ‐33.9	±	3.0	
OH
(3‐36R_H)	
C	–	(C2)(H)	
C	–	(C)(C)(H2)	
2x	C	–	(C2)(H2)	
C	–	(C)(C)(O)(H)	
O	–	(C)(H)	
Cyclopentane	
+171.5[120]	
‐20.9[120]	
2x	(‐20.9)[121]	
‐51.5[122]	
‐158.6[121]	
+29.7[121]	
‐71.6	 ‐71.6 (corr.) 
O
(3‐36R)	
C	‐	(CO)(C)(H)	
C	–	(C)(C)(H2)	
C	–	(C2)(H2)	
C	–	(CO)(C)(H2)	
CO	–	(C)(C)	
Cyclopentanone	
+138.9[120]	
‐20.9	
‐20.9[122]	
‐21.8[122]	
‐132.6[120]	
+25.9[122]	
‐31.4	 ‐41.8 ± 12.6	
(3‐4R)	
C	‐	(C)(H2)	
C	–	(C)(C)(H2)	
C	–	(C)(H3)	
+160.7	
‐20.9	
‐41.8[122]	
+98.0	 +100.0 ± 2.0 
(3‐2R)	
C	–	(CD)(H2)	
C	–	(C)(C)(H2)	
C	–	(C)(H3)	
+108.4	
+36.0	
+26.4[122]	
+170.8	 +171.0 ± 3.0
[123] 
(3‐34R_H)	
C	–	(C)(H2)	
C	–	(C)(C2)(H)	
2	x	C	–	(C)(H3)	
+160.7	
‐10.0	
2x	(‐41.8)	
+67.1	 +66.1 ± 1.3
[124] 
(3‐34R)	
C	–	(CD)(H2)	
CD	–	(C)(C)	
C	–	(CD)(H3)	
CD	–	(H2)	
+108.4	
+42.7	
‐41.8[122]	
+26.4[122]	
+135.7	 +137.9 
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Table	3.33	Benson	increment	system	(BGVA)	for	the	assignement	of	heats	of	formation	(in	kJ	mol‐1).	
fH0(exp.)	in	bold	style	are	estimated	by	the	correlation	in	Figure	3.16.	
  Benson	notation	 BGVA[115]	 fH0(BGVA) fH0(exp.)[115]
(3‐64R_H)	
C	–	(C)(H2)	
C	–	(C)(C)(H2)	
C	–	(C2)(H2)	
C	–	(C)(H3)	
+160.7	
‐20.9	
‐20.9[122]	
‐41.8[122]	
+77.1	 +77.8	±	2.1	
(3‐64R)	
C	–	(C)(H2)	
C	–	(C)(C)(H2)	
CD	–	(C)(CD)	
CD	–	(H2)	
+160.7	
‐20.9	
+36.8[122]	
+26.4[122]	
+203.0	 +192.5	
OH
(3‐65R_H)	
C	–	(C)(H3)	
C	–	(C2)(H)	
C	–	(C)(C)(O)(H)	
O	–	(C)(H)	
C	–	(C)(H3)	
‐41.8[120]	
+171.5[120]	
‐51.5[122]	
‐158.6[121]	
‐41.9[121]	
‐122.3	 ‐121.5	(corr.)	
O
(3‐65R)	
C	–	(CO)(H3)	
CO	–	(C)(C)	
C	‐	(CO)(C)(H)	
C	–	(C)(H3)	
‐41.8[122]	
‐132.6[120]	
+138.9[120]	
‐41.8	
‐77.3	 ‐70.3	±	7.1
OH
(3‐35R_H)	
C	–	(C)(H3)	
C	–	(C)(C)(H2)	
C	‐	(C)(O)(H)	
O	–	(C)(H)	
‐41.8[122]	
‐17.4	
+117.4[120]	
‐146.3[120]	
‐88.1	 ‐81.0	±	8.0	
OH
(3‐35R)	
CD	–	(CD)(H2)	
CD	–	(CD)(H)(C)	
C	‐	(CD)(O)(H)	
O	–	(C)(H)	
+26.4[122]	
+36.0	
+84.08[120]	
‐146.25[120]	
+0.23	 0.0	±	8.4	
OH
(3‐37R_H)	
C	–	(C)(H3)	
C	–	(C2)(H)	
C	–	(C)(O)(H2)	
O	–	(C)(H)	
‐41.8	
+171.5	
‐39.6[120]	
‐158.6[122]	
‐68.5	 ‐78.7	±	8.4	
O
(3‐37R)	
C	–	(C)(H3)	
C	–	(CO)(C)(H)	
CO	–	(C)(H)	
‐41.8[120]	
+153.2[122]	
‐145.0[122]	
‐33.6	 ‐34.2	(corr.)	
(3‐27R_H)	
C	–	(C2)(H)	
2x	C	–	(C)(C)(H2)	
3x	C	–	(C2)(H2)		
Cyclohexane	
+171.5	
2x	(‐20.9)	
3x	(‐20.9)[122]	
+2.9[122]	
64.1	 +58.2	±	4.0[120]	
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Table	3.34	Benson	increment	system	(BGVA)	for	the	assignement	of	heats	of	formation	(in	kJ	mol‐1).	
  Benson	notation	 BGVA[115]	 fH0(BGVA) fH0(exp.)[115]
(3‐27R)	
C	–	(CD)(C)(H)	
C	–	(C)(C)(H2)	
C	–	(C2)(H2)	
C	–	(C)(CD)(H2)	
CD	–	(C)(H)	
CD	–	(C)(H)	
Cyclohexene	
+109.6	
‐20.9	
‐20.9[122]	
‐20.1[122]	
+36.0[122]	
+36.0	
+2.1[122]	
+121.8	 +119.7	
(3‐29R_H)	
C	–	(C2)(H)	
2x	C	–	(C)(C)(H2)	
2x	C	–	(C2)(H2)		
Cyclopentane	
+171.5	
2x	(‐20.9)	
2x	(‐20.9)[122]	
+29.7[122]	
+117.6	 +107.0	±	2.5[120]	
(3‐29R)	
C	–	(CD)(C)(H)	
C	–	(C)(C)(H2)	
C	–	(C)(CD)(H2)	
CD	–	(C)(H)	
CD	–	(C)(H)	
Cyclopentene	
+109.6	
‐20.9	
‐20.1[122]	
+36.0[122]	
+36.0	
+24.7[122]	
+165.3	 +160.7	±	4.2	
	
Figure	 3.16	 Correlation	 of	 experimental	 available	 heats	 of	 formation	 fH0(exp.)	 vs.	 calculated	
fH0(BGVA)	using	Benson’s	group	additivity	values.	
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Table	3.35	Calculated	reaction	enthalpies	trhH	for	transfer	hydrogenation	of	3‐8R	to	3‐33R	at	various	
levels	of	theory	in	the	gas	phase	at	298.15	K	(in	kJ	mol‐1)	
HH
H H
H
H
+
HH
H H
+
O trhH OH
H
3-24 3-15 3-33R3-8R 	
	 trhH	(calc.)	 trhH	(HL)a	 trhH	(exp.)	 trhH	(BGAV)b	
G3(MP2)‐RAD	 +99.3	
+106.3	 +74.1±8.1	 +78.5	G3B3	 +104.5	
CBS‐QB3	 +105.3	
a	fH0(•CH2CH(OH)CH3)	=	‐64.02	kJ	mol‐1	at	CBS‐QB3	level	of	theory.[109]	b	fH0	estimated	by	Benson	group	additivity	values.	
RSE 
(kJ mol-1)
-10-20-30-40-50-60-70
RSE = -59.8 kJ mol-1
3-2R 3-4R
-80
RSE = -64.7 kJ mol-1
-90
3-27R 3-27R_H
RSE = -51.3 kJ mol-1
3-29R 3-29R_H
O OH
O OH
RSE = -26.4 kJ mol-1
3-3R 3-1R
RSE = -24.0 kJ mol-1
3-33R3-8R
CBS
	
Figure	3.17	 Relation	 of	RSE	 (red	 bars:	 experimental;	 black	 bars:	 G3(MP2)‐RAD	 values)	 and	hydH	
(grey	+	light	blue	bar	at	G3(MP2)‐RAD	level	in	the	gas	phase).	
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Table	3.36	Calculated	free	solvation	energies	Gsolv	in	water	(at	298.15	K	and	1	atm,	in	Hartree).	IEF‐
PCM	 =	 IEF‐PCM/UAHF/UHF/6‐31G(d),	 C‐PCM	 =	 C‐PCM/UAHF/UHF/6‐31G(d),	 SMD/UHF	 =	
SMD/UHF/6‐31G(d),	SMD/B3LYP	=	SMD/UB3LYP/6‐31G(d).	
O
OH
HO N
NH
O
O
HO
O
HO N
NH
O
O
HO O
3-52R 3-48Ra 	
O
OH
HO U
HO 	
						(3‐52R)	
G3(MP2)‐RAD	 IEF‐PCM	 C‐PCM	 SMD/UHF	 SMD/UB3LYP	
H298	 Gsolv	 Gsolv	 Gsolv	 Gsolv	
7	(A)	 ‐909.1510256	 ‐0.0317446	 ‐0.0321111	 ‐0.0375293	 ‐0.0269478	
22	(B)	 ‐909.1497844	 ‐0.0346130	 ‐0.0349796	 ‐0.0407962	 ‐0.0293860	
29(C)	 ‐909.1495886	 ‐0.0334816	 ‐0.0338481	 ‐0.0379756	 ‐0.0274259	
1	(D)	 ‐909.1509308	 ‐0.0326848	 ‐0.0330194	 ‐0.0362704	 ‐0.0268203	
16(E)	 ‐909.1487101	 ‐0.0338003	 ‐0.0341987	 ‐0.0378321	 ‐0.0269159	
6(F)	 ‐909.1491248	 ‐0.0316489	 ‐0.0319995	 ‐0.0392345	 ‐0.0287008	
11	(G)	 ‐909.1485694	 ‐0.0349158	 ‐0.0353302	 ‐0.0392345	 ‐0.0287486	
2	(H)	 ‐909.1484526	 ‐0.0351549	 ‐0.0355692	 ‐0.0397285	 ‐0.0290514	
O
HO D
HO O 	
					(3‐48Ra)	
G3(MP2)‐RAD	 IEF‐PCM	 C‐PCM	 SMD/UHF	 SMD/UB3LYP	
H298	 Gsolv	 Gsolv	 Gsolv	 Gsolv	
18	(A)	 ‐909.1743372	 ‐0.0396488	 ‐0.0400154	 ‐0.0443181	 ‐0.0342465	
6	(B)	 ‐909.1714346	 ‐0.0354736	 ‐0.0358242	 ‐0.0439994	 ‐0.0343103	
34	(C)	 ‐909.1724060	 ‐0.0389636	 ‐0.0392982	 ‐0.0434894	 ‐0.0340075	
40	(D)	 ‐909.1706399	 ‐0.0372106	 ‐0.0375453	 ‐0.0437125	 ‐0.0349477	
31	(E)	 ‐909.1713281	 ‐0.0378321	 ‐0.0381508	 ‐0.0429954	 ‐0.0340234	
25	(F)	 ‐909.1700141	 ‐0.0373700	 ‐0.0377046	 ‐0.0442384	 ‐0.0341987	
22	(G)	 ‐909.1709090	 ‐0.0385971	 ‐0.0388998	 ‐0.0436806	 ‐0.0347883	
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HH
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PCM/SMD/
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PCM/SMD/
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C
A
E
B
H
G
D
F
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B + H
G
D
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F
E
C C
H
B
G
D
A
F
E
A
E
H
G
D
B
F
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3-52R
	
 
A	(7)		 	 	 B	(1)		 	 	 	C	(22)		 	 D	(29)	
 
E	(6)		 	 	 F	(16)			 	 G	(11)		 	 H	(2)	
Figure	3.18	Relative	stability	of	conformers	of	the	C3’	uridinyl	radical	3‐52R	 in	water	(H298	+	Gsolv)	
and	 in	 gas	 phase	 (G3(MP2)‐RAD,	 at	 298.15	 K	 and	 1	 atm)	 and	 their	 graphical	 representations	
(conformer	denotation	in	parenthesis).	
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A	(018)		 	 B	(034)		 	 	C	(006)		 	 D	(031)	
 
						E	(022)		 	 					F	(040)		 	 		G	(025)	
Figure	 3.19	 Relative	 stability	 of	 conformers	 of	 3‐48Ra	 in	 water	 (H298	 +	 Gsolv)	 and	 in	 gas	 phase	
(G3(MP2)‐RAD,	at	298.15	K	and	1	atm)	and	their	graphical	representations	(conformer	denotation	in	
parenthesis).	
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Table	3.37	Boltzmann‐averaged	<trhH>	at	G3(MP2)‐RAD	level	with	and	without	implicit	solvation.	
O
OH
HO N
NH
O
O
HO
O
HO N
NH
O
O
HO O
<trhH>
2-48Ra3-52R 	
Method	 <trhH>	
Gas	phase	 ‐61.14	
IEF‐PCM/UAHF/UHF/6‐31G(d)	 ‐78.87	
C‐PCM/UAHF/UHF/6‐31G(d)	 ‐78.99	
SMD/UHF/6‐31G(d)	 ‐74.73	
SMD/UB3LYP/6‐31G(d)	 ‐77.85	
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Table	3.38	Energies	and	enthalpies	for	peptide	models	at	various	levels	of	theory	in	the	gas	phase,	in	
polar	and	apolar	media	in	Hartree	(IEF‐PCM	=	IEF‐PCM/UAHF/UHF/	6‐31G(d)//B3LYP/6‐31G(d)).	
H
N
O
N
H
O
R 	
B3LYP	 MP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H298	 Etot	 Etot	
Gsolv	(water)	
Gsolv	(heptane)	
R	=	CH2OH	(3‐53)	
1	
‐571.0620340	 ‐570.859332	 ‐570.0348734	 ‐570.4316029	
‐0.0226451	
‐0.0071075	
2	 ‐571.0709906	 ‐570.867570	 ‐570.0425815	 ‐570.4391284	
‐0.0185495	
‐0.0058326	
3	 ‐571.0655820	 ‐570.861955	 ‐570.0350951	 ‐570.4316030	
‐0.0206372	
‐0.0062947	
6	 ‐571.0642011	 ‐570.861305	 ‐570.0352212	 ‐570.4316541	
‐0.0237287	
‐0.0073146	
7	 ‐571.0649389	 ‐570.861801	 ‐570.0370142	 ‐570.4339784	
‐0.0229638	
‐0.0071075	
8	 ‐571.0593294	 ‐570.856504	 ‐570.0326945	 ‐570.4297998	
‐0.0230276	
‐0.0068525	
14	 ‐571.0584591	 ‐570.855887	 ‐570.032761	 ‐570.4292377	
‐0.0270275	
‐0.0070278	
R	=	CH(CH3)OH	(3‐54)	
1	
‐610.3811404	 ‐610.149515	 ‐609.2618449	 ‐609.7008546	
‐0.0201750	
‐0.0060716	
2	 ‐610.3894761	 ‐610.157305	 ‐609.2685995	 ‐609.7075749	
‐0.0169081	
‐0.0050039	
3	 ‐610.3830920	 ‐610.150572	 ‐609.2607597	 ‐609.6996555	
‐0.0192348	
‐0.0057051	
4	 ‐610.3799844	 ‐610.148278	 ‐609.259719	 ‐609.6985144	
‐0.0223104	
‐0.0067091	
5	 ‐610.3788809	 ‐610.147158	 ‐609.2589904	 ‐609.6985079	
‐0.0200953	
‐0.0060398	
8	 ‐610.3813687	 ‐610.149316	 ‐609.2602881	 ‐609.6998488	
‐0.0183902	
‐0.0060398	
10	 ‐610.3797812	 ‐610.148074	 ‐609.2590826	 ‐609.6984778	
‐0.0209877	
‐0.0059760	
11	 ‐610.3785290	 ‐610.146754	 ‐609.2575604	 ‐609.6966008	
‐0.0242068	
‐0.0065019	
12	 ‐610.3773179	 ‐610.145193	 ‐609.2580187	 ‐609.6972749	
‐0.0232188	
‐0.0064860	
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Table	3.39	 Energies	 and	 enthalpies	 for	 open‐	 and	 closed‐shell	 peptide	models	 at	 various	 levels	 of	
theory	 in	 the	 gas	 phase,	 in	 polar	 and	 apolar	 media	 in	 Hartree	 (IEF‐PCM	 =	 IEF‐
PCM/UAHF/UHF/6‐31G(d)//B3LYP/6‐31G(d)).	
H
N
O
N
H
O
R 	
B3LYP	 MP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H298	 Etot	 Etot	
Gsolv	(water)	
Gsolv	(heptane)	
R	=	CH2SH	(3‐56)	
1	
‐894.0363528	 ‐893.838306	 ‐892.6248366	 ‐893.0401897	
‐0.0188683	
‐0.0071075	
2	 ‐894.0420128	 ‐893.843753	 ‐892.6297102	 ‐893.0450819	
‐0.0133385	
‐0.0058326	
3	 ‐894.0345536	 ‐893.836784	 ‐892.6236602	 ‐893.0387487	
‐0.0217049	
‐0.0062947	
6	 ‐894.0382031	 ‐893.840085	 ‐892.6263236	 ‐893.0416149	
‐0.0151233	
‐0.0073146	
7	 ‐894.0381989	 ‐893.840031	 ‐892.6264810	 ‐893.0418597	
‐0.0189479	
‐0.0071075	
8	 ‐894.0363536	 ‐893.838192	 ‐892.6238242	 ‐893.0394555	
‐0.0184220	
‐0.0068525	
14	 ‐894.0345535	 ‐893.836785	 ‐892.6236587	 ‐893.0387490	
‐0.0216889	
‐0.0070278	
R	=	H	(3‐6)	
1	
‐456.5361652	 ‐456.368827	 ‐455.6900430	 ‐456.0154026	
‐0.0246052	
‐0.0076652	
2	 ‐456.5375162	 ‐456.369616	 ‐455.6921794	 ‐456.0175637	
‐0.0214021	
‐0.0069800	
3	 ‐456.5333571	 ‐456.365764	 ‐455.6876553	 ‐456.0128928	
‐0.0258960	
‐0.0077449	
H
N
O
N
H
O
R 	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H298	 Etot	 Etot	
Gsolv	(water)	
Gsolv	(heptane)	
R	=	CH2OH	(3‐53R)	
1	
‐570.4201342	 ‐570.230115	 ‐569.3866481	 ‐569.7778763	
‐0.0188842	
‐0.0071553	
3	 ‐570.4248155	 ‐570.234356	 ‐569.3921047	 ‐569.7831742	
‐0.0187248	
‐0.0065975	
5	 ‐570.4142197	 ‐570.224153	 ‐569.3829485	 ‐569.7740108	
‐0.0215296	
‐0.0068684	
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Table	3.40	Energies	and	enthalpies	for	open‐shell	peptide	models	at	various	levels	of	theory	in	the	gas	
phase,	 in	polar	and	apolar	media	 in	Hartree	 (IEF‐PCM	=	 IEF‐PCM/UAHF/UHF/	6‐31G(d)//B3LYP/6‐
31G(d)).	
H
N
O
N
H
O
R 	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H298	 Etot	 Etot	
Gsolv	(water)	
Gsolv	(heptane)	
R	=	CH(CH3)OH	(3‐54R)	
1	
‐609.7397421	 ‐609.520676	 ‐608.6137032	 ‐609.0478499	
‐0.0153623	
‐0.0059441	
3	 ‐609.7412543	 ‐609.521836	 ‐608.6151059	 ‐609.0491706	
‐0.0169878	
‐0.0062151	
4	 ‐609.7370238	 ‐609.517588	 ‐608.6113142	 ‐609.0458527	
‐0.0144062	
‐0.0060876	
5	 ‐609.7352530	 ‐609.516364	 ‐608.6087335	 ‐609.0432045	
‐0.0157926	
‐0.0062151	
7	 ‐609.7362162	 ‐609.517088	 ‐608.609109	 ‐609.0434529	
‐0.0172747	
‐0.0063903	
R	=	H	(3‐6R)	
1	
‐455.8974817	 ‐455.742962	 ‐455.0483585	 ‐455.3672737	
‐0.0205575	
‐0.0071075	
2	 ‐455.8854499	 ‐455.730742	 ‐455.0352881	 ‐455.3554901	
‐0.0205575	
‐0.0077290	
3	 ‐455.8854880	 ‐455.731089	 ‐455.0373616	 ‐455.3569559	
‐0.0233941	
‐0.0074103	
H
N
O
N
H
O
S 	
(3‐56R)	
UB3LYP	 ROMP2	 G3(MP2)‐RAD	 IEF‐PCM	
Etot	 H298	 Etot	 Etot	
Gsolv	(water)	
Gsolv	(heptane)	
1	 ‐893.4003394	 ‐893.212432	 ‐891.9864284	 ‐892.3938784	
‐0.0172268	
‐0.0058007	
2	 ‐893.4042928	 ‐893.215712	 ‐891.9888371	 ‐892.3968615	
‐0.0169559	
‐0.0062310	
3	 ‐893.3951177	 ‐893.206829	 ‐891.9794748	 ‐892.3872680	
‐0.0253064	
‐0.0078405	
6	 ‐893.4003391	 ‐893.212435	 ‐891.9864258	 ‐892.3938777	
‐0.0172428	
‐0.0058007	
7	 ‐893.3992237	 ‐893.210847	 ‐891.9844058	 ‐892.3924448	
‐0.0224220	
‐0.0074740	
14	 ‐893.3961382	 ‐893.208367	 ‐891.9833696	 ‐892.3905888	
‐0.0228045	
‐0.0063585	
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Table	3.41	Energies	and	enthalpies	for	open‐shell	peptide	models	at	various	levels	of	theory	in	the	gas	
phase	at	298.15	K	and	1	atm	in	Hartree.	
H
N
O
N
H
O
R 	
E(UB3LYP)	 H(UB3LYP)	 E(ROMP2)	 E(G3(MP2)‐RAD	
R	=	CHO	(3‐59R)	
2	
‐569.2276250	 ‐569.061217	 ‐568.1973426	 ‐568.5712370	
4	 ‐569.2339133	 ‐569.067427	 ‐568.2031731	 ‐568.5764921	
R	=	CH3CO	(3‐60R)	
2	
‐608.5476982	 ‐608.352290	 ‐607.4228036	 ‐607.8401684	
3	 ‐608.5500818	 ‐608.354825	 ‐607.4269579	 ‐607.8440836	
4	 ‐608.5322092	 ‐608.337400	 ‐607.4127905	 ‐607.8297855	
R	=	H2C=COH	(3‐61Rb)	
2	
‐608.5250550	 ‐608.330477	 ‐607.4088542	 ‐607.8278750	
3	 ‐608.5236818	 ‐608.328792	 ‐607.4077166	 ‐607.8257739	
H
N
O
N
H
O
OH
	
(3‐61Ra_H)	
E(UB3LYP)	 H(UB3LYP)	 E(ROMP2)	 E(G3(MP2)‐RAD	
1	 ‐609.7083097	 ‐609.491090	 ‐608.5909557	 ‐609.0241559	
2	 ‐609.7153128	 ‐609.497839	 ‐608.5971186	 ‐609.0303711	
3	 ‐609.7089514	 ‐609.491153	 ‐608.5889031	 ‐609.0220723	
4	 ‐609.7078654	 ‐609.490837	 ‐608.5886489	 ‐609.0216434	
15	 ‐609.7105614	 ‐609.492613	 ‐608.5911036	 ‐609.0249362	
H
N
O
N
H
O
O
	
(3‐61Rb)	
E(UB3LYP)	 H(UB3LYP)	 E(ROMP2)	 E(G3(MP2)‐RAD	
1	 ‐608.5227376	 ‐608.328374	 ‐607.4049916	 ‐607.8224614	
2	 ‐608.5231213	 ‐608.328708	 ‐607.4047428	 ‐607.8224344	
9	 ‐608.5154982	 ‐608.321203	 ‐607.399195	 ‐607.8169806	
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4 Calculation	of	Chemical	Properties	of	Allenic	Zinc	
Compounds		
Parts	of	this	chapter	have	been	published	in	
Preparation	 of	 Tri‐	 and	 Tetrasubstituted	 Allenes	 via	 Regioselective	 Lateral	
Metalation	of	Benzylic	(Trimethylsilyl)alkynes	Using	TMPZnCl•LiCl	
P.	 Quinio,	 C.	 François,	 A.	 Escribano	 Cuesta,	 A.	 K.	 Steib,	 F.	 Achrainer,	 H.	 Zipse,	 K.	
Karaghiosoff,	P.	Knochel,	Org.	Lett.	2015,	17,	1010	–	1013.	
New	 In	Situ	Trapping	Metalations	of	Functionalized	Arenes	and	Heteroarenes	
with	TMPLi	in	the	Presence	of	ZnCl2	and	Other	Metal	Salts	
A.	Frischmuth,	M.	Fernandez,	N.	M.	Barl,	F.	Achrainer,	H.	Zipse,	G.	Berionni,	H.	Mayr,	K.	
Karaghiosoff,	P.	Knochel,	Angew.	Chem.	Int.	Ed.	2014,	53,	7928	–	7932.	
4.1 Introduction	
Since	 the	discovery	 of	 the	 first	 organozinc	 compound	diethyl	 zinc	Et2Zn	by	Edward	
Frankland	 in	 1849	 organometallic	 chemistry	 has	 witnessed	 an	 incredible	 and	 fast	
development.[125]	 Numerous	 syntheses	 and	 applications	 were	 only	 possible	 or	 in	
much	 shorter	 reaction	 steps	 through	 the	 processing	 of	 organometallic	 research.	
Among	 these,	 organozinc	 reagents	 possess	 outstanding	 properties	 concerning	
functional	 group	 compatibility,	 synthetic	 versatility,	 reactivity	 tuning,	 thermal	
stability,	 and	 the	 lack	 of	 toxicity.[126]	 However,	 the	 benefit	 of	 high	 functional	 group	
tolerance	 is	 accompanied	 by	 low	 reactivity	 compared	 e.g.	 to	 organolithium	 or	
Grignard	 reagents,	 which	 are	 characterized	 by	 a	 highly	 heteropolar	 carbon‐metal‐
bond.[127]	The	structures	of	organozinc	compounds	in	solution	are	comparable	to	the	
Schlenk	 equilibrium	 found	 for	 Grignard	 compounds	 and	 depend	 strongly	 on	 the	
solvent,	 temperature,	 concentration	 and	 the	 nature	 of	 the	 organic	 substituent	
(Scheme	4.1).[128]	
R ZnCl2 R Zn
Cl
Cl
Zn R R2Zn     +     ZnCl2
	
Scheme	4.1	The	Schlenk	equilibrium	of	organozinc	compounds.	
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With	its	electron	configuration	3d104s2	the	full	low‐lying	3d	shell	of	the	Zn2+	ion	does	
not	 generate	 ligand‐field	 effects	 and	 the	 structural	 properties	 can	 therefore	 be	
supposed	to	be	comparatively	simple.	Organozinc	compounds	possess	two	vacant	4p	
orbitals	on	the	zinc	atom	which	can	accommodate	 two	or	 four	electrons	 from	other	
organometallic	derivatives	to	 form	tri‐	or	 tetrasubstituted	homo‐	or	heteroleptic	ate	
complexes.[129]	These	zincates	are	generally	more	reactive	than	organozinc	halides	or	
diorganozinc	reagents	and	add	optionally	to	carbonyl	groups,	open	epoxides	without	
the	 aid	 of	 promoters	 or	 create	 multiple	 carbon‐carbon	 bonds	 in	 a	 one‐pot	
reaction.[126]	 The	 identification	 of	 structural	 characteristics	 or	 dynamics	 in	 solution	
with	the	help	of	nuclear	magnetic	resonance	spectroscopy	(NMR)	is	very	popular,	fast	
and	reliable.	Nevertheless,	sometimes	the	assignment	of	signals	can	be	difficult,	time	
consuming	 and	 providing	 disputable	 results.	 Under	 these	 circumstances,	 NMR	 shift	
calculations	 using	 high	 level	 theory	 represent	 a	 helpful	 alternative	 in	 contrast	 to	
database	 search	 or	 the	 sometimes	 extensive	 synthesis	 of	 side	 products.[130]	 In	 the	
following	chapter,	in	collaboration	with	the	group	of	Prof.	Paul	Knochel,	the	formation	
of	 allenic	 zinc	 compounds	 has	 been	 studied	 spectroscopically	 and	 theoretically	 by	
NMR	shift	calculations	and	thermochemical	analysis.		
4.2 Allenic	Organozinc	Reagents	–	Synthesis	and	Reactivity	
Allenes	are	classified	as	polyenes	with	cumulated	double	bonds,	which	exhibit	higher	
reactivity	 than	 normal	 alkenes.	 They	 represent	 a	 versatile	 multi‐reactivity	
functionality	because	they	can	act	either	as	nucleophile,	electrophile	or	as	substrate	
for	 cycloadditions.[131]	 The	 central	 carbon	 atom	 is	 sp‐	 and	 the	 two	 neighbouring	
carbons	 are	 sp2‐hybridized.	 Due	 to	 the	 geometrical	 feature	 of	 allenes	 they	 possess	
axial	chirality,	if	two	different	substituents	are	connected	on	each	of	the	two	terminal	
carbon	atoms.		
H
H3C
TMS Br
H
CH3
Br TMS
H
CH3(Ra) (Sa)
TMS
Br H
H3C Br
TMS
	
Figure	4.1	Axial	chirality	of	allenes.	
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Allenes	 are	 isomers	 of	 readily‐available	 propargylic	 molecules	 and	 can	 easily	 be	
interconverted	 by	 prototropic	 isomerisation.	 A	 very	 convenient	 and	 high‐yielding	
synthesis	 of	 phenylallene	 has	 been	 published	 by	 electrocyclic	 ring	 contraction	 of	
cycloheptatriene	4‐1	followed	by	acidic	isomerisation.[132]	
R H
H
H
R
	
Scheme	4.2	The	acetylene‐allene	rearrangement.	
4-1
H+
H

4-34-2 	
Scheme	4.3	Acid‐catalyzed	rearrangement	of	cycloheptatriene	4‐1	to	phenylallene	(4‐3).	
Another	well	 examined	 process	 is	 the	 ability	 of	 conjugated	 enyne‐allenes	 and	 their	
benzannulated	 derivatives	 to	 cyclize	 under	 mild	 thermal	 conditions	 to	 form	
biradicals,	which	react	 further	 in	H‐abstraction	reactions.	The	preferred	outcome	of	
cyclization	is	dictated	by	the	substituent	at	the	acetylenic	position.[133]	
R
C2-C6 
R = Ar, tBu, TMS
R
Schmittel
C2-C7 
R = H, Alkyl
Myers-Saito
R
7
6
5
4 3
2
1
	
Scheme	4.4	The	Myers‐Saito	vs.	the	Schmittel	cyclisation.	
The	 use	 of	 organometallic	 reagents	 for	 the	 synthesis	 of	 allenes	 is	 highly	 developed	
and	covers	a	wide	range	of	reactions,	the	most	important	of	which	are	SN2’	reactions	
with	unsaturated	electrophiles	to	generate	allenic	molecules.[131]	One	disadvantage	of	
this	 strategy	 is	 the	 need	 of	 already	 functionalized	 starting	 materials	 with	 leaving	
groups	or	electron	acceptors.		
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LG
R-M
SN2'
R
Acc
R-M
H+
1,4-Addition
R
Acc
	
Scheme	4.5	Metal‐mediated	syntheses	of	allenes.	
An	alternative	route	is	available	in	the	already	mentioned	deprotonation	of	terminal	
protected	 acetylenes	 at	 the	 propargylic	 position,	 followed	 by	 isomerization	 and	
electrophilic	 interception.	Usually	the	product	outcome	is	non‐selective	with	respect	
to	the	formation	of	allenic	or	propargylic	molecules.	But	in	general	the	regioselectivity	
is	mainly	provided	by	the	nature	of	the	starting	material	and	the	applied	conditions.	
For	example,	Ma	recently	discovered	a	highly	selective	allene	synthesis	from	1‐aryl‐1‐
propynes	by	varying	the	metallation	reagent.[134]	He	also	investigated	the	influence	of	
substituent	effects	on	the	product	formation.[135]	
Ph CH3
TMS CH3
1.) n-BuLi, -78 °C
2.) ZnBr2, THF, -78 °C to RT
3) 5 mol% Pd(PPh3)4
I
CH3
Ph
CH3 Ph
CH3
4-7a (0 %) 4-7b (100 %)
TMS
CH3 TMS
CH3
4-8a (100 %) 4-8b (0 %)
4-4
4-5
4-6 	
Scheme	4.6	Influence	of	the	substituent	on	the	propargyl‐allenyl	isomerization.	
4.3 NMR	Properties	of	the	Reformatsky	Reagent	–	Method	
Benchmarking	
It	seems,	that	limited	literature	is	found	for	the	theoretical	description	of	NMR	shifts	
of	organozinc	compounds.[126]	Therefore	a	short	preliminary	benchmark	study	using	
the	Reformatsky	 reagent	4‐10	 as	model	 compound	 has	 been	 conducted	 to	 verify	 a	
reliable	 and	 even	 for	 larger	 systems	 applicable	 computation	 routine.	 The	 classic	
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Reformatsky	 reaction	 involves	 the	 addition	 of	 ‐halocarboxylic	 ester	 to	 a	 carbonyl	
compound	in	the	presence	of	zinc	to	form	‐hydroxy	esters.[136]	
O
OR'
Hal
1) Zn, THF
2) R2CO, H
+
O
OR'
OH
R
R
	
Scheme	4.7	The	classical	Reformatsky	reaction.	
The	 currently	 accepted	 mechanism	 proposes	 a	 preceding	 equilibrium	 between	
enolate	and	alkyl	zinc	intermediate,	in	which	only	the	enolate	is	capable	of	attacking	
the	electrophile.	
O
Zn
O
O
Br
OEt
Zn
O
O
Br OEt
O H
4-9 4-10 	
Scheme	4.8	Ester‐enol	equilibrium	of	Reformatsky	reagent	4‐9	to	4‐10.	
The	 Reformatsky	 reagent	 containing	 a	 Zn‐C	 bond	 is	 more	 stable	 by	 +51.8	 kJ	 mol‐1	
(B3LYP/631SVP)	than	the	respective	compound	having	an	enolate	structure.	Implicit	
solvation	 in	 a	 THF	 continuum	 lowers	 the	 endothermicity	 only	 marginally	 to	
+48.9	kJ	mol‐1	 (SMD/B3LYP/6‐31G(d)//B3LYP/631SVP).	 This	 is	 in	 agreement	 with	
already	published	 results	 by	Dewar	and	Cossio,	who	 investigated	 the	kinetics	of	 the	
Reformatsky	 addition	 to	 formaldehyde	 and	 identified	 the	 zinc	 enolate	 as	 attacking	
intermediate	 and	 the	 enolisation	 as	 rate‐determining	 step.[137]	 The	 structure	 of	
Reformatsky	 esters	 have	 been	 the	 objective	 of	 investigations	 over	 decades	 and	
includes	 NMR	 studies,[138]	 EXAFS	 investigations	 in	 solution[139]	 and	 X‐ray	 single	
crystal	determination.[140]	The	results	indicate,	that	in	coordinating	polar	solvents	the	
Reformatsky	compounds	are	best	represented	as	dimers	of	structure	4‐11,	which	are	
in	equilibrium	with	the	monomer	(4‐9)	and	the	enolate	form	(4‐10),	respectively.		
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4-11 4-9
4-10 	
Scheme	4.9	Equilibrium	of	Reformatsky	enolates	in	solution	(S	=	coordinating	polar	solvent).	
In	 order	 to	 identify	 the	 most	 reliable	 method	 for	 calculating	 chemical	 shifts	 of	
organozinc	compounds,	1H	and	13C	NMR	spectra	of	4‐9	in	THF‐d8	have	been	measured	
which	are	displayed	 in	Figure	4.2	 and	Figure	4.3.	 The	 reagent	was	 synthesized	by	
insertion	of	activated	zinc	into	the	C‐Br	bond	of	bromo	ethyl	acetate	in	THF.[140b]		
OEt
O
Br
Zn, TMSCl
THF, 45 °C
Zn
O
O
Br OEt
O
4-12 4-9 	
Scheme	4.10	Synthesis	of	the	Reformatky	reagent	EtO2CCH2ZnBr	•	2	THF	(4‐9).	
	
Figure	4.2	 1H	 NMR	 (600	MHz,	 THF‐d8)	 at	 298	 K	 of	 the	Reformatsky	 reagent	 EtO2CCH2ZnBr•2	 THF	
(3‐9).	Ethyl	acetate	formed	as	a	result	of	hydrolysis	is	marked	by	an	asterisk.	
OCH2CH3
OCH2CH3
CH2ZnBr
THF
THF
THF-d8 THF-d8
*
*
*
Zn
O
O
Br OEt
O
4-9
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Figure	4.3	 13C	 NMR	 (100	MHz,	 THF‐d8)	 at	 298	 K	 of	 the	Reformatsky	 reagent	 EtO2CCH2ZnBr•2	 THF	
(4‐9).	Ethyl	acetate	formed	as	result	of	hydrolysis	is	marked	by	an	asterisk.	
Due	to	the	three	different	existing	isomers	of	4‐9	in	solution	all	structures	have	been	
evaluated	 theoretically.	 The	 number	 of	 basis	 sets	 for	 zinc	 and	 bromine	 as	 4th	 row	
elements	 are	 usually	 limited	 to	 expensive	 basis	 sets,	 like	 Ahlrichs’	 def2[141]	 or	
Dunning’s	 correlation	consistent	sets.[142]	With	 the	elemental	decomposition	C,	H,	O,	
Zn	 and	 Br	 only	 one	 Pople	 basis	 set	 (3‐21G)	 is	 available.	 The	 B3LYP	 optimized	
structural	 parameters	 for	 the	Reformatsky	 dimer	4‐11	 at	 three	 different	 levels	 are	
summarized	together	with	the	experimentally	determined	values	via	single	crystal	X‐
ray	 diffraction	 of	 (tBuO2CCH2ZnBr	•	THF)2	 in	 Table	 4.1.[140a]	 The	 B3LYP/631SVP	
approach	was	recently	used	by	Thaler	et	al.	for	the	investigation	of	diastereoselective	
Negishi	cross	coupling	reactions	of	cycloalkylzinc	compounds[143]	and	includes	for	C,	
H,	O,	Cl	the	6‐31G(d,p)	and	for	Zn	the	all‐electron	def2‐SVP	basis	set.	The	overall	DFT‐
optimized	structure	applying	the	631SVP	basis	set	gives	good	geometrical	agreement	
compared	 to	 the	 X‐ray	 structure	 in	 solid	 state	 including	 the	 twisted	 boat	
conformation,	 but	 overestimates	 the	 bond	 lengths	 in	 all	 cases.	 The	more	 expensive	
double	ξ	basis	set	cc‐pVDZ	gives	related	results,	but	takes	almost	four	times	longer	to	
fulfill	its	task.		
THF-d8
THF-d8
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Figure	4.4	Graphical	 representation	 of	 the	 B3LYP/631SVP	 optimized	 gas	 phase	 structure	 of	 dimer	
4‐11.	
Table	4.1	Selected	bond	 lengths	(in	pm)	and	angles	(in	°)	 for	the	DFT‐optimized	Reformatsky	dimer	
4‐11.		
	 B3LYP/3‐21Ga	 B3LYP/cc‐pVDZ B3LYP/631SVPb
(tBuO2CCH2ZnBr	•	THF)2
[X‐ray]	
Zn‐OCO	 187.2	 201.7	 201.1	 202.0	(1)	
Zn‐CH2	 196.7	 207.9	 207.8	 198.0	(2)	
Zn‐OTHF	 192.4	 215.9	 214.1	 205.0	(1)	
Zn‐Br	 245.5	 237.8	 239.0	 234.6	(3)	
O2C‐CH2	 141.9	 144.6	 144.5	 141.0	(2)	
Br‐Zn‐CH2	 115.1	 125.9	 124.4	 127.6	(5)	
OCO‐Zn‐OTHF	 102.5	 89.2	 90.4	 93.2	(4)	
OTHF‐Zn‐CH2	 113.6	 105.5	 109.3	 106.9	(6)	
OCO‐Zn‐CH2	 110.5	 109.6	 109.7	 111.2	(6)	
Zn‐OCO‐CCO	 144.6	 131.1	 128.5	 125.0	(1)	
aAveraged	arithmethically.	b	6‐31G(d,p)	for	C,	H,	O,	def2‐SVP	basis	set	for	Zn	and	Br.	
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Figure	 4.5	 Graphical	 representation	 of	 the	 B3LYP/631SVP	 optimized	 gas	 phase	 structure	 of	
monomeric	4‐9	in	the	ester	(top)	and	enol	form	(bottom).	
Usually,	 basis	 sets	 are	 developed	 in	 order	 to	 predict	 bonding	 phenomena	 in	 an	
accurate	 way,	 thus	 putting	 particular	 emphasis	 on	 the	 valence	 region.	 A	 proper	
description	of	the	molecular	orbital	structure	and	thus	the	electron	density	near	the	
nucleus	is	essential	for	the	simulation	of	spectroscopic	data	like	NMR	shifts	or	EPR	g‐
values.	 An	 all‐purpose	 basis	 set	 for	 NMR	 shift	 calculations	 is	 the	 IGLO‐III	 set[144]	
developed	by	Kutzelnigg	and	already	used	for	the	13C	NMR	evaluation	of	alkyl	and	aryl	
lithium	 compounds.[145]	 Recently,	 Jensen	 proposed	 a	 polarization‐consistent	 set	 of	
basis	sets	with	hybrid‐DFT	methods	termed	“pc‐n”,	which	are	applicable	even	for	4th	
row	elements.[146]	The	benchmark	results	for	the	different	isomers	of	the	Reformatsky	
reagent	together	with	the	experimental	NMR	shifts	calculated	by	the	GIAO	scheme[147]	
are	collected	in	Table	4.2	and	Table	4.3.	
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Table	4.2	Method	benchmarking	using	the	GIAO	method	in	combination	with	the	IGLO‐IIIa	basis	set	for	
the	calculation	of	chemical	shifts	for	the	Reformatsky	reagent.	
	
Zn
THF
THF
Br O
O
4-9 	
Chemical	shift		
B3LYP	
Gas	phase	
mPW1K	
Gas	phase
B3LYP
SMDb	
mPW1K
SMDb	
B3LYP
UAHFc
mPW1K	
UAHFc
(exp.)		
CH2Zn	 1.70	 1.57	 1.67	 1.56	 1.87	 1.77	 1.84	
CH3CH2O	 4.01	 3.90	 3.98	 3.89	 4.09	 4.00	 3.97	
CH3CH2O	 1.19	 1.14	 1.21	 1.18	 1.24	 1.22	 1.16	
CH2Zn	 19.41	 17.34	 20.28	 18.28	 19.86	 18.07	 21.67	
CO2	 191.94	 193.07	 194.51 195.62	 196.00 197.13	 186.78	
CH3CH2O	 65.52	 62.85	 67.12	 64.39	 66.24	 63.60	 61.48	
CH3CH2O	 16.37	 15.83	 16.69	 16.08	 16.00	 15.45	 14.51	
MAD	 1.90	 2.25	 2.83	 2.90	 3.15	 3.45	 	
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Table	4.3	Method	benchmarking	using	the	GIAO	method	in	combination	with	the	IGLO‐IIIa	basis	set	for	
the	calculation	of	the	dimeric	(4‐10)	and	the	enol	form	(4‐11)	of	the	Reformatsky	reagent.	
Zn O
ZnOO
Br
O
THF
Br
THF
4-11 	
	
Chemical	shift		
B3LYP	
Gas	phase	
mPW1K	
Gas	phase
B3LYP
SMDb	
mPW1K
SMDb	
B3LYP
UAHFc
mPW1K	
UAHFc
(exp.)	
CH2Zn	 2.00	 1.92	 2.09	 2.02	 2.26	 2.22	 1.84	
CH3CH2O	 4.39	 4.28	 4.44	 4.34	 4.51	 4.43	 3.97	
CH3CH2O	 1.34	 1.31	 1.33	 1.32	 1.36	 1.35	 1.16	
CH2Zn	 24.15	 23.00	 25.82	 24.60	 25.43	 24.32	 21.67	
CO2	 201.73	 203.74	 203.81 205.76	 204.19 206.11	 186.78
CH3CH2O	 71.26	 68.36	 73.15	 70.19	 72.45	 69.60	 61.48	
CH3CH2O	 16.66	 16.19	 17.40	 16.83	 16.78	 16.26	 14.51	
MAD	 5.35	 5.77	 6.10	 6.42	 6.12	 6.50	 	
	
O
Zn
O
O
Br
4-10
EtO
	
	
B3LYP	
Gas	phase	
mPW1K	
Gas	phase
B3LYP
SMDb	
mPW1K
SMDb	
B3LYP
UAHFc
mPW1K	
UAHFc
(exp.)	
CH2Zn	 2.80	 2.81	 2.65	 2.69	 2.70	 2.75	 1.84	
CH3CH2O	 3.94	 3.78	 4.00	 3.87	 4.10	 3.98	 3.97	
CH3CH2O	 1.16	 1.11	 1.16	 1.13	 1.19	 1.17	 1.16	
CH2Zn	 53.56	 55.95	 50.40	 52.84	 51.53	 54.27	 21.67	
CO2	 181.85	 180.77	 184.98 182.76	 183.93 182.79	 186.78
CH3CH2O	 64.79	 61.90	 66.30	 63.43	 65.46	 62.65	 61.48	
CH3CH2O	 17.49	 16.88	 18.00	 17.30	 17.36	 16.72	 14.51	
MAD	 10.59	 11.57	 9.56	 10.43	 9.92	 11.00	 	
aIGLO‐III	 for	 C,	 H,	 O;	 pc‐4	 for	 Zn	 and	 Br.	 bSMD/B3LYP/IGLO‐III//B3LYP/631SVP	 in	 THF.	 cPCM/UAHF/B3LYP/IGLO‐
III//B3LYP/631SVP.	
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Two	hybrid	functionals	have	been	applied,	namely	the	well‐established	B3LYP[148]	and	
the	one‐parameter	hybrid	functional	mPW1K	developed	by	Truhlar	et	al.	[149]	The	two	
different	functionals	give	almost	the	same	results	for	shift	calculations,	wether	in	the	
gas	phase	or	 including	 continuum	solvation	 in	THF.	The	overall	 performance	of	 the	
PCM/SMD	 and	 the	 PCM/UAHF	 model	 is	 better	 in	 combination	 with	 the	 mPW1K	
functional.	 The	mean	 absolute	 deviation	 (MAD)	 for	 the	 gas	 phase	 calculations	 have	
the	lowest	value	compared	to	the	simulation	in	a	solvent	continuum.	The	monomeric	
species	 4‐9	 gives	 the	 best	 agreement	 between	 theory	 and	 experiment,	 thus	
confirming	its	presence	in	THF	solution.	
4.4 NMR	Shifts	of	Allenic	Zinc	Compounds	
In	order	to	provide	structural	information	on	the	metallation	of	allenes	using	different	
reagents	 (see	Scheme	4.11),	 their	 formation	 has	 been	 investigated	 by	Quinio	 NMR	
spectroscopically.	 Therefore,	 aryl	 substituted	 propargyl	 silanes	 of	 type	 4‐13	 have	
been	 deprotonated	 with	 two	 different	 organometallic	 bases	 (TMPZnCl•LiCl	 or	 n‐
BuLi),	followed	by,	if	required,	transmetallation	to	zinc	with	the	aid	of	ZnCl2	in	THF‐d8.	
THF-d8, 25 °C
R
TMS
n-BuLi
THF-d8, 0 °C
R
TMS
Li
4-13a 4-13b
S
4-13
ZnCl2
THF-d8, 25 °C
R
H
3-17
4-16
N
ZnCl LiCl
Li
TMS
ZnX2
R
H
4-15
TMS
ZnX
6 days
4-14
	
Scheme	4.11	Syntheses	of	allenic	zinc	compounds	of	proposed	structure	4‐15	and	4‐17.	
NMR	 analysis	 of	 the	 reaction	 of	 4‐13	 with	 TMPZnCl•LiCl	 indicated	 complete	
conversion	 within	 5	 min	 affording	 direct	 formation	 of	 allenylzinc	 species	 4‐15	
identified	by	the	appearance	of	an	allenic	13C	signal	at	around	200	ppm.	On	the	other	
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hand,	lithiation	of	4‐13	with	n‐BuLi	gave	rise	to	a	propargylic	lithium	species	4‐16,	as	
evidenced	 by	 the	 appearance	 of	 a	 propargyl	 signal	 at	 3.33	 ppm	 in	 the	 1H	 NMR	
spectrum.	No	allenic	carbon	resonance	has	been	observed.[150]	Nevertheless,	after	the	
addition	 of	 ZnCl2	 an	 allenic	 species	 (4‐17)	was	 formed.	 This	 compound	 is	 the	 final	
product	 upon	 metalation,	 since	 it	 is	 also	 formed	 after	 six	 days	 from	 intermediate	
4‐15.	 Comparison	 of	 the	 NMR	 spectra	 for	 the	 two	 distinguishable	 zinc	 species	
indicates	only	small	differences	in	chemical	shifts	for	the	allenic	carbon	atoms	C2,	C3	
and	 its	 attached	proton	H3	 irrespective	of	 the	nature	of	 the	organometallic	 reagent.	
Interestingly,	 the	 higher	 electron	 density	 in	 the	 proposed	 zincate	 4‐17a	 has	 no	
influence	on	the	chemical	shift	of	C1.	
To	support	the	hypothesis,	what	kind	of	metalation	is	present,	the	chemical	shifts	of	
allenes	4‐15a	 and	4‐15b	 together	with	 their	 ate	 counterparts	have	been	 calculated	
with	 chlorine	 ligands	 and	 THF	 molecules	 to	 saturate	 their	 coordination	 sphere	 as	
benchmarked	for	the	Reformatsky	reagent	(X/IGLO‐III//B3LYP/631SVP).	
TMS
Zn
O
O
Cl
R
H
TMS
Zn
O
Cl
Cl
R
H
R = Ph (4-15a), 3-thioph (4-15b) R = Ph (4-17a), 3-thioph (4-17b) 	
Figure	4.6	Lewis	structures	of	the	theoretically	considered	zinc	allenes.	
Although	 allenes	 are	 quite	 rigid,	 a	 complete	 conformational	 search	 is	 in	 principle	
advisable	for	any	organic	molecule	to	evaluate	the	degree	of	error	introduced	by	only	
one	considered	conformation.	The	global	minimum	is	arguably	the	best	choice	 for	a	
single	 conformation.	 Therefore,	 the	 conformers	 for	 all	 examined	 allenes	 have	 been	
preselected	 with	 the	 MM3*	 force	 field[79]	 and	 after	 DFT	 optimization	 Boltzmann‐
averaged	over	free	energies,	enthalpies	and	free	solvation	energies.	This	Boltzmann‐
approach	 has	 been	 proposed	 by	Hoye	 and	Cramer	 for	 the	 calculation	 of	 1H	 and	 13C	
shifts	 of	 stereoisomers	 and	 rotamers	 of	 cyclohexanols.[151]	 The	 obtained	 results	 for	
phenyl	 allene	 4‐15a	 and	 4‐17a	 are	 shown	 in	 Table	 4.4.	 The	 GIAO	 prediction	 in	
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combination	 with	 the	 two	 functionals	 B3LYP	 and	 mPW1K	 gives	 almost	 the	 same	
results	regarding	the	protons.		
Table	4.4	Boltzmann‐averaged	chemical	shifts	<>a	at	various	levels	of	theory	(in	ppm).	
	
C3
H3
C2
TMS
C1 Zn
THF
THF
Cl
4-15a 	
C3
H3
C2
TMS
C1 Zn
THF
Cl
Cl
4-17a 	
H3	 C3	 C2	 C1	 Si	 H3	 C3	 C2	 C1	 Si	
(exp)a	 4.99	 70.18	 202.83	 93.97	 ‐4.59	 4.62 70.25 197.36	 93.94	 ‐6.16	
Gas		
phase	
(GIAO/B3LYP/IGLO‐III//B3LYP/631SVP)	
Eb	 5.16	 77.85	 212.61	 101.94	 ‐7.07	 4.87	 75.41	 206.24	 104.13	 ‐9.79	
H	
G	
Gsolc	
5.16	
5.15	
5.14	
78.13	
78.17	
78.32	
213.15	
213.02	
212.26	
101.62
101.65
101.59
‐7.08	
‐7.03	
‐7.04	
4.83
4.80
4.77
75.32
75.30
74.98
204.82	
203.82	
202.45	
104.32	
104.43	
104.67	
‐9.77	
‐10.09
‐10.09
	 RMSD		(Gsol)	
4.79	
RMSD		(Gsol)	
4.95	
Gas	
phase	 (GIAO/mPW1K/IGLO‐III//B3LYP/631SVP)	
Eb	 5.16	 76.34	 213.53	 100.30	 ‐6.03	 4.85	 73.75	 207.47	 102.80	 ‐8.75	
H	
G	
GsolC	
5.16	
5.15	
5.14	
76.60	
76.62	
76.76	
214.04	
213.90	
214.13	
99.98	
100.01
99.93	
‐6.03	
‐6.00	
‐6.00	
4.82
4.78
4.76
73.65
73.63
73.27
206.23	
205.36	
204.06	
103.04	
103.19	
103.49	
‐8.70	
‐8.93	
‐8.95	
	 RMSD		(Gsol)	
4.62	
RMSD		(Gsol)	
4.42	
THF	 (GIAO/SMD/mPW1K/IGLO‐III//B3LYP/631SVP)	
Eb	 5.38	 75.86	 213.10	 102.06	 ‐6.35	 5.16	 73.24	 209.14	 103.85	 ‐8.32	
H	
G	
Gsolc	
5.37	
5.37	
5.36	
76.03	
76.12	
76.24	
213.47	
213.42	
213.58	
101.83
101.77
101.75
‐6.34	
‐6.31	
‐6.31	
5.15
5.14
5.14
73.34
73.43
73.25
208.43	
207.97	
207.77	
103.74	
103.66	
103.62	
‐8.25	
‐8.40	
‐8.35	
	 RMSD		(Gsol)	
4.65	
RMSD		(Gsol)	
4.99	
a	 Using	 tetramethylsilane	 Si(CH3)4	 as	 standard	 for	 experimental	 and	 calculated	 values,	 respectively.	 b	 Only	 global	 minimum	
structure	considered.	c	SMD/B3LYP/6‐31G(d)//B3LYP/631SVP	(THF).	
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The	B3LYP	functional	predicts	chemical	shifts	in	all	cases	low	field‐shifted	compared	
to	mPW1K	and	they	are	not	depending	on	the	overall	averaged	extensive	property	(H,	
G,	Hsol,	Gsol)	for	the	individual	nuclei.	The	induced	error	by	examining	only	the	global	
minimum	structures	is	negligible	(see	line	E	in	Table	4.4).		
Table	4.5	Experimentally	measured	and	theoretically	calculated	chemical	shifts		obtained	in	the	gas	
phase	at	mPW1K/IGLO‐III/B3LYP/631SVP	level	of	theory	(in	ppm).a,b	
	
C3
H3
C2
TMS
Hp
C1 Zn
O
O
Cl
4-15a
C3
H3
C2
TMS
Hp
C1 Zn
O
Cl
Cl
4-17a 
Gas	
mPW1K/	
IGLO‐III	
(exp.)c	 	
mPW1K/	
IGLO‐III	
(exp.)c	 	
H3	 5.14	 4.99	 0.15	 4.76	 4.62	 0.14	
Hp	 7.21	 6.78	 0.43	 6.72	 6.65	 0.07	
C3	 76.76	 70.2	 6.58	 73.27	 70.3	 3.02	
C2	 214.13	 202.8	 11.30	 204.06	 197.4	 6.70	
C1	 99.93	 94.0	 5.96	 103.49	 93.9	 9.55	
TMS	 ‐6.00	 ‐4.59	 ‐1.41	 ‐8.95	 ‐6.16	 ‐2.79	
	
C3
H3
C2
TMS
C1 Zn
O
O
ClS
4-15b 	
C3
H3
C2
TMS
C1 Zn
O
ClS
Cl
4-17b 	
Gas	
mPW1K/	
IGLO‐III	
(exp.)c	 	
mPW1K/	
IGLO‐III	
(exp.)c	 	
H3	 5.16	 5.11	 0.05	 4.80	 4.71	 0.09	
C3	 71.78	 68.7	 3.08	 68.45	 65.5	 2.95	
C2	 216.87	 204.5	 12.37	 207.43	 199.0	 8.43	
C1	 99.14	 93.6	 5.54	 103.49	 93.9	 9.59	
TMS	 ‐6.07	 ‐5.0	 ‐1.07	 ‐9.81	 ‐3.01	 ‐3.01	
aUsing	tetramethylsilane	Si(CH3)4	as	standard	for	experimental	and	calculated	values,	respectively.	b	Applying	Boltzmann‐
averaged	shielding	tensors		obtained	from	G	+	Gsolv.	c	Measured	in	THF‐d8.	
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Figure	4.7	Conformational	dependence	of	calculated	shielding	tensors		of	the	allenic	carbon	atom	C2	
in	neutral	allenic	zinc	reagents	(top)	and	zincate	(bottom).	
H
R
TMS
OTHF
OTHF
Cl
H
R
TMS
OTHF
OTHF
Cl
H
R
TMS
Cl
OTHF OTHF
H
R
TMS
Cl
OTHF
Cl
H
R
TMS
Cl
Cl
OTHF
H
R
TMS
Cl
OTHF Cl
	 4		Calculation	of	Chemical	Properties	of	Allenic	Zinc	Compounds	
	 213	
The	mPW1K/IGLO‐III	 gas	 phase	 calculation	 performs	 best	 in	 all	 four	 studied	 cases	
(R	=	 Ph,	 3‐thioph).	 The	 simulation	 for	 the	 specific	 allenic	 carbon	 atoms	 C3	 and	 its	
attached	protons	H3	is	in	good	agreement	with	the	experimental	results,	regarding	the	
effective	 range	of	 the	 corresponding	nuclei.	The	 largest	 deviations	 are	observed	 for	
the	sp‐hybridized	carbon	atom	C2	(see	Table	4.5).	The	differences		are	smaller	for	
the	 zincates	 than	 the	neutral	 zinc	 allenes.	 In	Figure	4.7	 the	 influence	of	 the	 chloro	
ligand	 as	 virtual	 dipole	 to	 the	 calculated	 shielding	 tensor	 is	 plotted	 against	 the	
dihedral	angle	C2‐C1‐Zn‐Cl	 to	provide	a	criterion	 for	dipole‐nucleus	 interactions	and	
the	 complete	 conformational	 space	 has	 to	 be	 examined	 for	 accurate	 chemical	 shift	
calculations.	The	most	negative	‐values	are	found	for	compounds	with	a	syn‐chloro‐
Csp	conformation,	whereupon	the	anti	conformation	gives	values	of	8	ppm	shifted	to	
higher	field.	The	dihedral	angle	dependence	of	allene	4‐15b	 is	not	so	distinctive	due	
to	the	higher	polarity	of	the	thiophene	group.		
	
	
Figure	 4.8	 B3LYP/631SVP	 optimized	 structures	 of	 the	 energetically	 most	 favored	 conformers	 of	
allenic	and	propargylic	zinc	reagents	in	the	gas	phase.	
3-15a
3-17a
3-19a
3-20a
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The	 presence	 of	 corresponding	 phenyl	 substituted	 propargylic	 zinc	 compounds	 in	
solution	can	be	excluded	due	to	the	large	deviation	from	experimental	chemical	shifts	
(see	Table	4.6).	On	the	other	hand,	intermediate	4‐16a	generated	by	the	reaction	of	
4‐13a	with	n‐BuLi	can	be	verified	by	the	NMR	shift	calculations.	Since	the	structure	of	
organolithium	 reagents	 has	 a	 major	 impact	 on	 the	 molecular	 properties,	 the	
optimization	 of	 4‐16a	 has	 been	 conducted	 by	 attaching	 three	 THF	 to	 the	 lithium	
atom.[152]		
Table	4.6	Calculated	chemical	shifts	a	for	propargylic	and	allenic	organozinc	and	‐lithium	reagents	at	
GIAO/mPW1K/IGLO‐III//B3LYP/Xb	level	of	theory	(in	ppm).c		
 Hp	 H3	 C3	 C2	 C1	 TMS	
C3
C2
C1
TMS
Hp
Li H3
4-16a 	
(exp.	in	THF‐d8)	
6.07 3.33 51.9	 151.4	 95.0	 ‐18.83	
C3
C2
C1
TMS
Hp
(THF)3Li H
3
4-16a 	
6.53	 3.10	 42.90 140.30 97.71	 ‐26.66	
C3
H3
C2
TMS
Hp
C1 Li(THF)3
4-18a 	
6.82	 4.16	 64.10 184.84 108.89	 ‐15.47	
C3
C2
C1
TMS
Hp
(THF)2ClZn H
3
4-19a 	
7.25	 3.46	 23.81 127.75 91.31	 ‐24.86	
C3
C2
C1
TMS
Hp
(THF)Cl2Zn H
3
4-20a 	
6.81	 3.39	 29.64 132.62 87.30	 ‐27.84	
a	Using	tetramethylsilane	Si(CH3)4	as	standard	for	experimental	and	calculated	values,	respectively.	b	6‐31+G(d)	for	Li,	631SVP	
for	Zn.	c	Using	the	global	minimum	of	all	structures.	
	
The	quantum	chemical	treatment	of	organolithium	compounds	has	been	the	subject	
of	numerous	publications	including	explicit	solvation[153]	and	aggregate	formation.[154]	
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Accordingly	 the	 lithium	 species	 4‐16a	 and	 4‐18a	 have	 been	 optimized	 using	 the	
B3LYP	 functional	 in	 combination	 with	 the	 double	 ξ	 basis	 set	 6‐31+G(d).	 The	
characteristic	shift	for	the	sp‐hybridized	C2	has	a	deviation	of	(4‐16a)=	+11.1	ppm	
at	GIAO/mPW1K/IGLO‐III	level.	For	the	allenic	form	3‐18a	a	deviation	of	(4‐18a)	=	
‐33.44	 ppm	 was	 found.	 Interestingly,	 the	 chemical	 shift	 for	 the	 C1	 atom	 in	 4‐16a	
reveals	 the	 overall	 best	 match	 in	 all	 calculations	 ((4‐16a)	 =	 ‐2.71	 ppm)	 and	 in	
addition	 confirms	 the	 presence	 of	 the	 propargylic	 lithium	 intermediate	 4‐16a	 in	
THF.[155]	
4.5 Thermochemical	Analysis		
1H	and	 13C	NMR	spectroscopy	(see	Chapter	4.4)	 shows	 that	 two	allenylzinc	species	
are	generated,	which	most	likely	differ	by	the	second	substituent	at	zinc	(monomeric	
or	 dimeric	 organozinc	 halide	 or	 LiCl‐complexed	 ate	 complex).	 Thermochemical	
analysis	 of	 the	 organic	 zinc	 species	 optimized	 at	 B3LYP/631SVP	 level	 of	 theory	 in	
combination	 with	 solvation	 free	 energies	 for	 THF	 at	 SMD/B3LYP/6‐31G(d)	 level	
reveals,	that	the	isomerization	to	the	phenyl‐substituted	allenic	moiety	is	exothermic	
by	‐25.5	kJ	mol‐1	in	its	monomeric	zinc	form	4‐15a	and	‐23.8	kJ	mol‐1	in	its	anionic	ate	
complex	4‐17a	(Table	4.7).	
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Table	4.7	Reaction	enthalpies	for	the	propargyl‐allenyl	isomerization	(in	kJ	mol‐1).	
R
TMS
R
H
TMS
ZnCl(THF)2
ZnCl(THF)2
H
4-19a/b 4-15a/b 	
R	
H298	(gas)	
B3LYP/631SVPa
Hsol	(THF)	
SMD/B3LYP/6‐31G(d)//	
B3LYP/631SVP	
Phenyl	(4‐15a)	 ‐25.76	 ‐25.50	
3‐Thienyl	(4‐15b)	 ‐19.64	 ‐18.92	
R
TMS
R
H
TMS
ZnCl2(THF)
ZnCl2(THF)
H
4-20a/b 4-17a/b 	
R	
H298	(gas)	
B3LYP/631SVPa
Hsol	(THF)	
SMD/B3LYP/6‐31G(d)//	
B3LYP/631SVP	
Phenyl	(4‐17a)	 ‐29.86	 ‐23.75	
3‐Thienyl	(4‐17b)	 ‐28.25	 ‐21.34	
a	6‐31G(d,p)	for	C,	H,	O,	Si,	Cl,	def2‐SVP	basis	set	for	Zn.	
	
Moving	from	the	phenyl	to	the	thiophene‐3‐yl	substituted	systems	lowers	the	reaction	
enthalpy	 to	 ‐18.9	 kJ	 mol‐1	 (ZnCl(THF)2)	 and	 to	 ‐21.3	 kJ	 mol‐1	 (ZnCl2‐(THF)),	
respectively.	 Furthermore,	 according	 to	 the	 NMR	 studies,	 it	 is	 evident	 that	 the	
propargyl	isomer	(4‐16a)	is	the	most	stable	organometallic	species	in	the	case	of	the	
lithium	 cation,	 whereas	 the	 allenyl	 structure	 (4‐15a)	 is	 the	 dominant	 species	 in	
solution	for	zinc.[156]	Single‐point	calculations	at	MP2(FC)/6‐31+G(d,p)	level	of	theory	
including	implicit	THF	solvation	(SMD/B3LYP/6‐31G(d))	confirms	a	major	difference	
in	 stability	 order	 for	 the	 propargyl	 and	 allenyl	 isomers	 of	 the	 respective	
organometallics.	 A	 reaction	 enthalpy	 of	 +1.4	 kJ	 mol‐1	 for	 the	 two	 organolithium	
isomers	has	been	calculated	(see	Figure	4.9)	as	opposed	to	‐7.8	for	the	neutral	zinc	
and	‐8.2	kJ	mol‐1	for	the	ate	complex,	respectively.	
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Figure	4.9	Propargyl	to	allenyl	isomerization	in	THF	solution	(SMD/B3LYP/6‐31G(d))	at	MP2(FC)/6‐
31+G(d,p)	level	(gas	phase	values	in	parenthesis).	
In	agreement	with	these	theoretical	results	only	allenic	products	have	been	 isolated	
after	 Negishi	 cross‐coupling.	 This	 reaction	 sequence	 can	 even	 be	 extended	 to	 a	
subsequent	metalation	with	TMPZnCl•LiCl	 (4‐14)	 to	yield,	 after	 successful	 trapping	
with	various	electrophiles,	tetra‐substituted	allenes	in	a	one‐pot	fashion.	As	example,	
allene	 3‐39	 was	 isolated	 in	 63	 %	 yield	 after	 two‐step	 metalation	 with	 1.2	 eq	 of	
TMPZnCl•LiCl	 (4‐14)	 at	 room	 temperature	 within	 an	 hour,	 respectively.	 Full	
conversion	 to	 tri‐substituted	 allene	 4‐40	 using	 phenyl	 iodide	 as	 electrophile	 and	
2	mol%	 Pd(OAc)2/S‐Phos	 was	 accomplished	 within	 4	 h,	 followed	 by	 the	 second	
coupling	step	with	3‐bromothiophene	within	12	h	at	25	°C.		
Ph
TMS
1.) 3-14, 25 °C, 1h
2.) Pd(OAc)2, S-Phos, 
     25 °C, 12h S
Br
Ph
H
TMS
Ph
1.) 3-14, 25 °C, 1h
2.) PhI, Pd(OAc)2, 
     S-Phos, 25 °C, 4h
Ph
TMS
Ph
S
4-39 (63 %)
4-13a
4-40
	
Scheme	4.12	Successive	zincation	of	4‐13a	with	TMPZnCl•LiCl	(4‐14)	and	subsequent	Negishi‐cross	
coupling.	
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4.6 Calculation	of	Relative	pKa	Values	of	Weak	C‐H	Acids	in	DMSO	
Solution	
The	conversion	of	organic	molecules	into	organometallics	by	metalation	with	a	strong	
base	 is	a	well‐established,	 fast	and	reliable	method	 to	synthesize	polyfunctionalized	
molecules.	 In	 numerous	 publications	 non‐nucleophilic	 amide	 bases,	 like	 lithium	
diisopropyl	 amide	 (LDA,	4‐21),	 lithium	 bis(trimethylsilyl)amide	 (LiHMDS,	4‐22)	 or	
lithium	tetramethylpiperidinide	(LiTMP,	4‐23)	have	been	used	for	 this	purpose.	The	
thermodynamic	driving	 force	 for	 this	kind	of	reaction	 is	a	reflection	of	different	pKa	
values.	 Not	 included	 in	 this	 consideration	 are	 interactions	 of	 Lewis	 basic	 moieties	
which	interact	with	Lewis	acidic	metal	ions	to	form	stable	chelates	(direct	metalation	
group,	DMG).	
N
Li
N
SiSi
Li
N
Li
4-21
(+35.7)
4-22
(+25.8)
4-23
(+37.3) 	
Figure	 4.10	 Lewis	 structures	 of	 commonly	 used	 lithium	 amide	 bases	 (pKa	 values	 in	 THF	 in	
parenthesis).[157]	
Since	 the	 experimental	 determination	 of	 acidities	 or	 basicities	 of	 organic	 and	
inorganic	 compounds	 is	 rather	 challenging,	 a	 computational	 method	 that	 predicts	
protonation	 patterns	 in	 terms	 of	 pKa	 values	 in	 a	 fast	 and	 reliable	way	would	 be	 of	
general	 use.	 The	 B3LYP/6‐311++G(2df,2p)	 level	 of	 theory	 has	 been	 identified	 as	 a	
good	 compromise	 between	 accuracy	 and	 computational	 effort.	 Recently,	 Guo	 and	
coworkers	used	a	similar	approach	to	calculate	pKa	values	of	related	heteroaromatic	
compounds	 (B3LYP/6‐311++G(2df,2p)//B3LYP/6‐31G(d)).[158]	 Relative	 acidities	 in	
solution	 have	 been	 calculated	 using	 the	 thermochemical	 cycle	 of	Scheme	4.13	 and	
compared	with	pKa	values	of	a	test	set	of	ten	organic	compounds.		
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R-H         +        Ref
G0gas
G0sol
G0(R-H)solv G
0(Ref-)solv G
0(R-)solv G
0(Ref-H)solv
R           +        Ref-H
R-H         +        Ref R           +        Ref-H 	
Scheme	4.13	Thermochemical	cycle	for	the	calculation	of	pKa	values	in	solution.	
The	definition	of	pKa	is	
	
pKa	=	–	log	Ka		 	 	 	 (eq.	4.1)	
	
and	 since	 free	 energies	 are	 connected	 to	 equilibrium	constants	K	 by	 the	Boltzmann	
equation,	the	pKa	values	can	be	calculated	by		
	
G0	=	–2.303	R	T	log	Ka	 	 	 	 (eq.	4.2)	
	
G0	under	standard	conditions	(T	=	298.15	K,	p	=	1	atm)	can	be	calculated	according	
to	Scheme	4.13	as	
	
G0sol	=	G0gas	–	G0(R‐H)solv	–	G0(Ref‐)solv	+	G0(R‐)solv	+	G0(Ref‐H)solv	 (eq.	4.3)	
	
Finally,	relative	acidities	in	condensed	phase	are	obtained	according	to	eq.	4.4:	
	
pKa	(R‐H)	=	pKa	(Ref‐H)	+	G0sol/2.303	RT	 	 	 (eq.	4.4	)	
	
The	passage	 from	gas	phase	 to	 liquid	phase	has	been	accomplished	by	employing	a	
polarizable	continuum	model	(PCM)	for	DMSO	(4‐24H)	as	the	respective	solvent.	The	
solvent	model	 density	 by	Truhlar	 and	 coworkers	 (SMD)[60]	 in	 combination	with	 the	
B3LYP	functional	and	the	6‐31G(d)	basis	set	has	been	identified	to	perform	best	in	the	
calculation	 of	 pKa	 values	 of	 aromatics	 and	 heteroaromatics.	 As	 expected,	 errors	
depend	on	the	accuracy	of	the	calculations	of	Ggas	and	Gsolv.	In	these	cycles	Ggas	is	
usually	calculated	with	high‐level	ab	initio	or	density	functional	methods	and	Gsolv	is	
a	result	of	isotropic	solute‐solvent	interactions	on	a	molecular	cavity	of	electrostatic	
origin.	 Thus,	 the	 major	 incorrect	 contribution	 can	 be	 considered	 in	 the	 solvent	
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calculation.	 As	 a	 starting	 point	 to	 find	 the	 best	 reference	 compound	 in	 the	
thermodynamic	 cycle	 of	 Scheme	 4.13	 the	 free	 solvation	 energies	 of	 the	
deprotonation	by	different	reference	anions	have	been	examined.	The	largest	absolute	
value	of	the	free	reaction	energies	Gsolv	has	been	found	for	DMSO	(4‐24H)	and	
the	smallest	for	thiophene	(4‐27H)	as	reference	system	(see	Figure	4.11).		
	
Figure	 4.11	 Reference‐dependent	 differences	 in	 free	 solvation	 energies	 Gsolv	 in	 DMSO	 at	
SMD/B3LYP/	6‐31G(d)//B3LYP/6‐311++G(2df,2p)	level	of	theory.	
Using	 eq.	 4.4	 and	 DMSO	 (4‐24H),	 and	 thiophene	 (4‐27H)	 as	 the	 references	 the	
obtained	pKa	values	of	the	test	set	are	summarized	in	Table	4.8.	
DMSO (4-24H)
Benzene (4-25H)
Indole (4-34H)
30.9
22.0
20.8
Benzoxazole (4-33H) 23.7
Benzothiophene (4-32H) 25.7
Benzofuran (4-31H) 21.4
Imidazole (4-29H) 26.0
N-Aminopyrrole (4-30H) 20.2
Pyrrole (4-28H) 26.1
Thiophene (4-27H) 19.3
Furan (4-26H) 22.5
         +
Gsolv
R       +Ref Ref HR H
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Table	 4.8	 Comparison	 of	 literature	 values	 with	 theoretically	 calculated	 pKa	 values	 in	 DMSO	
(SMD/B3LYP/6‐31G(d)//B3LYP/6‐311++G(2df,2p)).	
         +
G0sol
R       +Ref Ref HR H 	
Ref‐H	
4-25 	
O
4-26 	
S
4-27 	
N
4-28 	
N
N
4-29 	
pKa	(exp.)	 ~	+43[159]	 +35.0[160]	 +32.5[160]	 +38.7[160]	(corr.)b	 +33.1[160]	
S
O
4-24Ha 	
+45.05	 +37.40	 +35.57	 +39.98	 +36.07	
S
4-27H 	
41.98	 +34.34	 n/a	 +36.91	 +33.01	
Ref‐H	
N
N
4-30 	
O
4-31
	
S
4-32 	
O
N
4-33 	
N
4-34 	
pKa	(exp.)	 +36.4[160]	 +32.7[161]	 +32.9[160]	 +24.4[161]	 +37.3[160]	
S
O
4-24Ha 	
+38.88	 +36.12	 +34.75	 +29.09	 +38.80	
S
4-27H 	
+35.82	 +33.05	 +31.68	 +26.02	 +35.73	
a	pKa	(DMSO)	=	‐35.1[162].	b	Using	the	pKa	value	in	THF	and	corrected	it	with	Streitwieser‘s	correlation.	
	
All	considered	compounds	of	Table	4.8	are	predicted	to	be	less	acidic	if	DMSO/dimsyl	
anion	 is	used	as	 the	reference,	 indicated	by	 larger	pKa	values.	As	expected	 from	the	
previous	Gsolv	survey	(Figure	4.11),	thiophene	gives	the	overall	best	correlation	of	
theory	 and	 experiment,	 which	 is	 shown	 in	 Figure	 4.12.	 The	 arithmetic	 mean	
deviation	of	+1.47	pKa	units	with	respect	to	the	reference	thiophene	(4‐27H)	reflects	
a	good	procedure	to	estimate	C‐H	acidities	in	organic	compounds.		
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Figure	 4.12	 Test	 set	 correlation	 of	 calculated	 vs.	 experimental	 pKa	 values	 in	 DMSO	 using	 either	
thiophene	(4‐27H,	top)	or	DMSO	(4‐24H,	bottom)	as	the	reference.	
Nevertheless,	applying	the	Gsolv	approach	for	experimentally	relevant	substrates	
like	 benzonitrile	 4‐35H	 or	 thiophene	 ester	4‐37H	 yielded	 in	 the	 case	 of	 DMSO	 as	
reference	 the	 smallest	 differences	 in	 free	 solvation	 energies	 Gsolv	 (see	
S
4-27H
S
O
4-24H
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Theoretical	Appendix	Table	4.30).	Related	results	for	aqueous	systems	have	already	
been	 described	 by	 Liptak	 and	 Shields[163]	 and	 in	 DMSO	 by	 Liu	 and	 Guo[164]	 for	 the	
absolute	pKa	calculations	of	carboxylic	acids,	wherein	the	combination	of	solvent	and	
reference	system	gave	good	results	in	agreement	with	experimental	condensed	phase	
acidities.	This	endorsed	the	use	of	DMSO	and	its	dimsyl	anion	as	reference	system	for	
the	ongoing	pKa	evaluation	despite	of	the	inferior	correlation	to	thiophene	(4‐27H).		
Since	 almost	 all	 organometallic	 transformations	 are	performed	 in	THF	 solution,	 the	
obtained	 acidity	 values	 in	 DMSO	 have	 been	 corrected	 to	 “contact	 ion	 pair”	 values	
using	Streitwieser’s	linear	correlation:[165]		
	
pKa	(THF)	=	1.046	pKa	(DMSO)	–	0.963	 	 	 (eq.	4.5)	
	
This	procedure	has	now	been	used	to	identify	the	most	acidic	positions	in	a	variety	of	
aromatic	and	heterocyclic	compounds	to	predict	the	outcome	of	metalation	reactions.	
The	so	obtained	values,	corrected	as	numbers	for	THF,	are	depicted	in	Figure	4.13.	
CN
CO2Et
S
CO2Et
CN
Cl
Cl
TMS TMSSTMSTMS
28.0
32.2
32.4
35.2
37.9
35.7
38.0
35.7
31.3
37.3
15.5 19.4 22.4
34.3
38.3.1
33.7
42.1
42.9
43.2
4-35H 4-36H 4-37H
4-38H 4-13aH 4-13bH 	
Figure	4.13	SMD/B3LYP/6‐31G(d)//B3LYP/6‐311++G(2df,2p)	calculated	pKa	values	using	DMSO	and	
the	dimsyl	anion	as	reference	(corrected	to	THF	solution).	
As	expected,	the	most	acidic	centers	are	the	propargylic	CH	positions	with	pKa	values	
of	 +19.4	 for	 the	 phenyl	 (4‐13aH)	 and	 +22.4	 for	 the	 thienyl	 system	 (4‐13bH),	
respectively.	 Interestingly,	 the	 introduction	 of	 a	 TMS	 acetylene	 group	 increases	 the	
aciditiy	 dramatically.	 For	 example,	 the	 pKa	 value	 of	 the	 benzylic	 position	 in	
diphenylmethane	is	+32.3	in	DMSO[166]	(+32.8	corr.	in	THF)	and	is	almost	divided	by	
half	 in	 the	 case	 of	 4‐38H.	 Apparently,	 the	 	 system	 of	 the	 alkyne	 is	 easily	 able	 to	
transfer	electron	density	to	the	electropositive	silicon	center	and	therefore	possesses	
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greater	 abilities	 to	 stabilize	 negative	 charge	 than	 a	 thienyl	 or	 phenyl	 substituent,	
indicated	 by	 an	 even	 lower	 pKa	 value	 of	 +15.5	 in	4‐38H.	 Implying	 the	 pKa	 value	 of	
+37.3	of	the	TMP	anion	(4‐23)	in	THF[157]	the	preferred	metalation	of	the	propargylic	
position	is	supported.		
4.7 Conclusion	
The	zinc	base	TMPZnCl•LiCl	(4‐14)	has	been	used	to	synthesize	neutral	allenic	zinc	
intermediates	 from	 benzylic	 propynes,	 which	 can	 be	 quenched	 by	 the	 addition	 of	
various	electrophiles.	The	analogous	zincates	have	been	prepared	by	transmetallation	
of	the	corresponding	Li	organyls	with	ZnCl2	in	THF.	In	order	to	support	their	presence	
in	solution,	the	experimental	NMR	shifts	have	been	matched	with	theoretical	1H	and	
13C	shielding	calculations.		
R
TMS
4-13
R
H
4-17
Li
TMS
ZnX2
R
H
4-15
TMS
ZnX
N ZnCl
LiCl
n-BuLi, ZnCl2
4-14 	
Scheme	4.14	Syntheses	of	allenic	zinc	compounds	of	type	4‐15	and	4‐17.	
Different	basis	sets,	functionals	and	solvation	states	have	been	benchmarked	with	the	
well‐known	Reformatsky	reagent	4‐9.	B3LYP/631SVP	geometries	in	combination	with	
GIAO/mPW1K/IGLO‐III	calculations	in	the	gas	phase	are	sufficient	enough	to	perform	
well	 in	 calculating	NMR	shifts	of	 organozinc	 reagents	 in	THF	 solution.	The	 reaction	
outcome	 of	 neutral	 and	 anionic	 zinc	 allenes	 4‐15	 and	 4‐17,	 as	 well	 as	 for	 the	
corresponding	organolithium	isomers	4‐16a	and	4‐18a,	were	successfully	predicted	
by	thermochemical	analysis	of	the	propargyl‐allenyl	isomerization.	
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Scheme	4.15	Propargyl‐allenyl	isomerization	of	organometallics.	
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4.8 Experimental	
All	 reactions	 were	 carried	 out	 under	 magnetic	 stirring	 in	 flame‐dried	 glass	 flasks	
using	standard	Schlenk	techniques	and	P4O10‐predried	N2	as	inert	gas.	Syringes	were	
used	to	transfer	reagents	and	solvents	and	were	purged	with	N2	prior	to	use.	Nuclear	
magnetic	 resonance	 spectra	 were	 recorded	 on	 a	Varian	Mercury	 600	 spectrometer.	
The	 chemical	 shifts	 	 were	 specified	 in	 ppm	 relative	 to	 the	 partially	 deuterated	
solvent	THF‐d8	(1H:	1.72	and	3.58,	13C:	67.2	and	25.3).[167]		
4.8.1 EtO2CCH2ZnBr•2	THF	(4‐9)	
Zn
O
O
Br OEt
O
4-9 	
A	 10	mL	 round	 bottom	 flask	 equipped	with	 stirring	 bar	 and	 gas	 inlet	was	 charged	
under	 nitrogen	 atmosphere	 with	 zinc	 dust	 (0.52	 g,	 7.95	 mmol)	 and	 THF	 (2	 mL)	
followed	 by	 TMSCl	 (0.05	mL,	 0.043	 g,	 0.40	mmol).	 The	 suspension	was	 stirred	 for	
40	min	at	room	temperature	before	a	solution	of	bromoethyl	acetate	(0.44	mL,	0.66	g,	
3.95	mmol)	 in	 5	mL	 THF	was	 slowly	 added	 dropwise	 over	 10	min	 resulting	 in	 an	
exothermic	reaction.	After	heating	the	suspension	for	one	hour	to	45	°C,	followed	by	
cooling	 to	 room	 temperature	 the	 suspension	 was	 allowed	 to	 settle.	 2	 ML	 of	 the	
supernatant	 yellowish	 solution	was	 cannulated	 to	 a	 Schlenk	 flask	 and	 concentrated	
under	reduced	pressure.	The	resulting	yellow	solid	was	dried	under	high	vacuum	and	
redissolved	in	1	mL	THF‐d8.	0.6	ML	of	the	deuterated	THF	solution	were	transferred	
to	a	dry	nitrogen‐flushed	NMR	tube	and	flame	sealed.	
	
1H	NMR	(600	MHz,	THF‐d8)		4.03	(q,	OCH2CH3,	3J	7.1	Hz),	3.58	–	3.54	(m,	CH2OTHF),	
1.84	(s,	CH2Zn),	1.73	–	1.71	(m,	CH2,THF),	1.16	(t,	OCH2CH3,	3J	7.1	Hz)	ppm.	
13C	NMR	(100	MHz,	THF‐d8)	186.78	(CO),	68.01	(CH2OTHF),	61.48	(OCH2CH3),	26.08	
(CH2,THF),	21.67	(CH2Zn),	14.51	(OCH2CH3)	ppm.	
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4.9 Theoretical	Appendix	
Geometry	optimizations	have	been	performed	at	 the	B3LYP/631SVP	 level	of	 theory.	
This	involves	the	all‐electron	6‐31G(d,p)	basis	set	for	the	elements	H,	C,	Si,	O,	S,	and	Cl;	
the	all‐electron	def2‐SVP	basis	set	by	Ahlrichs	 and	coworkers[168]	 for	Zn.	For	organo	
lithium	 compounds	 the	 previously	 used	 6‐31+G(d)	 basis	 set	 has	 been	 used	 for	
optimization,[153‐154]	 followed	 by	 single	 point	 calculations	 at	 MP2(FC)/6‐31+G(d,p)	
level.	Thermal	corrections	to	enthalpies	at	298.15	K	have	been	calculated	at	the	same	
level	 using	 the	 rigid	 rotor/harmonic	 oscillator	 model.	 Initial	 structures	 have	 been	
searched	extensively	with	the	MM3*	force	field[79]	and	the	systematic	search	routine	
implemented	 in	MACROMODEL	 9.7[80]	 in	 order	 to	 identify	 all	 possible	 low	 energy	
conformations	 which	 were	 finally	 Boltzmann‐averaged.	 These	 B3LYP/631SVP	
optimized	minima	have	been	directly	used	for	 the	gas	phase	NMR	shift	calculations.	
NMR	 shielding	 tensors	 	 have	 then	 been	 calculated	 using	 DFT	 methods	 (B3LYP,	
mPW1K)	 and	 the	 Gauge‐Invariant	 Atomic	 Orbital	 (GIAO)[147,	 169]	 method	 including	
Kutzelnigg’s	 IGLO‐III	basis	set[144]	 for	 the	elements	H,	C,	Si,	O,	S,	Cl	and	 Jensen’s	pc‐4	
basis	set	 for	Zn[146]	and	Li.[170]	Solvent	effects	have	been	 included	using	an	 IEF‐PCM	
model	 with	 either	 UAHF	 radii	 or	 Truhlar’s	 SMD	 model[60]	 and	 THF	 as	 solvent,	
respectively.	The	shielding	tensors	have	been	averaged	arithmetically	and	by	using	the	
Boltzmann‐weighting	factorsand	energies	obtained	at	B3LYP/631SVP	level:[151]	
	
	
exp ∆
	
∑ ∆
	
	
E 	 ∑ wiEni 1 		 	 	 	 (eq.	4.6)	
	
Relative	 1H,	 13C,	 and	 29Si	 chemical	 shifts	 	 between	 Zn	 compounds	 X	 and	
tetramethylsilane	(Si(CH3)4,	TMS,	(1H)	=	0.0,	(13C)	=	0.0,	(29Si)	=	0.0)	can	then	be	
derived	from	differences	in	shielding	values		as	expressed	in	eq.	4.7.	
	
(X)	=	(TMS)	–	(X)	+	(TMS)	 	 	 	 (eq.	4.7)	
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Calculated	 shielding	 tensors	 have	 been	 averaged	 arithmetically	 for	 magnetically	
equivalent	nuclei.	The	B3LYP/6‐311++G(2df,2p)	level	of	theory	was	recently	used	to	
calculate	C‐H	pKa	 values	of	heteroaromatic	 compounds	 in	 solution.[158,	 171]	The	SMD	
model	in	combination	with	B3LYP/6‐31G(d)	was	again	used	to	describe	the	transition	
from	 gas	 to	 liquid	 phase.	 Gsolv	 was	 determined	 at	 298.15	 K	 with	 DMSO	 as	 the	
respective	 solvent	 and	 corresponding	 G0sol	 values	 have	 been	 calculated	 using	
Scheme	4.13	and	eq.	4.8.	
R-H         +        Ref
G0gas
G0sol
G0(R-H)solv G
0(Ref-)solv G
0(R-)solv G
0(Ref-H)solv
R           +        Ref-H
R-H         +        Ref R           +        Ref-H 	
Scheme	4.16	Thermochemical	cycle	for	the	calculation	of	pKa	values	in	solution.	
G0sol	=	G0gas	–	G0(R‐H)solv	–	G0(Ref‐)solv	+	G0(R‐)solv	+	G0(Ref‐H)solv		 (eq.	4.8)	
	
Finally,	the	pKa	values	have	been	calculated	using	DMSO	(4‐24H)	and	its	dimsyl	anion	
as	reference	(pKa(DMSO)	=	+35.1)[162]	according	to	eq.	4.9:	
	
pKa(R‐H)	=	pKa(Ref‐H)	+	(G0sol	/	2.303·R·T)	 	 (eq.	4.9)	
	
where	 R	 is	 the	 universal	 gas	 constant	 (8.3145	 J	 K‐1	 mol‐1)	 and	 T	 the	 absolute	
temperature.	
Streitwieser’s	 linear	 correlation	was	 used	 to	 transform	 the	 calculated	 pKa	 values	 in	
DMSO	to	„ion	pair“	pKa	numbers	in	THF	(eq.	4.10).[165]	
	
pKa(THF)	=	–	0.963	+	1.046	pKa(DMSO)	 	 	 (eq.	4.10)	
	
All	calculations	have	been	performed	with	Gaussian	09	Rev.	C.01.[86]	
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Table	4.9	Total	energies,	enthalpies	and	free	solvation	energies	of	different	isomers	of	the	Reformatsky	
reagent	in	Hartree	(at	298.15	K	and	1	atm).	
	
B3LYP/631SVP	
SMD/B3LYP/6‐31G(d)	
(THF)	
Etot	 H298	 Gsolv	
Zn
THF
THF
Br OEt
O
	
(4‐9)	
‐5125.1946380	 ‐5124.823121	 ‐0.0213224	
O
Zn
THF
THF
Br
EtO
	
(4‐10)	
‐5125.1741519	 ‐5124.803403	 ‐0.0224220	
Zn O
ZnOEtO
Br
OEt
THF
Br
THF
	
(4‐11)	
‐9785.4749940	 ‐9784.980758	 ‐0.0224220	
	
Table	4.10	Calculated	shielding	tensors		in	ppm.	
Si(CH3)4	(TMS)	
	
B3LYP/IGLO‐III//B3LYP/6‐31G(d,p) mPW1K/IGLO‐III//B3LYP/6‐31G(d,p)
(1H) (13C) (29Si) (1H) (13C) (29Si) 
Gas phase 31.72 180.08 330.11 31.63 187.33 356.95 
SMD 31.66 181.37 330.00 31.58 188.61 356.93 
PCM/UAHF 31.68 181.08 329.92 31.60 188.31 356.83 
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Table	4.11	Calculated	shielding	tensors		in	ppm.	
Zn
THF
THF
Br OEt
O
	
(4‐9)	

B3LYP	
Gas	Phase	
mPW1K	
Gas	phase	
B3LYP	
SMD	(THF)	
mPW1K	
SMD	(THF)	
B3LYP	
UAHF	(THF)	
mPW1K	
UAHF	(THF)	
1H	
CH2Zn	 29.87,	30.17	 29.92,	30.20	 29.87,	30.11	 29.91,	30.13	 29.69,	29.93	 29.72,	29.94	
CH3CH2O	 27.63,	27.79	 27.64,	27.8	 27.64,	27.71	 27.65,	27.73	 27.55,	27.63	 27.56,	27.63	
CH3CH2O	
30.39,	30.64,	
3.57	
30.33,	30.52,	
30.61	
30.42,	30.44,	
30.49	
30.35,	30.39,	
30.45	
30.40,	40.43,	
30.48	
30.34,	30.37,	
30.44	
13C	
CH2Zn	 160.67	 169.99	 161.09	 170.33	 161.22	 170.24	
CO2	 ‐11.86	 ‐5.74	 ‐13.14	 ‐7.01	 ‐14.92	 ‐8.82	
CH3CH2O	 114.56	 124.48	 114.25	 124.22	 114.84	 124.71	
CH3CH2O	 163.71	 171.50	 164.68	 172.53	 165.08	 172.86	
O
Zn
THF
THF
Br
EtO
	
(4‐10)	
	
B3LYP	
Gas	Phase	
mPW1K	
Gas	phase	
B3LYP	
SMD	
mPW1K	
SMD	
B3LYP	
UAHF	
mPW1K	
UAHF	
1H	
CH2CO2Zn	 28.73,	29.11	 28.60,	29.04	 28.85,	29.16	 28.70,	29.08	 28.86,	29.10	 28.70,	29.00	
CH3CH2O	 27.68,	27.88	 27.76,	27.94	 27.57,	27.74	 27.63,	27.79	 27.49,	27.66	 27.54,	27.70	
CH3CH2O	
30.43,	30.47,	
30.79	
30.37,	30.41,	
30.77	
30.47,	30.48,	
30.56	
30.40,	30.42,	
30.53	
30.46,	30.47,	
30.55	
30,	39,	30.40,	
30.51	
13C	
CH2CO2Zn	 126.52	 131.38	 130.97	 135.77	 129.55	 134.04	
CO2	 ‐1.77	 6.56	 ‐3.61	 4.57	 ‐2.85	 5.52	
CH3CH2O	 115.92	 125.43	 115.07	 125.18	 115.62	 125.66	
CH3CH2O	 162.59	 170.48	 163.37	 171.31	 163.72	 171.59	
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Table	4.12	Calculated	shielding	tensors		in	ppm.	
Zn O
ZnOEtO
Br
OEt
THF
Br
THF
	
(4‐11)	
	
B3LYP	
Gas	Phase	
mPW1K	
Gas	phase	
B3LYP	
SMD	
mPW1K	
SMD	
B3LYP	
UAHF	
mPW1K	
UAHF	
1H	
CH2Zn	 29.57,	29.86	 29.84,	29.58	 29.51,	29.63	 29.64,	29.47	 29.42,	29.41	 29.36,	29.40	
CH3CH2O	 27.74,	26.91	 27.74,	26.96	 27.44,	27.00	 27.43,	27.05	 26.98,	27.35	 27.32,	27.01	
CH3CH2O	
30.14,	30.35,	
30.66	
30.07,	30.28,	
30.62	
30.24,	30.30,	
30.46	
30.16,	30.22,	
30.40	
30.22,	30.29,	
30.46	
30.14,	30.20,	
30.40	
13C	
CH2Zn	 155.93	 164.32	 155.55	 164.01	 155.65	 163.99	
CO2	 ‐21.65	 ‐16.42	 ‐22.44	 ‐17.15	 ‐23.11	 ‐17.80	
CH3CH2O	 108.82	 118.98	 108.22	 118.42	 108.63	 118.71	
CH3CH2O	 163.42	 171.14	 163.97	 171.78	 164.30	 172.05	
	
Table	4.13	Total	energies,	enthalpies	and	free	solvation	energies	of	4‐15a	in	Hartree	(at	298.15	K	and	
1	atm).	
TMS
Zn
THF
THF
Cl
H
	
(4‐15a)	
	
B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐2460.2235667	 ‐2459.721792	 ‐3459.826439	 ‐0.0298482	 ‐3544.9094366	
5	 ‐2460.2250223	 ‐2459.723067	 ‐3459.825295	 ‐0.0283024	 ‐3544.9119578	
7	 ‐2460.2217673	 ‐2459.719701	 ‐3459.820211	 ‐0.0274259	 ‐3544.9082162	
8	 ‐2460.2177352	 ‐2459.715763	 ‐3459.817379	 ‐0.0326370	 ‐3544.9028967	
10	 ‐2460.2250945	 ‐2459.723322	 ‐3459.827646	 ‐0.0290832	 ‐3544.9125564	
11	 ‐2460.2236684	 ‐2459.721644	 ‐3459.824388	 ‐0.0278084	 ‐3544.9085784	
14	 ‐2460.2217544	 ‐2459.719778	 ‐3459.822219	 ‐0.0294020	 ‐3544.9049148	
15	 ‐2460.2242080	 ‐2459.722411	 ‐3459.826278	 ‐0.0293064	 ‐3544.9100470	
16	 ‐2460.2216530	 ‐2459.719669	 ‐3459.820610	 ‐0.0283980	 ‐3544.9090319	
17	 ‐2460.2211686	 ‐2459.719098	 ‐3459.819452	 ‐0.0291151	 ‐3544.9082162	
18	 ‐2460.2251529	 ‐2459.723305	 ‐3459.826534	 ‐0.0289876	 ‐3544.9126771	
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Table	4.14	Total	energies,	enthalpies	and	free	solvation	energies	in	Hartree	(at	298.15	K	and	1	atm).	
TMS
Zn
Cl
THF
THF
	
(4‐19a)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
2	 ‐2460.2138479	 ‐2459.7118720	 ‐3459.815277	 ‐0.0290832	 ‐3454.9075078	
3	 ‐2460.2117067	 ‐2459.7098590	 ‐3459.813324	 ‐0.0318880	 ‐3454.9010496	
5	 ‐2460.2156417	 ‐2459.7136830	 ‐3459.815631	 ‐0.0293382	 ‐3454.9097070	
6	 ‐2460.2138453	 ‐2459.7118180	 ‐3459.815112	 ‐0.0294657	 ‐3454.9078462	
8	 ‐2460.2123887	 ‐2459.7105170	 ‐3459.815268	 ‐0.0304378	 ‐3454.9049108	
9	 ‐2460.2138616	 ‐2459.7119440	 ‐3459.814610	 ‐0.0295932	 ‐3454.9078222	
12	 ‐2460.2151100	 ‐2459.7131030	 ‐3459.815577	 ‐0.0292904	 ‐3454.9094722	
TMS
Zn
THF
THF
Cl
H
S
	
(4‐15b)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐3780.9732450	 ‐3780.505355	 ‐3780.608750	 ‐0.0284299	 ‐3775.3569190	
2	 ‐3780.9746331	 ‐3780.506602	 ‐3780.608455	 ‐0.0270116	 ‐3775.3591841	
3	 ‐3780.9713809	 ‐3780.503567	 ‐3780.606594	 ‐0.0287167	 ‐3775.3553078	
4	 ‐3780.9721540	 ‐3780.504374	 ‐3780.610830	 ‐0.0278721	 ‐3775.3555891	
5	 ‐3780.9725124	 ‐3780.504382	 ‐3780.607480	 ‐0.0261670	 ‐3775.3556898	
6	 ‐3780.9672297	 ‐3780.499160	 ‐3780.601472	 ‐0.0311549	 ‐3775.3504956	
8	 ‐3780.9708862	 ‐3780.502745	 ‐3780.602890	 ‐0.0280315	 ‐3775.3539561	
10	 ‐3780.9716599	 ‐3780.503839	 ‐3780.607685	 ‐0.0280793	 ‐3775.3568773	
11	 ‐3780.9699013	 ‐3780.502067	 ‐3780.603768	 ‐0.0279359	 ‐3775.3566107	
15	 ‐3780.9706366	 ‐3780.502795	 ‐3780.604568	 ‐0.0276649	 ‐3775.3570922	
16	 ‐3780.9734251	 ‐3780.505482	 ‐3780.608617	 ‐0.0271709	 ‐3775.3584101	
17	 ‐3780.9705937	 ‐3780.502414	 ‐3780.602394	 ‐0.0259120	 ‐3775.3563550	
18	 ‐3780.9695579	 ‐3780.501451	 ‐3780.602659	 ‐0.0270116	 ‐3775.3535887	
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Table	4.15	Total	energies,	enthalpies	and	free	solvation	energies	in	Hartree	(at	298.15	K	and	1	atm).	
TMS
Zn
Cl
THF
THF
S 	
(4‐19b)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐3780.9665092	 ‐3780.498456	 ‐3780.600321	 ‐0.0279359	 ‐3775.3582295	
2	 ‐3780.9608671	 ‐3780.492884	 ‐3780.596218	 ‐0.0301350	 ‐3775.3534099	
3	 ‐3780.9620110	 ‐3780.493939	 ‐3780.597975	 ‐0.0301988	 ‐3775.3526579	
5	 ‐3780.9628285	 ‐3780.494770	 ‐3780.597945	 ‐0.0286052	 ‐3775.3542749	
6	 ‐3780.9613990	 ‐3780.493518	 ‐3780.597627	 ‐0.0313621	 ‐3775.3475100	
TMS
Zn
THF
Cl
Cl
H
	
(4‐17a)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐3688.0719896	 ‐3687.693414	 ‐3687.786168	 ‐0.0762858	 ‐3682.8824531	
2	 ‐3688.0722292	 ‐3687.693606	 ‐3687.785142	 ‐0.0757121	 ‐3682.8820555	
7	 ‐3688.0735875	 ‐3687.694931	 ‐3687.785920	 ‐0.0749949	 ‐3682.8833878	
8	 ‐3688.0723486	 ‐3687.693692	 ‐3687.785373	 ‐0.0760148	 ‐3682.8813569	
9	 ‐3688.0721910	 ‐3687.693476	 ‐3687.785602	 ‐0.0760627	 ‐3682.8804562	
14a	 ‐3688.0713331	 ‐3687.692687	 ‐3687.784824	 ‐0.0765089	 ‐3682.8786147	
15	 ‐3688.0725306	 ‐3687.693788	 ‐3687.787050	 ‐0.0744531	 ‐3682.8797354	
16	 ‐3688.0726681	 ‐3687.694022	 ‐3687.785553	 ‐0.0755049	 ‐3682.8809793	
17	 ‐3688.0741545	 ‐3687.695395	 ‐3687.786495	 ‐0.0730507	 ‐3682.8834618	
18	 ‐3688.0717977	 ‐3687.693246	 ‐3687.785854	 ‐0.0751543	 ‐3682.8804076	
a	Using	restrained	coordinates	to	force	optimization.	
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Table	4.16	Total	energies,	enthalpies	and	free	solvation	energies	in	Hartree	(at	298.15	K	and	1	atm).	
TMS
Zn
Cl
Cl
THF
	
(4‐20a)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐3688.0605715	 ‐3687.681771	 -3687.775234 ‐0.0788674	 ‐3682.8741867	
2	 ‐3688.0614695	 ‐3687.682867	 -3687.775953 ‐0.0782937	 ‐3682.8785420	
3	 ‐3688.0607572	 ‐3687.681957	 -3687.775688 ‐0.0776722	 ‐3682.8735734	
4	 ‐3688.0592234	 ‐3687.680587	 -3687.773992 ‐0.0795208	 ‐3682.8742431	
5	 ‐3688.0625832	 ‐3687.683682	 -3687.774626 ‐0.0755368	 ‐3682.8786483	
6	 ‐3688.0610365	 ‐3687.682392	 -3687.775398 ‐0.0779750	 ‐3682.8767889	
7	 ‐3688.0623077	 ‐3687.683550	 -3687.776206 ‐0.0762061	 ‐3682.8757391	
8	 ‐3688.0619711	 ‐3687.683165	 -3687.775091 ‐0.0765726	 ‐3682.8775199	
12	 ‐3688.0621295	 ‐3687.683318	 -3687.774773 ‐0.0762220	 ‐3682.8776639	
TMS
Zn
THF
Cl
Cl
H
S
	
(4‐17b)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐4008.8210986	 ‐4008.476162	 ‐4008.570217	 ‐0.0739432	 ‐4003.3266690	
2	 ‐4008.8238141	 ‐4008.478849	 ‐4008.569453	 ‐0.0714731	 ‐4003.3312010	
4	 ‐4008.8198341	 ‐4008.475003	 ‐4008.568221	 ‐0.0747559	 ‐4003.3268852	
5	 ‐4008.8226499	 ‐4008.477819	 ‐4008.568931	 ‐0.0736244	 ‐4003.3290626	
6	 ‐4008.8231466	 ‐4008.478293	 ‐4008.568886	 ‐0.0735129	 ‐4003.3309767	
8	 ‐4008.8231735	 ‐4008.478356	 ‐4008.569517	 ‐0.0734173	 ‐4003.3310242	
10	 ‐4008.8216037	 ‐4008.476852	 ‐4008.567891	 ‐0.0742141	 ‐4003.3294869	
11	 ‐4008.8184093	 ‐4008.473645	 ‐4008.566962	 ‐0.0762220	 ‐4003.3242123	
16	 ‐4008.8208156	 ‐4008.476123	 ‐4008.568404	 ‐0.0741503	 ‐4003.3286354	
17	 ‐4008.8212911	 ‐4008.476358	 ‐4008.567482	 ‐0.0740069	 ‐4003.3280411	
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Table	4.17	Total	energies,	enthalpies	and	free	solvation	energies	of	4‐20b	in	Hartree	(at	298.15	K	and	
1	atm).	
TMS
Zn
Cl
Cl
THF
S 	
(4‐20b)	
	 B3LYP/631SVP	 SMD/B3LYP	 MP2	
Etot	 H298	 G298	 Gsolv	 Etot	
1	 ‐4008.8130686	 ‐4008.468214	 ‐4008.559655	 ‐0.0752977	 ‐4003.3274624	
2	 ‐4008.8119697	 ‐4008.466978	 ‐4008.559097	 ‐0.0738954	 ‐4003.3249972	
3	 ‐4008.8099782	 ‐4008.465250	 ‐4008.560166	 ‐0.0775447	 ‐4003.3226299	
4	 ‐4008.8112271	 ‐4008.466397	 ‐4008.560000	 ‐0.0770029	 ‐4003.3219456	
5	 ‐4008.8118210	 ‐4008.466881	 ‐4008.559429	 ‐0.0746125	 ‐4003.3248949	
6	 ‐4008.8118150	 ‐4008.466847	 ‐4008.558957	 ‐0.0747400	 ‐4003.3241502	
	
Table	4.18	Total	energies,	enthalpies	and	free	solvation	energies	in	Hartree	(at	298.15	K	and	1	atm).	
TMS
Li
THF
THF
THF
	
(4‐16a)	
	 B3LYP/6‐31+G(d)	 SMD/B3LYP	 MP2	
Etot	 H298	 Gsolv	 Etot	
3	 -1460.7994348 -1460.176430 -0.0284617 -1456.6433032 
4	 -1460.7995235 -1460.176295 -0.0279518 -1456.6434036 
5	 -1460.7992019 -1460.176071 -0.0277446 -1456.6416497 
TMS
Li
THF
THF
THF
H
	
(4‐18a)	
	 B3LYP/6‐31+G(d)	 SMD/B3LYP	 MP2	
Etot	 H298	 Gsolv	 Etot	
1	 -1460.8026118 -1460.179279 -0.0281908 -1456.6434157 
2	 -1460.8019447 -1460.178848 -0.0287167 -1456.6418434 
4	 -1460.8013881 -1460.178152 -0.0296729 -1456.6396068 
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Table	4.19	Calculated	shielding	tensors		in	ppm.	
C2
TMS
C1 Zn
THF
Cl
Cl
C3
H3
Hp 	
(4‐17a)	

GIAO/B3LYP/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 27.0419	 25.1793	 74.7547	 ‐19.1184	 105.8530	 340.6620	
2	 26.9711	 25.1629	 74.7995	 ‐20.7684	 105.6005	 339.4856	
7	 26.8616	 25.1128	 75.7013	 ‐25.0502	 104.6823	 339.8060	
8	 26.8687	 25.1494	 75.9990	 ‐24.635	 104.5175	 340.0766	
9	 26.8886	 25.1608	 75.7486	 ‐23.9344	 104.8137	 340.2231	
15	 26.9306	 25.1203	 75.6984	 ‐23.6962	 104.4586	 340.8834	
16	 26.9143	 25.1018	 76.1071	 ‐25.0986	 104.5973	 338.9028	
17	 26.8549	 25.0956	 75.9525	 ‐26.1560	 104.6718	 339.9045	
18	 26.9433	 25.1152	 75.8582	 ‐23.9450	 104.6640	 339.4440	
	
GIAO/mPW1K/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.9566	 24.9308	 83.0329	 ‐13.5690	 114.9418	 366.3391	
2	 26.8862	 24.9150	 83.1302	 ‐15.2213	 114.6450	 365.3920	
7	 26.7872	 24.8798	 84.2504	 ‐19.1866	 113.6198	 365.5947	
8	 26.7942	 24.9121	 84.5450	 ‐18.9294	 113.4017	 365.8010	
9	 26.8131	 24.9168	 84.2626	 ‐18.2341	 113.6943	 365.9216	
15	 26.8616	 24.8805	 84.1882	 ‐18.1010	 113.3394	 366.3607	
16	 26.8514	 24.8644	 84.6237	 ‐19.2478	 113.5188	 364.7725	
17	 26.7797	 24.8668	 84.5278	 ‐20.1369	 113.5757	 365.7010	
18	 26.8763	 24.8746	 84.3829	 ‐18.3639	 113.4851	 365.1852	
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Table	4.20	Calculated	shielding	tensors		in	ppm.	
C2
TMS
C1 Zn
THF
Cl
Cl
C3
H3
Hp 	
(4‐17a)	
	
GIAO/SMD/mPW1K/IGLO‐III//B3LYP/631SVP	(THF)	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.4370	 24.3157	 85.0200	 ‐19.1359	 115.5896	 365.4336	
2	 26.5069	 24.3241	 84.2214	 ‐17.0715	 115.7315	 365.0973	
7	 26.4146	 24.2926	 84.8590	 ‐20.0663	 115.1888	 365.1791	
8	 26.4245	 24.3108	 85.1433	 ‐19.6006	 115.4009	 365.2749	
9	 26.4370	 24.3157	 85.0200	 ‐19.1359	 115.5896	 365.4336	
15	 26.4404	 24.3027	 85.0255	 ‐18.9153	 114.8359	 365.7981	
16	 26.4304	 24.2980	 85.3173	 ‐19.9873	 114.7491	 364.3494	
17	 26.4191	 24.2823	 84.7598	 ‐20.5278	 115.3682	 365.2488	
18	 26.4533	 24.3021	 84.9653	 ‐18.8310	 115.0803	 364.6411	
C2
TMS
C1 Zn
THF
THF
Cl
C3
H3
Hp 	
(4‐15a)	
	
GIAO/B3LYP/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.6051	 24.6617	 78.8024	 ‐34.3752	 101.0584	 337.1566	
5	 26.5353	 24.6541	 78.4265	 ‐33.2387	 102.1859	 337.4016	
7	 26.4695	 24.6269	 80.1499	 ‐35.5752	 100.4296	 337.9006	
8	 26.482	 24.6261	 81.5347	 ‐40.8681	 99.6810	 339.0575	
10	 26.5682	 24.6550	 78.2969	 ‐32.3068	 102.2055	 337.1369	
11	 26.5427	 24.6473	 79.7069	 ‐34.8300	 101.0329	 336.6207	
14	 26.5988	 24.6433	 79.3078	 ‐35.3809	 99.9032	 337.4662	
15	 26.5834	 24.6550	 78.7602	 ‐34.0915	 101.2989	 337.0951	
16	 26.4365	 24.6311	 80.4088	 ‐36.0630	 100.4525	 337.6731	
17	 26.4368	 24.6549	 80.0196	 ‐35.2743	 100.6147	 338.0755	
18	 26.5550	 24.6515	 78.1437	 ‐32.5336	 102.2296	 337.1765	
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Table	4.21	Calculated	shielding	tensors		in	ppm.	
C2
TMS
C1 Zn
THF
THF
Cl
C3
H3
Hp 	
(4‐15a)	
	 GIAO/mPW1k/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.5074	 24.4255	 87.8244	 ‐27.9567	 109.9269	 362.9305	
5	 26.4450	 24.4101	 87.2718	 ‐26.8995	 110.8801	 363.1391	
7	 26.3621	 24.3910	 89.1785	 ‐29.3781	 109.2944	 363.6957	
8	 26.3686	 24.3989	 91.0664	 ‐34.5480	 108.3170	 364.7236	
10	 26.4836	 24.4165	 87.1390	 ‐25.9555	 110.9815	 362.9738	
11	 26.4419	 24.4131	 88.5876	 ‐28.4687	 109.8706	 362.4954	
14	 26.4981	 24.4044	 88.5555	 ‐29.0783	 108.7832	 363.1642	
15	 26.4922	 24.4176	 87.7072	 ‐27.6296	 110.1868	 362.8467	
16	 26.3320	 24.3946	 89.4645	 ‐29.8458	 109.2608	 363.5168	
17	 26.3377	 24.4136	 89.1642	 ‐29.0169	 109.4297	 363.8779	
18	 26.4728	 24.4105	 87.0253	 ‐26.1986	 110.9886	 362.9796	
	 GIAO/SMD/mPW1K/IGLO‐III//B3LYP/631SVP	(THF)	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.2499	 24.1641	 86.9022	 ‐25.7456	 111.8495	 363.1832	
5	 26.2053	 24.1524	 86.4940	 ‐24.7708	 112.9123	 363.4125	
7	 26.2131	 24.1271	 88.0969	 ‐27.1584	 112.0795	 363.5087	
8	 26.2238	 24.1391	 87.9221	 ‐29.0669	 112.5638	 364.2381	
10	 26.2038	 24.1579	 86.8260	 ‐24.3428	 112.7042	 363.3046	
11	 26.2057	 24.1495	 87.6950	 ‐26.3705	 111.8810	 362.6835	
14	 26.2573	 24.1591	 87.1226	 ‐26.5071	 111.1853	 363.0666	
15	 26.2256	 24.1545	 87.1764	 ‐25.8432	 111.9808	 363.1213	
16	 26.2069	 24.1338	 87.9999	 ‐27.1487	 112.4159	 363.3187	
17	 26.2123	 24.1479	 87.6315	 ‐26.3140	 112.6266	 363.6543	
18	 26.2003	 24.1528	 86.5519	 ‐24.4931	 112.7545	 363.2828	
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Table	4.22	Calculated	shielding	tensors		in	ppm.	
C2
TMS
C1 Zn
THF
Cl
Cl
C3
H3
S
	
(4‐17b)	
	 GIAO/B3LYP/IGLO‐III//B3LYP/6‐31SVP	
(1H):	H3	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.9272	 74.1563	 ‐23.7436	 110.2325	 342.8789	
2	 26.7073	 75.8214	 ‐29.5419	 109.4911	 340.3628	
4	 26.9654	 74.7536	 ‐22.5989	 111.9348	 340.9445	
5	 26.7741	 76.1486	 ‐28.3332	 109.6256	 339.8813	
6	 26.6905	 75.5766	 ‐29.3084	 109.4231	 339.8064	
8	 26.7146	 75.5958	 ‐28.4320	 109.5018	 340.3072	
10	 26.8273	 75.8292	 ‐27.3896	 111.0311	 340.2457	
11	 26.8578	 77.2211	 ‐31.6816	 110.2289	 340.7022	
16	 26.9196	 76.9756	 ‐27.3800	 111.5279	 340.7720	
17	 26.8453	 75.9696	 ‐27.1628	 111.1166	 340.1540	
	 GIAO/mPW1K/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.8751	 82.5198	 ‐17.4951	 118.8347	 367.9506	
2	 26.6592	 84.4790	 ‐22.9563	 117.8597	 366.0002	
4	 26.9415	 83.1604	 ‐16.5972	 120.5637	 366.4606	
5	 26.7367	 84.7275	 ‐21.8900	 118.0205	 365.4962	
6	 26.6373	 84.1876	 ‐22.7903	 117.8221	 365.5078	
8	 26.6660	 84.2119	 ‐21.9849	 117.9008	 365.9243	
10	 26.8096	 84.4472	 ‐21.1387	 119.5133	 365.9045	
11	 26.8337	 85.9408	 ‐25.4151	 118.5472	 366.2148	
16	 26.9155	 85.5272	 ‐21.1174	 119.9434	 366.2903	
17	 26.8227	 84.5030	 ‐20.9488	 119.6227	 365.8415	
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Table	4.23	Calculated	shielding	tensors		in	ppm	j.	
C2
TMS
C1 Zn
THF
THF
Cl
C3
H3
S
	
(4‐15b)	
	 GIAO/B3LYP/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.4686	 78.9243	 ‐36.6134	 105.8408	 337.7144	
2	 26.3852	 78.6151	 ‐36.2092	 106.7342	 337.8413	
3	 26.5115	 79.9489	 ‐36.1014	 106.3188	 338.0071	
4	 26.5310	 79.1958	 ‐36.4010	 107.2456	 337.1532	
5	 26.3754	 78.9628	 ‐35.9189	 105.7133	 337.2498	
6	 26.3046	 81.9903	 ‐43.4055	 104.4132	 338.8146	
8	 26.5792	 79.8350	 ‐38.3813	 104.3257	 339.0615	
10	 26.5576	 79.8267	 ‐34.3732	 107.8626	 337.1358	
11	 26.4272	 80.4914	 ‐36.2075	 106.9437	 338.4037	
15	 26.3445	 80.2023	 ‐36.5935	 105.6971	 338.7701	
16	 26.4769	 78.8225	 ‐35.1925	 108.2039	 337.8392	
17	 26.4719	 80.5538	 ‐36.5195	 106.6178	 337.9188	
18	 26.6759	 79.8832	 ‐36.5573	 105.7533	 338.2955	
	 GIAO/mPW1K/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 26.3947	 87.9712	 ‐29.6598	 114.3578	 363.3270	
2	 26.3221	 87.5672	 ‐29.3111	 115.0492	 363.4326	
3	 26.4654	 89.0618	 ‐29.5071	 114.9262	 363.6901	
4	 26.4932	 88.2232	 ‐29.6423	 115.7504	 362.9070	
5	 26.3165	 87.9701	 ‐29.0488	 114.1479	 362.8977	
6	 26.2116	 91.6279	 ‐36.6278	 112.7093	 364.5438	
8	 26.4721	 88.9546	 ‐31.5219	 112.9134	 364.5591	
10	 26.5105	 88.7003	 ‐27.7834	 116.3827	 362.9476	
11	 26.3846	 89.5100	 ‐29.6792	 115.4397	 364.0040	
15	 26.2677	 89.2529	 ‐29.8928	 114.1759	 364.3182	
16	 26.4471	 87.7133	 ‐28.4586	 116.5490	 363.4686	
17	 26.4208	 89.4726	 ‐30.0156	 115.1695	 363.6263	
18	 26.6078	 88.9339	 ‐29.8801	 114.4911	 363.9341	
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Table	4.24	Calculated	shielding	tensors		in	ppm.	
C3
C2
C1
TMSHp
Zn
H3
THF
Cl
THF
	
(4‐19a)	
	
GIAO/B3LYP/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
8	 28.0951 24.5848 89.5381	 53.8391	 151.9756	 358.0297	
	
GIAO/mPW1K/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
8	 28.1932 24.3778 96.0178	 59.5771	 163.5208	 381.8059	
C3
C2
C1
TMSHp
Zn
H3
THF
Cl
Cl
	
(4‐20a)	
	
GIAO/B3LYP/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
2	 28.1671 25.0274 93.5889	 48.4984	 146.0357	 361.3098	
	
GIAO/mPW1K/IGLO‐III//B3LYP/631SVP	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
2	 28.2372 24.8228 100.0251	 54.7082	 157.6873	 384.7873	
C3
C2
C1
TMSHp
Li
H3
THF
THF
THF
	
(4‐16a)	
	
GIAO/B3LYP/IGLO‐III//B3LYP/6‐31+G(d)	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
3	 28.5360 25.3371 82.7383	 39.9845	 134.3370	 359.6495	
	
GIAO/mPW1K/IGLO‐III//B3LYP/6‐31+G(d)	
(1H):	H3	 (1H):	Hp (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
3	 28.5347 25.1027 89.6174	 47.0322	 144.4308	 383.6148	
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Table	4.25	Calculated	shielding	tensors		in	ppm.	
C2
TMS
C1 Li
THF
THF
THF
C3
H3
Hp
	
(4‐18a)	
	
GIAO/B3LYP/IGLO‐III//B3LYP/6‐31+G(d)	
(1H):	H3	 (1H):	Hp	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 27.5121	 25.0578	 71.0520	 ‐3.8333	 113.8368	 347.1823	
	
GIAO/mPW1K/IGLO‐III//B3LYP/6‐31+G(d)	
(1H):	H3	 (1H):	Hp	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
1	 27.4701	 24.8131	 78.4381	 2.4868	 123.2315	 372.4195	
Zn
Cl
Zn
ClC1
C2
TMS
TMS
H
Ph
THF
THF
C3H
Hp 	
(4‐41)	
	
GIAO/B3LYP/IGLO‐III/B3LYP/631SVP	
(1H):	H3	 (1H):	Hp	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
	
26.5119	
26.5073	
24.6165	
24.6082	
78.9529	
79.3858	
‐33.0180	
‐33.8617	
100.3440	
100.1750	
338.2550	
337.7420	
	
GIAO/mPW1K/IGLO‐III	
(1H):	H3	 (1H):	Hp	 (13C):	C1 (13C):	C2 (13C):	C3 (29Si)	
	
26.4038	
26.4033	
24.3773	
24.3738	
88.4831	
88.8302	
‐26.7817	
‐27.6173	
109.0900	
109.3060	
363.9970	
363.5270	
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Figure	4.14	Graphical	representation	of	the	neutral	zinc	dimer	4‐41	optimized	at	B3LYP/631SVP	level	
of	theory	in	the	gas	phase.	
	
(4‐16a)	
	
(4‐18a)	
Figure	 4.15	 Graphical	 representation	 of	 the	 energetically	 most	 stable	 Li	 species	 4‐16a	 and	4‐18a	
optimized	at	B3LYP/6‐31+G(d)	level	of	theory	in	the	gas	phase.	
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Table	4.26	Boltzmann‐averaged	chemical	shifts	<>a	at	various	levels	of	theory	(in	ppm).	
	
C3
H3
C2
TMS
C1 Zn
THF
THF
Cl 	
(4‐15a)	
C3
H3
C2
TMS
C1 Zn
THF
Cl
Cl 	
(4‐17a)	
H3	 C3	 C2	 C1	 Si	 H3	 C3	 C2	 C1	 Si	
(exp)a	 4.99	 70.18	 202.83	 93.97	 ‐4.59	 4.62	 70.25	 197.36	 93.94	 ‐6.16	
Gas		
phase	
(GIAO/B3LYP/IGLO‐III//B3LYP/631SVP)	
H	
Hsolb	
G	
Gsolb	
Øc	
5.16	
5.15	
5.15	
5.14	
5.19	
78.13	
78.22	
78.17	
78.32	
79.07	
213.15	
213.22	
213.02	
212.26	
215.04	
101.62	
101.62	
101.65	
101.59	
100.67	
‐7.08	
‐7.07	
‐7.03	
‐7.04	
‐7.41	
4.83	
4.80	
4.80	
4.77	
4.80	
75.32	
75.15	
75.30	
74.98	
75.21	
204.82	
203.50	
203.82	
202.45	
203.68	
104.32	
104.50	
104.43	
104.67	
104.46	
‐9.77	
‐9.80	
‐10.09	
‐10.09	
‐9.82	
Ed	 5.16	 77.85	 212.61	 101.94	 ‐7.07	 4.87	 75.41	 206.24	 104.13	 ‐9.79	
Gas	phase	 (GIAO/mPW1K/IGLO‐III//B3LYP/631SVP)	
H	
Hsolb	
G	
Gsolb	
Øc	
5.16	
5.15	
5.15	
5.14	
5.20	
76.60	
76.68	
76.62	
76.76	
77.52	
214.04	
214.10	
213.90	
214.13	
215.96	
99.98	
99.70	
100.01	
99.93	
98.88	
‐6.03	
‐6.03	
‐6.00	
‐6.00	
‐6.35	
4.82	
4.79	
4.78	
4.76	
4.78	
73.65	
73.45	
73.63	
73.27	
73.53	
206.23	
205.03	
205.36	
204.06	
205.22	
103.04	
103.28	
103.19	
103.49	
103.23	
‐8.70	
‐8.72	
‐8.93	
‐8.95	
‐8.72	
Ed	 5.16	 76.34	 213.53	 100.30	 ‐6.03	 4.85	 73.75	 207.47	 102.80	 ‐8.75	
THF	 (GIAO/SMD/mPW1K/IGLO‐III//B3LYP/631SVP)	
H	
Hsolb	
G	
Gsolb	
Øc	
5.37	
5.37	
5.37	
5.36	
5.36	
76.03	
76.12	
76.12	
76.24	
76.34	
213.47	
213.54	
213.42	
213.58	
214.77	
101.83	
101.80	
101.77	
101.75	
101.30	
‐6.34	
‐6.31	
‐6.31	
‐6.31	
‐6.41	
5.15	
5.14	
5.14	
5.14	
5.14	
73.34	
73.28	
73.43	
73.25	
73.33	
208.43	
207.94	
207.97	
207.77	
207.86	
103.74	
103.66	
103.66	
103.62	
103.68	
‐8.25	
‐8.22	
‐8.40	
‐8.35	
‐8.23	
Ed	 5.38	 75.86	 213.10	 102.06	 ‐6.35	 5.16	 73.24	 209.14	 103.85	 ‐8.32	
a	 Using	 tetramethylsilane	 Si(CH3)4	 as	 standard	 for	 experimental	 and	 calculated	 values,	 respectively.	 b	 SMD/B3LYP/6‐
31G(d)//B3LYP/631SVP	(THF).	c	Averaged	arithmetically.	d	Only	global	minimum	structure	considered.	
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Table	4.27	 B3LYP/6‐311++G(2df,2p)	 optimized	 energies	 and	 solvation	 free	 energies	Gsolv	 (DMSO,	
SMD/B3LYP/6‐31G(d))	of	some	selected	hydrocarbons	and	heterocycles	in	Hartree..	
	 S
O
	
(4‐24H)	
S
O
	
				(4‐24)	
	
(4‐25H)	
	
(4‐25)	
O
	
(4‐26H)	
O
	
(4‐26)	
Etot	
G298	
Gsolv	
‐553.3002559	
‐553.249510	
‐0.0105178	
‐552.6882201	
‐552.651429	
‐0.0918074	
‐232.3270529	
‐232.254150	
‐0.0053226	
‐231.6744645	
‐231.617052	
‐0.1039985	
‐230.1034710	
‐230.059831	
‐0.0039681	
‐229.4676588	
‐229.438939	
‐0.1030583	
	
S
	
(4‐27H)	
S
	
(4‐27)	
N
	
(4‐28H)	
N
	
(4‐28)	
N
N
	
(4‐30H)	
N
N
	
(4‐30)	
Etot	
G298	
Gsolv	
‐553.0919720	
‐553.052618	
‐0.0044780	
‐552.4671930	
‐552.441980	
‐0.0973054	
‐249.5657763	
‐249.484854	
‐0.0083505	
‐248.9222598	
‐248.856438	
‐0.1093689	
‐344.2213801	
‐344.099106	
‐0.0083983	
‐343.5851177	
‐343.477640	
‐0.1048431	
	
N
N
	
(4‐29H)	
N
N
	
(4‐29)	
S 	
(4‐32H)	
S 	
(4‐32)	
O 	
(4‐31H)	
O 	
(4‐31)	
Etot	
G298	
Gsolv	
‐265.6193273	
‐265.549409	
‐0.0150595	
‐264.9847240	
‐264.929543	
‐0.1160143	
‐706.7864623	
‐706.703490	
‐0.0076971	
‐706.1726751	
‐706.104012	
‐0.0911541	
‐383.8002709	
‐383.713229	
‐0.0072350	
‐383.1799253	
‐383.107924	
‐0.0935285	
	 O
N
	
(4‐33H)	
O
N
	
(4‐33)	
N
	
(4‐34H)	
N
	
(4‐34)	
	 	
Etot	
G298	
Gsolv	
‐399.8545995	
‐399.778927	
‐0.0079999	
‐399.2505594	
‐399.190621	
‐0.0925883	
‐403.2602311	
‐403.135882	
‐0.0110118	
‐402.6338978	
‐402.523940	
‐0.0981181	
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Table	4.28	 B3LYP/6‐311++G(2df,2p)	 optimized	 energies	 and	 solvation	 free	 energies	Gsolv	 (DMSO,	
SMD/B3LYP/6‐31G(d))	in	Hartree.	
	
CN
Cl
Cl (4‐35H)	
CN
Cl
Cl (3‐35‐3H)	
CN
Cl
Cl (4‐35‐5H)	
CN
Cl
Cl (4‐35‐6H)	
Etot	
G298	
Gsolv	
‐1243.8459213	
‐1243.800541	
‐0.0102787	
‐1243.2576137	
‐1243.227241	
‐0.0769391	
‐1243.2483261	
‐1243.217865	
‐0.0765726	
‐1243.2478735	
‐1243.217406	
‐0.0774810	
	
CN
CO2Et (4‐36H)	
CN
CO2Et (4‐36‐2H)	
Etot	
G298	
Gsolv	
‐591.8888823	
‐591.758834	
‐0.0132110	
‐591.8893222	
‐591.758734	
‐0.0128763	
‐591.2708217	
‐591.156069	
‐0.0898792	
‐591.2750953	
‐591.160173	
‐0.0871223	
	
CN
CO2Et
(4‐36‐6H)	
CN
CO2Et (4‐36‐5H)	
Etot	
G298	
Gsolv	
‐591.2719228	
‐591.157241	
‐0.0841741	
‐591.2684706	
‐591.153801	
‐0.0863255	
‐591.2712926	
‐591.156832	
‐0.0864689	
‐591.2707768	
‐591.155925	
‐0.0867557	
	
CN
CO2Et (4‐36‐4H)	
S
CO2Et
(4‐37H)	
Etot	
G298	
Gsolv	
‐591.2766748	
‐591.161083	
‐0.0869788	
‐591.2772253	
‐591.161382	
‐0.0866601	
‐820.3845102	
‐820.283442	
‐0.0095616	
‐820.3849336	
‐820.283448	
‐0.0094501	
	
S
CO2Et
(4‐37‐5H)	
S
CO2Et
(4‐37‐4H)	
Etot	
G298	
Gsolv	
‐819.7771653	
‐819.690267	
‐0.0885087	
‐891.7780388	
‐819.690634	
‐0.0883493	
‐819.7593926	
‐819.672857	
‐0.0930505	
‐819.7596643	
‐819.672742	
‐0.0930186	
	
S
CO2Et
(4‐37‐3H)	
	 	
Etot	
G298	
Gsolv	
‐819.7622994	
‐819.675949	
‐0.0922058	
‐819.7599345	
‐819.673398	
‐0.0936720	
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Table	4.29	 B3LYP/6‐311++G(2df,2p)	 optimized	 energies	 and	 free	 solvation	 energies	Gsolv	 (DMSO,	
SMD/B3LYP/6‐31G(d))	in	Hartree.	
	 TMS
(4‐13aH)	
TMS
H
	
(4‐13a)	
TMS 	
(4‐13a‐2H)	
TMS
(4‐13a‐3H)	
Etot	
G298	
Gsolv	
‐756.5923863	
‐756.397948	
‐0.0064222	
‐756.0201032	
‐755.840553	
‐0.0760627	
‐755.9520498	
‐755.773740	
‐0.0928911	
‐755.9466344	
‐755.767789	
‐0.0969707	
	 TMS 	
(4‐13a‐4H)	
TMSTMS
(4‐38H)	
H
TMSTMS
(4‐38) 
 
Etot	
G298	
Gsolv	
‐755.9455281	
‐755.766319	
‐0.0979747	
‐1010.4046243	
‐1010.185825	
‐0.0025338	
‐1009.8411516	
‐1009.637799	
‐0.0712978	
 
	 TMSS 	
(4‐13bH)	
H
TMSS 	
(4‐13b)	
Etot	
G298	
Gsolv	
‐1077.3581882	
‐1077.198727	
‐0.0054661	
‐1077.3576215	
‐1077.196687	
‐0.0059282	
‐1076.7800454	
‐1076.633781	
‐0.0763495	
‐1076.7800108	
‐1076.633874	
‐0.0750746	
	 TMSS 	
(4‐13b‐2H)	
TMSS 	
(4‐13b‐5H)	
Etot	
G298	
Gsolv	
‐1076.7430600	
‐1076.595754	
‐0.0874888	
‐1076.7430445	
‐1076.596313	
‐0.0874888	
‐1076.7382618	
‐1076.593545	
‐0.0915206	
‐1076.7382573	
‐1076.593061	
‐0.0915206	
	 TMSS
(4‐13b‐4H)	
	 	 	
Etot	
G298	
Gsolv	
‐1076.7285417	
‐1076.583510	
‐0.0913134	
	 	 	
	
	 	
4.9	Theoretical	Appendix		
248	
Table	 4.30	 Reference‐depending	 free	 solvation	 energies	 Gsolv	 in	 kJ	 mol‐1	 (PCM/SMD/B3LYP/	
6‐31G(d)//B3LYP/6‐311++G(2df,2p)).	
         +
Gsolv
R       +Ref Ref HR H 	
	
CN
Cl
Cl 	
(4‐35‐3H)	
CN
Cl
Cl 	
(4‐35‐5H)	
CN
Cl
Cl 	
(4‐35‐6H)	
	
S
O
	
(4‐24H)	
+38.41	 +39.37	 +36.99	 	
S
	
(4‐27H)	
+68.70	 +69.66	 +67.28	 	
	
CN
CO2Et 	
(4‐36‐2H)	
CN
CO2Et
	
(4‐36‐6H)	
CN
CO2Et 	
(4‐36‐5H)	
CN
CO2Et 	
(4‐36‐4H)	
S
O
	
(4‐24H)	
+12.14	 +21.63	 +20.29	 +19.73	
S
	
(4‐27H)	
+42.43	 +51.92	 +50.58	 +50.03	
	
S
CO2Et
	
(4‐37‐5H)	
S
CO2Et
	
(4‐37‐4H)	
S
CO2Et
	
(4‐37‐3H)	
H
TMSTMS 	
(4‐38)	
S
O
	
(4‐24H)	
+6.20	 ‐5.87	 ‐6.87	 +32.89	
S
	
(4‐27H)	
+36.50	 +24.42	 +23.42	 +63.18	
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Table	 4.31	 Reference‐depending	 free	 solvation	 energies	 Gsolv	 in	 kJ	 mol‐1	 (PCM/SMD/B3LYP/	
6‐31G(d)//B3LYP/6‐311++G(2df,2p)).	
         +
Gsolv
R       +Ref Ref HR H 	
	
TMS
H
	
(4‐13a)	
TMS 	
(4‐13a‐2H)	
TMS
	
(4‐13a‐3H)	
TMS
	
(4‐13a‐4H)	
S
O
	
(4‐24H)	
+30.58	 ‐13.60	 ‐24.31	 ‐26.95	
S
	
(4‐27H)	
+60.88	 +16.69	 +5.98	 +3.35	
	
H
TMSS 	
(4‐13b)	
TMSS 	
(4‐13b‐2H)	
TMSS 	
(4‐13b‐5H)	
TMSS 	
(4‐13b‐3H)	
S
O
	
(4‐24H)	
+28.76	 ‐1.17	 ‐11.76	 ‐11.21	
S
	
(4‐27H)	
+59.06	 +29.12	 +18.53	 +19.08	
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Table	4.32	At	PCM/SMD/B3LYP/6‐31G(d)//B3LYP/6‐311++G(2df,2p)	 level	of	 theory	calculated	pKa	
values	using	DMSO/dimsyl	as	reference	system.	
	 pKa(gas)	 pKa(DMSO)	 pKa(DMSO,	corr.)a	 pKa(THF)b	
CN
Cl
Cl (4‐35‐3H)	
+23.70	 +30.43	 +27.64	 +27.95	
CN
Cl
Cl (4‐35‐5H)	
+28.01	 +34.91	 +31.88	 +32.38	
CN
Cl
Cl (4‐35‐6H)	
+28.23	 +34.71	 +31.69	 +32.18	
CN
CO2Et (4‐36‐2H)	
+35.38	 +37.73	 +34.54	 +35.17	
CN
CO2Et
(4‐36‐6H)	
+36.72	 +40.51	 +37.17	 +37.91	
CN
CO2Et (4‐36‐5H)	
+37.00	 +40.55	 +37.20	 +37.95	
CN
CO2Et (4‐36‐4H)	
+34.84	 +38.30	 +35.08	 +35.73	
a	Using	the	test	set	correlation	fit:	pKa(exp.)	=	0.9447	pKa(calc.)	–	1.1043.	
	b	Corrected	with	Streitwieser’s	linear	correlation	pKa	(THF)	=	1.046	pKa	(DMSO)	–	0.963.	
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Table	4.33	At	PCM/SMD/B3LYP/6‐31G(d)//B3LYP/6‐311++G(2df,2p)	 level	of	 theory	calculated	pKa	
values	using	DMSO/dimsyl	as	reference	system.	
	 pKa(gas)	 pKa(DMSO)	 pKa(DMSO,	corr.)a	 pKa(THF)b	
S
CO2Et
(4‐37‐5H)	
+32.75	 +33.84	 +30.86	 +31.32	
S
CO2Et
(4‐37‐4H)	
+40.87	 +39.85	 +36.54	 +37.26	
S
CO2Et
(4‐37‐3H)	
+39.49	 +38.29	 +35.07	 +35.72	
TMS
H
(4‐13a)	
+16.39	 +21.75	 +19.44	 +19.37	
TMS (4‐13a‐2H)	
+47.12	 +44.73	 +41.15	 +42.08	
TMS
(4‐13a‐3H)	
+49.85	 +45.59	 +41.96	 +42.93	
TMS
(4‐13a‐4H)	
+50.53	 +45,81	 +42.17	 +43.15	
H
TMSTMS (4‐38)	
+12.08	 +17.84	 +15.75	 +15.51	
H
TMSS (4‐13b)	
+19.73	 +24.77	 +22.30	 +22.36	
TMSS (4‐13b‐2H)	
+37.06	 +36.86	 +33.72	 +34.31	
TMSS (4‐13b‐5H)	
+38.35	 +36.29	 +33.18	 +33.74	
TMSS (4‐13b‐4H)	
+42.87	 +40.90	 +37.53	 +38.30	
a	Using	the	test	set	correlation	fit:	pKa(exp.)	=	0.9447	pKa(calc.)	–	1.1043.	
	b	Corrected	with	Streitwieser’s	linear	correlation	pKa	(THF)	=	1.046	pKa	(DMSO)	–	0.963.	
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5 The	Chemical	Fate	of	Paroxetine	Metabolites	
Parts	of	this	chapter	have	been	published	in		
The	 chemical	 fate	 of	 paroxetine	metabolites.	Dehydration	 of	 radicals	 derived	
from	4‐(4‐fluorophenyl)‐3‐(hydroxymethyl)piperidine	
D.	Šakić,	F.	Achrainer,	V.	Vrček,	H.	Zipse,	Org.	Biomol.	Chem.	2013,	11,	4232	–	4239.	
5.1 Introduction	
The	supply	of	drinking	water	is	one	of	the	biggest	challenges	of	humanity	in	the	next	
decades	or	even	centuries.	According	to	the	World	Health	Organisation	 (WHO)	since	
1990	 over	 two	 billion	 people	 have	 gained	 access	 to	 drinking	 water	 and	 improved	
sanitation.	But	more	than	700	million	of	earth’s	population	still	lack	free	entrance	to	
improved	 sources	 of	 drinkable	 water.[172]	 It	 is	 known,	 that	 the	 degree	 of	
industrialization	 is	 correlating	 with	 the	 analyzable	 amount	 of	 micro	 pollutants	 or	
organic	 metabolites	 in	 municipal	 wastewater.[173]	 A	 well‐known	 established	
procedure	to	remove	organic	compounds	is,	aside	from	ozonization	or	UV	irradiation,	
the	 chlorination	with	 agents	 like	 Cl2/ClO‐,	 NH2Cl	 or	 ClO2,	 which	 therefore	 plays	 an	
important	 role	 in	 environmental	 and	 biological	 chemistry.[174]	 The	 development	 of	
cheap	 disinfectants,	 which	 produce	 nontoxic,	 biodegradable	 byproducts	 or	 can	 be	
handled	safely,	is	still	an	ongoing	scientific	challenge.	The	main	byproducts	of	organic	
compounds	 upon	 chlorination	 are	 chloroform	 CHCl3,	 haloacetic	 acids,	 haloketones,	
cyanogen	chloride	and	chloramines.[175]	Due	to	the	potential	carcinogenicity	of	those	
compounds	 a	 regular	monitoring	 of	 their	 concentrations	 is	 highly	 regulated	 in	 the	
municipal	water	system.[176]		
The	 risk	 assessment	 of	 only	 a	 small	 number	 of	 organic	 compounds	 is	 known	 and	
documented.	 The	 amino	 moiety	 present	 in	 amines,	 amides	 or	 sulfonamides	 is	 an	
example	for	compounds	with	a	well‐known	behavior	against	chlorination.[177]	
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Scheme	5.1	Electrophilic	chlorination	of	nitrogen	containing	compounds.	
N‐Chlorosuccinimide	 (5‐1)	 and	 chloramine	 T	 (5‐2)	 are	 widely	 used	 reagents	 in	
synthesis.[178]	Even	the	oxidizing	potential	of	N‐chlorosaccharin	(5‐3)	as	a	source	for	
electrophilic	chlorine	cations	has	been	studied.[179]	Saccharin	is	an	example	of	a	food	
additive,	which	is	accumulated	in	wastewater	undigested	by	our	body.[180]	
N
O
O
Cl
S
S
N
O
O O
Cl
O
O N
Cl
Na
5-1 5-2 5-3 	
Figure	5.1	Commonly	used	N‐chloramines.	
Halogenated	 carboxylic	 amides	 readily	 undergo	 a	 Hofmann‐type	 rearrangement	 to	
generate	 mutagenic	 isocyanates	 or	 the	 respective	 primary	 amines	 upon	
hydrolysis.[181]	
R N
O
Cl O C N
R
H
H
Cl- H
+
O C N
R
H2O
CO2
R
N
H
H
	
Scheme	5.2	Mechanism	of	the	Hofmann	rearrangement.	
5.2 The	Chemistry	of	N‐centered	Radicals	
The	 chemistry	 of	 N‐chloro	 amines	 is	 dominated	 by	 ionic	 reactions	 involving	
electrophilic	 chlorine	 and	 radical	 reactions	 involving	N‐centered	 radicals.	 The	 term	
“nitrogen	centered	radical”	 refers	 to	a	species	where	 the	 initial	unpaired	electron	 is	
localized	on	the	nitrogen	atom.	N‐Centered	radicals	can	be	divided	into	four	classes:	
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Neutral	aminyl	 radicals	R2N•	 (5‐4),	protonated	aminyl	 radicals	R2NH•+	 (5‐5),	 aminyl	
radical	metal	complexes	R2N•‐M+Cl	(5‐6)[182]	and	triarylaminium	radicals	Ar3N•+.[183]	
N N
R
R N
N
N Cl
R
R

or h
h
N
R
R
N Cl
R
R
N OH
R
R
hor Fe2+, H TiCl3, H
N
R
R
H
N Cl
R
R CuCl or FeSO4
or TiCl3
N
R
R
MCl
5-4
5-5
5-6 	
Scheme	5.3	Generation	of	N‐centered	radicals.	
These	species	can	easily	be	generated	by	photolysis	or	single	electron	transfer	(SET)	
reactions.	 Free	 aminyl	 radicals	 of	 type	 5‐4	 are	 unique	 in	 that	 a	 lone	 pair	 and	 an	
unpaired	 electron	 are	 localized	 at	 the	 same	 atom.	 Therefore	 they	 are	 capable	 of	
existing	in	either	a		or		electronic	state.	By	EPR	spectroscopy	the		state	has	been	
identified	for	many	alkylaminyl	radicals	as	ground	state.[182a]	
N
R
R
N
R
R
  	
Figure	5.2	Electronic	states	of	neutral	aminyl	radicals	of	type	5‐4.	
Neutral	dialkylaminyl	radicals	R2N•	(5‐4)	prefer	dimerization	to	hydrazines	and	then	
disproportionate	 to	 amines	 and	 imines.	 In	 the	 presence	 of	 olefins	 or	 arenes	 they	
strongly	 tend	 to	 abstract	hydrogen	atoms	 forming	 stabilized	allyl	 or	benzyl	 radicals	
rather	than	to	add	to	the	C‐C	double	bond.	Homolytic	decomposition	of	N‐chloramines	
in	acidic	media	leads	to	the	formation	of	aminium	radicals	R2NH•+	(5‐5)	which	behave	
very	 differently	 than	 their	 neutral	 counterparts.	 The	 positive	 charge	 reduces	 the	
propensity	 to	 dimerize	 or	 disproportionate	 and	 increases	 the	 tendency	 to	 abstract	
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exposed	 or	 activated	 hydrogen	 atoms	 (Hofmann‐Löffler‐Freytag	 reaction)[184]	 or	 the	
addition	 to	 sp2‐hybridized	 hydrocarbons.[182b]	 Fragmentation	 reactions	 of	 the	
aminium	radicals	to	imines	and	stabilized	C‐centered	radicals	are	also	common.[185]	
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Scheme	5.4	Generally	accepted	reaction	pathways	of	aminyl	radicals.	
Single	electron	reduction	of	N‐chloramines	in	pH‐neutral	solution	by	metal	salts,	like	
Fe2+,	Cu+	or	Ti3+	 chlorides,	 leads	 to	 complexed	 radicals	with	 the	 lowest	 reactivity	 in	
the	row	of	aminyl	radicals,	only	capable	of	addition	reactions.	Triarylaminium	radicals	
are	mainly	used	as	one	electron	oxidants	with	tuneable	redox	potentials	through	the	
substitution	 pattern	 of	 the	 phenyl	 rings.[186]	 Their	main	 application	 is	 found	 in	 the	
initiation	 of	 radical	 cation	 Diels‐Alder	 reactions	 of	 electroneutral	 dienes	 and	
dienophiles.[187]	
5.3 Paroxetine	–	a	Selective	Serotonine	Reuptake	Inhibitor	
Paroxetine	(Paxil©,	5‐7)	is	an	often	prescribed	antidepressant	of	the	class	of	selective	
serotonine	 (5‐hydroxytryptamine,	5‐8)	 reuptake	 inhibitors	 (SSRI).[188]	 It	 is	 used	 to	
treat	major	depression,	obsessive‐compulsive	disorder,	social	anxiety,	and	panic	and	
stress	attacks.	Paroxetine	represents	one	of	the	most	specific	selective	SSRIs.		
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Figure	5.3	Paroxetine©	(5‐7).	
Messages	 are	 passed	 through	 cerebral	 nerve	 cells	 via	 a	 small	 gap	 by	 releasing	
neurotransmitters,	 e.g	 serotonine	 (5‐8),	 from	 the	 presynaptic	 cell	 into	 it.	 In	 the	 so	
called	synapse	the	neurotransmitters	are	then	recognized	by	receptors	on	the	surface	
of	the	postsynaptic	cell,	which	upon	stimulation	relays	the	signal.	About	90	%	of	the	
neurotransmitter	 are	 again	 released	 from	 the	 receptors	 and	 are	 then	 taken	 up	 by	
monoamine	transporters	to	the	presynaptic	cell.	Serotonine	reuptake	inhibitors	as	the	
name	implies	inhibit	the	reuptake	into	the	presynaptic	cell,	which	results	in	a	longer	
presence	 in	 the	 synapse	 increasing	 the	 signal	 relay	 between	neurons	 followed	by	 a	
serotonine	receptor	down‐regulation	in	the	central	nervous	system.	
Presynaptic neuron Postsynaptic neuron
N
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HO
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up
ta
ke
Serotonine
5-8
	
Figure	5.4	Schematic	overview	for	the	mechanism	of	serotonine	reuptake.	
In	 many	 examples	 the	 lead	 motif	 for	 serotonine	 reuptake	 inhibitors	 possesses	 a	
piperidine	 moiety.	 Related	 pharmaceuticals	 are	 Femoxetine©	 (5‐9),[189]	 Litoxetine©	
(5‐10)[190]	and	Ifoxetine©	(5‐11),[191]	where	the	latter	two	never	reached	market.		
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Figure	5.5	Femoxetine©	(5‐9),	Litoxetine©	(5‐10)	and	Ifoxetine©	(5‐11).	
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Starting	 in	 1977	 with	 the	 patent	 of	 Christensen	 and	 Squires	 using	 a	 selective	
diastereomer	 recrystallization	 strategy,[192]	 in	 the	 past	 years	 numerous	
enantioselective	 syntheses	 of	 paroxetine	 have	 been	 established.	 These	 include,	 for	
example,	 enzymatic	 resolution	 of	 intermediates,[193]	 chiral	 auxiliary‐assisted	
synthesis,[194]	 desymmetrization	 of	 prochiral	 diesters[195]	 or	 the	 catalytic	 selective	
formation	of	the	‐stereocenter	of	a	2‐piperidone	derivative.[196]	
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N
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Michael-system reduction
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Scheme	5.5	Schematic	overview	of	different	paroxetine	syntheses.	
5.4 Photolysis	of	Paroxetine	
Recent	 studies	 have	 shown,	 that	 paroxetine	 and	 its	 metabolites	 can	 accumulate	 in	
wastewaters,[197]	but	also	in	the	tissue	of	fish.[198]	With	respect	to	environmental	risk	
assessment	 only	 paroxetine	 (5‐7)	 itself	 and	 its	major	 human	metabolite	5‐12	 have	
been	 studied	 in	more	 detail	 until	 today.[199]	 Paroxetine	 appears	 to	 be	 hydrolytically	
stable,	but	Kwon	and	Armbrust	have	shown,	that	the	compound	exposed	to	simulated	
sunlight	 easily	 undergoes	 hydrolysis	 to	 5‐12	 and	 furthermore	 dehydrates	 to	 an	
unknown	photoproduct.[200]	No	mechanistic	pathway	has	been	provided	and	the	only	
structural	 information	 for	 the	 dehydrated	product	 is	 the	mass	 spectrum	 signal	m/z	
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192	 [M	 +	 H]+,	 which	 they	 proposed	 to	 be	 5‐13.	 Vrček	 and	 coworkers	 recently	
investigated	 a	 number	 of	 possible	 base‐catalyzed	 rearrangements	 of	 the	 N‐
chlorinated	piperidine	derivate	5‐12Cl	 in	aqueous	media.	 In	addition	 to	hydrolyzed	
product	 5‐13	 alternative	 products	 have	 been	 suggested	 for	 the	 chemical	 fate	 of	
paroxetine	 (5‐7).	 Nevertheless,	 these	 investigations	 included	 only	 closed‐shell	
intermediates,	no	open‐shell	compounds	which	can	occur	upon	photolysis,	have	been	
studied.[201]		
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	Scheme	5.6	Degradation	of	paroxetine	(5‐7)	and	proposed	formation	of	key	intermediate	5‐12R+	in	
the	environment.	
5.5 Computation	of	Chemical	Properties	of	N‐centered	Piperidinyl	
Radicals	
The	formation	of	the	N‐centered	piperidyl	radical	(5‐12R+)	is	the	initial	key	step	for	
the	following	reaction	pathway[202]	and	therefore	has	been	specifically	examined.	The	
BDE	(bond	dissociation	energy)	can	easily	be	calculated	by	combining	the	isodesmic	
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reaction	enthalpy	rxnH,	which	is	nothing	else	than	a	reflection	of	the	radical	stability	
and	the	experimentally	measured	bond	strength	of	the	reference	(Ref‐H).	
X H +     Ref
rxnH
= RSE
X + Ref H
BDE (X-H) = RSE + BDE (Ref-H) 	
Scheme	5.7	General	definition	of	radical	stability	and	calculation	of	bond	dissociation	energies.	
The	 theoretical	 results	 for	different	piperidine	derivatives	are	 summarized	 in	Table	
5.1	and	Table	5.2	
Table	 5.1	 Theoretically	 calculated	 reaction	 enthalpies	 and	 N‐X	 BDEs	 of	 differently	 substituted	
piperidines.	
	
X
Y
+     NH2
X
+ Y NH2
R2
R1
R2
R1RSE
	
	
X	 Y	 R1	 R2	
RSE	
UB3LYPa	
RSE	
ROMP2b
RSE	
G3(MP2)‐RAD	
BDE	(X‐Y)d	
G3(MP2)‐RAD	
5‐14Cl	 N	 Cl	 H	 H	 ‐22.94	 +10.71	 ‐1.24	 +251.86	
5‐14Cl+	 NH+	 Cl	 H	 H	 ‐72.17	 ‐22.05	 ‐38.33	 +214.77	
5‐14	 N	 H	 H	 H	 ‐52.21	 ‐43.62	 ‐46.68	 +403.40	
5‐14H	 NH+	 H	 H	 H	 ‐37.86	 ‐35.29	 ‐28.01	 +422.07	
5‐12Cl	 N	 Cl	 CH2OH	 Arc	 ‐27.13	 +6.79	 ‐5.22	 +247.88	
5‐12	 N	 H	 CH2OH	 Arc	 ‐53.70	 ‐45.20	 ‐48.49	 +401.59	
5‐12H	 NH+	 H	 CH2OH	 Arc	 ‐39.40	 ‐14.33	 ‐22.52	 +427.56	
a	B3LYP/6‐31G(d).	b	ROMP2(FC)/6‐311+G(3df,2p)//UB3LYP/6‐31G(d).	c	p‐F‐C6H5.	d	BDE(NH2Cl)	=	+253.1	kJ	mol‐1;	BDE(NH3)	=	
+450.08	kJ	mol‐1.[115]	
	
Upon	 protonation	 the	 stabilization	 of	 N‐centered	 piperidine	 radical	 5‐12R+	 is	
decreased	by	approximately	25	kJ	mol‐1	 at	G3(MP2)‐RAD	 level	 in	 the	gas	phase.[203]	
Also,	 the	 impact	of	 the	attached	residues	 is	enhanced	due	to	the	 introduction	of	 the	
positive	charge	on	the	nitrogen	center	(see	Figure	5.6).	The	formation	of	N‐centered	
radical	5‐12R	by	photolytic	cleavage	of	the	N‐Cl	compared	to	the	N‐H	bond	is	favored	
by	BDE	=	+153.7	kJ	mol‐1.	
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Table	5.2	Theoretically	obtained	reaction	enthalpies	and	C‐H‐BDEs	of	differently	charged	piperdines.	
N
X
+ N
X
+
H
N NH
	
X	
rxnH	
UB3LYPa	
rxnH	
ROMP2b
rxnH	
G3(MP2)‐RAD
BDE	(Z‐H)c	
G3(MP2)‐RAD	
H	(5‐14R+)	 ‐29.62	 ‐31.50	 ‐28.59	 +75.21	
/	(5‐14R)	 ‐14.21	 ‐10.59	 ‐8.68	 +95.12	
N
X
+       CH3 N
X
+ H CH3H
	
X	
rxnH	
UB3LYPa	
rxnH	
ROMP2b
rxnH	
G3(MP2)‐RAD
BDE	(Z‐H)c	
G3(MP2)‐RAD	
H	(5‐14)	 ‐63.74	 ‐47.87	 ‐48.79	 +390.51	
H2	(5‐14H)	 ‐14.43	 +1.35	 +1.17	 +440.47	
a	B3LYP/6‐31G(d).	b	ROMP2(FC)/6‐311+G(3df,2p)//UB3LYP/6‐31G(d).	c	BDE(CH4)	=	+439.3	kJ	mol‐1;	
BDE	((H3C)2N•)	=	(fH(CH2=NCH3)	+	fH(H•))	‐	fH((H3C)2N•)	=	+103.8	kJ	mol‐1.[115]	
	
The	 N‐Cl	 bond	 of	 protonated	 N‐chloropiperidine	 (5‐14ClH)	 is	 weakened	 by	
37.1	kJ	mol‐1	 compared	 to	 that	 in	neutral	N‐chloropiperidine.	On	 the	other	hand	 the	
homolytic	 N‐H	 cleavage	 of	 piperidinium	 ion	 5‐14H	 is	 raised	 to	 a	 value	 of	
+422.1	kJ	mol‐1	 in	 the	 gas	 phase.	 The	 experimental	 determined	 BDE	 of	 5‐14H	 in	
DMSO	 was	 estimated	 to	 be	 +431.4	kJ	mol‐1.	 Applying	 a	 continuum	 model	
(SMD/UB3LYP/	6‐31G(d))[60]	 to	the	isodesmic	reaction	the	theoretical	BDE	values	is	
matching	 the	 experiment	 well	 (BDEsol(5‐14H)	 =	 +425.88	 kJ	 mol‐1).	 The	 results	 for	
piperidinium	ion	5‐14ClH	and	the	chloro	derivative	5‐14Cl	can	easily	be	explained	by	
the	 increase	 of	 polarization	 of	 the	 N‐halogen	 bond	 upon	 charge	 induction.	 The	
weakest	 bond	 is	 not	 the	 N‐Cl	 but	 the	 C‐H	 bond	 in	 the	 neighboring	 ‐position	 of	
protonated	 piperidinyl	 radical	5‐14R+	 (BDE	 =	 +75.21	 kJ	 mol‐1),	 which	 is	 displayed	
graphically	in	Figure	5.6.		
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Figure	5.6	 Experimental[115]	 (red	 bars)	 vs	 calculated	 (black	 bars,	 G3(MP2)‐RAD)	 bond	 dissociation	
energies	in	the	gas	phase	(Ar	=	p‐F‐C6H5).	
The	‐CH	bond	in	neutral	piperidinyl	radical	5‐14R	is	about	20	kJ	mol‐1	stronger.	This	
low	 bond	 energy	 is	 not	 only	 the	 result	 of	 inductive	 effects	 induced	 by	 the	 positive	
charged	 nitrogen	 center,	 but	 can	mainly	 be	 explained	 by	 the	 bond	 situation	 in	 the	
newly	 formed	 product.	 Upon	 CH	 bond	 homoysis	 of	 5‐14R	 or	 5‐14R+	 a	 	 bond	 is	
formed	together	with	the	hydrogen	atom.	For	closed‐shell	molecules	like	neutral	(5‐
14)	 or	 protonated	 piperidine	 (5‐14H)	 such	 gain	 in	 energy	 is	 not	 possible	 (Figure	
5.7).	
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Figure	5.7	 Homolytic	 cleavage	with	 high	 (left)	 and	 low	BDE	 (right)	 due	 to	 the	 formation	of	 double	
bonds.	
Secondly,	in	the	case	of	saturated	N‐heterocycles	the	unpaired	electron	in	the	nitrogen	
	orbital	interacts	with	the	*(C‐H).	For	the	closed‐shell	piperidinium	ion	5‐14H	this	
overlap	 is	 reduced,	 resulting	 in	 the	 highest	 BDE	 of	 +440	 kJ	mol‐1	 (see	Figure	5.8).	
Therefore	 a	 mechanism	 involving	 the	 cleavage	 of	 ‐CH	 bonds	 in	 paroxetine	
metabolite	5‐12R+	is	very	likely	to	proceed	and	indeed	such	intermediates	have	been	
identified	computationally	by	Vrçek.[204]	
N
H
R
H
*(C-H)
N R
H
*(C-H)
H
H

5-14H 5-14R+ 	
Figure	5.8	 Secondary	orbital	 interactions	 responsible	 for	 the	 low	‐CH	bond	dissociation	 energy	of	
aminyl	radicals.	
The	 pKa	 values	 for	 protonated	 amines	 and	 aminyl	 radicals	 have	 been	 calculated	
according	to	the	equations	in	Chapter	4.6	using	H2O/H3O+	as	reference	(pKa	=	‐15.7)	
and	the	so	obtained	results	for	piperidinium	ion	5‐14H	and	its	radical	5‐14R	are	in	
good	agreement	with	 literature	known	numbers	 (see	Table	5.3).	 The	acidity	of	 the	
respective	open‐shell	intermediate	5‐12R+	is	quite	similar	to	its	parent	aminyl	radical	
5‐14R,	which	 in	general	 is	 the	result	of	 the	 larger	amount	of	s	character	 in	the	 lone	
pair	orbital	 (sp2)	compared	to	 the	closed‐shell	amine	with	 its	sp3	 configuration.	The	
pKa	value	of	+3.8	suggests	 that	both	species,	 the	neutral	and	the	protonated	radical,	
can	coexist	in	neutral	media.		
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Table	5.3	Boltzmann‐averaged	free	energies	of	proton	transfer	at	various	levels	of	theory	(in	kJ	mol‐1,	
at	 298.15	 K	 and	 1	 atm,	 Ar	 =	 p‐F‐C6H5).	 Aqueous	 solvation	 free	 energies	 Gsolv	 for	 individual	
components	are	obtained	from	SMD/(U)HF/6‐31G(d)//(U)B3LYP/6‐31G(d).	
+     H2ON
GrxnR H
X
N
R
X
(sol) (sol) (sol) (sol)
+     H3O
	
	
(U)B3LYPa	 (U)CCSD(T)b (RO)MP2c	
G3(MP2)‐
RAD	 Exp.	
N
H
H 	
5-14H 
Ggas	 +260.07	 +263.45	 +262.20	 +265.19	 	
Gsol	 +142.08	 +145.46	 +144.21	 +147.20	 	
pKa	 +9.19	 +9.78	 +9.56	 +10.08	 +11.2[205]
N H
	
5-14R+ 
Ggas	 +245.67	 +234.50	 +241.17	 +246.46	 	
Gsol	 +111.15	 +99.98	 +106.65	 +111.94	 	
pKa	 +3.77	 +1.81	 +2.98	 +3.91	 +5.8[206]	
N
H
H
Ar
HO 	
5-12H 
Ggas	 +280.90	 +279.79	 +275.36	 +278.03	 	
Gsol	 +152.36	 +151.25	 +146.82	 +149.49	 	
pKa	 +10.99	 10.79	 +10.02	 +10.49	 	
N HAr
HO
5-12R+	
Ggas	 +267.60	 +248.52	 +245.34	 +252.96	 	
Gsol	 +125.79	 +106.71	 +103.53	 +111.15	 	
pKa	 +6.33	 +2.99	 +2.43	 +3.77	 	
a	UB3LYP/6‐31G(d).	b	(U)CCSD(T)/6‐31G(d).	c	(RO)MP2(FC)/6‐311+G(3df,2p).		
5.6 Hydrogen	Atom	Transfer	
5.6.1 Intramolecular	Pathways	
As	 already	 mentioned	 in	 Chapter	 5.2,	 aminium	 radicals	 R2NH•+	 easily	 abstract	
exposed	hydrogen	atoms	either	intra‐	or	intermolecularly	to	form	more	stable	open‐
shell	 intermediates	 and	 ammonium	 ions.	 Hydrogen	 atom	 transfer	 (HAT)	 is	 per	
definition	the	concerted	movement	of	a	proton	and	an	electron	in	a	single	kinetic	step	
from	 one	 group	 to	 another.	 In	 piperidinyl	 radical	 5‐12R+	 of	 paroxetine	 metabolite	
5‐12	four	exposed	positions	are	feasible	and	have	been	examined	theoretically.	Kwon	
and	Armbrust	have	estimated	the	unimolecular	rate	constant	for	photodegradation	of	
paroxetine	metabolite	5‐12	to	be	0.0529	h‐1	(calculated	as	the	rate	of	disappearance	
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of	paroxetine	5‐7)	which	corresponds	to	a	barrier	of	ca.	100	kJ	mol‐1	at	pH	7	and	25	
°C.[200]	All	theoretically	calculated	barriers	should	therefore	not	exceed	this	value.		
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Figure	5.9	Schematic	energy	profile	of	hydrogen	atom	transfer	in	the	gas	phase	at	G3(MP2)‐RAD	level	
of	theory	at	298.15	K	and	1	atm	(Ar	=	p‐F‐C6H5).	
Besides	 the	 well‐established	 G3(MP2)‐RAD	 approach,[81]	 Radom	 recently	
benchmarked	various	methods	to	obtain	accurate	barriers	for	water‐mediated	proton	
transfer	 and	 identified	 the	dispersion‐corrected	double	hybrid	 functional	B2PLYP‐D	
as	 a	 reasonable	 compromise	 of	 accuracy	 and	 computing	 time.[207]	 The	 results	 are	
summarized	 together	with	 the	G3(MP2)‐RAD	 results	 in	Table	5.4.	 Solvation	 effects	
have	 been	 included	 using	 a	 conductor‐like	 polarizable	 continuum	 model	 (C‐PCM)	
with	 United	 Atom	 Hartree‐Fock	 (UAHF)	 radii	 and	 B3LYP/6‐31G(d)	 single	 point	
calculation.[82]	 The	 differences	 in	 reaction	 barriers	 for	 both	 methods	 are	 almost	
identical,	 but	 reaction	 free	 energies	 G298	 (G3(MP2)‐RAD)	 are	 more	 negative,	
especially	 in	 the	 case	 for	 the	 generation	 of	 open‐shell	 intermediate	 5‐17R.	
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Considering	 gas	 phase	 calculations	 only	 the	 barriers	 for	 the	 formation	 of	
intermediates	 5‐17R	 and	 5‐18R	 are	 lower	 than	 the	 experimental	 threshold	 of	
+100	kJ	mol‐1	(see	Table	5.4).		
Table	5.4	Boltzmann‐averaged	 free	energy	differences	 for	H‐atom	transfer	of	N‐centered	paroxetine	
metabolite	5‐12R+	in	the	gas	phase	or	in	solutiona	(in	kJ	mol‐1,	at	298.15	K	and	1	atm,	Ar	=	p‐F‐C6H5).	
	 UB3LYPb	 ROMP2c	 UB2PLYPd	 G3(MP2)‐RAD	
3
2
N
H
4
Ar
7
OH
5-12R+ 	
<G‡>	
<Gsol‡>	
<G>	
<Gsol>	
<G‡>	
<Gsol‡>
<G>	
<Gsol>
<G‡>	
<Gsol‡>
<G>	
<Gsol>	
<G‡>	
<Gsol‡>	
<G>	
<Gsol>
N	→C2	
+201.2	
+195.8	
+32.2	
+29.4	
+154.6	
+150.0	
‐9.00	
‐12.8	
+181.9	
+173.4	
+13.8	
+8.25	
+177.4	
+172.0	
+6.55	
+1.41	
N	→C3	
+167.6	
+190.7	
+8.08	
+2.93	
+126.7	
+150.7	
‐26.7	
‐29.0	
+153.8	
+174.9	
‐5.83	
‐11.5	
+152.3	
+175.5	
‐12.2	
‐16.5	
N	→C4	
+98.9	
+130.1	
‐46.9	
‐41.5	
+67.7	
+99.7	
‐70.9	
‐64.7	
+93.3	
+122.4	
‐48.8	
‐45.6	
+96.0	
+127.3	
‐61.2	
‐73.9	
N	→C7	
+78.9	
+88.6	
+7.71	
‐11.1	
+40.2	
+50.7	
‐33.7	
‐50.1	
+67.1	
+74.7	
‐12.2	
‐30.4	
+71.0	
+80.8	
‐17.2	
‐35.2	
a	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d).	b	UB3LYP/6‐31G(d).	c	ROMP2(FC)/6‐311++G(3df,2p)//UB3LYP/	
6‐31G(d)	d	UB2PLYP‐D/aug‐cc‐pVDZ//UB3LYP/6‐31G(d).	
	
The	identified	transition	states	are	displayed	in	Figure	5.10.	All	methods	predict	the	
lowest	barrier	for	transfer	of	the	hydrogen	atom	in	‐position	of	the	hydroxyl	group	
to	 the	 nitrogen	 center.	 The	 chair‐like	 5‐membered	 transition	 state	 is	 favored	 by	 ca.	
11	kJ	 mol‐1	 over	 the	 alternative	 boat‐shaped	 transition	 state	 with	 the	 large	 phenyl	
group	in	equatorial	position.	
N
Ar
H
HO
N
Ar
H
H OH
H
N
OH
H
Ar
G   = + 82.1 kJ mol-1 G   = + 71.0 kJ mol-1
5-12R+
	
Scheme	5.8	Boat‐	 vs.	 chair‐like	 transition	 states	 for	 the	N→C7‐hydrogen	atom	transfer	at	G3(MP2)‐
RAD	level	of	theory	in	the	gas	phase	(Ar	=	p‐F‐C6H5).	
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N →	C4	 	 	 	 		N →	C7 
			 	
	 	 	 			N →	C3	 	 	 	 	 N	→	C2	
Figure	 5.10	 Graphical	 representation	 of	 the	 UB3LYP/6‐31G(d)	 optimized	 transition	 states	 of	 the	
hydrogen	atom	transfer	reactions	for	5‐12R+.	Distances	are	given	in	pm.	
5.6.2 Water‐assisted	Pathways	
For	 the	 correct	 description	 of	 open‐shell	 systems	 in	water	 the	 inclusion	 of	 specific	
solvent	effects	 in	either	 implicit	or	explicit	 form	 is	mandatory.	According	 to	Pliego’s	
approach,[208]	Vrček	 identified	 the	most	 stable	 structures	 by	 varying	 the	 number	 of	
explicit	 water	 molecules	 (n	 =	 0‐3)	 and	 compared	 the	 resulting	 Gibbs	 energies	 of	
solvation.[204]	 He	 found	 that	 one	 water	 molecule	 added	 to	 5‐12R+	 gives	 the	 most	
negative	 Gsolv	 and	 substantially	 lowers	 all	 examined	 barriers.	 The	 most	 suitable	
coordination	 site	 for	H2O	was	 assigned	 upon	Mulliken	 charge	 analysis	 for	 the	most	
positively	 charged	 hydrogen	 atom	 and	 nearest	 proximity	 to	 the	 reaction	 centers.	
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Three	 different	 transfer	modes	 have	 been	 examined	 theoretically	 and	 are	 depicted	
graphically	 in	Scheme	5.9.	 In	 the	 spectator	mode	 (TS1)	 the	water	molecule	 has	 no	
influence	on	the	transfer	of	the	respective	hydrogen	atom	to	the	electrophilic	nitrogen	
center.	 However,	 in	 the	 shuttle	 (TS2)	 or	 carrier	 mode	 (TS3)	 the	 H2O	 molecule	
facilitates	 the	 transfer	 in	a	cooperative	way	comparable	 to	 the	well	known	histidine	
proton	 shuttle	 in	proteins.	The	 calculated	Gibbs	 energies	 are	 collected	 in	Table	5.5	
and	shown	graphically	in	Figure	5.10.	
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Scheme	5.9	Theoretically	examined	water‐assisted	transfer	modes:	spectator	(TS1),	carrier	(TS2)	and	
shuttle	mode	(TS3).	
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Table	5.5	Boltzmann‐averaged	barriers	and	free	reaction	energies	for	water‐assisted	H‐atom	transfer	
of	N‐centered	paroxetine	metabolite	5‐12R+	 in	the	gas	phase	or	 in	solutiona	(in	kJ	mol‐1,	at	298.15	K	
and	1	atm,	Ar	=	p‐F‐C6H5).	
3
2
N
H
4
Ar
R
	
UB3LYPb	 ROMP2c	 UB2PLYPd	 G3(MP2)‐RAD	
TS1	
<G‡>	
<Gsol‡>	
<G>	
<Gsol>	
<G‡>	
<Gsol‡>
<G>	
<Gsol>
<G‡>	
<Gsol‡>
<G>	
<Gsol>
<G‡>	
<Gsol‡>	
<G>	
<Gsol>
N+•	→	C2	
+200.7	
+193.2	
+44.8	
+24.5	
+161.5	
+153.9	
+10.5	
‐10.1	
+184.0	
+176.4	
+28.7	
+8.08	
+182.8	
+175.0	
+23.2	
+2.38	
N+•	→	C3	
+175.1	
+190.1	
+9.69	
+0.94	
+138.6	
+153.4	
‐17.9	
‐23.7	
+162.6	
+177.4	
‐2.26	
‐9.19	
+162.8	
+177.5	
‐6.54	
‐12.8	
N+•	→	C4	
+113.0	
+131.4	
‐44.6	
‐43.9	
+85.1	
+103.3	
‐62.0	
‐61.6	
+107.6	
+125.8	
‐45.4	
‐45.0	
+111.0	
+129.1	
‐55.5	
‐55.1	
TS2	
<G‡>	
<Gsol‡>	
	
<G‡>	
<Gsol‡>
	
<G‡>	
<Gsol‡>
	
<G‡>	
<Gsol‡>	
	
N+•	→	C2	
+193.8	
+193.9	
	 +152.8	
+152.7	
	 +173.5	
+173.4	
	 +172.2	
+172.1	
	
N+•	→	C3	
+172.2	
+172.3	
	 +147.2	
+147.2	
	 +164.0	
+164.0	
	 +163.7	
+163.5	
	
N+•	→	C4	
+196.1	
+132.0	
	 +161.8	
+97.6	
	 +182.0	
+117.9	
	 +176.7	
+112.4	
	
TS3	
<G‡>	
<Gsol‡>	
	
<G‡>	
<Gsol‡>
	
<G‡>	
<Gsol‡>
	
<G‡>	
<Gsol‡>	
	
N+•	→	C2	
+205.0	
+121.2	
	 +176.5	
+92.6	
	 +192.7	
+108.7	
	 +195.6	
+111.5	
	
N+•	→	C3	
+189.0	
+204.6	
	 +207.0	
+222.5	
	 +195.7	
+211.2
	 +220.4	
+235.8	
	
N+•	→	C4	
+136.5	
+147.0	
	 +123.5	
+133.9	
	 +132.6	
+142.9	
	 +156.6	
+166.8	
	
a	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d).	b	UB3LYP/6‐31G(d).	c	ROMP2(FC)/6‐311+G(3df,2p)//UB3LYP/6‐31G(d)	
d	UB2PLYP‐D/aug‐cc‐pVDZ//UB3LYP/6‐31G(d).	
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Figure	5.11	Graphical	representation	of	the	obtained	barriers	and	reaction	free	energies	at	G3(MP2)‐
RAD	level	in	gas	phase	and	solution.	
Again,	 the	most	exergonic	pathway	 is	that	 for	 the	formation	of	C4‐centered	benzylic	
radical	5‐17R	 at	G3(MP2)‐RAD	 level	 (G298	=	 ‐55.5	kJ	mol‐1,	Gsol	 =	 ‐55.1	kJ	mol‐1).	
Feasible	barriers	in	solution	with	one	explicit	water	molecule	have	been	identified	for	
the	hydrogen	 transfer	 to	 yield	 either	C2‐centered	 radical	5‐20R‐H2O	 (carrier	mode	
TS3,	G‡sol	 =	 +111.5	 kJ	mol‐1)	 or	 C4	 radical	5‐17R‐H2O	 (shuttle	mode	 TS2,	G‡sol	 =	
+112.4	 kJ	 mol‐1).	 Nevertheless,	 the	 formation	 of	 C2	 radical	 5‐20R‐H2O	 can	 be	
neglected	due	to	its	endergonic	free	reaction	energies	(G298	=	+23.2	kJ	mol‐1,	Gsol	=	
+2.38	kJ	mol‐1).	The	optimized	 transition	states	 for	 the	 three	modes	 to	 form	radical	
5‐17R‐H2O	are	shown	in	Figure	5.12.	
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   TS1         TS2 
	
          TS3 
Figure	 5.12	 Graphical	 representation	 for	 the	 UB3LYP/6‐31G(d)	 optimized	 transition	 states	 TS1	
(spectator	mode),	 TS2	 (shuttle	mode)	 and	 TS3	 (carrier	mode)	 for	 the	 hydrogen	 atom	 transfer	 from	
position	C4.	Distances	are	given	in	pm.	
5.7 Radical‐induced	Dehydration	Pathways	
As	 already	 shown	 in	 Chapter	 5.5	 the	 C‐H	 BDE	 with	 the	 very	 low	 value	 of	
+75.2	kJ	mol‐1	 at	 G3(MP2)‐RAD	 level	 of	 theory	 is	 a	 preferential	 point	 of	 attack	 for	
chemical	 transformations	 of	 paroxetine	 metabolite	 5‐12	 upon	 excitation.	 As	 an	
alternative	unimolecular	pathway	N‐centered	radical	cation	5‐12R+	ican	involve	C‐H	
cleavage,	 in	which	 the	 hydrogen	 atom	 at	 C2	 position	will	 be	 transferred	 to	 the	 C7‐
hydroxy	 group	 to	 form	 the	 appropriate	water	 leaving	 group.	 The	 resulting	 iminium	
radical	5‐22R+	can	now	either	attack	the	phenyl	ring	nucleophilly	to	generate	Kwan’s	
proposed	 tricycle	 5‐26R+	 (G‡sol	 =	 +72.9	 kJ	 mol‐1)	 or	 forms	 allyl‐stabilized	 radical	
cation	5‐24R+	via	1,2‐H‐shift	(G‡sol	=	+76.9	kJ	mol‐1).	Radical	5‐24R+	represents	the	
most	exergonic	product	of	all	considered	reaction	pathways	in	solution	(Gsol	=	‐102.3	
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kJ	 mol‐1)	 at	 G3(MP2)‐RAD	 level	 in	 combination	 with	 explicit	 and	 implicit	 water	
solvation	(Figure	5.13).		
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Figure	5.13	Schematic	free	energy	profile	in	solution	G298	+	Gsolv	(C‐PCM/UAKS/UB3LYP/6‐31G(d))	
for	 dehydration	 of	 5‐12R+	 (imine	 formation	 in	 brown,	 cyclodehydration	 formation	 in	 green)	 at	
G3(MP2)‐RAD	level	of	theory.	Explicit	water	molecules	have	been	omitted	for	clarity.[204]	
The	 Vrçek	 group,	 who	 was	 responsible	 for	 the	 identification	 of	 these	 structures,	
studied	additional	pathways	including	the	formation	of	bycyclic	pyridines	5‐30R	and	
5‐32R	 or	 allyl	 radical	 5‐28R	 starting	 from	 C4‐centered	 radical	 5‐17R.[204]	
Unfortunatelly,	these	reactions	are	unfeasible,	because	either	the	barrier	is	too	high	or	
endergonic	products	are	formed	(Figure	5.14).		
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Figure	 5.14	 Schematic	 free	 energy	 profile	 in	 solution	 G298	 +	 Gsolv	 (C‐PCM/UAKS/UB3LYP/	
6‐31G(d))	 for	 dehydration	 of	 5‐12R+	 (alkene	 formation	 in	 red,	 three‐membered	 ring	 formation	 in	
blue)	at	G3(MP2)‐RAD	level	of	theory.	Explicit	water	molecules	have	been	omitted	for	clarity.[204]	
From	a	kinetic	point	of	view	the	formation	of	imines	5‐22R,	5‐24R	and	the	tricycle	5‐
26R	 is	 favoured	 compared	 to	 alkene	5‐28R	 or	 bicyclic	 intermediates	5‐30R	 and	5‐
32R.	But	the	opposite	is	observed	from	the	thermochemical	standpoint.		
In	 2004	 Potáček	 and	 coworkers	 examined	 the	 N‐methyl	 derivative	 of	 paroxetine	
metabolite	 5‐12	 for	 possible	 ionic	 elimination	 reactions	 and	 indeed	 were	 able	 to	
isolate	 under	 microwave	 irradiation	 in	 the	 presence	 of	 alumina	 or	 KF‐alumina	
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mixtures	of	the	two	isomeric	piperidyl	alkenes	5‐28a	and	5‐28b.[209]	The	existence	of	
5‐28a/5‐28b	 has	 also	 been	 confirmed	 by	 applying	 electrospray	 ionization	 mass‐
spectrometry	(ESI‐MS).		
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Scheme	5.10	Ionic	elimination	to	5‐28a	according	to	Potáček	et	al.[209]	
In	order	to	complete	this	project	considering	not	only	kinetic	but	also	thermodynamic	
stability,	radical	stabilization	energies	of	all	products	are	explored.	
5.7.1 RSE	of	Hydrolysis	Intermediates		
Based	 on	 the	 computational	 results	 presented	 herein,	 a	 central	 position	 in	 the	
reaction	cascade	is	occupied	by	the	initial	hydrogen	atom	transfer,	which	serves	as	the	
starting	 point	 for	 all	 outlined	 pathways.	 The	 stabilization	 energies	 for	 these	
intermediates	at	different	levels	of	theory	have	been	summarized	in	Table	5.6.		
The	 benzylic	 radical	 5‐17R	 is	 the	 most	 stable	 open‐shell	 species	 with	 an	 RSE	 of	
‐71.8	kJ	mol‐1	at	G3(MP2)‐RAD	level	among	the	four	considered	key	intermediates	for	
the	 dehydration	process.	 Radical	5‐19R	 is	 a	 typical	 example	 of	 a	 stabilized	 tertiary	
radical	and	features	an	RSE	of	‐21.1	kJ	mol‐1,	which	is	slightly	decreased	compared	to	
the	archetypical	tert‐butyl	radical	5‐34R	(RSE	=	‐28.5	kJ	mol‐1).[93]	This	is	mainly	the	
results	 of	 the	 presence	 of	 stereoelectronic	 interactions.	 The	‐hydroxy	 substituted	
radical	5‐18R,	for	which	the	lowest	barrier	of	its	formation	was	found,	is	stabilized	by	
‐30.4	kJ	mol‐1.	The	worst	stabilization	is	found	for	open‐shell	species	5‐20R	with	the	
unpaired	spin	located	in	direct	proximity	to	the	positively	charged	ammonium	group	
(RSE	=	‐4.0	kJ	mol‐1	at	G3(MP2)‐RAD	level	of	theory).	In	conclusion,	oxygen‐centered	
radical	5‐33R,	which	could	be	 formed	via	a	6‐membered	 transition	state,	 cannot	be	
considered	as	a	likely	intermediate	due	to	its	high	O‐H	dissociation	energy	of	+461.6	
kJ	mol‐1	as	compared	to	the	less	stabilized	radical	5‐20R	(BDE	=	+435.3	kJ	mol‐1).	
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Table	 5.6	 Theoretical	 Boltzmann‐averaged	 radical	 stabilization	 energies	 of	 C‐centered	 radicals	 (in	
kJ	mol‐1,	Ar	=	p‐F‐C6H5).	
R H +      CH3 R +    CH4
+
RSE
RO H OH +RO H2O 	
R•	 UB3LYPa ROMP2b G3(MP2)‐RAD BDEc	
H2N
Ar
O
5-33R 	
‐42.29	 ‐27.84	 ‐35.53	 +461.6	
H2N
Ar
HO
5-20R 	
‐19.76	 ‐2.09	 ‐4.04	 +435.3	
H2N
Ar
HO
5-19R 	
‐41.96	 ‐18.16	 ‐21.13	 +418.2	
H2N
Ar
HO
5-18R 	
‐46.72	 ‐29.28	 ‐30.38	 +408.9	
H2N
Ar
HO
5-17R 	
‐98.63	 ‐64.03	 ‐71.76	 +367.5	
a	 UB3LYP/6‐31G(d).	 b	 ROMP2(FC)/6‐311+G(3df,2p)//UB3LYP/6‐31G(d).	 c	 BDE	 (R‐H)	 =	 RSE	 (R•)	 +	 BDE	 (Ref),	 BDE(CH4)	 =	
+439.3,	BDE	(H2O)	=	+497.1	kJ	mol‐1.[115]	
	
The	role	of	benzyl	radical	5‐17R	as	key	intermediate	of	Vrçek’s	reaction	pathways	is	
confirmed	here,	since	it	displays	the	overall	most	stable	open‐shell	species	compared	
to	all	C‐centered	and	aminyl	radicals	(see	Figure	5.15).	
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Figure	5.15	RSE	and	BDE	values	of	a	variety	of	C‐	and	N‐centered	radicals	in	the	gas	phase	(G3(MP2)‐
RAD,	in	kJ	mol‐1).[93]	
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5.7.2 RSE	of	Dehydration	Products	
What	all	reaction	products	of	this	survey	have	in	common	are,	that	they	mainly	belong	
to	 the	 class	of	 trisubstituted	benzyl	 radicals.	The	effect	of	 the	electron‐withdrawing	
fluoro	substituent	in	para	position	of	the	phenyl	ring	is	small	and	lowers	the	RSE	by	
about	 2	 kJ	mol‐1	 compared	 to	 the	 dimethyl	 benzyl	 radical	5‐40R.	 This	 incidence	 is	
known	for	para	substituted	benzyl	radicals	and	is	indicated	by	smaller	spin	densities	
at	 the	 benzylic	 position	 (5‐40R:	 0.751,	 5‐17R:	 0.734,	 5‐30R:	 0.713).	 Interestingly,	
allylic	radical	5‐39R	shows	the	same	stability	compared	to	Kwon’s	postulated	tricycle	
5‐13R[200]	(see	Figure	5.16).		
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Figure	5.16	Boltzmann‐averaged	RSE	of	benzylic	radicals	at	G3(MP2)‐RAD	level	 in	the	gas	phase	(in	
kJ	mol‐1).	
The	stabilization	energies	for	all,	in	principle,	feasible	C‐centered	radicals	considered	
by	Vrçek	are	depicted	in	Table	5.7.	
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Table	 5.7	 Theoretical	 Boltzmann‐averaged	 radical	 stabilization	 energies	 of	 C‐centered	 radicals	 (in	
kJ	mol‐1,	Ar	=	p‐F‐C6H5).	
R H +      CH3
RSE
R +    CH4 	
R•	 UB3LYPa ROMP2b G3(MP2)‐RAD BDEc	
HN
Ar
5-22R 	
‐15.20	 +0.95	 ‐0.87	 +438.4	
HN
Ar
5-30R 	
‐96.35	 ‐63.27	 ‐70.79	 +368.5	
H2N
F
5-13R 	
‐109.29	 ‐76.64	 ‐82.35	 +356.9	
H2N
Ar
5-28R 	
‐111.65	 ‐79.56	 ‐82.54	 +356.8	
HN
Ar
5-39R 	
‐134.62	 ‐94.26	 ‐95.74	 +343.6	
HN
F
5-26R 	
‐117.47	 ‐101.61	 ‐97.03	 +342.3	
HN
Ar
5-24R 	
‐132.87	 ‐101.99	 ‐100.14	 +339.2	
a	 UB3LYP/6‐31G(d).	 b	 ROMP2(FC)/6‐311+G(3df,2p)//UB3LYP/6‐31G(d).	 c	 BDE	 (R‐H)	 =	 RSE	 (R•)	 +	 BDE	 (CH4),	 BDE(CH4)	 =	
+439.3	kJ	mol‐1.[115]	
	
It	is	known	in	the	literature,	that	protonated	aminyl	radicals	undergo	fragmentation	if	
highly	 stabilized	 radicals	 are	 formed.[185]	 Under	 these	 circumstances,	 allyl	 radical	
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5‐39R	 is	 generated	 as	 dehydration	 product,	 which	 is	 characterized	 by	 the	 largest	
radical	stabilization	of	all	benzyl	radicals.	Unfortunately,	all	attempts	to	find	a	reaction	
pathway	to	its	formation,	particularly	the	proton	transfer	from	the	ammonium	to	the	
hydroxyl	 group,	 was	 not	 found	 by	 DFT	 theory	 (UB3LYP/6‐31G(d)).	 Nevertheless,	
optimization	of	intermediate	5‐17R	led	to	the	instantaneous	elimination	of	water	and	
5‐39R.	
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Scheme	5.11	Proposed	mechanism	of	the	formation	of	allyl	benzyl	radical	5‐39R.	
The	piperidinium	radical	5‐22R	 located	on	the	pathway	for	the	cyclization	to	5‐26R	
represents	a	very	 reactive	primary	 radical	 as	 indicated	by	an	almost	 thermoneutral	
stabilization	of	‐0.9	kJ	mol‐1	in	the	gas	phase.	The	probability	to	handle	this	reactivity	
by	the	subsequent	[1,2‐H]	migration	to	form	heteroallylic	5‐24R	or	cyclization	to	5‐
26R	 is	 verified	 by	 its	 low	 RSE	 and	 barriers.	 Similar	 results	 are	 found	 for	 the	
biologically	 important	adenosyl	 radical	 (5‐42R),	which	either	undergoes	 cyclization	
to	 open‐shell	 8,5’‐anhydroadenosine	 (5‐43R)	 or	 hydrogen	 transfer	 to	 5’‐
desoxyadenosine	(5‐44).[210]	
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Scheme	5.12	Possible	reactions	of	5‘‐adenosyl	radical	5‐42R.	
Heteroallyl	 radical	5‐24R	 is	 the	most	 stable	 among	 all	 reaction	 products	 either	 on	
enthalpic	 or	 on	 kinetic	 scale	with	 an	RSE	 value	 of	 ‐100.1	 kJ	mol‐1.	 The	 protonation	
state	has	almost	no	influence	on	the	radical	stabilization	energy	as	indicated	in	Figure	
5.17	 with	 the	 more	 simple	 iminyl	 radicals	 5‐46R	 and	 5‐46R+.	 Similarly,	 the	 spin	
densities	as	indicators	for	delocalization	are	not	changed.	
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Figure	5.17	Mulliken	spin	densities	and	RSEs	at	G3(MP2)‐RAD	level	(in	kJ	mol‐1).[93]	
The	 influence	 of	 the	 substitution	 pattern	 of	 delocalized	 aminyl	 radical	 5‐46R	 and	
5‐46R+	 has	 been	 examined	 carefully	 by	 simple	 addition	 of	 methyl	 groups.	 The	
comparison	with	the	isolelectronic	all‐carbon	derivatives	are	depicted	in	Figure	5.18.		
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Figure	5.18	Saturation	behavior	of	multiply	substituted	C‐centered	radicals	at	G3(MP2)‐RAD	level.[93]	
One	 notices	 immediately,	 that	 the	 stabilities	 of	 the	 four	 respective	 systems	 are	 not	
equally	 spaced.	 The	 enthalpy	 differences	 are	 significantly	 larger	 for	 the	 more	
electrophilic	nitrogen	containing	radicals	than	the	allylic	counterparts.	This	behavior	
of	 saturation	 can	 be	 observed	 by	 repeated	 addition	 of	 the	 same	 residue	 both	with	
simple	alkyl	and	more	strongly	interacting	substituents[211].	The	influence	of	the	ring	
conformation	is	negligible	upon	replacement	of	a	CH	with	an	NH+	group.	
5.8 Conclusion	
The	accumulation	of	pharmaceutically	active	compounds	in	waste	or	drinking	water	
is	 of	 growing	 importance	 for	 the	world’s	 population.	 Therefore,	 quantum	 chemical	
calculations	have	been	used	to	evaluate	the	chemical	properties	and	possible	reaction	
channels	 of	 open‐shell	 piperidine	 5‐12R+,	 which	 is	 considered	 to	 be	 the	 key	
intermediate	 in	 the	 environmental	 (photo)degradation	 of	 paroxetine	 (5‐7).	 This	
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included,	 for	example,	bond	dissociation	energies,	hydrogen	atom	transfer	reactions	
and	radical‐induced	dehydrations.	
N
FO
H
O
O
N
FHO
H
N
FHO
H
Paroxetine (5-7)
5-12 5-12R+e
h
H2N
FHO
5-17R
HN
F
G  < 100 kJ mol-1
5-22RH2O
H2N
F
G  > 100 kJ mol-1
5-28RH2O
~ H(C4)~ H(C7)
H2N
FHO
5-18R 	
Scheme	5.13	Exemplary	reaction	pathways	of	the	hydrolysis	product	5‐12	of	paroxetine	(5‐7)	upon	
photolysis.	
Considering	the	hydrogen	atom	transfer,	 the	[1,4]‐H	shift	 to	yield	5‐17R	 is	 the	most	
favorable	pathway	if	a	cluster	continuum	model	with	water	as	solvent	and	reagent	is	
included.	 In	 the	 gas	 phase	 without	 explicit	 solvation	 the	 formation	 of	 ‐hydroxy	
radical	5‐18R	is	preferred.		
The	unpaired	spin	at	the	nitrogen	atom	has	a	significant	impact	on	the	bond	strength	
of	the	‐CH	bond,	which	is	decreased	dramatically	and	opens	a	dehydration	pathway	
never	considered	before	with	iminium	radical	5‐22R	as	intermediate.		
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Table	5.8	Theoretical	obtained	bond	dissociation	energies	(G3(MP2)‐RAD	level)	in	the	gas	phase	for	
varies	piperidines	
	 N
H
H
5-14
NH
5-14R 	
N
H
H
5-14R+
N
H
5-14 	
N
H
5-12
Ar
HO
	
N
Cl
5-12Cl
Ar
HO
BDE	
(kJ	mol‐1)	 +390.5	 +95.1	 +75.2	 +403.4 +401.7	 +247.2
	
In	addition,	the	stability	of	different	dehydrated	product	radicals	has	been	evaluated	
to	 support	 the	 existence	 of	 proposed	 reaction	 products	 even	 on	 a	 thermochemical	
scale.		
For	 structures	 5‐28R	 and	 5‐30R	 the	 experimentally	 observed	 reaction	 barrier	 of	
around	 +100	 kJ	 mol‐1	 is	 exceeded,	 but	 nevertheless	 it	 has	 to	 be	 noted	 that	 the	
formation	 of	 5‐28	 has	 already	 been	 proven	 and	 most	 likely	 proceeds	 without	 the	
intermediacy	 of	 free	 radicals.	 Kwon’s	 tricyclic	 piperidine	 5‐13	 and	 the	 newly	
proposed	enamine	5‐24	are	up	to	now	the	most	relevant	intermediates	to	be	formed	
in	 the	 (photo)degradation	 either	 from	 the	 kinetic	 or	 the	 thermochemical	 point	 of	
view.	
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Figure	5.19	Comparison	of	barriers,	reaction	free	energies	and	radical	stabilities.	
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5.9 Theoretical	Appendix	
Geometry	 optimizations	 of	 all	 systems	 have	 been	 performed	 at	 the	 (U)B3LYP/	
6‐31G(d)	 level	 of	 theory.	 Thermochemical	 corrections	 to	 298.15	 K	 have	 been	
calculated	at	the	same	level	of	theory	using	the	rigid	rotor/harmonic	oscillator	model.	
A	scaling	factor	of	0.9806	has	been	used	for	this	latter	part.	Single	point	energies	have	
then	 been	 calculated	 at	 different	 levels	 of	 theory,	 including	 the	 (RO)MP2(FC)/	
6‐311+G(3df,2p)	 and	 (U)B2PLYP‐D/aug‐cc‐pVDZ	 level.	 Combination	 of	 these	 total	
energies	 with	 thermochemical	 corrections	 obtained	 at	 B3LYP	 level	 yield	 the	
enthalpies	termed	as	"MP2"	or	“B2PLYP”	in	the	text:		
	
H(HL)	=	Etot(HL)	+	H(B3LYP,	0.9806)	–	Etot(B3LYP)	 	 (eq.	5.1)	
	
Improved	relative	energies	are	obtained	using	the	G3(MP2)‐RAD	scheme	proposed	by	
Radom	et	al.[81]	These	are	based	on	the	same	geometries	and	thermal	corrections	as	
the	MP2	level:	
	
Etot(G3(MP2)‐RAD)	=	Etot((U)CCSD(T)/6‐31G(d)//UB3LYP/6‐31G(d)	+	
+	DE(G3MP2large)	+	DE(HLC)	 	 	 (eq.	5.2)	
	
DE(G3MP2large)	=	(RO)MP2(FC)/G3MP2large	–	(RO)MP2(FC)/6‐31G(d)	 (eq.	5.3)	
	
DE(HLC)	=	‐A	n()	–	B	(n()	–	n())		 	 (eq.5.4)	
	
with	A	=	9.413x10‐3	 au,	B	=	3.969x10‐3	au	and	n()	 and	n()	 represent	 the	valence	
electrons,	respectively.	Finally,	enthalpies	are	averaged	by	the	Boltzmann	method:	
	
	
exp ∆
	
∑ ∆
	
	
H298 	 ∑ wiHini 1 			 	 	 (eq.	5.5)	
	
Additional	consideration	of	solvation	was	included	by	calculating	free	energies	using	
the	 polarizable	 continuum	 solvation	model	 in	 its	 C‐PCM[119]	 or	 SMD[60]	 variant	 and	
adding	 them	 to	 the	 gas	 phase	 enthalpies.	 (U)CCSD(T)	 calculations	 have	 been	
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performed	 with	 MOLPRO,[84]	 the	 geometry	 optimizations,	 frequencies	 and	 C‐PCM	
calculations	 with	 Gaussian03	 Rev.	 D.01.[85]	 The	 SMD	 model	 is	 implemented	 in	
Gaussian09	Rev.	C.01.[86]	
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Table	5.9	Energies	and	enthalpies	of	studied	compounds	(closed‐	and	open‐shell)	at	various	levels	of	
theory	in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
CH4	 ‐40.5183890	 ‐40.470240	 ‐40.4055437	 ‐40.4651605	
•CH3	 ‐39.8382922	 ‐39.804975	 ‐39.7316815	 ‐39.7851922	
NH3	 ‐56.5479476	 ‐56.510271	 ‐56.4504323	 ‐56.5036014	
•NH2	 ‐55.8726187	 ‐55.850247	 ‐55.7686657	 ‐55.8192957	
NH2Cl	 ‐516.1034330	 ‐516.073561	 ‐515.5082404	 ‐515.6084632	
N
X Y 	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	H	(5‐14)	 ‐251.9043988	 ‐251.740953	 ‐251.3373000	 ‐251.5876572	
X	=	•	(5‐14R)	 ‐251.2503261	 ‐251.100813	 ‐250.6735196	 ‐250.9225046	
X,	Y	=	H	(5‐14H)	 ‐252.2859532	 ‐252.107338	 ‐251.7102525	 ‐251.9636606	
X	=	H,	Y	=	•	(5‐14R+)	 ‐251.6243289	 ‐251.461735	 ‐251.0364096	 ‐251.2893059	
X	=	Cl	(5‐14Cl)	 ‐711.4700162	 ‐711.315399	 ‐710.4148056	 ‐710.7088087	
X	=	H,	Y	=	Cl	(5‐14ClH)	 ‐711.8264093	 ‐711.657573	 ‐710.7663371	 ‐711.0626184	
N
X 	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	/	(5‐53)	 ‐250.6879270	 ‐250.548845	 ‐250.1275807	 ‐250.3643284	
X	=	H	(5‐53H)	 ‐251.0687400	 ‐250.915636	 ‐250.4993520	 ‐250.7396565	
N
X Y
ArOH
	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	H	(5‐12)	
1	
‐696.7047170	 ‐696.429590	 ‐695.3578394	 ‐695.8880547	
2	 ‐696.7052976	 ‐696.429916	 ‐695.3589258	 ‐695.8890284	
3	 ‐696.7053907	 ‐696.430212	 ‐695.3593569	 ‐695.8894093	
4	 ‐696.7058900	 ‐696.430492	 ‐695.3603363	 ‐695.8902106	
5	 ‐696.69181855	 ‐696.416383	 ‐695.3453579	 ‐695.8762566	
6	 ‐696.6982159	 ‐696.422306	 ‐695.3502836	 ‐695.8810932	
7	 ‐696.6965504	 ‐696.421012	 ‐695.3502359	 ‐695.8810534	
8	 ‐696.6980953	 ‐696.422529	 ‐695.3524956	 ‐695.8831429	
9	 ‐696.7059898	 ‐696.429713	 ‐695.3571829	 ‐695.8873961	
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Table	5.10	Energies	and	enthalpies	of	studied	compounds	(closed‐	and	open‐shell)	at	various	levels	of	
theory	in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
N
X Y
ArOH
	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X,	Y	=	H	(5‐12H)	
1	
‐697.0973763	 ‐696.806475	 ‐695.7400695	 ‐696.2729667	
3	 ‐697.0796011	 ‐696.789152	 ‐695.7244486	 ‐696.2578215	
4	 ‐697.0904568	 ‐696.800185	 ‐695.7339445	 ‐696.2671066	
X	=	Cl	(5‐12Cl)	
1	
‐1156.2701199	 ‐1156.003759	 ‐1154.4363418	 ‐1155.0098548	
2	 ‐1156.2640590	 ‐1155.997352	 ‐1154.4310511	 ‐1155.0050468	
3	 ‐1156.26877040	 ‐1156.001610	 ‐1154.4334001	 ‐1155.0069384	
X	=	•	(5‐12R)	
1	
‐696.0521673	 ‐695.790747	 ‐694.6966258	 ‐695.2252238	
2	 ‐696.0416065	 ‐695.780204	 ‐694.6850463	 ‐695.2144278	
3	 ‐696.0510773	 ‐695.789096	 ‐694.6922163	 ‐695.2213836	
X	=	•,	Y	=	H	(5‐12R+)	
1	
‐696.4344588	 ‐696.160120	 ‐695.0609196	 ‐695.5939959	
2	 ‐696.4364562	 ‐696.161715	 ‐695.0631977	 ‐695.5966076	
3	 ‐696.4300297	 ‐696.155932	 ‐695.0518066	 ‐695.5860462	
4	 ‐696.4312302	 ‐696.157060	 ‐695.0594352	 ‐695.5925036	
N
X Y 	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	H	(5‐54R)	 ‐251.2501181	 ‐251.099965	 ‐250.6832114	 ‐250.9278106	
X,	Y	=	H	(5‐54R+)	 ‐251.6113195	 ‐251.447570	 ‐251.0358414	 ‐251.2836958	
N
X 	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	H	(5‐15)	 ‐409.1596691	 ‐408.881243	 ‐408.2301409	 ‐408.6488242	
X	=	•	(5‐15R)	 ‐408.5056768	 ‐408.240617	 ‐407.5652418	 ‐407.9828487	
N
X 	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
X	=	H	(5‐16)	 ‐135.1628504	 ‐135.066310	 ‐134.8608089	 ‐134.9999147	
X	=	•	(5‐16R)	 ‐134.5094855	 ‐134.427626	 ‐134.1990378	 ‐134.3362540	
N
	(5‐55)	 ‐133.9423365	 ‐133.870244	 ‐133.6497130	 ‐133.7754365	
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Figure	5.20	Conformational	dependence	of	the	radical	stability	of	5‐12	and	5‐14	in	their	neutral	and	
protonated	forms	(Ar	=	p‐F‐C6H5).	Red	bars	represent	Boltzmann‐averaged	values.	
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Table	5.11	Total	and	Gibbs	free	energies	at	various	levels	of	theory	for	the	calculation	of	pKa	values	in	
aqueous	media	in	Hartree	(SMD/HF	=	SMD/HF/6‐31G(d)//B3LYP/6‐31G(d)).	
	
Etot(B3LYP)	
G298(B3LYP)	
Etot(CCSD(T))	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/HF)	
H2O	
‐76.4089533	
‐76.405863	
‐76.2078377	 ‐76.3181017	 ‐76.3633998	 
H3O+	
‐76.6890842	
‐76.673565	
‐76.4874515	 ‐76.5888203	 ‐76.6360307	 
N
X Y
ArOH
	
Etot(B3LYP)	
G298(B3LYP)	
Etot(CCSD(T))	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/HF)	
X	=	H	(5‐12)	
1	
‐696.7047170	
‐696.485403	
‐694.6929141	 ‐695.3578394	 ‐695.8880547	 ‐0.0202388	
2	
‐696.7052976	
‐696.485561	
‐694.6942974	 ‐695.3589258	 ‐695.8890284	 ‐0.0196013	
3	
‐696.7053907	
‐696.485834	
‐694.6937394	 ‐695.3593569	 ‐695.8894093	 ‐0.0183583	
4	
‐696.7058900	
‐696.485973	
‐694.6950801	 ‐695.3603363	 ‐695.8902106	 ‐0.0173384	
5	
‐696.69181855	
‐696.471530	
‐694.6804747	 ‐695.3453579	 ‐695.8762566	 ‐0.0197925	
6	
‐696.6982159	
‐696.476783	
‐694.6872663	 ‐695.3502836	 ‐695.8810932	 ‐0.0182468	
7	
‐696.6965504	
‐696.476032	
‐694.6852116	 ‐695.3502359	 ‐695.8810534	 ‐0.0213383	
8	
‐696.6980953	
‐696.477606	
‐694.6871978	 ‐695.3524956	 ‐695.8831429	 ‐0.0171631	
9	
‐696.7059898	
‐696.483142	
‐694.6952591	 ‐695.3571829	 ‐695.8873961	 ‐0.0142309	
X,	Y	=	H	(5‐12H)	
1	
‐697.0973763	
‐696.860408	
‐695.0869582	 ‐695.7400695	 ‐696.2729667	 ‐0.0946281	
3	
‐697.0796011	
‐696.844746	
‐695.0684628	 ‐695.7244486	 ‐696.2578215	 ‐0.1102614	
4	
‐697.0904568	
‐696.856005	
‐695.0793122	 ‐695.7339445	 ‐696.2671066	 ‐0.1064845	
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Table	5.12	Total	and	Gibbs	ree	energies	at	various	levels	of	theory	for	the	calculation	of	pKa	values	in	
aqueous	media	in	Hartree	(SMD/HF	=	SMD/(U)HF/6‐31G(d)//(U)B3LYP/6‐31G(d)).	
N
X Y
ArOH
	
Etot(B3LYP)	
G298(B3LYP)	
Etot(CCSD(T))	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/HF)	
X	=	•	(5‐12R)	
1	
‐696.0521673	
‐695.847245	
‐694.0519473	 ‐694.6966258	 ‐695.2252238	 ‐0.0236172	
2	
‐696.0416065	
‐695.836191	
‐694.0411763	 ‐694.6850463	 ‐695.2144278	 ‐0.0244618	
3	
‐696.0510773	
‐695.843391	
‐694.0504012	 ‐694.6922163	 ‐695.2213836	 ‐0.0152348	
X	=	H,	Y	=	•	(5‐12R+)	
1	
‐696.4344588	
‐696.216665	
‐694.4248535	 ‐695.0609196	 ‐695.5939959	 ‐0.1049228	
2	
‐696.4364562	
‐696.217042	
‐694.4285135	 ‐695.0631977	 ‐695.5966076	 ‐0.0961102	
3	
‐696.4300297	
‐696.212552	
‐694.4151135	 ‐695.0518066	 ‐695.5860462	 ‐0.1088749	
4	
‐696.4312302	
‐696.213835	
‐694.4228363	 ‐695.0594352	 ‐695.5925036	 ‐0.1053690	
N
X Y 	
Etot(B3LYP)	
G298(B3LYP)	
Etot(CCSD(T))	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(SMD/HF)	
X	=	H	(5‐14)	
‐251.9043988	
‐251.776169	
‐251.0941830	 ‐251.3373000	 ‐251.5876572	 ‐0.0060397	
X,	Y	=	H	(5‐14H)	
‐252.2859532	
‐252.142928	
‐251.4765055	 ‐251.7102525	 ‐251.9636606	 ‐0.0996320	
X	=	•	(5‐14R)	
‐251.2503263	
‐251.136930	
‐250.4510442	 ‐250.6735352	 ‐250.9225045	 ‐0.0124142	
X	=	•,	Y	=	H	(5‐14R+)	
‐251.6243289	
‐251.498203	
‐250.8202743	 ‐251.0364096	 ‐251.2893059	 ‐0.0997117	
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Table	 5.13	 Total	 and	 Gibbs	 free	 energies	 at	 various	 levels	 of	 theory	 in	 Hartree	 (298.15	 K,	 1	 atm,	
CPCM/UB3LYP	=	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d)).	
N
H
ArOH
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot	(UB2LPYP)	 Etot	(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐12R+)	
1	
‐696.4344588	
‐696.216665	
‐695.0609196	 ‐695.861664	 ‐695.5939959	 ‐0.0977675	
2	
‐696.4364562	
‐696.217042	
‐695.0631977	 ‐695.8648262	 ‐695.5966076	 ‐0.0905166	
3	
‐696.4300297	
‐696.212552	
‐695.0518066	 ‐695.8553786	 ‐695.5860462	 ‐0.0934807	
4	
‐696.4312302	
‐696.213835	
‐695.0594352	 ‐695.8597707	 ‐695.5925036	 ‐0.0992336	
N→C2‡	
‐696.3529656	
‐696.1401680	
‐694.9973444	 ‐695.7885658	 ‐695.5220389	 ‐0.0994249	
N→C3‡	
‐696.3665174	
‐696.152968	
‐695.008717	 ‐695.8000126	 ‐695.5323474	 ‐0.0885406	
N→C4‡	
‐696.3946218	
‐696.179113	
‐695.0331669	 ‐695.8250143	 ‐695.5557395	 ‐0.0854808	
N→C7‡	
(chair)	
‐696.4035768	
‐696.186743	
‐695.0449624	 ‐695.8363187	 ‐695.5665728	 ‐0.0936720	
N→C7‡	
(boat)	
‐696.4003917	
‐696.184401	
‐695.2761532	 ‐695.8311545	 ‐695.5615451	 ‐0.0940066	
N
H2
ArOH
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot	(UB2LPYP)	 Etot	(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐20R)	
1	
‐696.4156447	
‐696.197155	
‐695.0585586	 ‐695.8511515	 ‐695.5862724	 ‐0.1059905	
2	
‐696.4247646	
‐696.204571	
‐695.0670447	 ‐695.8600108	 ‐695.5945270	 ‐0.0961899	
N
H2
ArOH
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot	(UB2LPYP)	 Etot	(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐19R)	
1	
‐696.4342693	
‐696.213753	
‐695.074138	 ‐695.8678203	 ‐695.6020398	 ‐0.0960783	
2	
‐696.4283820	
‐696.209893	
‐695.067528	 ‐695.8613575	 ‐695.5958137	 ‐0.1032495	
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Table	 5.14	 Total	 and	 Gibbs	 free	 energies	 at	 various	 levels	 of	 theory	 in	 Hartree	 (298.15	 K,	 1	 atm,	
CPCM/UB3LYP	=	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d)).	
N
H2
ArOH
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot	(UB2LPYP)	 Etot	(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐17R)	
1	
‐696.4562821	
‐696.234665	
‐695.0920655	 ‐695.8852521	 ‐695.6217839	 ‐0.0952974	
2	
‐696.4308613	
‐696.210506	
‐695.0668778	 ‐695.861375	 ‐695.6141778	 ‐0.1085084	
N
H2
ArOH
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot	(UB2LPYP)	 Etot	(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐18R)	
1	
‐696.4311173	
‐696.211875	
‐695.0729357	 ‐695.8659587	 ‐695.6003529	 ‐0.1065005	
2	
‐696.4362715	
‐696.214079	
‐695.0786122	 ‐695.8719957	 ‐695.6057780	 ‐0.0965564	
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Table	 5.15	 Total	 and	 Gibbs	 free	 energies	 at	 various	 levels	 of	 theory	 in	 Hartree	 (298.15	 K,	 1	 atm,	
CPCM/UB3LYP	=	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d)).	
N
ArOH
H
H2O 	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐12R+‐H2O)	
1	
‐772.8719350	
‐772.637845	
‐771.4064873	 ‐772.2675860	 ‐771.9833326	 ‐0.0861502	
2	
‐772.8709712	
‐772.630781	
‐771.4037671	 ‐772.2671892	 ‐771.980868	 ‐0.0843813	
N
H H
OH Ar
OH2
	
TS1	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
N→C2‡	
‐772.7921261	
‐772.561400	
‐771.3416131	 ‐772.1941070	 ‐771.9103794	 ‐0.0890346	
N→C3‡	
‐772.8020679	
‐772.571137	
‐771.3505172	 ‐772.2024973	 ‐771.9181955	 ‐0.0804929	
N→C4‡	
‐772.8266104	
‐772.594778	
‐771.3717919	 ‐772.2243403	 ‐771.9388298	 ‐0.0792021	
N
H H
OH Ar
H2O
	
TS2	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
N→C2‡	
‐772.7978756	
‐772.564034	
‐771.3480438	 ‐772.201239	 ‐771.9175147	 ‐0.0861502	
N→C3‡	
‐772.8102189	
‐772.572230	
‐771.3542959	 ‐772.2089998	 ‐771.924913	 ‐0.0861502	
N→C4‡	
‐772.8010445	
‐772.563160	
‐771.3486481	 ‐772.2020261	 ‐771.9198588	 ‐0.1105801	
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Table	 5.16	 Total	 and	 Gibbs	 free	 energies	 at	 various	 levels	 of	 theory	 in	 Hartree	 (298.15	 K,	 1	 atm,	
CPCM/UB3LYP	=	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d)).	
N
H
OH Ar
H
O H
H
	
TS3	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
N→C2‡	
‐772.7948956	
‐772.559756	
‐771.3402911	 ‐772.1952354	 ‐771.9098993	 ‐0.1181178	
N→C3‡	
‐772.8020962	
‐772.565853	
‐771.3298024	 ‐772.1951882	 ‐771.9015625	 ‐0.0802379	
N→C4‡	
‐772.8231060	
‐772.585846	
‐771.3625955	 ‐772.2202325	 ‐771.9268777	 ‐0.0821980	
N
ArOH
HH
H2O
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐20R‐H2O)	
1	
‐772.8556732	
‐772.620967	
‐771.4033039	 ‐772.2574901	 ‐771.9754045	 ‐0.0938154	
2	
‐772.8557696	
‐772.618741	
‐771.4037982	 ‐772.2580406	 ‐771.9759132	 ‐0.0922058	
N
ArOH
HH
H2O
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐19R‐H2O)	
1	
‐772.8709036	
‐772.634136	
‐771.4161773	 ‐772.2714117	 ‐771.9887242	 ‐0.0865326	
2	
‐772.8665353	
‐772.631041	
‐771.4109351	 ‐772.2662921	 ‐771.9835952	 ‐0.0925086	
3	
‐772.8761873	
‐772.634214	
‐771.4190663	 ‐772.2754790	 ‐771.9908176	 ‐0.0896083	
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Table	 5.17	 Total	 and	 Gibbs	 free	 energies	 at	 various	 levels	 of	 theory	 in	 Hartree	 (298.15	 K,	 1	 atm,	
CPCM/UB3LYP	=	C‐PCM/UAHF/UB3LYP/6‐31G(d)//UB3LYP/6‐31G(d)).	
N
ArOH
HH
H2O
	
Etot(UB3LYP)	
G298(UB3LYP)	
Etot(ROMP2)	 Etot(UB2LPYP)	 Etot(G3(MP2)‐RAD)	
Gsolv	
(CPCM/UB3LYP)	
(5‐17R‐H2O)	
1	
‐772.8926329	
‐772.654803	
‐771.4338376	 ‐772.2886123	 ‐772.0082323	 ‐0.0859271	
2	
‐772.8697636	
‐772.633118	
‐771.4108941	 ‐772.2667916	 ‐771.9851624	 ‐0.0974169	
3	
‐772.8697039	
‐772.630890	
‐771.4109150	 ‐772.2669858	 ‐771.9851492	 ‐0.0954568	
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Table	5.18	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
CH4	 ‐40.5183890	 ‐40.470240	 ‐40.4055437	 ‐40.4651605	
•CH3	 ‐39.8382922	 ‐39.804975	 ‐39.7316815	 ‐39.7851922	
H2O	 ‐76.4089533	 ‐76.384416	 ‐76.3181017	 ‐76.3633998	
•OH	 ‐75.7234547	 ‐75.712016	 ‐75.6176489	 ‐75.6628743	
N
H2
ArOH
(5‐12H)	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐697.0973763	 ‐696.806475	 ‐695.7400695	 ‐696.2729667	
3	 ‐697.0796011	 ‐696.789152	 ‐695.7244486	 ‐696.2578215	
4	 ‐697.0904568	 ‐696.800185	 ‐695.7339445	 ‐696.2671066	
N
H2
ArO
(5‐33R)	
Etot(UB3LYP)	 H298(UB3LYP)	 Etot(ROMP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐696.4264601	 ‐696.150172	 ‐695.0487338	 ‐695.5844400	
2	 ‐696.4162231	 ‐696.139959	 ‐695.0396277	 ‐695.5742936	
N
H2
ArOH
(5‐20R)	
Etot(UB3LYP)	 H298(UB3LYP)	 Etot(ROMP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐696.4156447	 ‐696.140255	 ‐695.0585586	 ‐695.5862724	
2	 ‐696.4247646	 ‐696.148674	 ‐695.0670447	 ‐695.5945270	
N
H2
ArOH
(5‐19R)	
Etot(UB3LYP)	 H298(UB3LYP)	 Etot(ROMP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐696.4342693	 ‐696.157174	 ‐695.074138	 ‐695.6020398	
2	 ‐696.4283820	 ‐696.152041	 ‐695.067528	 ‐695.5958137	
N
H2
ArOH
(5‐17R)	
Etot(UB3LYP)	 H298(UB3LYP)	 Etot(ROMP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐696.4562821	 ‐696.178740	 ‐695.0920655	 ‐695.6217839	
2	 ‐696.4308613	 ‐696.153677	 ‐695.0668778	 ‐695.6141778	
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Table	5.19	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
N
H2
ArOH
(5‐18R)	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
1	 ‐696.4311173	 ‐696.154748	 ‐695.0729357	 ‐695.6003529	
2	 ‐696.4362715	 ‐696.158990	 ‐695.0786122	 ‐695.6057780	
N
H2
Ar
(5‐28)	
‐620.6476626	 ‐620.387070	 ‐619.390153	 ‐619.8807985	
N
H2
Ar
(5‐28R)	
‐620.0119822	 ‐619.764330	 ‐618.7484839	 ‐619.2341610	
N
H
Ar
(5‐39)	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
9	 ‐620.6172567	 ‐620.360248	 ‐619.3556370	 ‐619.8496166	
6	 ‐620.6163369	 ‐620.359351	 ‐619.3553544	 ‐619.8493633	
3	 ‐620.6146982	 ‐620.357753	 ‐619.3484535	 ‐619.8431816	
8	 ‐620.6144354	 ‐620.357447	 ‐619.3518305	 ‐619.8462650	
7	 ‐620.6141452	 ‐620.356940	 ‐619.3493499	 ‐619.8437562	
17	 ‐620.6139230	 ‐620.356849	 ‐619.3484900	 ‐619.8430658	
1	 ‐620.6139336	 ‐620.356791	 ‐619.3484656	 ‐619.8430437	
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Table	5.20	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
N
H
Ar
(5‐39R)	
Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
3	 ‐619.9903176	 ‐619.746164	 ‐618.7197996	 ‐619.2082755	
9	 ‐619.9882919	 ‐619.744311	 ‐618.7192621	 ‐619.2076865	
10	 ‐619.9886573	 ‐619.744288	 ‐618.7169172	 ‐619.2057050	
18	 ‐619.9850393	 ‐619.740921	 ‐618.7094029	 ‐619.1992911	
5	 ‐619.9850445	 ‐619.740920	 ‐618.7092833	 ‐619.1991655	
4	 ‐619.9852604	 ‐619.741175	 ‐618.7091540	 ‐619.1990094	
6	 ‐619.9857357	 ‐619.741936	 ‐618.7188697	 ‐619.2059670	
2	 ‐619.9849875	 ‐619.740825	 ‐618.7095568	 ‐619.1995824	
N
H
Ar
(5‐30)	
‐620.6329420	 ‐620.371872	 ‐619.3772914	 ‐619.8651080	
N
H
Ar
(5‐30R)	
‐619.9909782	 ‐619.743305	 ‐618.7289607	 ‐619.2135363	
N
H
Ar
(5‐22)	
‐620.6679645	 ‐620.408967	 ‐619.4039932	 ‐619.8950718	
N
H
Ar
(5‐22R)	
‐619.9943128	 ‐619.749493	 ‐618.7304221	 ‐619.2160875	
N
H
Ar
(5‐24R)	
‐620.0400565	 ‐619.794308	 ‐618.7705607	 ‐619.2548263	
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Table	5.21	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	 Etot(B3LYP)	 H298(B3LYP)	 Etot(MP2)	 Etot(G3(MP2)‐RAD)	
N
H2
F
(5‐13)	
‐620.6740891	 ‐620.412081	 ‐619.4200626	 ‐619.9066648	
N
H2
F
(5‐13R)	
‐620.0370841	 ‐619.788444	 ‐618.7768548	 ‐619.2595265	
N
H
F
(5‐26)	
‐620.6257278	 ‐620.366155	 ‐619.3633574	 ‐619.8596808	
N
H
F
(5‐26R)	
‐619.9911960	 ‐619.745631	 ‐618.7290217	 ‐619.2174915	
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Table	5.22	Energies	and	enthalpies	for	closed‐	and	open‐shell	compounds	at	various	levels	of	theory	
in	the	gas	phase	in	Hartree	(298.15	K,	1	atm).	
	
N
H 	
(5‐46R+)	
N
H 	
(5‐46+)	
N
H 	
(5‐47R+)	
N
H 	
(5‐47+)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐172.9850104	
‐172.882792	
‐173.6389523	
‐173.523493	
‐212.3172722	
‐212.185736	
‐212.9553790	
‐212.810184	
G3(MP2)‐RAD	
‐172.7516328	
‐172.6494144	
‐173.4129251	
‐173.2974658	
‐212.0280626	
‐211.8965264	
‐212.6766973	
‐212.5315023	
	
N
H 	
(5‐48R+)	
N
H 	
(5‐48+)	
	
(5‐52R)	
	
(5‐52)	
Etot	
H298	
Etot	
H298	
Etot	
H298	
Etot	
H298	
B3LYP	
‐251.6434184	
‐251.482641	
‐252.2724055	
‐252.098081	
‐273.3286682	
‐273.162659	
‐273.9630016	
‐273.783331	
G3(MP2)‐RAD	
‐251.3021794	
‐251.1414020	
‐251.9430866	
‐251.7687621	
‐272.9565059	
‐272.7904967	
‐273.5994374	
‐273.4197668	
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6 Abbreviations	
(d)A	 (Desoxy)adenosine	(adenine)	 CCSD(T)	 Coupled‐cluster	 with	 single,	 double	
and	perturbative	triple	excitations	
(d)C	 (Desoxy)cytidine	(cytosine)	 Cp	 Heat	capazity	at	constant	pressure	
(d)G	 (Desoxy)guanosine	(guanine)	 C‐PCM	 Conductor‐like	PCM	
(d)T	 (Desoxy)thymidine	(thymine)	 CpG	 Cytosine‐phosphatidyl‐guanine	
(U)HF	 (Unrestricted)	Hartree‐Fock	 D	 Dihydrouridine	(dihydrouracil)	
3‐thioph	 3‐thienyl	  Chemical	shift	
Ac	 Acetyl	 DCE	 1,2‐dichlorethane	
AID	 Activation‐induced	deaminase	 DCM	 Dichloromethane	
AP	 Abasic	site	 DDQ	 2,3‐Dichloro‐5,6dicyano‐1,4‐
benzoquinone	
Ar	 Aryl	 fH0	 Heat	 of	 formation	 under	 standard	
conditions	
ATR	 Attenuated	total	reflectance	 DFT	 Density	functional	theory	
aug‐cc‐
pVXZ	
Dunning’s	 correlation	 consistent	 basis	 set	 (X	 =	
D(double),	 X	 =	T	 (triple)),	 augmented	 (aug)	with	
diffuse	functions	
G298	 Gibbs	free	energy	at	298	K	
B2PLYP‐
D	
Double‐hybrid	 density	 functional	 by	 Grimme	
including	dispersion	corrections	
Gsolv	 Free	solvation	energy	
B3LYP	 Hybrid	density	functional	including	Becke’s	three‐
parameter	 exchange	 functional	 and	 Lee‐Yang‐
Parr’s	correlation	functional	
hydH	 Heat	of	hydrogenation	
B98	 Becke’s	1998	hybrid	density	functional		 DIBAL	 Di‐isobutylaluminium	hydride	
BDE	 Bond	dissociation	energy	 DMAP	 4‐Dimethylaminopyridine	
BER	 Base	excision	repair	 DMF	 N,N‐Dimethylformamide	
BGVA	 Benson	increment	values	for	the	estimation	of	fH	 DMSO	 Dimethyl	sulfoxide	
Bn	 Benzyl	 rxnH	 Heat	of	reaction	
Boc	 tert‐Butoxycarbonyl	 subH	 Heat	of	sublimation	
Bu	 Butyl	 trhH	 Heat	of	transfer	hydrogenation	
Bz	 Benzoyl	 vapH	 Heat	of	vaporization	
C(ys)	 Cysteine	 E	 Glutamate	
ca5dC	 5‐Carboxyl	desoxycytosine	 EI	 Electron	impact	ionisation	
calc.	 Calculated	 ENDOR	 Electron	nuclear	double	resonance	
CBS	 Complete	basis	set	 EPR	 Electron	paramagnetic	resonance	
CBz	 Benzyloxycarbamate	 eq.	 equation	
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ESI	 Electron	spray	ionisation	 M	 Molar	
Et	 Ethyl	 m3U	 3‐Methyl	uridine	
EtOAc	 Ethyl	acetate	 m5dC	 5‐Methyl	desoxycytosine	
eV	 Electron	volt	 MCA	 Methyl	cation	affinity	
EXAFS	 Extended	X‐ray	absorption	fine	structure	 Me	 Methyl	
exp.	 Experimental	 min	 Minute	
f5dC	 5‐Formyl	desoxycytosine	 MM3	 Molecular	 mechanics	 developed	
by	Allinger	
FGE	 Formyl‐generating	enzyme	 MPn(FC)	 Nth	 order	 Møller‐Plesset	
perturbation	 theory	 with	 frozen	
core	approximation	
G3(MP2)‐
RAD	
Adaption	 of	 G3(MP2)	 theory	 on	 open‐shell	
species	
MPn(Full)	 Nth	 order	 Møller‐Plesset	
perturbation	 theory	 with	 inner	
core	electrons	included	
G3B3	 Gaussian	 3‐theory	 with	 geometries	 and	 zero‐
point	vibrational	energies	calculatedat	B3LYP/6‐
31G(d)	level	
mPW1K	 Modified	 Perdew‐Wang	 one	
parameter	 hybride	 density	
functional	for	kinetics	
G3large	 Extension	of	the	6‐311G(d,p)	basi	set	with	more	
flexible	 polarization	 functions	 (2df)	 and	
polarization	 of	 the	 core	 electrons	 (3d2f	 on	 Na‐
Ar)	
mRNA	 Messenger	RNA	
G3MP2large	 G3large	 basis	 set	 excluding	 core	 polarization	
functions	
MW	 Micro	wave	
GIAO	 Gauge	including	(invariant)	atomic	orbitals	  frequency	
h	 Hour	 N	 Asparagine	
hm5dC	 5‐Hydroxymethyl	desoxycytosine	  Wave	number	
HMBC	 Heteronuclear	multiple‐bond	correlation	 n/a	 Not	available	
HOMO	 Highest	occupied	molecular	orbital	 NADP	 Nicotineamide	 adenine	
dinucleotide	phosphate	
HRMS	 High	resolution	mass	spectrometry	 NMR	 Nuclear	magnetic	resonance	
HSQC	 Heteronuclear	single	quantum	correlation	 PCC	 Pyridinium	chlorochromate	
IEF‐PCM	 Integral	equation	formalism	variant	of	PCM	 PCM	 Polarizable	continuum	model	
IGLO	 Individual	gauge	for	localized	orbitals	 PE	 Petrol	ether	
IR	 Infrared	 Ph	 Phenyl	
k	 Rate	constant	 p	 Partial	pressure	
K	 Equilibrium	constant	 pKa	 Negative	 lg	 of	 acid	 dissociation	
constant	(Ka)	
LDA	 Lithium	diisopropylamide	 py	 Pyridine	
LiHMDS	 Lithium	hexamethyldisilazide	 PP	 Diphosphate	
m	 Mass	 Q	 Glutamine	
M	 Molar	mass	 QCISD(T)	 Quadratic	 configuration	
interaction	 with	 single,	 double	
and	 perturbative	 triple	
excitations	
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R	 Universal	 gas	 constant	
(8.3145	J	mol‐1	K‐1)	
TS	 Transition	state	
R	 Organic	rest	 UAHF	 United	atom	Hartree‐Fock	
refl.	 reflux	 UAKS	 United	atom	Kohn‐Sham	
RMSE	 Root	mean	square	deviation	 Um	 2’‐Methoxy	uridine	
RNR	 Ribonucleotide	Reductase	 UV	 Ultraviolet	
RO	 Restricted	open‐shell	 V	 Volume	
RP‐
18	
Reverse	 phase	 silica	 chain	
length	18	
w	 Boltzmann	factor	
rRNA	 Ribosomal	RNA	 Wn	 Weizmann	n‐theory	
RSE	 Radical	stabilization	energy	 X‐YZ+G(ndf,mpd)	 Valence‐double‐	 basis	 set	 by	 Pople	 et	 al.	
Supplemented	 by	 polarization	 (df,pd)	 and	 diffuse	
(+	or	++)	functions,	e.g.	6‐31+G(2d,p)	
RT	 Room	temperature	 X‐YZW+G(ndf,mpd)	 Valence‐triple‐	 basis	 set	 by	 Pople	 et	 al.	
Supplemented	 by	 polarization	 (df,pd)	 and	 diffuse	
(+	or	++)	functions,	e.g.	6‐311++G(3df,2p)	
 Shielding	tensor	 Y	 Tyrosine	
S(er)	 Serine	 Ψ	 Pseudouridine	
SMD	 Solvent	model	density	 	 	
sol	 In	solution	 	 	
SOMO	 Semi‐occupied	 molecular	
orbitals	
	 	
SSRI	 Selective	 serotonine	
reuptake	inhibitor	
	 	
T	 Temperature	 	 	
T(hr)	 Threonine	 	 	
TBAI	 Tetrabutylammonium	
iodide	
	 	
Tc	 Coalescence	temperature	 	 	
TDG	 Thymine	DNA	glycolase	 	 	
TET	 Ten‐eleven	translocation	 	 	
TFA	 Trifluoracetic	acid	 	 	
THF	 Tetrahydrofuran	 	 	
TLC	 Thin	layer	chromatography	 	 	
TMP	 2,2,6,6‐
Tetramethylpiperidine	
	 	
TMS	 Trimethylsilyl	 	 	
tRNA	 Transfer	RNA	 	 	
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